Editorial Panel

Editors

Mohamed Azmi Bin Ahmad Hassali, PhD

Professor Discipline of Social and Administrative Pharmacy School of Pharmaceutical Sciences Universiti Sains Malaysia, Minden 11800 Penang, Malaysia
1. Social Pharmacy
2. Pharmacy Practice
3. Public Health Pharmacy
Member in Professional/ Academic Associations
Member
1. 1999- Present: Registered Pharmacist with the Malaysian Pharmacy
Board.
2. 2009-Present: Council Member of Malaysian Pharmaceutical Society.
3. 1998-2002: Member of Malaysian Diabetes Society.
4. 2002-Present: Member of Malaysian Cancer Society.
5. 2002-2006: Member of Australasian Pharmaceutical Science
Association.
6. 2008-Present: Life Member for Penang Hospice Society.
7. 2008- Present: Member of International WHO’s WHO Historical Society.
8. 2008-Present: Member of International Society for
Pharmacoepidemiology.
9. 2008-Present: Member of International Society forPharmacovigilance.
10. 2009-Present: Member of International Pharmaceutical Federation (FIP).
11. 2009-Present: Member of The International Society of Pharmacoeconomics and Outcomes Research.
12. 2012-Present: Member of Young Scientist Network of The Academy of Sciences Malaysia.
13. 2013-2014: Member of International Sociey of Pharmacoeconomics and Outcome Research (ISPOR).
Committee Member (Conference/Seminar/Workshop)
International
1. Post: International Scientific Committee Member
Year: 2012
Event: International Conference on Statistics in Science, Business and Engineering 2012 (ICSSBE2012)
2. Post: Advisor to Committee
Year: 2013
Event: 2nd Annual HTAsiaLink Conference
3. Post: Committee Member (Department of Scientific/Abstract)
Year: 2016
Event: International Conference on Pharmacy Education & Practice 2016
National
1. Post: Scientific Committee Member
Year: 2001
Event: 1st Malaysian Pharmacy Scientific Conference
Organiser & Venue: University of Malaya and Malaysian Pharmaceutical Society , Selangor, Malaysia
2. Post: Organising Committee Member
Year: 2007
Event: Seminar entitled “Equitable access to medicines for Malaysian: A way forward through a medicine pricing policy”
Organiser & Venue: School Of Pharmaceutical Sciences, USM and USM’s Women’s Development Research Centre, Penang, Malaysia
3. Post: Organising Committee Member
Year: 2007
Event: Workshop entitled “National Pharmacognosy Curriculum”
Organiser & Venue: School Of Pharmaceutical Sciences, USM and Malaysian Pharmaceutical Society.
4. Post: Organising Committee Member
Year: 2009
Event:Kuala Lumpur Pharmaceutical Services Department Research Methodology Course
Organiser & Venue: Kuala Lumpur Pharmaceutical Services Department
5. Post: Workshop Coordinator
Year: 2009
Event: Negeri Sembilan Health Department Basic Research Methodology Workshop
Organiser & Venue: Negeri Sembilan Health Department, Sepang, Selangor
6. Post: Workshop Coordinator
Year: 2008
Event: Wilayah Persekutuan Health Department Basic Research Methodology Workshop
Organiser & Venue: Wilayah Persekutuan Health Department, Kuala Lumpur
7. Post: Workshop Coordinator
Year: 2006
Event: Research Methodology and Report Writing
Organiser & Venue: 4th National Pharmacy R&D Conference, Melaka, Malaysia
8. Post: Workshop Coordinator
Year: 2007
Event: Research Methodology-Intermediate Level
Organiser & Venue: Ministry of Health, Pharmaceutical Services Department, Penang, Malaysia
9. Post: Workshop Coordinator
Year: 2007
Event: Home Medication Review
Organiser & Venue: Negeri Sembilan State Health Department)
10. Post: Seminar Coordinator
Year: 2009
Event: Pharmacoepidemiology and Pharmacovigilance for Pharmacists
Organiser & Venue: Malaysian Pharmaceutical Society (Penang Area Committee) and Discipline of Social and Administrative Pharmacy, USM Penang, Malaysia
11. Post: Workshop Coordinator
Year: 2009
Event: Introduction to Research Methods’ as part of Discipline of Social and Administrative Pharmacy Short Course Series with USAINS Holding
Venue: USM Penang, Malaysia
12. Post: Workshop Coordinator
Year: 2009
Event: Step-by-step to Data Analysis Using SPSS’ as part of Discipline of Social and Administrative Pharmacy Short Course Series with USAINS Holding
Venue: USM Penang, Malaysia
13. Post: Committee Member
Year: 2010
Association: Malaysian Health Promotion Board
14. Post: Chairperson
Year: 2011
Event: 1st Conference of MPharm (Clinical Pharmacy) 2011
15. Post: Committee Member
Year: 2011
Event: 1st Conference of MPharm (Clinical Pharmacy) 2011
16. Post: Member of Scientific Committee
Year: 2011
Event: MPS – Pharmacy Scientific Conference 2011
17. Post: Committee Member
Year: 2013
Event: 1st National Quality Use of Medicines (QUM) Conference
4.0 CONSULTANCY
Consultation With Monetary Rewards
1. Teaching and co-ordinating pharmacy students at Kolej Teknologi Pulau, Penang until 2010 for the following subjects:
a. Public Health Pharmacy (Course Code:FAR152)
b. Statistics for Pharmacy (Course Code: FAR 151)
2. Project Title: A National Survey on the use of medications by Malaysian consumers (A collaborative project between Malaysian Pharmaceutical Services Division, Ministry of Health (MOH) and USM). Sponsor: Ministry of Health.Duration: October 2007 till October 2009 (2 years).
3. Appointed as consultant (Project Leader) for National Survey on the Use of Medications by Malaysian Consumer 2012 by Pharmaceutical Services Division, MOH Malaysia
4. Organized Workshop on ‘Introduction to Research Methods’ as part of Discipline of Social and Administrative Pharmacy Short Course Series with USAINS Holding, 16-18th June 2009, USM, Malaysia
5. Organized a full workshop on ‘Step-by-step to Data Analysis Using SPSS’ as part of Discipline of Social and Administrative Pharmacy Short Course Series with USAINS Holding, 27-28th October 2009, USM, Malaysia
Consultation Without Monetary Rewards
4. Consultation with CCM (A local generic pharmaceutical company) in developing patient education material on generic medicines
5. Appointed as Member of Advisory Board of Medicine Price Review 2011/2012 by Pharmaceutical Services Division, MOH Malaysia
6. Appointed as advisor to the research entitled ‘Perceptions of primary health care physicians and pharmacists on medication errors’ by Pharmaceutical Services Division, Kuala Lumpur & Federal Territory Health Department on 2011
5.0 SERVICE TO THE UNIVERSITY AND COMMUNITY
University Administration
1. Acting Chairperson of Discipline of Social & Administrative Pharmacy (3 Apr 2008 – 31 Dec 2009)
2. Chairperson of Discipline of Social & Administrative Pharmacy (1 Jan 2010 – 31 Dec 2012)
3. Chairperson of Postgraduate (Master) Thesis Examiner Council (27 June 2011 – present)
4. Deputy Dean of Student Development, Industry & Community Network (1 Jan 2013 – present).
University Committee
1. Member of Human Research Ethics Committee (2009 – 2011)
2. Interviewer Panel for Mock Interview by Student Affairs & Development Division USM
3. Chief Invigilator for Examinations FAR192 & FAR191 1st Semester 2012/2013 Academic Session
4. Member, Universiti Community Engagement Cluster (April 2013 to December 2015).
5. Committee member for proposing establishment of School of Lifestyle Sciences, April 2014.
6. Interviewer Panel for Bachelor in Pharmacy (Hons) Programme Universiti Sains Malaysia, Academic Sessions of 2014/2015.
School Committee
1. School of Pharmacy Steering Committee For Student’s Thesis Publication
2. Member of School’s Examination Committee
3. Member of School’s KPI Committee
4. Member of School’s Postgraduate Committee
5. Member of Joint Ethics Committee of School of Pharmaceutical Sciences, USM and Hospital Lam Wah Ee on Clinical Studies (2007 – present)
6. Advisor, Pharmacy Student Society of USM (2010 – present)
7. Member of Kedai Farmasi, Pusat Sejahtera Administration Committee (2010)
8. Member of School’s Curriculum Review Committee (2010)
9. Member of School’s Annual Report Committee (2010)
10. Employer Representative for School’s JKKP Committee (2011)
11. Coordinator for School’s JKKP Committee (2012)
12. Member of School’s Technical Report Evaluation Committee (2012)
13. Council Member of School of Pharmaceutical Sciences USM (2006 - present)
14. Committee Member of Higher Degree School of Pharmaceutical Sciences ( Jan 2014-present)
National Membership/ Committee
National
1. Advisor of Malaysian Pharmacy Students’ Association (MyPSA) (2010 – present)
State
1. Involvement as consultant pharmacist in the Penang Health Fair Health Talk. 10th May, 2009, Penang.(Organized by Malaysian Pharmaceutical Society (Penang Area))
2. Panellist of Program Wacana Intelektual Melayu Muda organised by Persatuan Bina Ilmu Pulau Pinang, 11 June 2011 at Kompleks Masyarakat Penyayang Pulau Pinang
3. Volunteer of Community Wellness Program organised by Yayasan Bina Ilmu Pulau Pinang, 30th Sept 2012 in Batu Lanchang, Penang
4. Participant of UNFPA Project MYSOR 2009 organised by Penang FHDA, July – December 2012 in Penang
5. Volunteer for Community Wellness Programme organised by Yayasan Bina Ilmu Pulau Pinang, 8th Apr 2012 at Georgetown, Penang
6. Volunteer for Community Wellness Programme organised by Komuniti 1Malaysia Jalan Makloom Pulau Pinang, 6th June 2012 at Jalan Makloom 1Malaysia Community Hall, Pulau Pinang
7. Contributor to the Endline Assessment Analysis Report under VOICES Project organised by Penang Family Health Development Association (FHDA)
District / Village / Institution
Each activity will be awarded 1 mark (Example:PIBG,JKKK,RELA)
1. Appointed Deputy President of Persatuan Bina Ilmu Pulau Pinang (2011)
2. Appointed Member of Board of Trustees, Penang Bina Ilmu Foundation (2012)
3. Appointed Health Advisor Penang Bina Ilmu Foundation (2013)
4. Appointed Health Advisor Komuniti 1Malaysia Jalan Makloom (2013)
Research Book/Monograph
1. Hassali MA. Quality Use of Generic Medicines: What The Healthcare Practitioners and Consumer Should Know. Saarbrucken, Germany; 2010; ISBN: 978-3-8383-8362-0.
2. Hassali MA, Shafie A, Sulaiman SAS, Al-Haddad MSdM, Thambyappa J, Masood I, et al. Education on Antibiotic Resistance in Medical and Pharmacy Schools: Findings from curriculum Survey in Selected Southeast Asian Universities. Penang, Malaysia: Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia; 2011. ISBN: 978-967-394-065-3.
3. Bahri S, Othman NH, Hassali MA, Shafie AA, Ibrahim MI, et al. 2008: A National Survey On The Use Of Medicines (NSUM) By Malaysian Consumers. Selangor, Malaysia: Pharmaceutical Services Department, Ministry Of Health Malaysia; 2008. ISBN: 978-967-5570-01-8
4. Hassali MA, Ooi GS, Shafie AA, Alrasheedy AA, Yann RU. Assessment of Malaysian Community Pharmacists’ involvement in extended pharmacy services. School of Pharmaceutical Sciences, USM. ISBN: 978-967-11964-7-2
5. Hassali MA, Shafie AA, Saleem F. National Survey Exploring Consumer Satisfaction And Perception Towards Medicines Dispensing Services. Pharmaceutical Services Division, Ministry of Helath, Malaysia. ISBN: 978-967-5570-62-9
6. Hassali MA, Saleem F. A National Survey on the Use of Medicines III (NSUM III) By Malaysian Consumers 2015. Pharmaceutical Services Division, Ministry of Health Malaysia.
7. Hassali MA et al. Understanding Antibiotic Resistance: A Quick Guide for Healthcare Professionals 2016. School of Pharmaceutical Sciences, Universiti Sains Malaysia. ISBN 978-967-13914-3-3
8. Hassali MA, Thambyappa J, Shafie AA. What You Should Know About Generic Medicines. Penang, Malaysia: Penerbit Universiti Sains Malaysia; 2012. ISBN: 978-983-861-543-3.
9. Hassali MA, Thambyappa J, Hay YK, Chua GN, Saleem F, Shafie AA. Understanding Generic Medicines: What Healthcare Professional Should Know. Malaysia: Kotra Pharma; 2012.
10. Masood I, Ibrahim MIM, Hassali MA, Shafie AA. Doctors and Pharmaceutical Industry: Insight from Malaysia Scenario. Penang, Malaysia: Penerbit Universiti Sains Malaysia; 2012. ISBN: 978-983-861-564-8.
11. Shafie AA, Yun KX, Hassali MA. Economic Evaluation of Dispensing Separation Policy in Malaysia: A Decision Analysis Approach. Penang, Malaysia: Penerbit Universiti Sains Malaysia; 2013. ISBN: 978-983-861-605-
12. Bahri BS, Hassali MA, Thambyappa T, Onn TPJ, Abidin ZM, Mustapa D, Chua GN. What prescribers should know about generic medicines? Pharmaceutical Services Division, Ministry of Health Malaysia; ISBN: 978-9675570-37-7, 2013
13. Yen SL, Izham MIM, Hassali MA, Shafie AA, Othman TA, Mohamed NH, Hamdi AM. Road to a Healthy Heart. Universiti Sains Malaysia; ISBN: 978-983-44596-0-4, 2009.
14. Alshakka AM, Izham MIM, Palain S, Hassali MA. Importance of consumer reporting of adverse drug reactions in Malaysia. Discipline of Social & Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-394019-6, 2010.
15. Hassali MA, Ooi GS, Shafie AA, Alrasheedy AA, Ho RY. Assessment of Malaysian Community Pharmacists’ Involvement in Extended Pharmacy Services. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-11964-7-2, 2014.
16. Sariff A, Hassali MA, Nordin N. Introduction to ‘STARZ-DRP’: A Step-by-step Approach for Triaging Decision in Community Pharmacy. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13162-2-1, 2015.
17. Hamzah AA, Hassali MA. Gejala Mati Pucuk (Disfungsi Erektil): Usah Gentar Menghadapinya!. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13914-1-9, 2017.
18. Hamzah AA, Hassali MA. Batu Karang Urinari: Usah Gentar Menghadapinya!. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13914-2-6. 2017.
19. Hassali MA, Thambyappa J, Hamzah AA, Ho RY, Hussain R, Verma AK. What You Should Know About Parkinson’s Disease. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13914-6-4, 2017.
Chapters In International Books
1. Williams, H Lofgren, et. al. The New Political Economy of Drugs. Hampshire, England: Palgrave Macmillan; 2013. ISBN: 978-023-028463-0
Chapter: Hassali MA, Thambyappa J, Shafie AA, Nambiar S, et al. TRIPS, Free Trade Agreements and Pharmaceutical Industries in Malaysia
2. Hassali MA et al. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia. In: The New Political Economy of Pharmaceuticals Production, Innovation and TRIPS in the Global South. Edited by Hans Lofgren and Owain David Williams; Palgrave Macmillan; 2013 (ISBN: 978-0-230-28463-0)
3. Hassan BA, Yusoff Z, Hassali MA, Othman S. Supportive and Palliative Care In Solid Cancer Patients.In: Cancer Treatment-Conventional and InnovativeApproaches. Edited by : Leticia Rangel; Intech Publications; 2013 (ISBN:978-953-571-1098-9)
4. Babar ZUD. Pharmaceutical prices in the 21st century.Springer Cham Heidelberg, New York. 2014 ISBN: 978-3-319-12168-0
Chapter: Hassali et al. Pharmaceutical Pricing in Malaysia
5. Fathelrahman AL, Ibrahim MIM, Wertheimer A. Pharmacy practice in developing countries: Elsevier; 2016. ISBN: 978-0-12-801714-2
Chapter: Hassali et al. Pharmacy practice in Malaysia
6. G. Arora et al. (eds.). Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Springer International Publishing AG; 2017. ISBN: 978-3-319-48683-3. DOl: 10.1007/978-3-319-48683-3
Chapter: Godman B, Fadare J, Kibuule D, Irawati L, Mubita M, Oguuleye O, Oluka M, Paramadhas BDA, Costa JDO, Lemos LLP, Junior AAG, Alrasheedy AA, Hassali MA, Saleem F, Huoog T, Truter I. Initiatives across Countries to Reduce Antibiotic Utilisation and Resistance Patterns: Impact and Implications.
7. Babar ZUD. Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International Publishing AG; 2017. ISBN: 978-3-319-51673-8. DOI: 10.1007/978-3-319-51673-8
Chapter: Alrasheedy AA, Hassali MA, Wong ZY, Aljadhey H, AL-Tamimi SK, Saleem F. Pharmaceutical Policy in Saudi Arabia. 329-347 pp.
Present Challenges and Future Solutions, in Ibrahim, M., Wertheimer, A., and Babar, Z., eds.,
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries:
United Kingdom, Elsevier; ISBN: 978-0-12-811228-1
Chapter: Hassali MA, Wong ZY, Overcoming Challenges of Generic Medicines Utilization in Low- and Middle-Income Countries: Lessons Learned From International Experiences. pp 197-210.
Books Related To Teaching (CAI/Multimedia/Material/Course Ware)
1. Hassali MA, Sattar MZA, Shafie AA, Saleem F, Ho RY, Jaki MS. Empowering Community In Quality Use of Medicines: Initiatives from Smart Partnership Programmes Between Local Communities and Universiti Sains Malaysia. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-11964-5-B, 2013.
CPD Module for Professionals
1. Hassali MA, Thambyappa J, Yuen KH, Chua GN, Saleem F, Shafie AA. Understanding Generic Medicines: What Healthcare Professionals Should Know. School of Pharmaceutical Sciences, Universiti Sains Malaysia.
2. Hassali MA, Irawati L, Hamzah AA, Ho RY, Saleem F, Shafie AA, Lim CJ. Understanding Antibiotic Resistance: A Quick Guide for Healthcare Professionals. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13914-3-3, 2016.
Books for Community
1. Hassali MA, Thambyappa J, Shafie AA. Apakah yang Anda perlu Tahu tentang Ubat Generik. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-983-86154-2-6, 2012.
2. Hassali MA, Thambyappa J, Shafie AA. What You Should Know About Generic Medicines. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-983-86154-3-3, 2012.
3. Hassaii MA, Thambyappa, Shafie AA, Massod I, Chua GN, Saleem F, Jaki MS, Mustapa MD, Rusli RA. What You Should Know About Antibiotics. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN:978-983-44596-9-7, 2012.
4. Hassali MA, Thambyappa, Chua GN, Saleem F, Shafie AA, Jaki MS. Memperkasakan Kesihatan Golongan Berpendapatan Rendah dan Sederhana di Pulau Pinang, Malaysia. Laporan Pendekatan Perkongsian Bijak di antara Universiti dan Masyarakat. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-983-44596-7-3, 2013.
5. Hassali MA, Ho RY. Infografik: Apakah yang Anda perlu Tahu tentang Penyakit Diabetes dan Hipertensi. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13162-1-4, 2014
6. Hassali MA, Ho RY, Wong ZY, Romaisa LSW. Kenali Ubat Generik. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13162-4-5, 2015.
7. Hassali MA, Ho RY, Wong ZY, Romaisa LSW. Understanding Generic Medicines. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13162-3-8, 2015.
8. Irawati L, Hassali MA, Saleem F, Alrasheedy AA. Get Smart about Antibiotics. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13162-8-3, 2015.
9. Irawati L, Hassali MA, Saleem F, Alrasheedy AA. Bijak Antibiotik. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13162-7-6, 2015.
10. Hassali MA, Saleem F, Ho RY, Irawati L. Apakah yang Anda perlu Tahu tentang Penggunaan Ubat secara Berkualiti? School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13162-6-9, 2015.
11. Hassali MA, Shafie AA, Ibrahim B, Saleem F, Lim CJ, Ho RY, Jaki MS. Penjagaan Diri bagi Pesakit Hipertensi. School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-11964-9-6, 2015.
12. Hamzah AA, Hassali MA. Batu Karang Urinari: Usah Gentar Menghadapinya! School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13914-2-6, 2016.
13. Hassali MA, Thambyappa J, Hamzah AA, Ho RY, Hussain R, Verma AK. What You Should Know Aboutparkinson’s Disease, School of Pharmaceutical Sciences, Universiti Sains Malaysia; ISBN: 978-967-13914-6-4
Journal/E-Journal/Journal Proceeding
1. Hassali MA, Kong DC, Stewart K. Utilisation of generic medicines in the Australian healthcare system. Journal of Generic Medicines. 2004; 2(1):42-52. (Indexed in PubMed)
2. Hassali MA, Stewart K, Kong D. Quality use of generic medicines. Australian Prescriber. 2004; 27:80-1. (IF: 0.831)
3. Hassali MA, Ibrahim MIM, Sulaiman SAS, Ahmad Z, Hasali JBA. A clinical and economic study of community-acquired pneumonia between single versus combination therapy. Pharmacy World & Science. 2005; 27(3):249-53. (IF: 1.265)
4. Hassali MA, Kong D, Stewart K. Generic medicines: perceptions of community pharmacists in Melbourne, Australia. Journal of Pharmaceutical Finance Economics and Policy. 2005; 14(3):27. (Indexed in PubMed)
5. Hassali MA, Kong D, Stewart K. Generic medicines: perceptions of consumers in Melbourne, Australia. International Journal of Pharmacy Practice. 2005; 13(4):257-64. (Indexed in PubMed)
6. Hassali MA, Kong DC, Stewart K. Generic medicines: perceptions of general practitioners in Melbourne, Australia. Journal of Generic Medicines. 2006; 3(3):214-25. (Indexed in PubMed)
7. Hassali MA, Kong D, Stewart K. A comparison between senior medical students' and pharmacy pre‐registrants' knowledge and perceptions of generic medicines. Medical Education. 2007; 41(7):703-10. (IF: 3.546)
8. Hassali MA, Kong D, Stewart K. Knowledge and perceptions of recent pharmacy graduates about generic medicines. Pharmacy Education. 2007; 7(1):89-95. (Indexed in PubMed)
9. Hassali MA. Quality use of generic medicines in Malaysia. Journal of Pharmacy Practice and Research. 2007;37(4):334. (Indexed in PubMed)
10. Ahmed SI, Hassali MA. The controversy of PharmD degree. American Journal of Pharmaceutical Education. 2008;72(3). (IF: 1.85)
11. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharmacy Practice. 2008;6(2):93-7. (Indexed in PubMed)
12. Al-Gedadi NA, Hassali MA. Pharmacists' views on generic medicines: a review of the literature. Journal of Generic Medicines. 2008;5(3):209-18. (Indexed in PubMed)
13. Hassali MA, Stewart K, Kong D. A national survey on knowledge and perceptions of senior medical students in Australia about generic medicines. The Medical Journal of Australia. 2008;188(2):123. (Indexed in PubMed)
14. Ping CC, Bahari MB, Hassali MA. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia. Pharmacoepidemiology and Drug Safety. 2008;17(1):82-9. (IF: 2.897)
15. Shafie AA, Hassali MA. Price comparison between innovator and generic medicines sold by community pharmacies in the state of Penang, Malaysia. Journal of Generic Medicines. 2008;6(1):35-42. (Indexed in PubMed)
16. Hassali MA, Palaian S, Shafie AA, Elkalmi RM, Shrestha R. Medicine Safety Seminar for Malaysian Community Pharmacists. Journal of Pharmacy Practice and Research. 2009;60:653-8. (Indexed in PubMed)
17. Ahmed SI, Hassali MA, Aziz NA. An assessment of the knowledge, attitudes, and risk perceptions of pharmacy students regarding HIV/AIDS. American Journal of Pharmaceutical Education. 2009;73(1):15. (IF: 1.85)
18. Azhar S, Hassali MA, Ibrahim MI, Ahmad M, Masood I, Shafie AA. The role of pharmacists in developing countries: the current scenario in Pakistan. Human Resource for Health 2009;13(7):54. (IF: 2.05)
19. Hassali MA, Shafie A, Jayabalan T, Subish P. Medicine dispensing in Malaysia: a case for separation of roles. Indian Journal of Pharmacy Practice. 2009;2:84-5. (Indexed in PubMed)
20. Hassali MA, Subish P, Shafie A, Ibrahim M. Perceptions and barriers towards provision of health promotion activities among community pharmacists in the State of Penang, Malaysia. Journal of Clinical and Diagnostic Research. 2009;3:1562-8. (Indexed in PubMed)
21. Hassali MA, Awaisu A, Shafie AA, Saeed MS. Professional Training and Roles of Community Pharmacists In Malaysia: Views From General Medical Practitioners. Malaysian Family Physician. 2009;4(2&3). (Indexed in PubMed)
22. Hassali MA, Khan T, Shafie A. Motivational factors to pharmacy as a career: Findings of a preliminary survey conducted among pharmacy undergraduate students. Techniques Technologies Education Management. 2009;4(1):21-5. (Indexed in PubMed)
23. Hassali MA, Khan TM, Shafie AA, Nazir M. Public knowledge about herbal beverages in Penang, Malaysia. Australasian Medical Journal. 2009;2(6):1-11. (Indexed in PubMed)
24. Hassali MA, Shafie A, Palaian S, Awaisu A. Public opinion on dispensing doctors in Malaysia. Journal of Clinical and Diagnostic Research. 2009;2(2):1776-8. (Indexed in PubMed)
25. Hassali MA, Shafie AA, Awaisu A, Ibrahim MIM, Ahmed SI. A public health pharmacy course at a Malaysian pharmacy school. American Journal of Pharmaceutical Education. 2009;73(7). (IF: 1.85)
26. Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers' views on generic medicines: a review of the literature. International Journal of Pharmacy Practice. 2009;17(2):79-88. (Indexed in PubMed)
27. Hassali MA, Shafie AA, Khalid Y, Hari R. Assessment of knowledge and perception of erectile dysfunction among diabetic and non-diabetic patients university health center in Malaysia. Asian Journal of Pharmaceutical and Clinical Research 2009; 2(3):60-65. (Indexed in PubMed)
28. Hassali MA, Shafie AA. Status of generic medicine use in Malaysia. Journal of Pharmacy Practice and Research 2009; 39(4):329. (Indexed in PubMed)
29. Hassali MA, Yuen KH, Ibrahim MIM, Wong JW, Ng BH, San Ho DS. Malaysian pharmaceutical industry: Opportunities and challenges. Journal of Generic Medicines. 2009;6(3):246-52. (Indexed in PubMed)
30. Hassali MA. Quality use of generic medicines in developing countries: a way forward. The Journal of Medicine Use in Developing Countries 2009; 1(2):1-2.
31. Jamshed S, Babar Z, Ibrahim M, Hassali M. Generic medicines as a way to improve access and affordability: a proposed framework for Pakistan. Journal of Clinical and Diagnostic Research. 2009;3(3):1596-600. (Indexed in PubMed)
32. Khan T, Hassali MA, Gillani S, Hameed M. Clinical presentation of “Rove Beetle Dermatitis”. Australasian Medical Journal 2009;1(7): 19-24. (Indexed in PubMed)
33. Khan TM, Sulaiman SAS, Hassali MA. Risk Factors For Depression; Findings Of A Descriptive Study Conducted In Penang, Malaysia. Journal of Clinical and Diagnostic Research. 2009;3:1859-66. (Indexed in PubMed)
34. Khan TM, Sulaiman SA, Hassali MA, Tahir H. Attitude toward depression, its complications, prevention and barriers to seeking help among ethnic groups in Penang, Malaysia. Mental Health in Family Medicine. 2009;6(4):219. (Indexed in PubMed)
35. Khan TM, Sulaiman SA, Hassali MA. Incidence of Depression and Its Demographic Correlates: Outcome of Descriptive Study at the Psychiatry OPD Penang, Malaysia. HealthMed Journal 2009; 3(3):204-211. (IF: 0.435)
36. Khan TM, Sulaiman SAS, Hassali MA. Evaluation Of Cost And Daily Drug Dose Of Fluoxetine And Sertraline In General Hospital Pulau Penang Malaysia. Asian Journal of Pharmaceutical and Clinical Research. 2009;2(1):77-80. (Indexed in PubMed)
37. Khan TM, Syed AS, Hassali MA. The Causes of Depression? A Survey among Malaysians about perception for causes of depression. Asian Journal of Pharmaceutical and Clinical Practices 2009: l2(2):6-9. (Indexed in PubMed)
38. Masood I, Ibrahim M, Hassali MA, Ahmed M. Evolution of marketing techniques, adoption in pharmaceutical industry and related issues: a review. Journal of Clinical and Diagnostic Research. 2009;3:1942-52. (Indexed in PubMed)
39. Neoh CF, Hassali MA, Shafie AA, Awaisu A, Tambyappa J. Compliance towards dispensed medication labelling standards: a cross-sectional study in the state of Penang, Malaysia. Current Drug Safety. 2009;4(3):199.203. (Indexed in PubMed)
40. Palain S, Hassali MA, Shankar PR. Introducing the concept of disease mongerng to social pharmacy students in Malaysia. Journal of Pharmacy Practice and Research. 2009;39(1):79-80. (Indexed in PubMed)
41. Rizal HR, Bahari MB, Hassali MA, Eni AR, Hishamshah MI. Outcomes of anti-microbial therapy for febrile neutropenia among children with cancer in a Malaysian tertiary centre: A retrospective study. Malaysian Journal of Pharmacy. 2009;1(2):284-9. (Indexed in PubMed)
42. Sharrad AK, Hassali MA, Shafie AA. Generic medicines: Perceptions of Pharmacists in Basrah, Iraq. Australasian Medical Journal. 2009;1(8):58-64. (Indexed in PubMed)
43. Yahaya AH, Hassali MA, Awaisu A, Shafie AA. Factors Associated with Warfarin Therapy Knowledge and Anticoagulation Control among Patients Attending a Warfarin Clinic in Malaysia. Journal of Clinical and Diagnostic Research. 2009;3(4):1663–1670. (Indexed in PubMed)
44. Abougalambou SSI, Mohamed M, Sulaiman SAS, Abougalambou AS, Hassali MA. Current clinical status and complications among type 2 diabetic patients in Universiti Sains Malaysia hospital. International Journal of Diabetes Mellitus. 2010;2(3):184-8. (Indexed in PubMed)
45. Ahmed SI, Hasan SS, Hassali MA. Clinical pharmacy and pharmaceutical care: a need to homogenize the concepts. American Journal of Pharmaceutical Eeducation. 2010;74(10):193g. (IF: 1.85)
46. Alabid AH, Ibrahim MIM, Hassali MA. Malaysian community pharmacists’ professional practices and services. Journal of Pharmacy Practice and Research 2010;40(2):165. (Indexed in PubMed)
47. Al-Haddad M, Hassali MA. Challenges To Pharmacy Students Training in Community Pharmacies. Archives of Pharmacy Practice. 2010 1(1):3-4. (Indexed in PubMed)
48. Al-Haddad M, Ibrahim MIM, Hassali MA, Sulaiman SAS, Maarup N. Social and Psychological Evaluations of Diabetic Patients Towards Disease Management: A Cross-Sectional Study At A University Health Center In Malaysia. Journal Of Clinical and Diagnostic Research 2010;4:2798-803. (Indexed in PubMed)
49. Al‐Qazaz H, Hassali MA, Shafie A, Sulaiman S, Sundram S. The 14‐item Michigan Diabetes Knowledge Test: translation and validation study of the Malaysian version. Practical Diabetes International. 2010;27(6):238-241. (Indexed in PubMed)
50. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Research and Clinical Practice. 2010;90(2):216-21. (IF: 2.741)
51. Alshakka MA, Izham MIM, Hassali MA, Subish P. Promoting the role of Malaysian non-governmental organizations in the safety of medicines. The Internet Journal of Third World Medicine. 2010; 9. (Indexed in Scopus)
52. Awaisu A, Samsudin S, Amir NA, Omar CG, Hashim MI, Mohamad MH, Shafie AA, Hassali MA. Measurement of nicotine withdrawal symptoms: linguistic validation of the Wisconsin Smoking Withdrawal Scale (WSWS) in Malay. BMC Medical Research Methodology. 2010;10(1):46. (IF: 2.211)
53. Azhar S, Hassali MA, Ibrahim MIM, Khan TM. A qualitative evaluation of Nurses’ percpetion towards the role of pharmacist in healthcare setup of Pakistan. HealthMed. 2010;4(1):71. (IF: 0.435)
54. Hadi MA, Hassali MA, Shafie AA, Awaisu A. Evaluation of breast cancer awareness among female university students in Malaysia. Pharmacy Practice. 2010;8(1):29-34. (Indexed in PubMed)
55. Hadi MA, Hassali MA, Shafie AA, Awaisu A. Knowledge and perception of breast cancer among women of various ethnic groups in the state of Penang: a cross-sectional survey. Medical Principles and Practice. 2010;19(1):61-7. (IF: 0.963)
56. Hasan SS, Chong DWK, Ahmadi K, Se WP, Hassali MA, Hata EM, et al. Influences on Malaysian Pharmacy Students' Career Preferences. American Journal of Pharmaceutical Education. 2010;74(9):166. (IF: 1.85)
57. Hassali MA, Shafie AA, Al-Haddad M, Balamurugan T, Awaisu A, Siow Y. A qualitative study exploring the impact of the pharmaceutical price war among community pharmacies in the state of Penang, Malaysia. Journal Of Clinical and Diagnostic Research. 2010. 4:3161-3169. (Indexed in PubMed)
58. Hassali MA, Shafie AA, Awaisu A, Ibrahim MI, Ping CC, Jamshed S. Physicians' views on generic medicines: a narrative review. Journal of Generic Medicines. 2010;7(1):30-9. (Indexed in PubMed)
59. Ibrahim SS, Sulaiman SAS, Gillani SW, Hassali MA, Abougalambou ASI, Mohamed M. Evaluation of direct medical cost among outpatients of type 2 diabetes mellitus: cost analysis in teaching hospital of Malaysia. Preview Papers. 2010;45(1):3. (Indexed in PubMed)
60. Jamshed S, Hassali MA, Ibrahim M, Shafie A, Babar Z. Knowledge, perception and attitude of community pharmacists towards generic medicines in Karachi, Pakistan: A qualitative insight. Tropical Journal of Pharmaceutical Research. 2010;9(4):409-415. (IF: 0.500)
61. Jamshed S, Mohamed IM, Hassali M. Icebreakers-unexpected outcomes. Journal of the College of Physicians and Surgeons. 2010;20(2):142. (IF: 0.301)
62. Jamshed SQ, Ibrahim MIM, Hassali MA, Shafie AA, Al-Haddad MS, Elkalmi R. Rigor: An Essentiality in Qualitative Research. Innovations in Pharmacy. 2010;1(2):1. (Indexed in PubMed)
63. Jamshed Sq, Ibrahim Mim, Hassali MA, Khalid S. Perception Of Academic Pharmacists Regarding Their Career Growth: A Qualitative Case Study From Pakistan. Journal Of Clinical And Diagnostic Research. 2010; 4(5):3075-82. (Indexed in PubMed)
64. Khan AH, Sulaiman SAS, Hassali MA, Muttalif AR. Anti-Tubercular Chemotherapy and Drug Induced Hepatitis. HealthMED. 2010; 4(3):536-544. (IF: 0.435)
65. Khan AH, Sulaiman SAS, Muttalif AR, Hassali MA, Abdullah R. Gender differences in the prevalence of Tuberculous Lymphadenitis at the State of Penang, Malaysia: Findings from a cross-sectional study. Archives of Pharmacy Practice. 2010;1(1):7-11. (Indexed in Scopus)
66. Khan TM, Sulaiman SA, Hassali MA. Mental health literacy towards depression among non‐medical students at a Malaysian university. Mental Health in Family Medicine. 2010;7(1):27-35. (Indexed in PubMed)
67. Khan TM, Syed Sulaiman SA, Hassali MA, Anwar M, Wasif G, Khan AH. Community knowledge, attitudes, and beliefs towards depression in the State of Penang, Malaysia. Community Mental Health Journal. 2010;46(1):87-92. (Indexed in PubMed)
68. Liau SY, Izham MIM, Hassali MA, Shafie AA Othman AT, Nik MH, Hamdi MA. Outcomes Of Cardiovascular Risk Factors Screening Programme Among Employees Of A Malaysian Public University. Journal of Clinical and Diagnostic Research. 2010;4:2208-16. (Indexed in PubMed)
69. Liau SY, Izham MM, Hassali MA, Shafie A. A literature review of the cardiovascular risk-assessment tools: applicability among Asian population. Heart Asia. 2010;2(1):15-8. (Indexed in PubMed)
70. Permala J, Hassali MA, Awaisu A, Shafie AA. Dosing information in a standard drug reference: Are pediatrics still therapeutically neglected? Pediatrics International. 2010;52(2):290-5. (IF: 0.875)
71. Ping CC, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A Web-Based Survey on Australian Community Pharmacists' Perceptions and Practices of Generic Substitution. Journal of Generic Medicines. 2010;7(4):342-53. (Indexed in PubMed)
72. Saleem F, Hassali MA, Shafie AA. Hypertension in Pakistan: time to take some serious action. British Journal of General Practice. 2010;60(575):449. (IF: 2.034)
73. Saleem F, Hassali MA, Shafie AA. Patients' perceptions of hypertension management: a concern for healthcare practitioners. British Journal of General Practice. 2010;60(578):691. (IF: 2.034)
74. Shafie AA, Hassali MA. Willingness to pay for a pharmacist’s dispensing service: a cross-sectional pilot study in the state of Penang, Malaysia. Pharmacy Practice. 2010;8(2):116-21. (Indexed in PubMed)
75. Sharrad KA, Hassali MA, Shafie AA. Generic medicines: Percpetions of pharmacists in Basra, Iraq. HealthMed. 2010;4(1):38. (IF: 0.435)
76. Suhil MA, Hassali MA, Ibrahim MIM. Evaluation of Direct Medical Cost in Treating Hypertension in a Malaysian Public University. Asian Journal of Pharmaceutical and Clinical Research. 2010; 3(3):170-173. (Indexed in PubMed)
77. Syed IA, Hassali MA, Khan TM. General Knowledge & Attitudes Towards Aids Among Final Year Medical and Pharmacy Students. Preview Papers. 2010;45(1):9-13. (Indexed in PubMed)
78. Azhar S, Hassali MA, Ibrahim MIM. Doctors’ percpetion and expectations of the role of the pharmacist in Punjab, Pakistan. Tropical Journal of Pharmaceutical Research. 2010;9(3):205-222. (IF: 0.500)
79. Chong CP, Hassali MA, Bahari MB, Shafie AA. Evaluating community pharmacists’ perceptions of future generic substitution policy implementation: A national survey from Malaysia. Health Policy. 2010;94(1):68-75. (IF: 1.550)
80. Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010;95(2):229-35. (IF: 1.550)
81. Elkalmi RM, Hassali MA, Ibrahim MI, Shafie AA. Community pharmacist’s involvement in the pharmacovigilance program in Malaysia. Journal of Pharmacy Practice and Research. 2010; 40 (3): 245-246. (Indexed in PubMed)
82. Oh AL, Hassali MA, Al-Haddad MS, Sulaiman SAS, Shafie AA, Awaisu A. Public knowledge and attitudes towards antibiotic usage: a cross-sectional study among the general public in the state of Penang, Malaysia. The Journal of Infection in Developing Countries. 2011;5(5):338-47. (IF: 1.2)
83. Abougalambou SS, Abougalambou AS, Sulaiman SA, Hassali MA. Prevalence of hypertension, control of blood pressure and treatment in hypertensive with type 2 diabetes in Hospital University Sains Malaysia. Diabetes and Metabolic Syndrome; 2011;5(3):115-9. (Indexed in PubMed)
84. Abougalambou SSI, Hassali MA, Sulaiman S, Abougalambou A. Prevalence of Vascular Complications among Type 2 Diabetes Mellitus Outpatients at Teaching Hospital in Malaysia. Journal of Diabetes & Metabolism. 2011;2(1):1-4. (Indexed in PubMed)
85. Abrika OSS, Hassali MA, Abduelkarem AR. Social pharmacy courses are often neglected in the developing world. American Journal of Pharmaceutical Education. 2011;75(4):65b. (IF: 1.85)
86. Al-Qazaz HK, Hassali MA, Shafie AA, Syed Sulaiman SA, Sundram S. Perception and knowledge of patients with type 2 diabetes in Malaysia about their disease and medication: A qualitative study. Research in Social and Administrative Pharmacy. 2011;7(2):180-91. (IF: 2.350)
87. Al-Qazaz HK, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, Saleem F. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. International Journal of Clinical Pharmacy. 2011:33(6):1028-35. (IF: 0.859)
88. Atif M, Sulaiman SAS, Shafie AA, Ali I, Hassali MA, Saleem F, et al. Addressing tuberculosis management in context of default and side effects associated with anti tuberculosis drugs: A case report from Malaysia. African Journal of Pharmacy and Pharmacology. 2011;5(23):2522-5. (IF: 0.84)
89. Azhar S, Hassali MA, Ibrahim M, Izham M, Saleem F, Siow Yen L. A survey evaluating nurses’ perception and expectations towards the role of pharmacist in Pakistan’s healthcare system. Journal of Advanced Nursing. 2011;68(1):199-205. (IF: 1.527)
90. Azhar S, Hassali MA, Ibrahim MM. Perceptions of Hospital Pharmacist’s Role in Pakistan’s Healthcare System: A Cross-Sectional Survey. Tropical Journal of Pharmaceutical Research. 2011;10(1):11-17. (IF: 0.500)
91. Babar ZUD, Ibrahim MIM, Hassali MA. Pharmaceutical industry, innovation and challenges for public health: case studies from Malaysia and Pakistan. Journal of Pharmaceutical Health Services Research. 2011;2(4):193-204. (Indexed in PubMed)
92. Chin LK, Hassali MA, Shafie AA. Behavioural component of patient care. Journal of Pharmacy Practice and Research. 2011;41;332. (Indexed in PubMed)
93. Chong CP, Hassali MA, Bahari MB, Shafie AA. Exploring community pharmacists’ views on generic medicines: a nationwide study from Malaysia. International Journal of Clinical Pharmacy. 2011;33(1):124-31. (IF: 0.859)
94. Chong CP, Hassali MA, Bahari MB, Shafie AA. Generic medicine substitution practices among community pharmacists: a nationwide study from Malaysia. Journal of Public Health. 2011;19(1):81-90. (IF: 1.993)
95. Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139-48. (IF: 1.550)
96. Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. Brand substitution involved identical alternatives: a nationwide study undertaken among Australian community pharmacists. Journal of Generic Medicines. 2011;8(3):157-65. (Indexed in PubMed)
97. Elkalmi RM, Hassali MA, Ibrahim MIM, Liau SY, Awaisu A. A qualitative study exploring barriers and facilitators for reporting of adverse drug reactions (ADRs) among community pharmacists in Malaysia. Journal of Pharmaceutical Health Services Research. 2011;2(2):71-8. (Indexed in PubMed)
98. Elkalmi RM, Hassali MA, Ibrahim MIM, Widodo RT, Efan QM, Hadi MA. Pharmacy Students’ Knowledge and Perceptions about Pharmacovigilance in Malaysian Public Universities. American Journal of Pharmaceutical Education. 2011;75(5):96. (IF: 1.85)
99. Elkalmi RM, Hassali MA, Ibrahim MIM. Impact of Educational Intervention for Improving Pharmacist Knowledge in Adverse Drug Reactions (ADR) Reporting: Experience from Malaysia. The Open Drug Safety Journal. 2011;2(1);47-53. (Indexed in Scopus)
100. Farooqui M, Hassali MA, Abdul Shatar AK, Shafie AA, Seang TB, Farooqui MA. Complementary and Alternative Medicine (CAM) use by Malaysian oncology patients. Complementary Therapies in Clinical Practice. 2011;18(2):114-120. (Indexed in PubMed)
101. Farooqui M, Hassali MA, Shatar AK, Shafie AA, Seang TB, Farooqui MA. A qualitative exploration of Malaysian cancer patients' perspectives on cancer and its treatment. BMC Public Health. 2011;11(1):525. (IF: 2.076)
102. Ahmed SI, Hassali MA, Bukhari NI, Sulaiman SA. A comparison of HIV/AIDS-related knowledge, attitudes and risk perceptions between final year medical and pharmacy students: A cross sectional study. HealthMED. 2011;2(5):326-335. (IF: 0.435)
103. Fatokun O, Ibrahim MIM, Hassali MA. Generic competition and drug prices in the Malaysian off-patent pharmaceutical market. Journal of Applied Pharmaceutical Sciences. 2011;1(09):33-7. (Indexed in PubMed)
104. Hassali MA, Khan TM, Shafie AA. Use of drug information resources by the community pharmacist in Penang, Malaysia. Informatics in Primary Care. 2011;18(3):213-6. (Indexed in PubMed)
105. Hassali MA, Shafie AA, Al-Haddad MSd, Abduelkarem AR, Ibrahim MI, Palaian S, et al. Social pharmacy as a field of study: The needs and challenges in global pharmacy education. Research in Social and Administrative Pharmacy. 2011;7(4):415-20. (IF: 2.350)
106. Hassali MA, Shafie AA, Al-Qazaz H, Tambyappa J, Palaian S, Hariraj V. Self-medication practices among adult population attending community pharmacies in Malaysia: an exploratory study. International Journal of Clinical Pharmacy. 2011;33(5):794-9. (IF: 0.859)
107. Hassali MA, Shafie AA, Palaian S. Lack of medicine safety communication channel: the case of HPV vaccine in Malaysia. Journal of Pharmacy Practice and Research 2011; 41(1): 80-81. (Indexed in PubMed)
108. Hassali MA. Challenges and future directions for public health pharmacy education in developing countries. American Journal of Pharmaceutical Education. 2011;75(10):195. (IF: 1.85)
109. Hassan BAR, Yusoff ZBM, Azmi M, Hassali MA. Association and Correlation of Different Chemotherapeutic Regimens and Doses with Onset and Severity of Anemia among Solid Cancer Patients. Asian Pacific Journal of Cancer Prevention. 2011;12(10):2753-8. (IF: 1.271)
110. Hassan BAR, Yusoff ZBM, Azmi M, Hassali MA. Treatment Patterns and Outcomes in Management of Solid Cancer Patients Suffering from Thrombocytopenia in Penang Hospital. Asian Pacific Journal of Cancer Prevention. 2011;12:2841-5. (IF: 1.271)
111. Jamshed S, Hassali MA, Ibrahim M, Babar Z. Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: a qualitative study. Journal of the Pakistan Medical Association. 2011;61(1):80-83. (IF: 0.409)
112. Jamshed S, Ibrahim M, Al-Haddad M, Hassali MA. Is bioethics in pharmacy inconceivable? Journal of the Pakistan Medical Association. 2011;61(4):407-408. (IF: 0.409)
113. Jamshed SQ, Ibrahim MIM, Hassali MA. Generic medicines in Pakistan: a questionable boon. International Journal of Clinical Pharmacy. 2011;33(1):53-4. (IF: 0.859)
114. Jamshed SQ, Ibrahim MIM, Shafie AA, Hassali MA, Babar Z. Generic medicines in Pakistan: a viable cost-effective option for consumers. European Journal of Clinical Pharmacology. 2011;67(9):969-70. (IF: 2.741)
115. Khan AH, Sulaiman S, Muttalif A, Hassali MA, Khan T. Tuberculous Lymphadenitis at Penang General Hospital, Malaysia. Medical Principles and Practice. 2011;20(1):80-4. (IF: 0.963)
116. Khan T, Hassali MA, Al-Haddad M. Patient-physician communication barrier: A pilot study evaluating patient experiences. Journal of Young Pharmacists. 2011;3(3):250-255. (Indexed in PubMed)
117. Khan T, Hassali MA, Tahir H, Khan A. A Pilot Study Evaluating the Stigma and Public Perception about the Causes of Depression and Schizophrenia. Iranian Journal of Public Health. 2011;40(1):50-56. (IF: 0.405)
118. Khan TM, Hassali MA, Al-Haddad MSM. Nutraceuticals use among the inhabitants of Penang, Malaysia. International Journal of Collaborative Research on Internal Medicine and Public Health. 2011;3(5):402-14. (Indexed in PubMed)
119. Khan TM, Sulaiman SA, Hassali MA, Tahir H. Clinical presentation of depression among Malaysian women in Penang Island. Mental Health in Family Medicine. 2011;8(3):205-8. (Indexed in PubMed)
120. Lee ML, Hassali MA, Shafie AA, Aziz AMA. Challenges of Pharmacist-Managed Smoking Cessation Services. A Viewpoint. Nicotine & Tobacco Research. 2011;13(6):504-5. (IF: 2.447)
121. Liau SY, Hassali MA, Shafie AA, Ibrahim MIM. Assessing quality of a worksite health promotion programme from participants’ views: findings from a qualitative study in Malaysia. Health Expectations. 2011. DOI: 10.1111/j.1369-7625.2011.00742.x. (IF: 2.110)
122. Malik M, Hassali MA, Shafie AA, Hussain A. Strategic solution to malaria eradication in Pakistan. Journal of Pharmacy Practice and Research. 2011;41(1):73. (Indexed in PubMed)
123. Ming LC, Hassali MA, Shafie AA, Awaisu A, Hadi MA, Al-Haddad M. Perspectives of heart failure patients in Malaysia towards medications and disease state management: findings from a qualitative study. Journal of Public Health. 2011;19(6):569-77. (IF: 1.993)
124. Neoh CF, Hassali MA, Shafie AA, Awaisu A. Nature and adequacy of information on dispensed medications delivered to patients in community pharmacies: a pilot study from Penang, Malaysia. Journal of Pharmaceutical Health Services Research. 2011;2(1):41-6. (Indexed in PubMed)
125. Saleem F, Hassali MA, Shafie A, Bashir S, Atif M. Perceptions of Disease State Management among Pakistani Hypertensive Patients: Findings from a Focus Group Discussion. Tropical Journal of Pharmaceutical Research. 2011;10(6):833-40. (IF: 0.500)
126. Saleem F, Hassali MA, Shafie AA, Atif M. Education and health-related quality of life: Are interventions always beneficial? Journal of Pharmacy Practice and Research. 2011;41(4):333. (Indexed in PubMed)
127. Saleem F, Hassali MA, Shafie AA, Muhammad A, George A. Predictors of Medication Adherence in a Hypertensive Population of Pakistan. Latin American Journal of Pharmacy. 2011;30(9):1714-9. (IF: 0.244)
128. Shafie AA, Hassali MA, Liau SY. A cross-sectional validation study of EQ-5D among the Malaysian adult population. Quality of Life Research. 2011;20(4):593-600. (IF: 2.412)
129. Shafie AA, Hassali MA. Community pharmacy dispensing costs in the state of Penang, Malaysia. Journal of Applied Pharmaceutical Sciences. 2011;1(06):143-5. (Indexed in PubMed)
130. Shafie AA, Hassali MA. Is there a role for pharmacoeconomics in developing countries? Pharmacoeconomics. 2011;29(1):83-4. (IF: 2.861)
131. Shafie AA, Khor XY, Hassali MA. Separation of the dispensing role–an indispensable health reform. Journal of Pharmacy Practice and Research. 2011;41(2):173. (Indexed in PubMed)
132. Shankar PR, Hassali MA, Subish P, Piryani RM, Thapa BB, Mishra N. ‘GenMed 010’: a one day workshop on generic medicines. Australasian Medical Journal. 2011; 4(3):133-5. (Indexed in PubMed)
133. Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq: Preliminary findings from a qualitative study. Research in Social and Administrative Pharmacy. 2011;7(1):108-12. (IF: 2.350)
134. Sharrad AK, Hassali MA. Knowledge and Perceptions of Final Year Medical Students in Iraqi Universities about Generic Medicines. Journal of Bioequivalence & Bioavailability. 2011. DOI: 3: 086-091. doi:10.4172/jbb.1000065. (Indexed in PubMed)
135. Sharriff A, Nordin N, Hassali MA. STARZ-DRP: A step by step approach for pharmacy triage services. Malaysian Journal of Pharmacy. 2011;1(9):311-324. (Indexed in PubMed)
136. Wasif G, Sulaiman SA, Ai Ling O, Hassali MA, Sari OY, Uzbek UH. Population Based Knowledge Assessment on Irrational Practice of Antibiotics Use in Pulau Pinang, Malaysia. Journal of Pharmaceutical Research & Clinical Practice 2011; 1(1):2-17. (Indexed in PubMed)
137. Saleem F, Hassali MA, Shafie A, Awad A, Bashir S. Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan. Tropical Journal of Pharmaceutical Research. 2011;10(2):125-132. (IF: 0.500)
138. Jamshed SQ, Hassali MA, Ibrahim MIM. Qualiative or quantitative-an enigma? Journal of The College of Physicians and Surgeons-Pakistan 2011;21(9):580. (IF: 0.301)
139. Liau SY, Shafie AA, Ibrahim MI, Hassali MA, Othman AT, Mohamed MH, Hamdi MA. Stages of change and health-related quality of life among employees of an institution. Health Expectations 2013;16(2):199-210. (IF: 2.110)
140. Abdulameer S, Syed Sulaiman S, Hassali MA, Subramaniam K, Sahib M. Psychometric properties and osteoprotective behaviors among type 2 diabetic patients: osteoporosis self-efficacy scale Malay version (OSES-M). Osteoporosis International. 2012:1-12. (IF: 4.039)
141. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do? Patient Preference and Adherence. 2012;6:435-48. (IF: 1.333)
142. Abdulameer SA, Syed Sulaiman SA, Hassali MA, Subramaniam K, Sahib MN. Is there a link between osteoporosis and type 1 diabetes? Findings from a systematic review of the literature. Diabetology International. 2012:1-18. (Indexed in PubMed)
143. Abrika OSS, Hassali MA, Abduelkarem AR. Importance of social pharmacy education in Libyan pharmacy schools: perspectives from pharmacy practitioners. Journal of Educational Evaluation for Health Professions. 2012;9:6. DOI: doi: http://dx.doi.org/10.3352/jeehp.2012.9.6. (Indexed in Scopus)
144. Abrika OSS, Hassali MA, Abduelkarem AR. Perceptions towards the Need of Social Pharmacy Courses in Libya: Findings from Cross-Sectional Survey among Senior Pharmacy Students. Prime Research on Education. 2012;2(3):237-43. (Indexed in Scopus)
145. Ahmadi K, Hassali MA. Professionalism in Pharmacy: A Continual Soietal and Intellectual Challenge. American Journal of Pharmaceutical Education. 2012;76(4). (IF: 1.85)
146. Al-Areefi MA, Hassali MA, Ibrahim MIBM. A qualitative study exploring medical representatives’ views on current drug promotion techniques in Yemen. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 2012;12(3):143-9. (Indexed in PubMed)
147. Al-Areefi MA, Hassali MA. The role of pharmaceutical marketing and other factors in prescribing decisions: The Yemeni experience. Research in Social and Administrative Pharmacy. 2012. DOI: http://dx.doi.org/10.1016/j.sapharm.2012.10.006. (IF: 2.350)
148. Al-Dulaimy SNY, Hassali MA, Awaisu A. An evaluation of senior pharmacy students' perceptions and knowledge of complementary and alternative medicine at a Malaysian university. Journal of the Australian Traditional-Medicine Society. 2012;18(1):41. (IF: 0.111)
149. Alfadl AA, Ibrahim MIM, Hassali MA. Consumer behaviour towards counterfeit drugs in a developing country. Journal of Pharmaceutical Health Services Research. 2012;3(3):165-172. (Indexed in PubMed)
150. Al-Hamdi AY, Hassali MA, Ibrahim MIM. Impact of pharmaceutical promotion on healthcare professional’s practices and behaviour: Views from general practitioners, medicine dispensers and medical representatives in Yemen. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 2012. DOI: 10.1177/1745790412455942. (Indexed in PubMed)
151. Ansari M, Ibrahim MI, Hassali MA, Shankar P, Koirala A, Thapa N. Mothers’ beliefs and barriers about childhood diarrhea and its management in Morang district, Nepal. BMC Research Notes. 2012;5(1):576. (Indexed in PubMed)
152. Atif M, Sulaiman S, Shafie A, Muttalif A, Hassali MA, Saleem F. Health-Related Quality of Life (HRQoL) in Co-Morbid Tuberculosis Relapse Patient: A Case Report from Malaysia. Tropical Journal of Pharmaceutical Research. 2012;11(4):651-5. (IF: 0.500)
153. Atif M, Sulaiman SAS, Shafie AA, Ali I, Hassali MA, Saleem F. WHO guidelines for treatment of tuberculosis: the missing links. International Journal of Clinical Pharmacy. 2012;34(4):506-9. (IF: 0.859)
154. Hassali MA, Zeehan SI, Saleem F, Maryam F, Hisham A. Assessment Of Students’ Perceptions Towards E-Learning Management System (E-LMS) In A Malaysian Pharmacy School: A Descriptive Study. Malaysian Journal of Public Health Medicine. 2012;12(1):14-20. (Indexed in PubMed)
155. Hassan BAR, Yusoff ZBM, Azmi M, Hassali MA, Weiderpass E. Impact of Chemotherapy on Hypercalcemia in Breast and Lung Cancer Patients. Asian Pacific Journal of Cancer Prevention. 2012;13(9):4373-8. (IF: 1.271)
156. Azhar S, Hassali MA, Murtaza G, Hussain I. Current Clinical Practices in Pakistan and Hospital Pharmacist’s Perception towards Their Role: A Qualitative Approach. Latin American Journal of Pharmacy. 2012;31. (IF: 0.244)
157. Babar ZUD, Hassali MA, Shyong TL, Hin TK, Cien CS, Bin LS, Anantham SC, Kirubakaran R, Ping SB, Kirubakaran R, Chuen CS, Singh JK. An Evaluation of Consumers’ Perceptions Regarding “Modern Medicines” in Penang, Malaysia. Journal of Young Pharmacists. 2012;4(2):108-113. (Indexed in PubMed)
158. Chen LL, Tangiisuran B, Shafie AA, Hassali MA. Evaluation of potentially inappropriate medications among older residents of Malaysian nursing homes. International Journal of Clinical Pharmacy. 2012;34(4):596-603. (IF: 0.859)
159. Farooqui M, Hassali MA, Abdul Shatar AK, Shafie AA, Farooqui MA, Saleem F, Aljadhey H. Complementary and alternative medicines (CAM) disclosure to the health care providers: A qualitative insight from Malaysian cancer patients. Complementary Therapies in Clinical Practice. 2012;18(4):252-6. (Indexed in PubMed)
160. Farooqui M, Hassali MA, Shatar AKA, Shafie AA, Farooqui MA, Saleem F. Use of Mind–Body Complementary Therapies (MBCTs) in Patients with Cancer. Journal of Alternative and Complementary Medicine. 2012;18(8):727-8. (IF: 1.464)
161. Haq NU, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H. A cross sectional assessment of knowledge, attitude and practice towards Hepatitis B among healthy population of Quetta, Pakistan. BMC Public Health. 2012;12(1):692. (IF: 2.076)
162. Hassali MA, Shafie A, Khan T. General public expectation from the communication process with their healthcare providers. Journal of Young Pharmacists. 2012;4(3):193-8. (Indexed in PubMed)
163. Hassali MA, Shafie A, Saleem F, Al-Qazaz H, Masood I, Atif M, et al. A pilot study exploring awareness among general public toward issues related to medication safety in the state of Penang, Malaysia. Chronicles of Young Scientists. 2012;3(2):156-159. (Indexed in Scopus)
164. Hassali MA, Saleem F, Aljadhey H, Khan TM. Evaluating the Content of Advertisements for Dietary Supplements in Malaysian Women’s Magazines. Drug Information Journal. 2012;46(6):723-728. (IF: 0.401)
165. Hassali MA, Saleem F, Shafie AA, Aljadhey H, Chua GN, Masood I, Haq N. Perception Towards Health Promotion Activities: Findings From A Community Survey In The State Of Penang, Malaysia. Malaysian Journal of Public Health Medicine. 2012;12(2):6-14. (Indexed in PubMed)
166. Hassali MA, Saleem F, Shafie AA, Al-Qazaz HK, Farooqui M, Aljadhey H, Atif M, Masood I. Assessment of general public perceptions toward traditional medicines used for aphrodisiac purpose in state of Penang, Malaysia. Complementary Therapies in Clinical Practice. 2012;18(4):257-60. (Indexed in PubMed)
167. Hassali MA, Saleem F. The Need to Include Lifestyle Medicine Education in Malaysian Pharmacy Curriculum. American Journal of Pharmaceutical Education. 2012;76(5):93. (IF: 1.85)
168. Hassali MA, Shafie AA, Babar ZUD, Khan TM. A study comparing the retail drug prices between Northern Malaysia and Australia. Journal of Pharmaceutical Health Services Research. 2012;3(2):103-7. (Indexed in PubMed)
169. Hassali MA, Shafie AA, Chong CP, Saleem F, Atif M, Chua G, et al. Community pharmacist’s perceptions towards the quality of locally manufactured generic medicines: A descriptive study from Malaysia. Journal of Applied Pharmaceutical Science. 2012;2(01):56-60. (Indexed in PubMed)
170. Hassali MA, Supian A, Ibrahim MI, Al-Qazaz HK, Al-Haddad M, Salee F, et al. The Characteristics of Drug Wastage at the Hospital, Tuanku Jaafar Seremban, Malaysia: A Descriptive Study. Journal of Clinical and Diagnostic Research. 2012;(5):787-790. (Indexed in PubMed)
171. Hassali MA, Thambyappa J, Saleem F. Generic Substitution in Malaysia: Recommendations from a Systematic Review. Journal of Applied Pharmaceutical Science. 2012;2(08):159-64. (Indexed in PubMed)
172. Jamshed SQ, Ibrahim MIM, Hassali MA, Masood I. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study. Southern Med Review. 2012;5(1):22-30. (Indexed in PubMed)
173. Khan TM, Sulaiman SAS, Hassali MA. Factors associated with suicidal behaviour among depressed patients in Penang, Malaysia. Archieves of Medical Sciences. 2012;8(4):697–703. (IF: 1.067)
174. Malik M, Hassali MA, Shafie AA, Hussain A. Prescribing practices for the treatment of malaria among public and private healthcare facilities: A comparative cross sectional study from Pakistan. HealthMED 2012;6(4):1147-1154. (IF: 0.435)
175. Malik M, Hassali MA, Shafie AA. Why Don’t Medical Practitioners Treat Malaria Rationally? A Qualitative Study from Pakistan. Tropical Journal of Pharmaceutical Research. 2012;11(4):673-81. (IF: 0.500)
176. Masood I, Ibrahim MIM, Hassali MA, Ahmad M, Mansfield PR. Evaluation of pharmaceutical industry–sponsored educational events attended by physicians in Pakistan. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 2012;12(1):22-9. (Indexed in PubMed)
177. Saleem F, Hassali MA, Shafie A, Atif M. Drug attitude and adherence: A qualitative insight of patients with hypertension. Journal of Young Pharmacists. 2012;4(2):101-7. (Indexed in PubMed)
178. Saleem F, Hassali MA, Shafie AA, Atif M, ul Haq N, Aljadhey H. Disease related knowledge and quality of life: a descriptive study focusing on hypertensive population in Pakistan. Southern Med Review. 2012;5(1):47–52. (Indexed in PubMed)
179. Saleem F, Hassali MA, Shafie AA, Awad GA, Atif M, ul Haq N, Aljadhey H, Farooqui M. Does treatment adherence correlates with health related quality of life? Findings from a cross sectional study. BMC Public Health. 2012;12(1):318. (IF: 2.076)
180. Saleem F, Hassali MA, Shafie AA, Morisky DE, Atif M, Al-Qazaz HK, Masood I, Haq N, Aljadhey H, Farooqui M. Translation and validation study of the Morisky Medication Adherence Scale (MMAS): The Urdu version for facilitating person-centered healthcare in Pakistan. International Journal of Person Centered Medicine 2012;2(3):384-390. (Indexed in PubMed)
181. Salih MR, Bahari MB, Hassali MA, Shafie AA, Al-lela OQ, Abd AY, Ganesan VM. Characteristics of seizure frequency among Malaysian children diagnosed with structural–metabolic epilepsy. Journal of Neurosciences in Rural Practice. 2012;3(3):244-250. (Indexed in PubMed)
182. Saleem F, Hassali MA, Shafie AA. A cross‐sectional assessment of health‐related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expectations. 2012. DOI: 10.1111/j.1369-7625.2012.00765.x. (IF: 2.110)
183. Salih MR, Bahari MB, Shafie AA, Hassali MA, Al-lela OQB, Abd AY, Ganesan VM. Cost-effectiveness analysis for the use of serum antiepileptic drug level monitoring in children diagnosed with structural-metabolic epilepsy. Epilepsy research. 2012;104(1-2):151-7. (IF: 2.241)
184. Salih MR, Bahari MB, Shafie AA, Hassali MA, Al-lela OQB, Abd AY, et al. Medical care costs of newly diagnosed children with structural-metabolic epilepsy: A one year prevalence-based approached. Seizure. 2012;21(10):764-9. (IF: 2.004)
185. Shafie AA, Hassali MA, Azhar S, See OG. Separation of prescribing and dispensing in Malaysia: A summary of arguments. Research in Social and Administrative Pharmacy. 2012;8(3):258-62. (IF: 2.350)
186. Solliman MA, Hassali MA, Al-Haddad M, Hadida MM, Saleem F, Atif M, et al. Assessment of Knowledge towards Tuberculosis among general population in North East Libya. Journal of Applied Pharmaceutical Science. 2012;2(04):24-30. (Indexed in PubMed)
187. Solliman MA, Hassali MA, Al-Haddad MS, Sulaiman SAS, Atif M, Saleem F. Treatment outcomes of new smear positive pulmonary tuberculosis patients in north east Libya. Latin American Journal of Pharmacy. 2012;31(4):567-73. (IF: 0.244)
188. Ul Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H. A cross sectional assessment of health related quality of life among patients with Hepatitis-B in Pakistan. Health and Quality of Life Outcomes. 2012;10(1):91. (IF: 2.272)
189. Hassali MA, Al-Haddad M, Shafie AA, Tangiisuran B, Saleem F, Atif M, Al-Qazaz H. Perceptions Among General Medical Practitioners Toward Implementation of Medication Reconciliation Program for Patients Discharged From Hospitals in Penang, Malaysia. Journal of Patient Safety 2012 Jun;8(2):76-80. (Indexed in PubMed)
190. Sarriff A, Nordin N, Hassali MA. Extending the Roles of Community Pharmacists: Views from General Medical Practitioners. Medical Journal of Malaysia. 2012;67(6):577-581. (Indexed in PubMed)
191. Malik M, Hassali MA, Shafie AA, Hussain A, Aljadhey H. Availability of different strengths of anti malarial preparations in Pakistan: Implication for patient safety. Journal of Pharmacological and Biomedical Analysis 2012;1:1. (Indexed in Scopus)
192. Ahmadi K, Anwar M, Hassali MA. Malaysian pharmacy educators’ view of the role of non-pharmacy trained educators in teaching pharmacy students. American Journal of Pharmaceutical Education 2012;76(7):138. (IF: 1.85)
193. Abrika OSS, Hassali MA, Abduelkarem AR. Perception of Libyan pharmacy academics on the importance of social pharmacy subjects in the current pharmacy undergraduate curriculum. Journal of Advanced Pharmacy Education and Research 2012;2(1):1-10. (Indexed in PubMed)
194. Al Qazaz HK, Sulaiman SA, Hassali MA, Shafie AA, Sundram S. Diabetes knowledge and control of glycaemia among type 2 diabetes patients in Penang, Malaysia. Journal of Pharmaceutical Health Services Research. 2012;3:49-55. (Indexed in PubMed)
195. Alshakka MA, Ibrahim MIM, Hassali MA. Evaluation of general public perceptions towards adverse drug reactions reporting. Pharmacoepidemiology and Drug Safety 2013;22(1):255. (IF: 2.897)
196. Alfadl AA, Hassali MA, Ibrahim MIM. Counterfeit drug demand: Perceptions of policy makers and community pharmacists in Sudan. Research in Social and Administrative Pharmacy. 2013;9(3):302-10. (IF: 2.350)
197. Farooqui M, Hassali MA, Abdul Shatar AK, Shafie AA, Farooqui MA, Saleem F, Haq N-u, Ayob HB, Othman CN: Use Of Mind Body Complementary Therapies (MBCTs) And Health Related Quality Of Life (HRQoL) Of Cancer Patients. ASEAN Journal of Psychiatry. 2013, 14(1):40-50. (Indexed in PubMed)
198. Farooqui M, Hassali MA, Knight A, Shafie AA, Farooqui MA, Saleem F, Haq NU, Aljadhey H: A qualitative exploration of Malaysian cancer patients’ perceptions of cancer screening. BMC Public Health. 2013;13(1):48. (IF: 2.076)
199. Hassali MA, Saleem F, Khan TM, Aljadhey H, Haq N. Pharmacists’ Perception of the Sale of Non-Clinically Proven Health Supplements in Penang, Malaysia. Tropical Journal of Pharmaceutical Research. 2013; 12 (3): 433-438. (IF: 0.500)
200. Hassali MA, Siang TC, Saleem F, Aljadhey H: A qualitative exploration of perceptions toward pharmaceutical price war among community pharmacists in the state of Penang, Malaysia. Journal of Medical Marketing. 2013;13(1):44-53. (Indexed in PubMed)
201. Hassali MA, Yahaya H, Shafie AA, Saleem F, Chua G, Aljadhey H. Patterns and Predictors of Non-Prescription Medicine Use among Malaysian Pharmacy Patrons: A National Cross Sectional Study. Plos One. 2013;8(4):e59231. (IF: 3.730)
202. Malik M, Hassali MA, Hussain A, Shafie AA. Standard treatment guidelines for malaria: Challenges in its implementation in Islamabad (federal capital) and Rawalpindi (twin city), Pakistan. Saudi Pharmaceutical Journal 2013; 21(1), 123–124. (IF: 0.954)
203. Shafie A, Hassali MA. Willingness to Pay for Voluntary Community-Based Health Insurance: Findings from an Exploratory Study in the State of Penang, Malaysia. Social Science & Medicine 2013;96:272-6. (IF: 2.733)
204. Fatokun O, Ibrahim MIM, Hassali MA. Generic industry’s perceptions of generic medicines policies and practices in Malaysia. Journal of Pharmacy Research. 2013;7:80-84. (Indexed in PubMed)
205. Syed AI, Sulaiman SAS, Hassali MA, Lee KCC. HIV/AIDS treatment and health related quality of life: Importance of knowing patients’ perspective. HIV & AIDS Review, 2013. DOI: dx.doi.org/10.1016/j.hivar.2013.02.003. (Indexed in PubMed)
206. Shafie AA, Hassali MA, Yahaya MHA. Health-Related Quality of Life among nonprescription medicine customer in Malaysia. Value in Health Regional Issues, 2013. DOI: dx.doi.org/10.1016/j.vhri.2013.02.005. (Indexed in PubMed)
207. Al-Tamimi KS, Hassali MA, Alrasheedy AA. Challenges to generic medicines utilization in Yemeni healthcare system. Generics and Biosimilars Initiative Journal, 2013. DOI: 10.5639/gabij.2013.0201.XXX. (Indexed in PubMed)
208. Elkalmi R, Hassali MA, Al-lela QA, Jamshed SQ. The teaching of subjects related to pharmacovigilance in Malaysian pharmacy undergraduate programs. Journal of Pharmacovigilance 2013, 1:2. DOI: http://dx.doi.org/10.4172/jp.1000106. (Indexed in PubMed)
209. Malik M, Hassali MA, Shafie AA, Hussain A, Aljadhey H, Saleem F. Case management of malaria fever at community pharmacies in Pakistan; a threat to rational drug use. Pharmacy Practice. 2013;11(1):8-16. (Indexed in PubMed).
210. Almalak H., Albluwi AI, Alkhelb DA, Alsaleh HM, Khan TM, Hassali MA, Aljadhey H. Students attitude towards Use of Over the Counter Medicines during exams in Saudi Arabia. Saudi Pharmaceutical Journal, 2013. DOI: http://dx.doi.org/10.1016/j.jsps.2013.02.004
211. Sulaiman SAS, Khan HA, Muttalif RA, Hassali MA, Ahmad N, Iqubal SM. Impact of Diabetes Mellitus on Treatment Outcomes of Tuberculosis patients in tertiary care setup. The American Journal of the Medical Sciences. 2013;345(4):321-325. (IF: 1.331)
212. Khan AH, Zakaria AD, Hassan S, Ahmad A, Hassali MA. Medical management of post-operative abdominal infection: A case of well management and appropriate medications. Tropical Meidcine & Surgery 2013. DOI: 10.4172/tpms.1000110. (Indexed in PubMed)
213. ul Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H. A cross-sectional assessment of knowledge, attitude and practice among Hepatitis-B patients in Quetta, Pakistan. BMC Public Health 2013 13:448. (IF: 2.076)
214. Ahmadi K, Reidpath DD, Allotey P, Hassali MA. Professionalisation and social attitudes: a protocol for measuring changes in HIV/ AIDS-related stigma among healthcare students. BMJ Open 2013;3(5). DOI:PII: e002755. 10.1136/bmjopen-2013-002755:e002755. (IF: 1.583)
215. Blebil AQ, Sulaiman SAS, Hassali MA, Dujaili JA, Subramaniam K, Aziz NA. Evaluation of smoking status among diabetes patients in the state of Penang, Malaysia. Tropical Journal of Pharmaceutical Research 2013; 12 (3): 445-448. (IF: 0.500)
216. Saleem F, Hassali MA, Shafie AA, Haq NU, Farooqui M, Aljadhey H, Ahmad FUD. Pharmacist intervention in improving hypertension-related knowledge, treatment medication adherence and health-related quality of life: a non-clinical randomized controlled trial. Health Expectations 2013. DOI: 0.1111/hex.12101. (IF: 2.110)
217. Abrika AS, Hassali MA. “Are social pharmacy courses needed in pharmacy curriculum in Libya: finding from a cross sectional survey with pharmacy academics. International Journal of Pharmaceutical Sciences and Research 2013. DOI: 10.13040/IJPSR.0975-8232.4(7).2696-04 (Indexed in PubMed)
218. Malik M, Hassali MA, Shafie AA, Hussain A. A qualitative study exploring perspectives towards rational use of medicines in Pakistan’s Malaria Control Program (MCP). Brazilian Journal of Pharmaceutical Sciences 2013; 49(2):1-12. (IF: 0.373)
219. Farooqui M, Hassali MA, Knight A, Shafie AA, Farooqui MA, Saleem F, Haq N, Othman CN, Aljadhey H. Cross Sectional Assessment of Health Related Quality of Life (HRQoL) among Patients with Cancer in Malaysia. Asian Pacific Journal of Cancer Prevention 2013;14(5):3017-21. (IF: 1.271)
220. Fatokun O, Ibrahim MIM, Hassali MA. Factors determining the post-patent entry of generic medicines in Malaysia: A survey of the Malaysian generic pharmaceutical industry. Journal of Generic Medicines 2013 (in press). (Indexed in PubMed)
221. Matalqah ML, Radaideh K, Sulaiman SAS, Hassali MA, Kader SAS. An instrument to measure anticoagulation knowledge among Malaysian community: A translation and validation study of the Oral Anticoagulation Knowledge (OAK) Test. Asian Journal of Biomedical and Pharmaceutical Sciences 2013; 3(20): 30-37. (Indexed in PubMed)
222. Abrika OSS, Hassali MA, Abduelkarem RA. Is there a need for social pharmacy courses in Libya?’’ Findings from a cross-sectional survey among pharmacy practitioners. Currents in Pharmacy Teaching and Learning 2013. DOI: dx.doi.org/10.1016/j.cptl.2013.02.001. (Indexed in PubMed)
223. Thanimalai S, Shafie AA, Hassali MA, Sinnadurai J. Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital. International Journal of Clinical Pharmacy 2013;35(5):736-43. (IF: 0.859)
224. Azhar S, Hassali MA, Taha A, Khan SA, Murtaza G, Hussain I. Evaluation of the perception of community pharmacists regarding their role in Pakistan’s healthcare system: A qualitative approach. Tropical Journal of Pharmaceutical Research August 2013;12(4):635-639. (IF: 0.500)
225. Khan AH, Sulaiman SAS, Muttalif AR, Hassali MA, Akram H, Gillani SW. Pleural tuberculosis and its treatment outcomes. Tropical Journal of Pharmaceutical Research August 2013;12(4):623-627. (IF: 0.500)
226. Nguyen TA, Hassali MA, McLachlan A. Generic medicines policies in the Asia Pasific region: Ways forward. WHO South-East Asia J Public Health 2013;2:72-74. (Indexed in PubMed)
227. Alrasheedy AA, Hassali MA, Aljadhey H, Ibrahim MIM, Al-Tamimi SK. Is there a need for a formulary of clinical interchangeable medicines to guide generic substitution in Saudi Arabia? Journal of Young Pharmacists June 2013;5(2):73-75. (Indexed in PubMed)
228. Al-Hamdi AY, Ibrahim MIM, Hassali MA. The role of healthcare professionals in establishing unhealthy pharmaceutical promotion activities in Yemen. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Markerting 21 June 2013. DOI: 10.1177/1745790413493921. (Indexed in PubMed)
229. Hassali MA, Ahmadi K, Goh CY. A need to rethink and mold consensus regarding pharmacy education in developing countries. American Journal of Pharmaceutical Education 2013;77(6):112. (IF: 1.85)
230. Al-Areefi MA, Hassali MA, Ibrahim MI. Physicians’ perceptions of medical representative visits in Yemen: A qualitative study. BMC Health Services Research 2013:13:331. (IF: 1.773)
231. Elkalmi R, Hassali MA, Al-ela OQ, Awadh AI, Al-Shami AK, Jamshed SQ. Adverse drug reactions reporting: Knowledge and opinion of general public in Penang, Malaysia. Journal of Pharmacy and Bioallied Sciences 2013;5(3):224-8. (Indexed in PubMed)
232. Abdulameer SA, Syed Sulaiman SA, Hassali MA, Subramaniam K, Sahib MN. Psychometric Properties of Osteoporosis Knowledge Tool and Self-Management Behaviours Among Malaysian Type 2 Diabetic Patients. Journal of Community Health. 2013;38:95-105. (IF: 1.491)
233. Salih MR, Bahari MB, Hassali MA, Shafie AA, Al-lela OQB, Abd AY, Ganesan V. Practices Associated with Serum Antiepileptic Drug Level Monitoring at a Pediatric Neurology Clinic: A Malaysian Experience. Journal of Pharmacy Practice. 2013;26(3):192-197. (Indexed in PubMed)
234. Lee ML, Hassali MA, Shafie AA. A qualitative exploration of the reasons for the discontinuation of smoking cessation treatment among Quit Smoking Clinics' defaulters and health care providers in Malaysia. Research in Social and Administrative Pharmacy 2013;9:405-418. (IF: 2.350)
235. Aljadhey H, Mahmoud MA, Hassali MA, Alrasheedy A, Alahmad A, Saleem F, Sheikh A, Murray M, Bates BW. Challenges to and the future of medication safety in Saudi Arabia: A qualitative study. Saudi Pharmaceutical Journal 2013. DOI: http://dx.doi.org/10.1016/j.jsps.2013.08.001. (IF: 0.954)
236. Mahmoud MA, Alswaida Y, Alshammari T, Khan TM, Alrasheedy A, Hassali MA, Aljadhey H. Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharmaceutical Journal 2013. DOI: http://dx.doi.org/10.1016/j.jsps.2013.07.005. (IF: 0.954)
237. Ashakka MA, Ibrahim MIM, Hassali MA. Do health professionals have positive perception towards consumer reporting of adverse drug reactions? Journal of Clinical and Diagnostic Research Oct 2013;7(10):2181-2185. (Indexed in PubMed)
238. Malik M, Hassali MA, Shafie AA, Hussain A. Why hospital pharmacists have failed to manage antimalarial drugs stock-outs in Pakistan? A qualitative insight. Malaria Research and Treatment 2013. DOI: http://dx.doi.org/10.1155/2013/342843. (Indexed in PubMed)
239. Saleem F, Hassali MA, Shafie AA, Ul Haq N, Farooqui M, Aljadhey H. Profile and predictors of health related quality of life in a hypertensive population of Pakistan. Achieve of Pharmacy Practice 2013;4(3):98-103. (Indexed in Scopus)
240. Alabid AH, Ibrahim MIM, Hassali MA. Dispensing practices of general practitioners and community pharmacists in Malaysia – A pilot study. Journal of Pharmacy Practice and Research 2013;43(3):187-189. (Indexed in PubMed)
241. Khan TM, Al-Haider I, Sulaiman SAS, Hassali MA. Linguistic validation of the 5D itching scale to Arabic in patients with end-stage kidney disease. Journal of Renal Care 2013. DOI: 10.1111/j.1755-6686.2013.12038.x. (Indexed in PubMed)
242. Syed IA, Syed Sulaiman SA, Hassali MA, Lee CK. Assessing HIV and AIDS treatment safety and health-relaed quality of life among cohort of Malaysian patients: a discussion on methodological approach. Health Expectations 2013. DOI: 10.1111/hex.12116. (IF:2.110)
243. Farooqui M, Hassali MA, Knight A, Shafie AA, Farooqui MA, Saleem F, Ul Haq N. The use of energy medicines (EM), manipulative body based therapies (MBBT), therapies from whole medical systems (WMS) and health related quality of life (HRQoL) of cancer patients. Alternative and Integrated Medicine 2013;2(5). DOI:10.4172/2327-5162.1000121. (Indexed in Scopus)
244. Chua GN, Yee LJ, Sim BA, Tan KH, Sin NK, Hassali MA, Shafie AA, Ooi GS. Job satisfaction, organization commitment and retention in the public workforce: A survey among pharmacists in Malaysia. International Journal of Pharmacy Practice 2013. DOI: 10.1111/ijpp.12077. (Indexed in PubMed)
245. Matalqah LM, Radaideh KM, Sulaiman SAS, Hassali MA, Abdul Kader MAS. Relationship between patients’ warfarin knowledge and anticoagulation control: Results of a validated tool in Malaysia. Journal of Pharmaceutical and Biomedical Sciences 2013;30(30):967-974. (Indexed in PubMed)
246. Alfadl AA, Ibrahim MIM, Hassali MA. Scale development on consumer behavior toward counterfeit drugs in a developing country: A quantitative study exploiting the tools of an evolving paradigm. BMC Public Health 2013;13:829. (IF:2.076)
247. Khan TM, Hassali MA, Rasool TS. A study assessing the impact of different teaching modalities for pharmacy students in a Cardio-Pulmonary Resuscitation (CPR) course. Saudi Pharmaceutical Journal 2013 Oct;21(4):375-8. DOI: 10.1016/j.jsps.2012.11.002. (IF:0.954)
248. Alkhani S, Ahmed Y, Sabbar N, Almogirah H, Alanoud A, Albanyan H, Adam M, Saleem F, Aljadhey H, Hassali MA, Vaida A. Current practices for labelling medications in hospitals in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal 2013 Oct;21(4):345-9. DOI:10.1016/j.jsps.2012.12.002. (IF:0.954)
249. Fatokun O, Ibrahim MIM, Hassali MA. Time to entry of generic medicines in Malaysia: implications for pharmaceutical cost containment. Journal of Pharmaceutical Health Services Research, 2013.4(4):203-210. DOI 10.1111/jphs.12031. (Indexed in PubMed)
250. Ibrahim ZS, Hassali MA, Saleem F, Ul Haq N, Khan TM, Aljadhey H. Perceptions and barriers towards English language proficiency among pharmacy undergraduates at Universiti Sains Malaysia. Pharmacy Education, 2013. 13 (1): 151 – 156. (Indexed in PubMed)
251. Alabid AH, Ibrahim MIM, Hassali MA. Do Professional Practices among Malaysian Private Healthcare Providers Differ? A Comparative Study using Simulated
Patients. Journal of Clinical and Diagnostic Research. 2013 Dec, 7(12): 2912-2916. DOI: 10.7860/JCDR/2013/6198.3789. (Indexed in PubMed)
252. Ali SM, Manan MM, Hassali MA, Kassab YW, Yee CW, Masri M. Use of generic medicines: Perspectives of consumers living in urban and suburban areas of Klang Valley in Malaysia. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 2013. DOI: 10.1177/1745790413516971. (Indexed in PubMed)
253. Alfadl AA, Ibrahim MIM, Hassali MA. The impact of demographic characteristics on vulnerability of consumers to counterfeit drugs in a developing country. Journal of Socialomics 2013; 2(2): 1000102. doi:10.4172/2167-0358.1000102. (Indexed in Scopus)
254. Malik M, Hassali MA, Shafie AA, Hussain A. Knowledge and perception of prescribers regarding adherence to standard treatment guidelines for Malaria. Eastern Mediterranean Health Journal 2014; 20(4): 221-228. (Indexed in PubMed)
255. Abdulameer SA, Sulaiman SAS, Hassali MA, Sahib MN, Karuppiah S. Psychometric properties of the Malay version of the Osteoporosis Health Belief Scale (OHBS-M) among Type 2 diabetic patients. International Journal of Rheumatic Diseases 2014 Jan, 17(1):93-105. DOI: 10.1111/1756-185X.12104. (IF:1.650)
256. Hassali MA; Alrasheedy AA, McLachlan A, Nguyen TA, AL-Tamimi SK, Ibrahim MIM, Aljadhey H. The experiences of implementing generic medicines policy in eight countries: a review and recommendations for a successful promotion of generic medicines use. Saudi Pharmaceutical Journal. 2014. DOI:10.1016:j.jsps.2013.12.017. (IF:0.954)
257. Hassali MA, Ching Min-Wei, Yusoff ZM, Hussein Z, Alresheedy AA, Al-Tamimi SK, Saleem F, ul Haq N, Aljadhey H, Khan Tahir. ‘Why I do not want to take insulin shots’: Findings from a qualitative study among diabetic patients in Malaysia. Journal of Public Health 2014.22(1):3-11. DOI: 10.1007/s10389-013-0594-3. (IF:1.993)
258. Al Aqqad SMH, Chen LL, Shafie AA, Hassali MA, Tangiisuran B. The use of potentially inappropriate medications and changes in quality of life among older nursing home residents. Dove Press. 2014. Doi:10.2147/CIA.S52356. (Indexed in PubMed)
259. Alabid AH, Ibrahim MIM, Hassali MA. Antibiotics Dispensing for URTIs by Community Pharmacists (CPs) and General Medical Practitioners in Penang, Malaysia: A Comparative Study using Simulated Patients (SPs). Journal of Clinical and Diagnostic Research. 2014 Jan, 8(1): 119-123. DOI: 10.7860/JCDR/2014/6199.3923. (Indexed in PubMed)
260. Hassali MA, Alrasheedy AA, Ab Razak BA, AL-Tamimi SK, Saleem F, Ul Haq N, Aljadhey H. Assessment of General Public Satisfaction with Public Healthcare Services in Kedah, Malaysia. Australasian Medical Journal. 2014. 7(1):35-44. DOI:10.4066/AMJ.2014.1936. (Indexed in PubMed)
261. Chan HK, Bakri E, Tan SY, Hassali MA, Saleem F, Khan TM. Prescribing patterns of celecoxib and prescribers’ perceptions among three general hospitals in Northern
Malaysia. Archives of Pharmacy Practice. 2014 Jan-March, 5(1):28-34. (Indexed in Scopus)
262. Blebil, A. Q., S Sulaiman, S. A., A Hassali MA, Dujaili, J. A., & Zin, A. M. Evaluation of the Psychometric Properties of the Malay Version of the Minnesota Nicotine Withdrawal Scale. Value in Health Regional Issues, 2014, 3:19-23. (Indexed in PubMed)
263. Almalak H, Albluwi AI, Alkhelb DA, Alsaleh HM, Khan TM, Hassali MA, Aljadhey H. Students' attitude toward use of over the counter medicines during exams in Saudi Arabia. Saudi Pharm J. 2014 Apr;22(2):107-112. doi: 10.1016/j.jsps.2013.02.004. Epub 2013 Mar 21. (IF:0.954)
264. Rayes IK, Hassali MA, Abduelkarem AR. A qualitative study exploring public perceptions on the role of community pharmacists in Dubai. Pharm Pract (Granada). 2014 Jan;12(1):363. Epub 2014 Mar 24. (Indexed in PubMed)
265. Al-Jumah KA, Hassali MA, Al-Zaag I. Adaptation and validation of a questionnaire assessing patient satisfaction with pharmacy services in general hospitals. DovePress. 2014. (Indexed in PubMed)
266. Alrasheedy AA, Hassali MA, Stewart K, Kong DCM, Aljadhey H, Ibrahim MIM, Al-Tamimi SK. Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature. DovePress. 2014 April: (6):1-29. Doi:10.2147/PI.S46737. (Indexed in PubMed)
267. Blebil AQ, Sulaiman SA, Hassali MA, Dujaili JA, Zin AM. Impact of additional counselling sessions through phone calls on smokingcessation outcomes among smokers in Penang State, Malaysia. BMC Public Health 2014, 14:460 doi:10.1186/1471-2458-14-460.(IF: 2.076)
268. Mahmoud MA, Aljadhey H, Hassali MA. Prescribing errors incidence in hospitalized Saudi patients: Methodology considerations. Saudi Pharmaceutical Journal. 2014. (IF: 0.954)
269. Rayes IK, Hassali MA, Abduelkarem AR. The role of pharmacists in developing countries: The current scenario in the United Arab Emirates. Saudi Pharmaceutical Journal. 2014.(IF: 0.954)
270. Wong ZY, Hassali MA, Saleem F, Yahaya AHM, Aljadhey AH.Translation and validation of the Malaysian version of generic medicines scale. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 2014. (Indexed in PubMed)
271. Alshammari TM, Alrwisan AA, Aljeraisy MI, Taher KW, Alissa FM, Mahmoud MA, Hassali MA, Aljadhey HS. Knowledge and attitude of healthcare professionals toward medication pregnancy category systems in Saudi hospitals. Saudi Medical Journal. 2014: 35(7):704-711.(IF:0.619)
272. Alrasheedy AA, Hassali MA, Aljadhey H, Al-Tamimi SK. The Need to Cover Generic Medications and Generic Substitution Practice in the Curricula of Pharmacy
Colleges in Saudi Arabia. American journal of pharmaceutical education, 2014:78(5). (Indexed in Pubmed)
273. Haq NU, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H, Ahmad FUD, Iqbal Q. Association between Hepatitis B-Related Knowledge and Health-Related Quality of Life. Tropical Journal of Pharmaceutical Research July 2014; 13 (7): 1163-1168. (IF: 0.802).
274. Hassali MA, Wong YZ, Alrasheedy AA, Saleem F, Yahaya MHA, Aljadhey H. Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review. HealthPolicy,2014.doi:http://dx.doi.org/10.1016/j.healthpol.2014.07.014 (IF: 1.725)
275. Elkalmi MR, Hassali MA, Ibrahim MIM, Jamshed QS, Al-lela QB. Community pharmacists’ attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight. Journal of patient Safety 2014;10(2):81-87. (IF: 0.877)
276. Alfadl AA, Ibrahim MIM, Hassali MA. How ethics influence intentions to buy counterfeit drugs perceptions of policymakers, community pharmacists and consumers in Sudan. Journal of Pharmaceutical Health Services Research 2014; 5: 181–186. (Indexed in Pubmed)
277. Saleem F, Hassali MA, Ibrahim ZS, Alrasheedy AA, Aljadhey H. Perceptions and Attitudes of Pharmacy Students Towards Volunteering at Health Promotional Programs: A Cross-Sectional Study from Malaysia. Journal of Community Health 2014. doi: 10.1007/s10900-014-9930-y (IF: 1.573)
278. Hassali MA. Saleem F. The need of sociology in health education. Research in Social and Administrative Pharmacy 2014. DOI: http://dx.doi.org/10.1016/j.sapharm.2014.07.005(IF: 1.56)
279. Hassali MA, See Go, Sook MV. Pharmacy practice in Malaysia. Journal of Pharmacy Practice and Research 2014; 1-4.(Indexed in PubMed)
280. Alshakka AM, Alshami MA, Izham MIm, Hassali MA, Alresheedy A, Altamimi S. The need of pharmacovigilance activities in Yemen. Global Journal of Medical Research: Drug Discovery, Toxicology and Medicine 2014; 14(1). (Indexed in Google Scholar)
281. Chan HK, Hassali MA. Modified labels for long-term medications: influences on adherence, comprehension and preferences in Malaysia. International Journal of Clinical Pharmacy 2014; 36(5): 904-13. (IF: 1.21)
282. Awadh AI, Hassali MA, Al-lela OQ, Bux SH, Elkalmi RM and Hadi H. Does an educational intervention improve parents’ knowledge about immunization? Experience from Malaysia.BMC Pediatrics 2014, 14:254. (IF: 2.5)
283. Shafie AA, Lim YW, Chua GN, Hassali MA. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia. ClinicoEconomics and Outcomes Research 2014:6 473–481. (Indexed in Scopus)
284. Hassali MA, Saleem F, Farooqui M, Aljadhey H. Strengthening Pharmacy Practice Research: The Need for Combining both Qualitative and Quantitative Methodology. Journal of Pharmaceutical Care &Health Systems 2014, 1(3): 1000112. (Indexed in Scopus)
285. Awadh AI, Hassali MA, Al-lela OQ, Bux SH, Elkalmi RM, Hadi H. Immunization knowledge and practice among Malaysian parents: a questionnaire development and pilot-testing. BMC Public Health 2014, 14:1107. doi:10.1186/1471-2458-14-1107. (IF: 2.5)
286. Jumah KA, Hassali MA, Qhatani DA, Tahir KE. Factors associated with adherence to medication among depressed patients from Saudi Arabia: a cross-sectional study. Neuropsychiatric Disease and Treatment2014:10 2031–2037 (Indexed in PubMed)
287. Tourkmani AM, Hassali MA, Alrasheedy AA, Aljadhey H, Alharbi TJ. Diabetes mellitus in Saudi Arabia: A major public health concern. Letters to Editor. Australian Medical Journal 2014, 7(10):429–431. (Indexed in PubMed)
288. Wong ZY, Hassali MA, Alrasheedy AA, Saleem F, Yahaya AHM, Aljadhey H. Malaysian generic pharmaceutical industries: perspective from healthcare stakeholders. Journal of Pharmaceutical Health Services Research2014.doi: 10.1111/jphs.12072. (Indexed in PubMed)
289. Hassali MA, Wong ZY, Alrasheedy AA, Saleem F, Yahaya AHM, Aljadhey H. Does educational intervention improve doctors’ knowledge and perceptions of generic medicines and their generic prescribing rate? A study from Malaysia. SAGE Open Medicine 2014 2. doi:10.1177/2050312114555722 (Indexed in Google Scholar)
290. Jacob SA, Ab Rahman, Hassali MA. Health-Related Quality of Life of Patients with Chronic Depression in Malaysia. Malaysian Journal of Pschiatry 2014;23 (1). (Indexed in Google Scholar).
291. Ibrahim RI, Hassali MA. The practice of pharmacy in Iraq. Health Med 2014; 8(11):1231-234. (IF=0.3)
292. Hassali MA, Saleem F, Hanif AA, Yinn CLT, Chee LP, Fen TT, Chua GN, Khan TM. A survey assessing knowledge and perception of prescribers towards generic medicines in Hospital Seberang Jaya. Journal of Generic Medicines 2014. DOI: 10.1177/1741134314559789 (Indexed in PubMed)
293. Syed AI, Sulaiman SAS, Hassali MA, Lee KCC. Adverse drug reactions and quality of life in HIV/AIDS patients: Advocacy on valuation and role of pharmacovigilance in developing countries. HIV & AIDS Review 2014. doi:10.1016/j.hivar.2014.07.004 (Indexed in PubMed)
294. Syed AI, Sulaiman SAS, Hassali MA, Lee KCC. A qualitative insight of HIV/AIDS patients' perspective on disease and disclosure. Health Expectations 2014. doi: 10.1111/hex.12268 (IF: 2.88)
295. Syed AI, Sulaiman SAS, Hassali MA, Lee KCC. Anti-ritroviral therapy and incidence of ADR among cohort of Malaysian HIV/AIDS patients. HealthMed 2014;8(9):1041-1049. (IF: 0.35)
296. Dujaili AJ, Sulaiman SAS, Hassali MA, Awaisu A, Belbil QA, Bredle MJ. Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq. International Journal of Infectious Diseases 2014; e4–e8. (IF: 2.33)
297. Ibrahim RI, Hassali MA, Saleem F. The use of complementary and alternative medicines in hypertension: a summary of Arab region. Australasian Medical Journal 2014;7(12):476-477. (Indexed in PubMed)
298. Al-Jumah KA, Hassali MA, Al-Zaagi I. Patient satisfaction with health services provided by the pharmacist at a general hospital in Riyadh, Saudi Arabia. European Journal for Person Centered Healthcare 2014;2(4):517-522.(Indexed in PubMed)
299. Wong ZY, Hassali MA, Alrasheedy AA, Saleem F, Yahaya AHM, Aljadhey H.Patients’ Beliefs about Generic Medicines in Malaysia. Pharmacy Practice 2014;12(4):474.(Indexed in PubMed)
300. Russel V, Hassali MA, Devi U, JunMin K, Saleem F. Malaysian medical students’ perceptions of a film to promote psychiatry as a career. Australasian Psychiatry 2014 DOI: 10.1177/1039856214568221. (IF: 0.5)
301. Hassali MA, Nazir SUR, Saleem F, Imran I. Literature Review: Pharmacists’ Interventions to Improve Control and Management in Type 2 Diabetes Mellitus. Alternative Therapies in Health and Medicines 2015;21(1):28-38. (IF: 1.28)
302. Saleem F, Hashmi FK, Atif N, Bukhari NI, Ahsan M, Saeed H, Hassali MA. A cross sectional assessment of health literacy among cardiovascular patients in Karachi, Pakistan. Health Economics and Outcome Research 2015; 1(1): 1000101. doi:10.4172/ heor.1000101 (Indexed in Scopus)
303. Hassali MA, Saleem F, Farooqui M, Khan TM. Scope of Mix-method studies in Pharmacy Practice Research. Indian Journal of Pharmaceutical Education and Research 2015; 49(2):93-98.(Indexed in PubMed)
304. Jha N, Rathore SN, Shankar PR, Gyawali S, Hassali MA, Alshakka M, Alshammri TM. Strengthening adverse drug reaction reporting in Nepal 2015. Asian Journal of Medical Sciences 2015; 6(4) 9-13.(Indexed in Scopus)
305. Chan HK, Shahabudina NA, Ghania NA, Hassali MA. Satisfaction with traditional counter versus value-added services for prescription claims in a Malaysian Tertiary Hospital. Journal of Pharmaceutical Health Services Research 2015. DOI: 10.1111/jphs.12087(Indexed in PubMed)
306. Zulkiflia WN, Aziza AN, Hassan Y, Hassali MA, Bahrina ZNL. Development of validated questionnaire to access public knowledge on registered drugs. Procedia - Social and Behavioral Sciences 2015;172:749-753.(Indexed in Scopus)
307. Hassali MA, Kamil TK, Yusof FA, Alrasheedy AA, Yusoff ZM, Saleem F, Al-Tamimi SK, Wong ZY, Aljadhey H, Godman B. General practitioners' knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications. Expert Review of Anti Infective Therapies 2015; 13(4):511-520. DOI: 10.1586/14787210.2015.1012497 (IF=3.05)
308. Rezal RS, Hassali MA, Alrasheedy AA, Saleem F , Aryani FY, Godman B. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: A systematic review of the literature. Expert Review in Anti Infective Therapies 2015. DOI: 10.1586/14787210.2015.1025057 (IF=3.05)
309. Rayes I, Hassali MA, Abduelkarem A. Perception of community pharmacists towards the barriers to enhanced pharmacy services in the healthcare system of Dubai, United Arab Emirates: a quantitative approach. Pharmacy Practice 2015 (accepted, indexed in PubMed).
310. Hassali MA, Alrasheedy A, Chan WS et al. Knowledge and perceptions of physicians from private medical centres towards generic medicines in the State of Perak, Malaysia: Findings and implications. Journal of Medical Marketing, 2015. DOI: 10.1177/1745790415583734 (Indexed in PubMed).
311. Chan HK, Hassali MA, Lim CJ, Saleem F. Using pictograms to assist caregivers in liquid medication administration: a systematic review. Journal of Clinical Pharmacy and Therapeutics, 2015 doi: 10.1111/jcpt.12272 (IF: 1.50)
312. AL-Tamimi SK, Hassali MA, Shafie AA, Alrasheedy AA. Substandard medications in Yemen. AMJ 2015;8(3):100–102. (Indexed in PubMed)
313. Jacob AS, Fateh AR, Hassali MA. Attitudes and beliefs of patients with chronic depression toward antidepressants and depression. Neuropsychiatric Disease and Treatment 2015:1–8. (IF: 2.154)
314. Abdulelah J, Sulaiman SAS, Hassali MA, Blebil A, Awaisu A, Bredle J. Development and Psychometric Properties of a Tuberculosis- Specific Multi dimensiona lHealth-Related Quality-of-Life Measure for Patients with Pulmonary Tuberculosis. Value in Health Regional Issues 2015;53-59. (Indexed in PubMed)
315. Jamshed QS, Izham MIM, Hassali MA, Sharrad HK, Shafie AA, Babr ZUD. Understanding and perceptions of final-year Doctor of Pharmacy students about generic medicines in Karachi, Pakistan: a quantitative insight. Advances in Medical Education and Practice 2015:6;359–366. DOI: dx.doi.org/10.2147/AMEP.S27762 (Indexed in PubMed)
316. Bashaar M, Hassali MA, Saleem F. Community pharmacists’ attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan. Journal of Pharmaceutical Policy and Practice 2015, 8:16. (Indexed in PubMed)
317. Kumar R, Hassali MA, Saleem F et al. Knowledge and perceptions of physicians from private medical centers towards generic medicines: a nationwide survey from Malaysia. Journal of Pharmaceutical Policy and Practice. 2015,16;8(1):11.(Indexed in PubMed)
318. Jamshed SQ, Ibrahim MIM, Hassali MA, Sharrad AK, Shafie AA, Babar ZU. Understanding and perceptions of final-year Doctor of Pharmacy students about generic medicines in Karachi, Pakistan: a quantitative insight. Advances in Medical Education and Practice 2015; 6:359-366. DOI: 10.2147/AMEP.S27762 (Indexed in PubMed)
319. Saleem F, Hassali MA, Ibrahim ZH, Alrasheedy A, Aljadhey H. Learning styles of pharmacy undergraduates: Experience from a Malaysian University. Pharmacy Education 2015;15(1):173 – 177. (Indexed in PubMed)
320. Chan HK, Hassali MA, Lim JC, Saleem F. Exploring health literacy and difficulty in comprehending pediatric medication labels among caregivers in Malaysia: a pilot study. Journal of Pharmaceutical Health Services Research 2015. DOI 10.1111/jphs.12102. (Indexed in PubMed)
321. Hassali MA, Saleem F, Aljadhey H (2015) Public Perceptions towards Implementation of Dispensing Separation: Results from a Cross Sectional Analysis. Journal of Pharmaceutical Care and Health System 2015: 143. doi:10.4172/2376-0419.1000143. (Indexed in Scopus)
322. Chow PE, Hassali MA, Saleem F, Aljadhey H. Effects of pharmacist-led patient education on diabetes-related knowledge and medication adherence: A home-based study. Health Education Journal 2015. DOI: 10.1177/0017896915597021 (IF: 0.805)
323. Fatumon O, Hassali MA, Izham MIM. Characterizing pharmaceuticals on data exclusivity in Malaysia. Journal of Intellectual Property Rights 2015;20:223-229.(Indexed in Scopus)
324. Rezal SR, Hassali MA, saleem F et al. Prescribing Patterns for Upper Respiratory Tract Infections: A Prescription-Review of Primary Care Practice Malaysia and the implications. Expert Reviews in Antiinfective Therapies 2015 (Accepted, IF: 3.450)
325. Balan S, Hassali MA. Awareness, Knowledge and Views of Off-label Prescribing in Children: A systematic review. British Journal of Clinical Pharmacology 2015. (Accepted,IF: 3.878)
326. AL-Aboudi IS, Hassali MA, Shafie AA, Hassan A, Alrasheedy AA. A cross-sectional assessment of health-related quality of life among type 2 diabetes patients in Riyadh, Saudi Arabia. SAGE Open Medicine 2015. DOI: 10.1177/2050312115610129 (Indexed in PubMed)
327. Nazir SUR, Hassali MA, Saleem F, Bashir S, Aljadhey H. Disease related knowledge, medication adherence and glycaemic control among patients with type 2 diabetes mellitus in Pakistan. Primary Care Diabetes 2015. (In press, IF: 1.25)
328. Bashaar M, Hassali MA, Saleem F, Shafie AA. Assessment of medical and pharmacy students’ knowledge & perceptions about Generic Medicines’ prices & quality in Kabul, Afghanistan. Journal of Applied Pharmaceutical Science 2015;5(08):100-104. (Indexed in PubMed)
329. Tan CL, Hassali MA, Saleem F, Shafie AA, Aljadhey H, Gan VB. Development, test-retest reliability and validity of the Pharmacy Value-Added Services Questionnaire (PVASQ). Pharmacy Practice 2015; 13(3):598. (Indexed in PubMed)
330. Tan CL, Hassali MA, Saleem F, Shafie AA, Aljadhey H, Gan VB. Building intentions with the theory of planned behaviour: a qualitative assessment of salient beliefs about pharmacy value added services in Malaysia. Health Expectations 2015. DOI:10.1111/hex.12416. (IF: 2.805)
331. Blebil AQ, Sulaiman SA, Hassali MA, Dujaili JA, Zin AM. The Malay version of the brief questionnaire on smoking urge: Translation and psychometric properties of the questionnaire. Journal of epidemiology and global health. 2015 5:15-22. DOI: 10.1016/j.jegh.2014.10.006.
332. Rayes IK, Hassali MA, Abduelkarem AR. Perception of community pharmacists toward their current professional role in the healthcare system of Dubai, United Arab Emirates. Saudi Pharmaceutical Journal. 2015 Jul 31;23(3):235-40
333. Jannoo Z, Yap BW, Musa KI, Lazim MA, Hassali MA. An audit of diabetes-dependent quality of life in patients with type 2 diabetes mellitus in Malaysia. Quality of Life Research. 2015 Sep 1;24(9):2297-302.
334. Aljumah K, Hassali MA. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC psychiatry. 2015 Sep 16;15(1):219.
335. Irawati L, Hassali MA & Saleem F. 2015. Toppling the top-down approach: an example of managing antibiotic resistance in Malaysia. Australasian Medical Journal, 8, 3, 100-101
336. Irawati L, Hassali MA, Saleem F & Alrasheedy AA 2016. Community residents' knowledge and attitudes towards antibiotics in Penang, Malaysia: a cross-sectional study. Value in Health, 19(7), A813. doi:10.1016/j.jval.2016.08.692
337. Irawati L, Hassali MA, Saleem F & Alrasheedy AA 2016. Community residents' knowledge and perceptions of antibiotic resistance in Penang, Malaysia: findings and implications. Value in Health, 19(7), A914. doi:10.1016/j.jval.2016.08.121
338. Saleem F, Hassali MA. The true picture of dispensing separation in Malaysia. Research in Social and Administrative Pharmacy. 2016 Jan 1;12(1):173-4.
339. Hassali MA, Dawood OT, AL-Tamimi SK, Saleem F. Role of pharmacists in health based non-governmental organizations (NGO): prospects and future directions. Pharmaceutica Analytica Acta. 2016;7(2):467. (Indexed in Scopus)
340. Saleem F, Hassali MA, Aljadhey H. Incorporating the concept of leadership in pharmacy curriculums of developing nations. Research in Social and Administrative Pharmacy. 2016;12(4):668. (IF: 1.45)
341. ALAboudi IS, Hassali MA, Shafie AA, Saleem F. Self-efficacy, self-care behaviours and glycaemic control in type 2 diabetic patients in Riyadh, Saudi Arabia. Journal of Public Health. 2016;24(4):281-90. (IF:2.01)
342. Khan MU, Hassali MAA, Ahmad A, Elkalmi RM, Zaidi STR, Dhingra S. Perceptions and practices of community pharmacists towards antimicrobial stewardship in the state of Selangor, Malaysia. Plos one. 2016;11(2):e0149623. (IF: 3.5)
343. Dawood OT, Rashan MAA, Hassali MA, Saleem F. Knowledge and perception about health risks of cigarette smoking among Iraqi smokers. Journal of Pharmacy & Bioallied Sciences. 2016;8(2):146-51. (Indexed in PubMed)
344. Wong ZY, Alrasheedy AA, Hassali MA, Saleem F. Generic medicines in Malaysian health care system: Opportunities and challenges. Research in Social and Administrative Pharmacy. 2016;12(5):807-10. (IF: 1.438)
345. Alshakka M, Said K, Babakri M, Ansari M, Aldhubhani A, Hassali MA, et al. A study on antibiotics prescribing pattern at outpatient department in four hospitals in Aden-Yemen. Journal of Pharmacy Practice and Community Medicine. 2016;2(3):88-93. (Indexed in Scholar)
346. Syed IA, Sulaiman SAS, Hassali MA, Syed SH, Shan LH, Lee CK. Factors associated with poor CD4 and viral load outcomes in patients with HIV/AIDS. Journal of Medical Virology. 2016;88(5):790-7. (IF: 2.347).
347. Ahmadi K, Reidpath D, Allotey P, Hassali MA. A latent trait approach to measuring HIV/AIDS related stigma in healthcare professionals: application of mokken scaling technique. BMC Medical Education,2016;16:155 (IF: 1.218)
348. Aftab RA, Khan AH, Sulaiman SAS, Ali I, Hassali MA, Saleem F. An assessment of adherence to asthma medication guideline: findings from a tertiary care center in the state of Penang, Malaysia. Turkish Journal of Medical Sciences. 2016;46:1300-5. (IF: 0.32)
349. Tourkmani AM, Hassali MA, Alharbi TJ, Alkhashan HI, Alobikan AH, Bakhiet AH, Alqahtani HB, Alrasheedy AA, Alawwad AD, Mishriky AM, Aljadhey H. Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 Diabetes. Patient Preference and Adherence 2016;10:1709-1717. (IF: 1.2)
350. Saleem F, Hasaali MA, Haq Nu. Sci-Hub & ethical issues. Research in Social and Administrative Pharmacy. 2017;13(1):253. (IF: 1.95)
351. Shankar PR, Hassali MA, Shahwani NA, Iqbal Q, Anwar M, Saleem F. Responsible use of fixed-dose combination antibiotics in India. Lancet Global Health. 2016:4(10):e689. (IF: 14.74)
352. Samsiah A, Othman N, Jamshed S, Hassali MA, Wan-Mohaina WM. Medication errors reported to the National Medication Error Reporting System in Malaysia: a 4-
year retrospective review (2009 to 2012). European Journal of Clinical Pharmacology 2016:15. (IF:2.9)
353. Hassali MA, Hashmi FK, Al-Tamimi SK. Defining clinical pharmacy: a new paradigm. The Pharmaceutical Journal. 2016;297(7894).
354. Samah S, Neoh CF, Wong YY, Hassali MA, Shafie AA, Lim SM, et al. Linguistic and psychometric validation of the Malaysian version of Diabetes Quality of Life-Brief Clinical Inventory (DQoL-BCI). Research in Social and Administrative Pharmacy. 2016:1-7. (IF: 1.95)
355. Zulkifli NW, Aziz NA, Hassan Y, Hassali MA, Bahrin NL. The development of the problem solving framework in managing unregistered drugs: pharmacists’ perspectives. Journal of Pharmacy Practice and Community Medicine. 2016;2(4):123-9. (Indexed in Scholar)
356. Zulkifli NW, Aziz NA, Hassan Y, Hassali MA, Bahrin NL, Ahmad A. Are we on the right track?: Overview of unregistered drugs in Malaysia. Journal of Pharmacy Practice and Community Medicine. 2016;2(4):107-15. (Indexed in Scholar)
357. Shankar PR, Herz BL, Dubey AK, Hassali MA. Assessment of knowledge and perceptions toward generic medicines among basic science undergraduate medical students at Aruba. Indian Journal of Pharmacology 2016;48, Suppl S1:29-32. (Indexed in PubMed)
358. Saleem F, Hassali MA, Iqbal Q, Baloch M, Shanker PR. Uncontrollable medicine prices in Pakistan. The Lancet. 2016;388(10060):2602. (IF: 44.002)
359. Zulkifli NW, Aziz NA, Hassan Y, Hassali MA, Bahrin NLZ. The unregistered drugs coverage in the media in Malaysia: content analysis of the public newspapers. Research in Pharmacy and Health Sciences. 2016;2(3):196-200. (Indexed in Scholar)
360. Zulkifli WN, Aziz AN, Hassan Y, Hassali MA, Bahrin ZLN. Do current awareness and educational program towards unregistered drugs effective for public? Pharmacists' perceptive. International Journal of Pharmacy and Pharmaceutical Sciences 2016;8(7):81-85. (Indexed in Scholar)
361. Alshakka M, Ibrahim MI, Hassali MA, Palaian S, Aljadhey H. Hazards of pharmaceuticals in water as new area in eco-pharmacovigilance research. Journal of Pharmacy Practice and Community Medicine 2016;2(1):3-8. (Indexed in Scholar)
362. Hassali MA, Saleem F, Alrasheedy AA, Ibrahim ZS, Khan TM, Aljadhey H. Leadership attitudes and beliefs of pharmacy students: A cross-sectional Study from a Malaysian University. Journal of Applied Pharmaceutical Science 2016;6(10):189-194.
363. Saleem F, Hassali MA, Thanoon Dawood OT, Ahmad A, Khan MU. Cost assessment for healthy diet in the state of Penang, Malaysia. Journal of Pharmacy Practice and Community Medicine 2016;2(4):130-136.
364. Farooqui M, Hassali MA, Shatar AK, Farooqui MA, Saleem F, Haq NU, Othman CN. Use of complementary and alternative medicines among Malaysian cancer
patients: A descriptive study. Journal of Traditional and Complementary Medicine 2016;6:321-326.
365. Shafie AA, Chaiyakunapruk N, Supian A, Lim J, Zafra M, Hassali MAA. State of rare disease management in Southeast Asia. Orphanet Journal of Rare Diseases. 2016;11(1):107.
366. Dujaili JA, Sulaiman SAS, Awaisu A, Hassali MA, Blebil AQ, Bredle JM. Comparability of interviewer-administration versus self-administration of the Functional Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB) Health-Related Quality of Life questionnaire in pulmonary tuberculosis patients. Pulmonary Therapy. 2016;2(1):127-37.
367. AL‐Tamimi SK, Hassali MA, Shafie AA, ALrasheedy AA. The need to incorporate generic medicines topic in the curriculum of Yemeni pharmacy colleges. International Journal of Pharmacy Practice. 2016;24(1):72-3.
368. Al-Aboudi IS, Hassali MA, Shafie AA. Knowledge, attitudes, and quality of life of type 2 diabetes patients in Riyadh, Saudi Arabia. Journal of Pharmacy & Bioallied Sciences. 2016;8(3):195-202.
369. Hamzah AA, Maw CY, Hassali MA, Saleem F, Verma AK. Metaplastic carcinoma of breast: clinically aggressive tumour case and literature review. SMU Medical Journal 2016;3(2):6-13.
370. Saleem F, Hassali M. Promoting quality use of antibiotics in developing countries: new societal approach. Health Economics and Outcome Research: Open Access. 2016;2(2):e103.
371. Rashan MA, Dawood OT, Razzaq HA, Hassali MA. The impact of cigarette smoking on lipid profile among Iraqi smokers. International Journal of Collaborative Research on Internal Medicine and Public Health. 2016;8(8):491-500.
372. Tan BY, Shafie AA, Hassali MAA, Saleem F, Muneswarao J. Association among calendar packaging and medication adherence: findings from a focus group discussion among hypertensive patients in Penang, Malaysia. 2016:1-7. (Indexed in PubMed)
373. Ismail WI, Hassali MAA, Farooqui M, Saleem F, Aljadhey H. Perceptions of thalassemia and its treatment among Malaysian thalassemia patients: a qualitative study. Australasian Medical Journal. 2016;9(5):103-10. (Indexed in PubMed)
374. Dawood OT, Hassali MA, Saleem F. A qualitative study exploring medicines use pattern and practice among general public in Malaysia. Pharmacy Practice. 2016;14(2):740. (Indexed in PubMed)
375. Chan HK, Hassali MA, Lim CJ, Saleem F, Ghani NA. Improving pediatric liquid medication labeling of the hospital information system in Malaysia: qualitative analysis of pharmacists' perceptions. Pharmacy Practice. 2016;14(2):699. (Indexed in PubMed)
376. Haseeb A, Faidah HS, Bakhsh AR, Al Malki WH, Elrggal ME, Saleem F, et al. Antimicrobial resistance among pilgrims: a retrospective study from two hospitals in Makkah, Saudi Arabia. International Journal of Infectious Diseases. 2016;47:92-4. (IF: 2.2)
377. Hashmi FK, Saleem Z, Ahmad M, Saeed H, Aziz MT, Saleem F, Hassali MA. Comparative study of changes in renal and electrolyte profiles induced by liposomal doxorubicin versus conventional doxorubicin-based regimens in cancer patients. Journal of Pharmacy and BioAllied Sciences. 2016. (Indexed in PubMed)
378. Balan S, Hassali M, Mak V. Challenges in pediatric drug use: A pharmacist point of view. Research in Social and Administrative Pharmacy. 2016:1-3. (IF: 1.96)
379. Samsiah A, Othman N, Jamshed S, Hassali MA. Perceptions and Attitudes towards Medication Error Reporting in Primary Care Clinics: A Qualitative Study in Malaysia. PloS one. 2016 Dec 1;11(12):e0166114.
380. Gyawali S, Hassali MA, Saha A. A survey exploring the knowledge and perceptions of senior medical students in Nepal toward generic medicines. SAGE Open Medicine. 2016;4:1-6. (Indexed in PubMed)
381. Haider S, Hassali MA, Iqbal Q, Anwer M, Saleem F. Crimean-Congo haemorrhagic fever in Pakistan. Lancet Infectious Diseases 2016. (IF: 21.02)
382. Zulkifli WN, Aziz AN, Hassan Y, Hassali MA, Bahrin ZLN. Do law and regulations of unregistered drug enough? : Pharmacists' perspective. International Journal of Pharmaceutical Sciences Review and Research 2016;38(1):1-7 (Indexed in Scholar).
383. Fatokun O, Mohamed Izham MI, Hassali MA. Generic medicines entry into the Malaysian pharmaceutical market. GaBI Journal 2016; 5(4):180-1. DOI: 10.5639/gabij.2016.0504.046
384. Nazir SU, Hassali MA, Saleem F, Bashir S, Aljadhey H. A cross sectional assessment of HRQoL among diabetes patients in Pakistan. Journal of Pharmacy and Bioallied Sciences 2016; 8(1): 64–68. DOI: 10.4103/09757406.171734 (Indexed in PubMed)
385. Nazir SU, Hassali MA, Saleem F, Bashir S, Aljadhey H. Association between disease related knowledge and medication adherence among diabetes patients in Pakistan. Alternate Therapies in Health and Medicine 2016; 22(6):8-13. (IF: 1.243)
386. Hassali MA. Pharmacists’ attitudes towards domestic generics in Afghanistan. GABi journal 2016. Aiavlable at: http://www.gabionline.net/Generics/Research/Pharmacists-attitudes-towards-domestic-generics-in-Afghanistan (Indexed in PubMed)
387. Lim PC, Zubaidah CE, Hassali MA, Thiagarajan A, Khan TM. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia. Pakistan Journal of Pharmaceutical Sciences 2016; 29(2):595-601. (IF:0.628)
388. Hassali MA, AL-Tamimi SK, Dawood OT. Consumer quality use of medicines: An important element in public health. Research in Social and Administrative Pharmacy 2017; 13(1): 261–265. DOI: 10.1016/j.sapharm.2016.06.011 (IF: 1.96)
389. Bashaar M, Thawani V, Hassali MA, Saleem F. Disposal practices of unused and expired pharmaceuticals among general public in Kabul. BMC Public Health 2017; 17:45. DOI 10.1186/s12889-016-3975-z (IF: 2.209)
390. Ansari M, Humagain B, Hassali MA. Generic medicines utilizations and generic prescribing in Nepal: A reflection of current scenario and possible solutions. Research in Social and Administrative Pharmacy 2017; DOI: 10.1016/j.sapharm.2017.01.004 (IF: 0.567)
391. Alrasheedy AA, Hassali MA, Wong ZY, Saleem F. Pharmacist-managed medication therapy adherence clinics: The Malaysian experience. Research in Social and Administrative Pharmacy 2017; DOI: 10.1016/j.sapharm.2017.02.011 (IF: 0.567)
392. Tan BY, Shafie AA, Hassali MA, Saleem F, Muneswarao J. Improving medication adherence through calendar packaging: results of a randomized controlled trial among hypertensive patients. Journal of Pharmaceutical Health Services Research 2017; DOI: 10.1111/jphs.12171 (Indexed in PubMed)
393. Khan MU, Arief M, Ahmad A, Malik S, Gogoi LJ, Kalita M, Saleem F, Hassali MA. A cross-sectional survey on the attitudes and interests of rural population towards expanded pharmacist prescribing in India. International Journal of Clinical Pharmacy 2017; DOI: 10.1007/s11096-017-0443-5 (IF: 0.859)
394. Wan OS, Hassali MA, Saleem F. Community pharmacists’ perspectives of online health-related information: A qualitative insight from Kuala Lumpur, Malaysia. Health Information Management Journal 2017; DOI: 10.1177/1833358317697718 (IF: 1.00)
395. Ahmed SI, Sulaiman SA, Hassali MA, Thiruchelvam K, Hasan SS, Lee CKC. Attitudes and barriers towards HIV screening: a qualitative study of people living with HIV/AIDS (PLWHA) in Malaysia. Journal of Infection Prevention 2017; DOI: 10.1177/1757177416689723 (IF: 0.251)
396. Neoh CF, Samah S, Wong YY, Hassali MA, Shafie AA, Lim SM, Ramasamy K, Hasir NM, Han YW, Burroughs T. Response to Editor-in-Chief Letter: Linguistic and psychometric validation of the Malaysian version of Diabetes Quality of Life-Brief Clinical Inventory (DQoL-BCI): Methodological issues to avoid misinterpretation. Research in Social and Administrative Pharmacy 2017; DOI: 10.1016/j.sapharm.2017.02.004 (IF: 1.936)
397. Ibrahim, Hassali MA, Saleem F, Tukmagi H. A qualitative insight on complementary and alternative medicines used by hypertensive patients. Journal of Pharmacy And Bioallied Sciences 2017; 8(4): 284-288. DOI: 10.4103/0975-7406.199349 (Indexed in PubMed)
398. Godman B, Baker A, Leporowski A, Morton A, Baumgärtel C, Bochenek T, Fadare J, Finlayson AE, Hussein S, Khan B, Kalaba M, Kibuule D, Kwon HY, Melien O,
Nascimento RCRM, Salem A, Schiffers K, Truter I, Voncina L, Hassali MA. Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context. Medical Research Archives 2017; 5(3) DOI: 10.18103/mra.v5i3.1071 (Indexed in PubMed)
399. Alshakka M, Hassali MA, Ali H, Abdulla AS, Shankar PR, Basaleem H, Ibrahim MI. Medication Safety beyond the Hospital and Role of Pharmacists in Ambulatory Medication Safety Process. Journal of Pharmacy Practice and Community Medicine 2017; 3(2): 43-47. DOI: 10.5530/jppcm.2017.2.12 (Indexed in Index Copernicus)
400. Hassali MA, Shafie AA, Palaian S. Senior Pharmacy Students’ Knowledge and Perception towards Herbal Medicines: A Preliminary study from Malaysia. Journal of Pharmacy Practice and Community Medicine 2017; 3(2): 53-57. DOI: 10.5530/jppcm.2017.2.1 (Indexed in Index Copernicus)
401. Arief M, Hassali MA, Saleem F, Khan MU, Ahmad A, Bhagavathulha AS, Jamshed SQ. A Cross-sectional Survey on the Knowledge and Attitudes towards Zika Virus and its Prevention among Residents of Selangor, Malaysia. Journal of Pharmacy Practice and Community Medicine 2017; 3(2): 81-89. DOI: 10.5530/jppcm.2017.2.20 (Indexed in Index Copernicus)
402. Godman B, Hassali MA. Strategies for pricing of pharmaceuticals and generics in developing countries. Generics and Biosimilars Initiative journal 2017; URL: http://strathprints.strath.ac.uk/id/eprint/60303 (Indexed in Scopus – Elsevier)
403. Wong ZY, Alrasheedy AA, Hassali MA, Saleem F. Goods and Services Tax on Pharmaceuticals in Malaysia. Therapeutic Innovation & Regulatory Science 2017. DOI: 10.1177/2168479016680256 (IF: 0.5)
404. Anchah L, Hassali MA, Lim MSH, Ibrahim MIM, Sim KH, Ong TK. Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation. Health and Quality of Life Outcomes 2017; 15:10. DOI 10.1186/s12955-016-0583-7 (IF: 2.212)
405. Hamzah AA, Choo YM, Hassali MA, Saleem F, Verma AK. Disseminated Intravascular Coagulation and Excessive Fibrinolysis (DIC XFL) Syndrome in Prostate Cancer: A Rare Complicated Disorder. Journal of Clinical and Diagnostic Research 2017; 11(1): XD01-XD02. DOI: 10.7860/JCDR/2017/22582.9313 (IF: 0.3)
406. Dawood OT, Hassali MA, Saleem F. Factors affecting knowledge and practice of medicine use among the general public in the State of Penang, Malaysia. Journal of Pharmaceutical Health Services Research 2017. DOI :10.1111/jphs.12167 (Indexed in PubMed)
407. Munsour EE, Awaisu A, Hassali MA, Darwish S, Abdoun E. Readability and Comprehensibility of Patient Information Leaflets for Antidiabetic Medications in Qatar. Journal of Pharmacy Technology 2017. DOI: 10.1177/8755122517706978 (IF: 0.123)
408. Hassali MA, Munsour EE. Undertaking Bioequivalence Studies: The Challenges and Way Forward. Modern Applications of Bioequivalence & Bioavailability 2017; 1(2): MABB.MS.ID.555557.
409. Bashaar M, Hassali MA, Saleem F, ALrasheedy AA, Thawani V, Babar Z. Efficacy of international approaches to medicine price regulation and control: A scoping review. Journal of Applied Pharmaceutical Science 2017; 7(04): 227-241. DOI: 10.7324/JAPS.2017.70434 (Indexed in PubMed)
410. Ishaq R, Baloch NS, Iqbal Q, Saleem F, Hassali MA, Iqbal J, Ahmed FuD, Anwar M, Haider S, Godman B. Frequency and evaluation of the perceptions towards caesarean section among pregnant women attending public hospitals in Pakistan and the implications. Hospital Practice 2017; DOI: 10.1080/21548331.2017.1328250 (IF: 0.25)
411. Balan S, Hassali MA, Mak VSL. Non-regulatory related factors leading to off-label prescribing in children: A concept map. Research in Social and Administrative Pharmacy 2017; DOI: /10.1016/j.sapharm.2017.05.013 (IF: 2.350)
412. Kho BP, Hassali MA, Lim CJ, Saleem F. Challenges in the management of community pharmacies in Malaysia. Pharmacy Practice 2017; 15(2):933. DOI: 10.18549/PharmPract.2017.02.933 (Indexed in PubMed)
413. Hassali MA, Hussain R, Saleem F, Iq-bal Q, Arief M, Ahmad A, et al. Perceived Emotional Intelligence and Its Association with the Demographic Characteristics among Pharmacy Students: A Cross-Sectional Study. Journal of Pharmacy Practice and Community Medicine. 2017;3(3):108-13
414. Lim YW, Shafie AA, Chua GN and Hassali MA. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia. Value in Health 2017; Article in Press (IF: 3.824)
415. Hassali MA, Arief M, Fahed S, Khan MU, Akram A, Mariam W, Bheemavarapu H and Lizhar SA. Assessment of attitudes and practices of young Malaysian adults about antibiotics use: a cross-sectional study. Pharmacy Practice 2017; 15(2), p.929. (Indexed in PubMed)
416. Kho BP, Hassali MA, Lim CJ, Saleem F. A qualitative study exploring professional pharmacy services offered by community pharmacies in the state of Sarawak, Malaysia. Journal of Pharmaceutical Health Services Research 2017; Article in Press. DOI: 10.1111/jphs.12181 (Indexed in PubMed)
417. Hashmi FK, Hassali MA, Khalid A, Saleem F, Aljadhey H, Babar ZuD and Bashaar M. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan. BMC Health Services Research 2017; 17:500. DOI: 10.1186/s12913-017-2442-6 (IF: 1.827)
418. Kho BP, Hassali MA, Lim CJ, Saleem F. Challenges in the management of community pharmacies in Malaysia. Pharmacy Practice 2017; 15(2):933. DOI: 10.18549/PharmPract.2017.02.933 (Indexed in PubMed)
419. Thanimalai S, Shafie AA, Hassali MA, Sinnadurai J. Cost-Effectiveness of Warfarin Medication Therapy Adherence Clinic versus Usual Medical Clinic at Kuala Lumpur Hospital. Value In Health Regional Issues 15c (2018) 34 – 41. DOI: 10.1016/j.vhri.2017.05.006 (IF: 0.401)
420. Ghaffar R, Iqbal Q, Khalid A, Saleem F, Hassali MA, Baloch NS, Ahmad FUD, Bashir S, Haider S, Bashaar M. Frequency and predictors of anxiety and depression among pregnant women attending tertiary healthcare institutes of Quetta City, Pakistan. BMC Womens Health 2017; 17(1):51. DOI: 10.1186/s12905-017-0411-1. (IF: 1.572)
421. Al-Gethamy MM, Faidah HS, Adetunji HA, Haseeb A, Ashgar SS, Mohanned TK, Mohammed AH, Khurram M, Hassali MA. Risk factors associated with multi-drug-resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia - a matched case-control study. Journal of International Medical Research 2017; 45(3):1181-1189. DOI: 10.1177/0300060517706284. (IF: 1.323)
422. Bashaar M, Thawani V, Hassali MA, Saleem F. Erratum to: Disposal practices of unused and expired pharmaceuticals among general public in Kabul. BMC Public Health 2017; 17(1):231. DOI: 10.1186/s12889-017-4139-5. (IF: 2.209)
423. Jannoo Z, Wah YB, Lazim AM, Hassali MA. Examining diabetes distress, medication adherence, diabetes self-care activities, diabetes-specific quality of life and health-related quality of life among type 2 diabetes mellitus patients. Journal of Clinical and Translational Endocrinology 2017; In Press. DOI: 10.1016/j.jcte.2017.07.003. (IF: 0.593)
424. Dawood OT, Hassali MA, Saleem F, Ibrahim IR, Abdulameer AH, Jasim HH. Assessment of health seeking behaviour and self-medication among general public in the state of Penang, Malaysia. Pharmacy Practice. 2017 Aug 16;15(3):991. (Indexed in Scopus)
425. Yousaf, M., Asif, U., Aamir, K., ur-rehman, I., Haider, S., Bashir, A., Hashmi, F., Hassali, M. and Saleem, Z. (2017). A Retrospective Analysis Regarding Comparative Efficacy and Safety of Hyper-CVAD and MEC Chemo-Protocols in Patients with Chronic Myelogenous Leukemia from Lahore, Pakistan. Journal of Pharmaceutical Research International, 18(3), pp.1-10.
426. Al-Areefi, M., Ibrahim, M., Hassali, M. and Alfadl, A. (2017). Perceptions of Yemeni physicians about interactions with medical representatives. Journal of Pharmaceutical Health Services Research.
427. Irawati L, Hassali MA, Saleem F & Alrasheedy AA 2017. Impact of an educational intervention on community residents’ knowledge and attitudes towards antibiotics in Penang, Malaysia. Value in Health, 20(5), A82-A83. doi: 10.1016/j.jval.2017.05.005 (IF: 4.23)
428. Irawati L, Hassali MA, Saleem F & Alrasheedy AA 2017. Assessment of a pharmacistled educational programme on community residents’ knowledge and perceptions of antibiotic resistance in Penang, Malaysia. Value in Health, 20(5), A83. doi:10.1016/j.jval.2017.05.005 (IF: 4.23)
429. Tan, B.Y., Shafie, A.A., Hassali, MA and Saleem, F., 2017. Assessment of medication adherence and the costs associated with a calendar blister pack intervention among hypertensive patients in Malaysia: A randomized controlled trial. SAGE Open Medicine, 5, p.2050312117709189. (Indexed in Pub Med Central)
430. Patel, I., Hussain, R., Khan, A., Ahmad, A., Khan, M. and Hassali, MA. (2017). Antimicrobial resistance in India. Journal of Pharmaceutical Policy and Practice, 10(1). (Indexed in Pub Med Central)
431. NORDIN, Nazri; SARRIFF, Azmi; HASSALI, Mohamed Azmi. STARZ-DRP: A TOOL FOR PHARMACY TRIAGE SERVICES. Asian Journal of Pharmaceutical and Clinical Research, [S.l.], p. 151-157, sep. 2017. ISSN 2455-3891.
432. NORDIN, Nazri; HASSALI, Mohamed Azmi Ahmad; SARRIFF, Azmi. ACTUAL OR POTENTIAL EXTENDED SERVICES PERFORMED BY MALAYSIAN COMMUNITY PHARMACISTS, PERCEPTIONS AND BARRIERS TOWARDS IT’S PERFORMANCE: A SYSTEMATIC REVIEW. International Journal of Pharmacy and Pharmaceutical Sciences, [S.l.], p. 13-20, oct. 2017. ISSN 0975-1491
433. Rashid Nazir, S., Hassali, M., Saleem, F., Bashir, S. and Aljadhey, H. (2017). Does adherence to the therapeutic regimen associate with health related quality of life: Findings from an observational study of type 2 diabetes mellitus patients in Pakistan. Pak. J. Pharm. Sci., Vol.30(No.6), pp.2159-2165.(IF: 0.682)
434. Rajah R, Hassali MA and Lim CJ (2017) Health Literacy-Related Knowledge, Attitude, and Perceived Barriers: A Cross-sectional Study among Physicians, Pharmacists, and Nurses in Public Hospitals of Penang, Malaysia. Front. Public Health 5:281. doi: 10.3389/fpubh.2017.00281 (Indexed in Scopus)
435. Asif, U., Saleem, Z., Yousaf, M., Saeed, H., Hashmi, F., Islam, M., Hassali, M. and Saleem, F. (2017). Genderwise clinical response of antipsychotics among schizophrenic patients: a prospective observational study from Lahore, Pakistan. International Journal of Psychiatry in Clinical Practice, pp.1-7. (IF: 1.174)
436. Rajah, R., Hassali, M. and Lim, C. (2017). An Interprofessional Evaluation of Health Literacy Communication Practices of Physicians, Pharmacists, and Nurses at Public Hospitals in Penang, Malaysia. Annals of Pharmacotherapy, p.106002801773903. (IF: 2.059)
437. Samah, S., Neoh, C., Wong, Y., Hassali, M., Shafie, A., Lim, S., Ramasamy, K., Mat Nasir, N., Han, Y. and Burroughs, T. (2017). Linguistic and psychometric validation of the Malaysian version of Diabetes Quality of Life-Brief Clinical Inventory (DQoL-BCI). Research in Social and Administrative Pharmacy, 13(6), pp.1135-1141. (IF: 2.350)
438. Balan, S., Hassali, M. and Mak, V. (2017). Challenges in pediatric drug use: A pharmacist point of view. Research in Social and Administrative Pharmacy, 13(3), pp.653-655. (IF: 2.350)
439. HASSALI, M. A. A. Role of Community Pharmacists in Medication Management: Current and Future Prospects in Asia. JAS4QoL 2017, 3(3) 1:1-18.
440. Naqvi, A., Hassali, M., Aftab, M., Naqvi, S., Zehra, F., Ahmad, R. and Ahmad, N. (2017). Development of Evidence-Based Disease Education Literature for Pakistani Rheumatoid Arthritis Patients. Diseases, 5(4), p.27. (IF: 2.690)
441. Ismail, W., Hassali, M., Farooqui, M. and Saleem, F. (2017). Complementary and alternative medicine use in the patients with thalassaemia in Malaysia. Archives of Pharmacy Practice, 0(0), p.0. (Indexed in Copernicus)
442. Nordin, N., Hassali, M. and Sarriff, A. (2017). STARZ-DRP: A structured framework for teaching community pharmacists to counsel self-care customers. International Journal of Pharmacy and Pharmaceutical Sciences, 9(12), p.271.
443. Ibrahim, I., Hassali, M., Saleem, F., Al Tukmagi, H. and Dawood, O. (2017). Use of complementary and alternative medicines: a cross-sectional study among hypertensive patients in Iraq. Journal of Pharmaceutical Health Services Research.
444. Tan, C., Hassali, M., Neoh, C. and Saleem, F. (2017). A qualitative exploration of hypertensive patients’ perception towards quality use of medication and
hypertension management at the community level. Pharmacy Practice, 15(4), pp.1074-1074. (Indexed in Scopus)
Proceedings
1. Hassali MA, Haddad M, Shafie AA. Role of community pharmacists in health-related education and counselling: views from general public in the state of Penang, Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand.
2. Hassali MA, Shafie AA. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the Northern State of Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand.
3. Hassali MA, Shafie AA, Mohamad Yahaya AH. A study evaluating pattern of non-prescription purchase by consumers from community pharmacies in Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
4. Azhar S, Hassali MA, Izham M. Evaluating the perception of academic pharmacist towards their role in healthcare system of Pakistan. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
5. Azhar S, Hassali MA, Izham M. Community pharmacist perception towards their role in healthcare system of Pakistan: A quantitative assessment. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
6. Hassali MA, Shafie AA, Liau SY. Validity of EQ-5D and SF-12 among Malaysian. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
7. Saleem F, Hassali MA, Shafie AA, Adherence to anti hypertensive medication: a qualitative study on out patients visiting public hospitals of Quetta, Pakistan. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
8. Al-Haddad MS, Hassali MA, Mohamed Ibrahim MIM, Shafie AA. General public satisfaction towards the provision of healthcare delivery by government hospitals and clinics in the state of Penang. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
9. Shafie AA, Hassali MA, Mohamad Yahaya AH. Assessment of health related Quality of life (HRQOL) among non prescription medicine customers in Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
10. Solliman MM, Hassali MA, AL-Haddad M, Hadidan MM. Assessment of knowledge about tuberculosis among Libyan population in North East Libya. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
11. Al- Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S. Translation and validation of Michigan diabetes knowledge scale into Malaysian version. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
12. Elkalmi RM, Hassali MA, Izham M. Assessment of the knowledge and perception of the Malaysian community pharmacists regarding pharmacovigilance: Finding from an interventional study. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010 Phuket, Thailand
13. Jamshed SQ, Hassali MA, Ibrahim MIM, Babar ZUD, Shafie AA. Do low-income groups in Pakistan understand the concept of generic medicine? ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
14. Shafie AA, Hassali MA. Determination of community pharmacy’s dispensing cost in Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand
15. Shafie AA, Hassali MA. Relationship between healthcare professionals and population health status: Do numbers count. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
16. Alamin A, Izham M, Hassali MA. A case study evaluating the Malaysian community pharmacists’ professional practices and services. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
17. Abdul Ghani N, Shafie AA, Hassali MA. Comparison of HRQOL between patient receiving Methadone maintenance therapy (MMT) and rehabilitation program. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
18. Chiew GP, Shafie AA, Hassali MA, Awaisu A, Cheah WK. Pharmacists-run Methadone clinic in a Malaysian Public health centre: evaluating patient satisfaction and quality of life outcomes. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand
19. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SAS, Sundram S, Morisky DE. The 8-Item Morisky Medication Adherence Scale (MMAS): Translation and Validation Study Of The Malaysian Version. ISPOR 13th European Annual European Congress6-9 November, 2010 Prague, Czech Republic
20. Saleem F, Hassali MA, Shafie AA, Bashir S.Association Between Knowledge And Drug Adherence In Patients With Hypertension In Quetta, Pakistan. ISPOR 13th European Annual European Congress6-9 November, 2010 Prague, Czech Republic
21. Al-Haddad M, Hassali MA. Dispensed Medications Labelling In Malaysia: Views From General Public. ISPOR 13th European Annual European Congress6-9 November, 2010Prague, Czech Republic
22. Azhar S, Hassali MA, Izham M. Evaluating the Perception Of Hospital Pharmacists Toward Their Current Clinical Role In Health Care System Of Pakistan. ISPOR 13th European Annual European Congress6-9 November, 2010 Prague, Czech Republic
23. Jamshed SQ, Hassali MA, Ibrahim MIM, Shafie AA, Babar ZUD. Do High-Income Groups In Pakistan Understand The Concept Of Generic Medicines? ISPOR 13th European Annual European Congress6-9 November, 2010 Prague, Czech Republic
24. Al-Haddad M, Hassali MA. An Exploratory Study Evaluating the Preparedness of Practicing Community Pharmacists In Malaysia For Management Roles. ISPOR 13th European Annual European Congress6-9 November, 2010 Prague, Czech Republic
25. Ghani N, Shafie AA, Hassali MA. Cost Analysis Of Methadone Maintenance Therapy (MMT) Program In Malaysia. ISPOR 13th European Annual European Congress 6-9 November, 2010 Prague, Czech Republic
26. Saleem F, Hassali MA, Shafie AA, Bashir S. Health Related Quality of Life in hypertensive patients visiting public hospitals of Quetta, Pakistan. ISPOR 16th Annual International Meeting 21-25 May 2011, Baltimore, USA
27. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui MA. Cancer patients’ perception towards the use of traditional & complementary medicines (T&CM) for cancer treatment: a qualitative study. ISPOR 16th Annual International Meeting 21-25 May 2011, Baltimore, USA
28. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui MA. Diversity in beliefs about the causes of cancer: a qualitative approach to evaluate cancer patients’ understanding towards cancer and its causes. ISPOR 16th Annual International Meeting 21-25 May 2011, Baltimore, USA
29. Haq N, Shafie AA, Hassali MA, Ibrahim MIM, Saleem F. Assessment of knowledge and awareness of Hepatitis-B among general public in Pakistan. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
30. Haq N, Shafie AA, Hassali MA, Ibrahim MIM, Saleem F. Assessment of health related quality of life (HRQoL) in Hepatitis-B Patients. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
31. Malik M, Hassali MA, Hussain A, Shafie AA. Why don’t health practitioners prescribe rationally in malaria? A qualitative study from Pakistan. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
32. Salih M, Bahari MB, Hassali MA, Shafie AA, Al-lela OQB, Abd AY, Ganesan V. Outcomes of antiepileptic drugs uses at doses above the recommended range among children with structural-metabolic epilepsy in Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
33. Alhaddad MS, Hassali MA, Maghrabi I. Evaluation of general public’s expenditure on health products. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
34. Alhaddad MS, Hassali MA, Maghrabi I. A study exploring the general public perceptions towards medicines. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
35. Saleem F, Hassali MA, Shafie AA, Bashir S. Predictors of Medication Adherence in a Hypertensive Population. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
36. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui MA. Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study among Cancer Patients at a local hospital in Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
37. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui M. Cancer patients’ perceptions towards the integration of Traditional & complementary medicines (T&CM) into the conventional cancer treatment: A qualitative insight. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
38. Al-Qazaz HK, Sullaiman SAS, Hassali MA, Shafie AA, Sundram S, Saleem F. Diabetes medication adherence and glycemic control in Penang, Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
39. Saleem F, Hassali MA, Shafie AA, Al-Qazaz HK, Atif M, Haq N, Ahmad N, Asif M. Translation and validation study of 14-item Michigan diabetes knowledge test (MDKT): The Urdu version. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
40. Al-Qazaz HK, Sullaiman SAS, Hassali MA, Shafie AA, Sundram S, Saleem F. Knowledge, medication adherence and glycemic control among patients with type 2 diabetes mellitus. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
41. Al-Qazaz HK, Sullaiman SAS, Hassali MA, Shafie AA, Sundram S, Saleem F. Impact of knowledge on medication adherence among type 2 diabetes patients. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
42. Solliman MM, Hassali MA, Shafie AA, Atif M, Saleem F, Al-Haddad MS, Hadidan M. Treatment outcomes of new smear positive pulmonary tuberculosis patients in North East Libya. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
43. Lee ML, Hassali MA, Shafie AA. Exploring the reasons smokers dropped out after enrolling at the quit smoking clinic (QSC) in Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain
44. Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F, Ali I. Cost of chest X-ray using activity based costing approach at Penang General Hospital, Malaysia. ISPOR 17th Annual International Meeting June 2-6, 2012, Washington, DC, USA.
45. Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F. Health Related Quality Of Life Trajectories Among General Population In The State Of Penang, Malaysia Using SF-36v2 Health survey. ISPOR 17th Annual International Meeting June 2-6, 2012, Washington, DC, USA.
46. Siddiqui MJ, Jamshed SQ, Ibrahim MIM, Hassali MA, Baber ZUD, Alkalami R. Do consumers in Pakistan understand the concept of generic medicines: A Qualitative insight? 17th International Social Pharmacy Workshop, 2012. Phuket, Thailand.
47. Jamshed SQ, Ibrahim MIM, Hassali MA, Baber ZUD, Alkalami R, Siddiqui MJ. Do community pharmacists understand the concept of generic medicines: A Qualitative insight from Karachi, Pakistan? 17th International Social Pharmacy Workshop, 2012. Phuket, Thailand.
48. Jamshed SQ, Ibrahim MIM, Hassali MA, Baber ZUD, Alkalami R, Siddiqui MJ. Do hospital pharmacists understand the concept of generic medicines: A mixed-method approach? 17th International Social Pharmacy Workshop, 2012. Phuket, Thailand.
49. Fatokun O, Ibrahim MIM, Hassali MA. Entry barriers to generic medicines in Malaysia: Policy implications for drug affordability and accessibility. 17th International Social Pharmacy Workshop, 2012. Phuket, Thailand.
50. Saleem F, Hassali MA, Shafie AA, Aljadhey H, Haq N, Atif M. Does Medication Adherence Correlates With Health-Related Quality Of Life? Findings from a Descriptive Analysis. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
51. Saleem F, Hassali MA, Shafie AA, Aljadhey H, Haq N, Atif M. Association Between Knowledge And Health Related Quality Of Life? Is Patient Education Always Beneficial? ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
52. Saleem F, Hassali MA, Shafie AA, Aljadhey H, Haq N, Atif M. A Non-Clinical Randomized Controlled Trial Assessing Impact Of Pharmacists Led Intervention Programme For Enhancing Medication Adherence And Health-Related Quality Of Life. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
53. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. A Descriptive Study Of Health Related Quality Of Life Among General Population Of Quetta, Pakistan. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
54. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Assessment Of Knowledge, Attitude And Practices Of Hepatitis B Patients Towards Their Disease. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
55. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Knowledge, Attitude And Practices Towards Hepatitis-B Among General Population Of Quetta, Pakistan. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
56. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Comparison Of Knowledge, Attitude And Practice Among Hepatitis-B Patients And Healthy Population Regarding Hepatitis-B. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
57. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Association Between Knowledge And Health Related Quality Of Life In Hepatitis B Patients. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
58. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Vaccination Status Against Hepatitis B Among Healthy Population Of Quetta, Pakistan. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
59. Solliman MM, Hassali MA, Al-Haddad Ms, Atif M, Shafie A, Saleem F, Aljadhey H, Haq N. Assessment Of Knowledge About Tuberculosis Among Libyan And Non Libyan Populations In North East Libya. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
60. Solliman MM, Hassali MA, Al-Haddad Ms, Atif M, Shafie A, Saleem F, Aljadhey H, Haq N. Assessment Of Knowledge Regarding Tuberculosis Among General Population In North East Libya. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
61. Hassali MA, Al-Haddad Ms, Atif M, Shafie A, Saleem F, Aljadhey H, Haq N. A Survey Evaluating General Public Perceptions towards Traditional Medicines Used for Aphrodisiac purpose. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
62. Hassali MA, Shafie AA, Saleem F, Atif M, Chua GN, Masood I, Haq N. Community Pharmacist's Perceptions towards the Quality of Locally Manufactured Generic Medicines: A Descriptive Study from Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
63. Hassali MA, Shafie AA, Saleem F, Atif M, Chua GN, Masood I, Haq N Perceptions Among General Medical Practitioners Towards Implementation Of Medication Reconciliation Program For Patients Discharged From Hospitals In Penang, Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
64. Hassali MA, Shafie AA, Saleem F, Atif M, Chua GN, Masood I, Haq N Development Of National Medicine Brand Substitution Guidelines And Pilot Assessment Of Its Adoptability Among Community Pharmacist And General Practitioners In The State Of Penang, Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
65. Hassali MA, Shafie AA, Saleem F, Atif M, Chua GN, Masood I, Haq N Perception Towards Health Promotion Activities: Findings From A Cross Sectional Survey Among Urban Poor Population In The State Of Penang, Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
66. Shafie AA, Atif M, Sulaiman SAS, Hassali MA, Saleem F, Haq N. Discriminative Properties Of Sf36v2 Health Survey In General Population Of Penang State (Malaysia) Using Norm Based Scoring Algorithms. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
67. Asif M, Atif M, Sulaiman SAS, Hassali MA, Shafie AA, Haq N, Saleem F. Diuretic Activity Of Aqueous Extract Of Boswellia Serrata Roxb Oleo Gum in Normal Albino Rats. ISPOR
5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
68. Atif M, Asif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F, Haq N. Development And Validation Of Rp-Hplc-Uv Method For Determination Of Glipizide In Human Plasma. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
69. Zafar M, Asif M, Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F, Haq N. Gastroprotective Evaluation Of Phyllanthus Emblica In The Patients With Gastric Ulcers. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
70. Farooqui M, Hassali MA, Shafie AA, Knight As. A Cross-Sectional Assessment of the Quality Of Life of Cancer Patients and Their Complementary and Alternative Medicines (Cam) Use. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
71. Farooqui M, Hassali MA, Shafie AA, Knight As. Anticoagulation Control Of A Pharmacist Managed Anticoagulation Clinic In A National Referral Centre In Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
72. Farooqui M, Hassali MA, Shafie AA, Knight As. Use of Mind Body Complementary Therapies among Malaysian oncology patients. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
73. Farooqui M, Hassali MA, Shafie AA, Knight As. A Qualitative Exploration Of Malaysian Cancer Patients' Perceptions Towards Cancer Screening. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Centre, Taipei, Taiwan
74. Bashaar M, Hassali MA. Evaluation of Public Perception towards Medicine Quality and Prices in Afghanistan. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
75. Khan Y, Sarriff A, Hayat khan A, Hassali MA. PRE-SCREENING TOOLS: a neglected approach to diagnose and cut cost associated with osteoporosis. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
76. Khan AH, Sulaiman SAS, Abdul Muttalif AR, Hassali MA, Ahmad N. Tuberculosis treatment outcomes in patients with and without Diabetes Mellitus. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
77. Khan AH, Sulaiman SAS, Abdul Muttalif AR, Hassali MA, Ahmad N. Tuberculosis treatment outcomes in four states of Malaysia. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
78. Malik M, Hassali MA, Shaffie A. Perceptions of hospital pharmacists regarding effective antimalarial drug management in Pakistan. A qualitative insight. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
79. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Assessment of the osteoporosis self-efficacy scale in relation to Osteoprotective behaviours among type 2 diabetics patients in North Malaysia. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
80. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Translation and validation of osteoporosis health belief scale Into Malaysian version among type 2 diabetic patients. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
81. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Translation and validation of osteoporosis knowledge tool into Malaysian version among type 2 diabetics patients. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
82. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Translation and validation of osteoporosis self-efficacy scale into Malaysian version among type 2 diabetics patients. ISPOR 15th ISPOR 5th Asia Pacific Conference November 2012: Berlin, Germany.
83. Dujaili JA, Blebil AQ, Dujaili MA, Awaisu A, Hassali MA, Syed Sulaiman SA. Prevelance of pulmonary tuberculosis and multi drug resistant tuberculosis patients in Baghdad, Iraq. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
84. Masood I, Ibrahim MI, Hassali MA, Ahmad M, Shafie AA, Saleem F, Masood MI. Complete drug information, a key for safe therapy: a comparative evaluation of drug brochures used for disseminating drug information by pharmaceutical companies in Pakistan and Malaysia. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
85. Malik M, Hassali MA, Shaffie AA, Hussain A. Knowledge and perceptions of prescribers regarding adherence to standard treatment guidelines for malaria. A threat to rational treatment practices for malaria in Pakistan. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
86. Farooqui M, Hassali MA, Knight A, Shaffie AA, Saleem F, Ul Haq N. Use of biologically based therapies (bbts) and assessment of health related quality of life (hrqol) among Malaysian cancer patients. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
87. Ul Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Farooqui M, Iqbal Q. Impact of pharmacists led intervention programme towards knowledge, attitude and practice among Hepatitis-B patients in Pakistan: a non clinical randomized controlled trial. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
88. Farooqui M, Hassali MA, Shattar AK, Shafie AA, Saleem F, Ul Haq N. The use of complementary and alternative medicines (cam) among patients with cancer: a descriptive study. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
89. Saleem F, Hassali MA, Shafie AA, Ul Haq N, Aljadhey H, Farooqui M, Iqbal Q. Predictors and correlates of health related quality of life in a hypertensive population of Pakistan.ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
90. Ul Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Farooqui M, Iqbal Q. Impact of pharmacists led health education programme on health-related quality of life in Pakistani Hepatitis-B patients. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
91. Dujaili JA, Blebil AQ, Awaisu A, Bredle J, Dujaili MA, Hassali MA,Syed Sulaiman SA . Development of a multi-dimensional health related quality of life measure specific for pulmonary tuberculosis patients in Iraq. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
92. Hassali MA, Saleem F, Chua GN, Ul Haq N, Aljadhey H. A cross sectional assessment of knowledge towards diabetes mellitus among urban poor population of Penang, Malaysia. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
93. Tan CS, Hassali MA, Saleem F. A qualitative exploration of perceptions towards pharmaceutical price war among community pharmacies in the state of Penang, Malaysia. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
94. Blebil AQ, Hassali MA, Syed Sulaiman SA, Dujaili JA, Zin AM. Translation and validation process for the Minnesota nicotine withdrawal scale to the Malay language.ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
95. Blebil AQ, Hassali MA, Syed Sulaiman SA, Dujaili JA, Zin AM. The psychometric properties of the Malay version of the brief questionnaire on smoking urge. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
96. Bashaar M, Hassali MA. Assessment of physicians' knowledge and perceptions towards medicine quality and prices in Kabul, Afghanistan. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
97. Hassali MA, Saleem F, Haq N, Aljadhey H. Knowledge, belief and attitude of general practitioners in prescribing antibiotics for upper respiratory tract infections. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
98. Khan AH, Sulaiman SA, Hassali MA, Saleem F, Aftab A, Ali I. Guideline Adherence and Cost of Asthma Treatment at Emergency Department. 24th International Congress 6 –10 September 2014, Munich, Germany.
99. Khan AH, Sulaiman SA, Hassali MA, Saleem F, Aftab A, Ali I. Guideline Adherence and Identifying Cost Effective Medication. 24th International Congress 6 –10 September 2014, Munich, Germany.
Conference Presentation (Oral & Poster)
International Conferences
1. Wong J, Amir J, Hassali MA, Chua SS, Chan SP. Outpatient treatment cost of type 2 diabetes mellitus in University Malaya Medical Centre. 19th Federation of Asian Pharmaceutical Associations Congress, 5-10 October 2002, Seoul, Korea.
2. Hassali MA, Kong DCM, Stewart K. Generic Medicines: Perceptions of consumers in Melbourne. Australasian Pharmaceutical Science Association Conference, 4-7 December 2004, Melbourne, Australia.
3. Hassali MA, Kong DCM, Stewart K. Generic Medicines: Perceptions of general practitioners in Melbourne. Joint Meeting of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and Australasian Pharmaceutical Science Association, 4-7 December 2005, Melbourne, Australia.
4. Hassali MA, Kong DCM, Stewart K. Knowledge of recent pharmacy graduates about generic medicines. Australasian Pharmaceutical Science Association Conference, 3-5 December 2006, Adelaide, Australia.
5. Sulaiman SA, Khan TM, Hassali MA. A study on help seeking interventions for depression among students at a Malaysian. The 8th Asian Conference on Clinical Pharmacy,1 -4 July 2008, Surabaya, Indonesia.
6. Yaseen SA, Hassali MA, Awaisu A. An evaluation of senior pharmacy students’ perception and knowledge on complementary and alternative medicines. The 8th Asian Conference on Clinical Pharmacy, 1-4 July 2008,Surabaya, Indonesia.
7. Khan AH, Sulaiman SA, Muttalif AR, Hassali MA, Hadi MA. Epidemiological evaluation of tuberculosis in the state of Penang: A retrospective analysis of year 2006. The 8th Asian Conference on Clinical Pharmacy, 1-4 July 2008,Surabaya, Indonesia.
8. Abdullah RB, Ahmed KB, Hassali MA. Hypertension knowledge and compliance in outpatient medical clinic in Miri Hospital Sarawak Malaysia. The 8th Asian Conference on Clinical Pharmacy,1-4 July 2008,Surabaya, Indonesia.
9. Khan TM, Sulaiman SA, Hassali MA. Public believes about the complications of depression. The 8th Asian Conference on Clinical Pharmacy,1-4 July 2008,Surabaya, Indonesia.
10. Khan AH, Sulaiman SA, Muttalif AR, Hassali MA, Hadi MA. Incidence of tuberculosis among diabetic patients. The 8th Asian Conference on Clinical Pharmacy,1-4 July 2008,Surabaya, Indonesia.
11. Neoh CF, Hassali MA. A study assessing labeling standards for dispensed medications sold by community pharmacists and private medical practitioners in the state of Penang, Malaysia. The 8th Asian Conference on Clinical Pharmacy,1-4 July 2008,Surabaya, Indonesia.
12. Shafie AA, Hassali MA, Ibrahim B, Hassali JB. Evaluation of asthma knowledge and management among rural adult patients in a Malaysian district hospital. 15th
International Social Pharmacy Workshop, 8th-11th July 2008,Queenstown, New Zealand.
13. Hassali MA, Shafie AA, Saeed M. A pilot study on the perceptions of general medical practitioners in the state of Penang, Malaysia, towards the professional training and roles of community pharmacists. 15th International Social Pharmacy Workshop, 8th-11th July 2008,Queenstown, New Zealand.
14. Jamshed S, Babar ZU, Hassali MA, Ibrahim MI, Masood MI, Hussain A, Azhar S. Evaluating perception,knowledge and attitude of dispensing doctors towards generic medicines in Pakistan. 22nd Federation of Asian Pharmaceutical Associations Congress (FAPA), 7th-10th November 2008, Singapore.
15. Hassali MA, Shafie AA, Ibrahim MI, Al-Haddad M. Public awareness of community pharmacy and pharmacists in Penang Island. 2nd USM-UNAIR Collaborative Conference,10-11th February 2009, Surabaya, Indonesia.
16. Hassali MA, Shafie AA, Ibrahim MI, Al-Haddad M. A study evaluating consumers’ awareness and perceptions towards health promotion activities in Penang. 2nd USM-UNAIR Collaborative Conference,10-11th February 2009, Surabaya, Indonesia.
17. Masood I, Ibrahim MIM,Hassali MA, Ahmed M, Azhar S, Jamshed S. Trends of drug promotion in Pakistan:An exploratory study.15th International Pharmacy Conference & Exihibition, 5-8th April 2009, Lahore, Pakistan.
18. Jamshed S, Hassali MA,Ibrahim MI, Babar ZU. Understanding and perception of generic medicines among hospital pharmacists in Pakistan.69th International Congress of FIP, 3-8 September 2009, Istanbul, Turkey.
19. Guzman JL, Sulaiman SA, Hassali MA, Shafie AA, Masood I. A pilot study evaluating the perceptions towards provision of extended pharmacy services among community pharmacists in the state of Penang. The 9th Asian Conference on Clinical Pharmacy, 26-28 September 2009,Seoul, Korea.
20. Sulaiman SA, Khan AH, Muttalif AR, Hassali MA. Sustainable health evaluation of tuberculosis in a prison: Malaysian experience.The 9th Asian Conference on Clinical Pharmacy, 26-28 September 2009,Seoul, Korea.
21. Azhar S, Hassali MA, Ibrahim MI. Doctors’ perception and expectations towards the role of pharmacist in Pakistan’s healthcare system.The 9th Asian Conference on Clinical Pharmacy, 26-28 September 2009,Seoul, Korea.
22. Alkalmi RM, Hassali MA, Ibrahim MI, Liau SY. Awareness and attitude of Malaysian community pharmacists towards ADR reporting. The 9th Asian Conference on Clinical Pharmacy, 26-28 September 2009,Seoul, Korea.
23. Al-Qazaz HK, Sulaiman SA, Hassali MA. Experience and knowledge of diabetic patients about their medications use: a qualitative study among patients attending a university
primary care center in Malaysia.The 9th Asian Conference on Clinical Pharmacy, 26-28 September 2009,Seoul, Korea.
24. Ibrahim SS, Sulaiman SA, Hassali MA,AbouglambouAS. Glycaemic targets achieved among type 2 diabetes patients.The 9th Asian Conference on Clinical Pharmacy, 26-28 September 2009,Seoul, Korea.
25. Sulaiman SA, Ibrahim SS, Hassali MA. Hypertension prevalence among type 2 diabetics. The 9th Asian Conference on Clinical Pharmacy, 26-28 September 2009,Seoul, Korea.
26. Azhar S,Hassali MA, Ibrahim MI. Nurses’ perceptions and expectations towards the role of pharmacist in Pakistan’s healthcare system: quantitative approach. International Conference on Pharmacy and Advanced Pharmaceutical Science, 5-6 October 2009, Yogyakarta, Indonesia.
27. Jamshed S, Ibrahim MI, Hassali MA, Babar ZU. Understanding and perception of dispensing doctors towards generic medicines in Karachi, Pakistan: An exploratory study.International Conference on Pharmacy and Advanced Pharmaceutical Science, 5-6 October 2009, Yogyakarta, Indonesia.
28. Hassali MA, Shafie AA, Egah P, Nazir MA, Awaisu A. A pilot study exploring utilization of drug information resources and perceptions towards Continuing Professional Development program among community pharmacistsin the state of Penang, Malaysia. The 4th Asian Conference on Pharmacoepidemiology, 23-25 October 2009, Tainan, Taiwan.
29. Shafie AA, Hassali MA, Yahaya AHM. Assessment of health related Quality of Life (HRQoL) among community pharmacy’s customers in Malaysia. The 4th Asian Conference on Pharmacoepidemiology, 23-25 October 2009, Taiwan.
30. Chong CP, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution pratices among Malaysian community pharmacists.The 4th Asian Conference on Pharmacoepidemiology, 23-25 October 2009, Tainan, Taiwan.
31. Azhar S, Hassali MA, Ibrahim MIM. A qualitative study evaluating perception of hospital pharmacists towards their role in Pakistan’s healthcare system. Health Services Research and Pharmacy Practice Conference, 12-13th April 2010Manchester, United Kingdom.
32. Saleem F, Hassali MA, Akmal A, Bashir S. Drug adherence to anti hypertensive agent: a qualitative study on out patients visiting public hospitals of Quetta , Pakistan. National Medicine Symposium, 26-28 May 2010, Melbourne, Australia.
33. Hassali MA, Akmal A, Hariraj A. An exploratory study evaluating self –medication practices among adult population in Kuala Lumpur, Malaysia. National Medicine Symposium, 26-28 May 2010, Melbourne, Australia.
34. Hassali MA, Akmal A, Awaisu A, Chua G. A survey exploring knowledge and perception of general practitioners towards the use of generic medicines in the northern state of Malaysia. National Medicine Symposium, 26-28 May 2010, Melbourne, Australia.
35. Hassali MA, Akmal A, Awaisu A, Egah P, Nazir M. A pilot study exploring utilization of drug information resources and perception towards continuing professional development programs among community pharmacists in the state of Penang, Malaysia. National Medicine Symposium, 26-28 May 2010, Melbourne, Australia.
36. Hassali MA, Haddad M, Shafie AA. Role of community pharmacists in health-related education and counseling: views from general public in the state of Penang, Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand.
37. Hassali MA, Shafie AA. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the NorthernState of Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
38. Hassali MA, Shafie AA, Mohamad Yahaya AH. A study evaluating pattern of non-prescription purchase by consumers from community pharmacies in Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
39. Azhar S, Hassali MA, Izham M. Evaluating the perception of academic pharmacist towards their role in healthcare system of Pakistan. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand
40. Azhar S, Hassali MA, Izham M. Community pharmacist perception towards their role in healthcare system of Pakistan: A quantitative assessment. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
41. Hassali MA, Shafie AA, Liau SY. Validity of EQ-5D among Malaysian. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
42. Saleem F, Hassali MA, Shafie AA, Adherence to anti hypertensive medication: a qualitative study on out patients visiting public hospitals of Quetta , Pakistan. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
43. Al-Haddad MS, Hassali MA, Mohamed Ibrahim MIM, Shafie AA. General public satisfaction towards the provision of healthcare delivery by government hospitals and clinics in the state of Penang. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
44. Shafie AA, Hassali MA, Mohamad Yahaya AH. Assessment of health related Quality of life (HRQOL) among non prescription medicine customers in Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
45. Solliman MM, Hassali MA, AL-Haddad M, Hadidan MM. Assessment of knowledge about tuberculosis among Libyan population in North East Libya. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
46. Al- Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S. Translation and validation of Michigan diabetes knowledge scale into Malaysian version. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
47. Elkalmi RM, Hassali MA, Izham M. Assessment of the knowledge and perception of the Malaysian community pharmacists regarding pharmacovigilance:Finding from an interventional study. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010 Phuket, Thailand.
48. Jamshed SQ, Hassali MA, Ibrahim MIM, Babar ZUD, Shafie AA. Do low -income groups in Pakistan understand the concept of generic medicine. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
49. Shafie AA, Hassali MA. Determination of community pharmacy’s dispensing cost in Malaysia. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
50. Shafie AA, Hassali MA. Relationship between healthcare professionals and population health status: Do numbers count. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
51. Alamin A, Izham M,Hassali MA. A case study evaluating the Malaysian community pharmacists’ professional practices and services. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010,Phuket, Thailand.
52. Abdul Ghani N, Shafie AA, Hassali MA. Comparison of HRQOL between patient receiving Methadone maintenance therapy (MMT) and rehabilitation program. ISPOR 4TH Asia-Pacific Conference 5-7 Septembe 2010,Phuket, Thailand.
53. Chiew GP, Shafie AA, Hassali MA, Awaisu A, Cheah WK. Pharmacists-run Methadone clinic in a Malaysian Public health center: evaluating patient satisfaction and quality of life outcomes. ISPOR 4TH Asia-Pacific Conference 5-7 September 2010, Phuket, Thailand.
54. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SAS, Sundram S, Morisky DE. The 8-Item Morisky Medication Adherence Scale (MMAS): Translation And Validation Study Of The Malaysian Version. ISPOR 13th European Annual European Congress6-9 November, 2010Prague, Czech Republic.
55. Saleem F, Hassali MA, Shafie AA, Bashir S.Association Between Knowledge And Drug Adherence In Patients With Hypertension In Quetta, Pakistan. ISPOR 13th European Annual European Congress6-9 November, 2010Prague, Czech Republic.
56. Al-Haddad M, Hassali MA.Dispensed Medications Labeling In Malaysia: Views From General Public. ISPOR 13th European Annual European Congress6-9 November, 2010Prague, Czech Republic.
57. Azhar S, Hassali A, Izham M.Evaluating The Perception Of Hospital Pharmacists Toward Their Current Clinical Role In Health Care System Of Pakistan. ISPOR 13th European Annual European Congress6-9 November, 2010Prague, Czech Republic.
58. Jamshed SQ, Hassali MA, Ibrahim MIM, Shafie AA, Babar ZUD.Do High-Income Groups In Pakistan Understand The Concept Of Generic Medicines?ISPOR 13th European Annual European Congress6-9 November, 2010Prague, Czech Republic.
59. Al-Haddad M, Hassali MA. An Exploratory Study Evaluating The Preparedness OfPracticing Community Pharmacists In Malaysia For Management Roles. ISPOR 13th European Annual European Congress6-9 November, 2010Prague, Czech Republic.
60. Ghani N, Shafie AA, Hassali MA. Cost Analysis Of Methadone Maintenance Therapy (MMT) Program In Malaysia. ISPOR 13th European Annual European Congress 6-9 November, 2010Prague, Czech Republic.
61. Hassali MA, Shafie AA, Chua GN, Awaisu A.Barriers to Generic Medicines Use in Developing Countries: Findings from a Survey Among General Practitioners in the Northern State of Malaysia. First Global Symposium on Health Systems Research 16-19 November 2010, Montreux, Switzerland.
62. Jamshed SQ, Obaid RM, Hassali MA, Siquidi MJA, Azhar I, Saleem F. Do pharmacy students in Pakistan understand the concept of cancer? The 7th Pharmaceutical Care Network Europe (PCNE) Working Conference 23-26 March 2011, Manchester, United Kingdom.
63. Saleem F, Hassali MA, Shafie AA, Bashir S. Health Related Quality of Life in hypertensive patients visiting public hospitals of Quetta, Pakistan. ISPOR 16th Annual International Meeting 21-25 May 2011, Baltimore, USA.
64. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui MA. Cancer patients’ perception towards the use of traditional & complementary medicines (T&CM) for cancer treatment: a qualitative study. ISPOR 16th Annual International Meeting 21-25 May 2011, Baltimore, USA.
65. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui MA. Diversity in beliefs about the causes of cancer: a qualitative approach to evaluate cancer patients’ understanding towards cancer and its causes. ISPOR 16th Annual International Meeting 21-25 May 2011, Baltimore, USA.
66. Shafie F, Shafie AA, Hassali MA. The impact of medication adherence on quality of life among type 2 diabetes patient. 5th conference of the Asian Association of Schools of Pharmacy (AASP) 16-19 June 2011, Bandung, Indonesia.
67. Jacob SA, Rahman AFA, Hassali MA. Randomized pharmacy-managed adherence program in Malaysian patient with depression. 5th Conference of the Asian Association of Schools of Pharmacy (AASP) 16-19 June 2011,Bandung, Indonesia.
68. Shafie AA, Hassali MA, Saleem F, Qazaz H. Evaluation of Pharmacoepidemiology Course For Undergraduate Pharmacy Program In MalaysiaThe 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 19-20 July, Yogyakarta, Indonesia.
69. Haq N, Shafie AA, Hassali MA, Ibrahim MIM, Saleem F. Assessment of knowledge and awareness of Hepatitis-B among general public in Pakistan. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
70. Haq N, Shafie AA, Hassali MA, Ibrahim MIM, Saleem F. Assessment of health related quality of life (HRQoL) in Hepatitis-B Patients. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
71. Malik M, Hassali MA, Hussain A, Shafie AA. Why don’t health practitioners prescribe rationally in malaria? A qualitative study from Pakistan. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
72. Salih M, BahariMB, Hassali MA, Shafie AA, Al-lela OQB, Abd AY, Ganesan V. Outcomes of antiepileptic drugs uses at doses above therecommended range among children with structural-metabolicepilepsy in Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
73. Alhaddad MS,Hassali MA, Maghrabi I. Evaluation of general public’s expenditure on health products. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
74. Alhaddad MS,Hassali MA, Maghrabi. A study exploring the general publicperceptions towards medicines. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
75. Saleem F, Hassali MA, Shafie AA, Bashir S. Predictors of Medication Adherence in a Hypertensive Population. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
76. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui MA. Disclosing Traditional & Complementary Medicines (T&Cm) Use to the Health Care Providers: A Qualitative Study among Cancer Patients at alocal hospital in Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
77. Farooqui M, Hassali MA, Knight A, Shafie AA, Tan BS, Farooqui M. Cancer patients’ perceptions towards the integration ofTraditional & complementary medicines (T&Cm) into the conventional cancer treatment: A qualitative insight. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
78. Al-Qazaz HK, Sullaiman SAS, Hassali MA, Shafie AA, Sundram S, Saleem F. Diabetes medication adherence and glycemic control in Penang,Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
79. Saleem F, Hassali MA, Shafie AA, Al-Qazaz HK, Atif M, Haq N, Ahmad N, Asif M. Translation and validation study of 14-item Michigan diabetesknowledge test (MDKT): The Urdu version. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
80. Al-Qazaz HK, Sullaiman SAS, Hassali MA, Shafie AA, Sundram S, Saleem F. Knowledge, medication adherence and glycemic control amongpatients with type 2 diabetes mellitus. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
81. Al-Qazaz HK, Sullaiman SAS, Hassali MA, Shafie AA, Sundram S, Saleem F. Impact of knowledge on medication adherence among type 2 diabetes patients. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
82. Solliman MM, Hassali MA, Shafie AA, Atif M, Saleem F, Al-Haddad MS, Hadidan M. Treatment outcomes of new smear positive pulmonarytuberculosis patients in North East Libya. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
83. Lee ML,Hassali MA, Shafie AA. Exploring the reasons smokers dropped out after enrolling at thequit smoking clinic (QSC) in Malaysia. ISPOR 14th Annual European Congress, 5-8 November 2011, Madrid, Spain.
84. Hassan B, Yusoff Z, Hassali MA, Othman S. Association of cancer stages and calcium level with chemotherapy doses. The 4th International Cancer Control Congress, 3-5 November 2011, Republic of Korea.
85. Hassali MA, Shafie AA, Awaisu A, Al-Haddad MS, Masood I, Saleem F, Al-Qazaz HK. Public Knowledge and Attitudes toward Antibiotic Usage: Findings from a Cross-Sectional Survey in the State of Penang, Malaysia. Third international Conference for Improving Use of Medicines Informed Strategies, Effective Policies, Lasting Solutions, November 14-18, 2011 Antalya, Turkey.
86. Hassali MA, Yee SM, Shafie AA, Tambyappa J, Al-Haddad MS, Masood I, Saleem F, Al-Qazaz HK. Evaluation of Prescribing Practices by Assistant Medical Officers at Malaysian Public Health Care Facilities. Third international Conference for Improving Use of Medicines Informed Strategies, Effective Policies, Lasting Solutions, November 14-18, 2011 Antalya, Turkey.
87. Alfadl AA, Izham MIM, Hassali MA. Consumer behavior toward counterfeit drugs: scale development in a developing country setting. Third international Conference for Improving Use of Medicines Informed Strategies, Effective Policies, Lasting Solutions, November 14-18, 2011 Antalya, Turkey.
88. Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F. Health related Quality of life profile of general population in the state of Penang, Malaysia. 7th Indochina Conference of Pharmaceutical Sciences, December 14-16, 2011, Bangkok, Thailand.
89. Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F. Determination of Chest X-ray cost using activity based approach at Penang General Hospital, Malaysia. 7th Indochina Conference of Pharmaceutical Sciences, December 14-16, 2011, Bangkok, Thailand.
90. Saleem F, Hassali MA, Shafie AA. Predictors of medication adherence in a hypertensive population. Health system reform in Asia. 9-12 December, 2011, Hong Kong.
91. Shafie AA, Hassali MA. Exploring the willingness to pay for voluntary community-based health insurance in Malaysia. Health System Reform in Asia. 9-12 December, 2011, Hong Kong.
92. Shafie AA, Khor XY, Hassali MA. Dispensing separation - Is it worthwhile? A decision modelling approach. Health System Reform in Asia. 9-12 December, 2011, Hong Kong.
93. Low VE, Lai J, Talib N, Mohommad S, Liew BH, Hassali MA, Haq A. Competence Assessment for Pharmacist in Medication Therapy Adherence Clinic (MTAC) Warfarin Service. Assessment of Competence in Medicine and the Healthcare Professions. 15th Ottawa Conference: 9-13 March 2012, Kuala Lumpur Convention Centre, Malaysia.
94. Jamshed SQ, Hassali MA, Siddiqui MJ, Ibrahim MIM, Babar ZUD. Focus Group Discussion with Pharmacy Students on Generic Medicines: An Exploratory Insight. Assessment of Competence in Medicine and the Healthcare Professions. 15th Ottawa Conference: 9-13 March 2012, Kuala Lumpur Convention Centre, Malaysia.
95. Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F, Ali I. Cost of chest X-ray using activity based costing approach atPenang General Hospital, Malaysia. ISPOR 17th Annual International MeetingJune 2-6, 2012, Washington, DC, USA.
96. Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F. Health Related Quality Of Life Trajectories Among GeneralPopulation In The State Of Penang, Malaysia Using SF-36v2 Healthsurvey. ISPOR 17th Annual International MeetingJune 2-6, 2012, Washington, DC, USA.
97. Hassali MA, Shafie AA, Saleem F, A tif M, Chua G. A survey evaluating general public perceptions towards traditional medicines used for aphrodisiac purpose. Asia Pacific Conference on National Medicines Policies; Better Health through National Medicine Policies, 26-29 May 2012, Sydney, Australia.
98. Hassali MA, Shafie AA, Saleem F, A tif M, Chua G. Perceptions among general medical practitioners towards implementation of medication reconciliation program for patients discharged from hospitals in Penang, Malaysia. Asia Pacific Conference on National Medicines Policies; Better Health through National Medicine Policies, 26-29 May 2012, Sydney, Australia.
99. Hassali MA, Shafie AA, Saleem F, A tif M, Chua G. Community pharmacists' perceptions of the quality of locally manufactured generic medicines: a descriptive study from
Malaysia. Asia Pacific Conference on National Medicines Policies; Better Health through National Medicine Policies, 26-29 May 2012, Sydney, Australia.
100. Salih RMM, Bahari BM, Hassali MA, Shafie AA, Al-lelaa BO, Abda A, Ganesanc V. Outlines of seizure frequency in children with st ructural-metabolic epilepsy: a Malaysian experience. 9thHTAi Annual Meeting. “HTA in Integrated Care for a Patient Centered System”Bilbao, 23rd-27th June 2012.
101. Saleem F, Hassali MA, Shafie AA, Aljadhey H, Haq N, Atif M. Does Medication Adherence Correlates With Health Related Quality Of Life? Findings from a Descriptive Analysis. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
102. Saleem F, Hassali MA, Shafie AA, Aljadhey H, Haq N, Atif M. Association Between Knowledge And Health Related Quality Of Life? Is Patient Education Always Beneficial? ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
103. Saleem F, Hassali MA, Shafie AA, Aljadhey H, Haq N, Atif M. A Non-Clinical Randomized Controlled Trial Assessing Impact Of Pharmacists Led Intervention Programme For Enhancing Medication Adherence And Health-Related Quality Of Life. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
104. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. A Descriptive Study Of Health Related Quality Of Life Among General Population Of Quetta, Pakistan. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
105. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Assessment Of Knowledge, Attitude And Practices Of Hepatitis B Patients Towards Their Disease. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
106. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Knowledge, Attitude And Practices Towards Hepatitis-B Among General Population Of Quetta, Pakistan. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
107. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Comparison Of Knowledge, Attitude And Practice Among Hepatitis-B Patients And Healthy Population Regarding Hepatitis-B. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
108. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Association Between Knowledge And Health Related Quality Of Life In Hepatitis B Patients. ISPOR
5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
109. Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Atif M, Iqbal Q. Vaccination Status Against Hepatitis B Among Healthy Population Of Quetta, Pakistan. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
110. Solliman MM, Hassali MA, Al-Haddad Ms, Atif M, Shafie A, Saleem F, Aljadhey H, Haq N. Assessment Of Knowledge About Tuberculosis Among Libyan And Non Libyan Populations In North East Libya. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
111. Solliman MM, Hassali MA, Al-Haddad Ms, Atif M, Shafie A, Saleem F, Aljadhey H, Haq N. Assessment Of Knowledge Regarding Tuberculosis Among General Population In North East Libya. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
112. Solliman MM, Hassali MA, Al-Haddad Ms, Atif M, Shafie A, Saleem F, Aljadhey H, Haq N. A Survey Evaluating General Public Perceptions towards Traditional Medicines Used for Aphrodisiac purpose. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
113. Hassali MA, Shafie AA, Saleem F, Atif M, Chua Gn, Masood I, Haq N. Community Pharmacist's Perceptions towards the Quality of Locally Manufactured Generic Medicines: A Descriptive Study from Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
114. Hassali MA, Shafie AA, Saleem F, Atif M, Chua Gn, Masood I, Haq N Perceptions Among General Medical Practitioners Towards Implementation Of Medication Reconciliation Program For Patients Discharged From Hospitals In Penang, Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
115. Hassali MA, Shafie AA, Saleem F, Atif M, Chua Gn, Masood I, Haq N Development Of National Medicine Brand Substitution Guidelines And Pilot Assessment Of Its Adoptability Among Community Pharmacist And General Practitioners In The State Of Penang, Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
116. Hassali MA, Shafie AA, Saleem F, Atif M, Chua Gn, Masood I, Haq N Perception Towards Health Promotion Activities: Findings From A Cross Sectional Survey Among Urban Poor Population In The State Of Penang, Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
117. Shafie AA, Atif M, Sulaiman Sa, Hassali MA, Saleem F, Haq N. Discriminative Properties Of Sf36v2 Health Survey In General Population Of Penang State (Malaysia) Using Norm
Based Scoring Algorithms. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
118. Asif M, Atif M, Sulaiman SAS, Hassali MA, Shafie AA, Haq N, Saleem F. Diuretic Activity Of Aqueous Extract Of Boswellia Serrata Roxb Oleo Gum in Normal Albino Rats. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
119. Atif M, Asif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F, Haq N. Development And Validation Of Rp-Hplc-Uv Method For Determination Of Glipizide In Human Plasma. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
120. Zafar M, Asif M, Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F, Haq N. Gastroprotective Evaluation Of Phyllanthus Emblica In The Patients With Gastric Ulcers. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
121. Farooqui M, Hassali MA, Shafie AA, Knight As. A Cross-Sectional Assessment Of The Quality Of Life Of Cancer Patients And Their Complementary And Alternative Medicines (Cam) Use. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
122. Farooqui M, Hassali MA, Shafie AA, Knight As. Anticoagulation Control Of A Pharmacist Managed Anticoagulation Clinic In A National Referral Centre In Malaysia. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
123. Farooqui M, Hassali MA, Shafie AA, Knight As. Prevalence Of Mind Body Complementary Therapies (Mbcts) Use And Their Potential Effects On Health Related Quality Of Life (Hrqol) In Patients With Cancer. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
124. Farooqui M, Hassali MA, Shafie AA, Knight As. A Qualitative Exploration Of Malaysian Cancer Patients' Perceptions Towards Cancer Screening. ISPOR 5th Asia Pacific Conference 2-4 September 2012. Taipei International Conventional Center, Taipei, Taiwan.
125. L.L. Chen LL, Tangiisuran B, Shafie AA, CH’NG ASH, Hassali MA. Prevalence of polypharmacy among older residents of nursing homes in the state of Penang, Malaysia and it’s impact towards health related quality of life. 12 Asian conference on Clinical pharmacy, 7-9 Juky 2012, HongKong, China.
126. Saleem F, Hassali MA, Shafie AA, Haq N, Chua GN. A randomized controlled trial assessing impact of pharmacist-led intervention programme for enhancing medication adherence and HRQoL among Pakistani hypertensive patients. Second Global Symposium on Health System Research, 2012. Beijing, China.
127. Hassali MA, Shafie AA, Saleem F, Haq N, Chua G. ADR reporting: Knowledge and perception of general public in Penang, Malaysia. Second Global Symposium on Health System Research, 2012. Beijing, China.
128. Ooi GS, Hassali MA, Shafie AA, Kong DCM, Chua GN. Perceptions, knowledge and attitude of community pharmacists in Malaysia towards professional practice: Are they ready for the next leap forward? Second Global Symposium on Health System Research, 2012. Beijing, China.
129. Bashaar M, Hassali MA. Evaluation of Public Perception towards Medicine Quality and Prices in Afghanistan. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
130. Khan Y, Sarriff A, Hayat khan A, Hassali MA. PRE-SCREENING TOOLS: a neglected approach to diagnose and cut cost associated with osteoporosis. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
131. Khan AH, Sulaiman SAS, Abdul Muttalif AR, Hassali MA, Ahmad N. Tuberculosis treatment outcomes in patients with and without Diabetes Mellitus. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
132. Khan AH, Sulaiman SAS, Abdul Muttalif AR, Hassali MA, Ahmad N. Tuberculosis treatment outcomes in four states of Malaysia. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
133. Malik M, Hassali MA, Shaffie A. Perceptions of hospital pharmacists regarding effective antimalarial drug management in Pakistan. A qualitative insight. ISPOR 15thAnnual European Congress November 2012: Berlin, Germany.
134. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Assessment of the osteoporosis self-efficacy scale in relation to Osteoprotective behaviours among type 2 diabetics patients in North Malaysia. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
135. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Translation and validation of osteoporosis health belief scale Into Malaysian version among type 2 diabetic patients. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
136. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Translation and validation of osteoporosis knowledge tool into Malaysian version among type 2 diabetics patients. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
137. Abdulameer SA, Sulaiman SAS, Hassali MA, Subramaniam K, Sahib MN. Translation and validation of osteoporosis self-efficacy scale into Malaysian version among type 2 diabetics patients. ISPOR 15th Annual European Congress November 2012: Berlin, Germany.
138. Dujaili JA, Blebil AQ, Dujaili MA, Awaisu A, Hassali MA, Syed Sulaiman SA. Prevelance of pulmonary tuberculosis and multi drug resistant tuberculosis patients in Baghdad, Iraq. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
139. Masood I, Ibrahim MI, Hassali MA, Ahmad M, Shafie AA, Saleem F, Masood MI. Complete drug information, a key for safe therapy: a comparative evaluation of drug brochures used for disseminating drug information by pharmaceutical companies in Pakistan and Malaysia. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
140. Malik M, Hassali MA, Shaffie AA, Hussain A. Knowledge and perceptions of prescribers regarding adherence to standard treatment guidelines for malaria. A threat to rational treatment practices for malaria in Pakistan. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
141. Farooqui M, Hassali MA, Knight A, Shaffie AA, Saleem F, Ul Haq N. Use of biologically based therapies (bbts) and assessment of health related quality of life (hrqol) among Malaysian cancer patients. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
142. Ul Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Farooqui M, Iqbal Q. Impact of pharmacists led intervention programme towards knowledge, attitude and practice among Hepatitis-B patients in Pakistan: a non clinical randomized controlled trial. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
143. Farooqui M, Hassali MA, Shattar AK, Shafie AA, Saleem F, Ul Haq N. The use of complementary and alternative medicines (cam) among patients with cancer: a descriptive study. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
144. Saleem F, Hassali MA, Shafie AA, Ul Haq N, Aljadhey H, Farooqui M, Iqbal Q. Predictors and correlates of health related quality of life in a hypertensive population of Pakistan. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
145. Ul Haq N, Hassali MA, Shafie AA, Saleem F, Aljadhey H, Farooqui M, Iqbal Q. Impact of pharmacists led health education programme on health-related quality of life in Pakistani Hepatitis-B patients. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
146. Dujaili JA, Blebil AQ, Awaisu A, Bredle J, Dujaili MA, Hassali MA, Syed Sulaiman SA . Development of a multi-dimensional health related quality of life measure specific for pulmonary tuberculosis patients in Iraq. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
147. Hassali MA, Saleem F, Chua GN, Ul Haq N, Aljadhey H. A cross sectional assessment of knowledge towards diabetes mellitus among urban poor population of Penang, Malaysia. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
148. Tan CS, Hassali MA, Saleem F. A qualitative exploration of perceptions towards pharmaceutical price war among community pharmacies in the state of Penang, Malaysia. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
149. Blebil AQ, Hassali MA, Syed Sulaiman SA, Dujaili JA, Zin AM. Translation and validation process for the Minnesota nicotine withdrawal scale to the Malay language. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
150. Blebil AQ, Hassali MA, Syed Sulaiman SA, Dujaili JA, Zin AM. The psychometric properties of the Malay version of the brief questionnaire on smoking urge. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
151. Bashaar M, Hassali MA. Assessment of physicians' knowledge and perceptions towards medicine quality and prices in Kabul, Afghanistan. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
152. Hassali MA, Saleem F, Haq N, Aljadhey H. Knowledge, belief and attitude of general practitioners in prescribing antibiotics for upper respiratory tract infections. ISPOR 18th Annual International Meeting 2013: New Orleans, USA.
153. Aljumah K, Hassali MA. Translation into Arabic and validation of a patient satisfaction questionnaire on drug dispensing. EAHP 19th Annual Congress 2014: Barcelona, Spain.
154. Aljumah K, Hassali MA. Relationship between Adherence And Satisfaction To? Antidepressant Medication? EAHP 19th Annual Congress 2014: Barcelona, Spain.
155. Ooi GS, Hassali MA, Shafie AA, Kong DCM, Chuan GN, Mak VSL. Community Pharmacists in Malaysia: Are They Ready for The Next Leap Forward? Health Services Research & Pharmacy Practice Conference 2014: Aberdeen, UK.
156. Ismail WI, Hassali MA, Farooqui M, Saleem F. Viewpoints of thalassemia patients on the combination of traditional & complementary medicine (T&CM) with the conventional thalassemia treatment: a qualitative understanding approach. ISPOR 19th Annual European Congress, October 29-November 2, 2016, Vienna, Austria.
157. Khan MU, Ahmad A, Arief M, Saleem F, Hassali MA, Bhagavathula AS. Public knowledge and attitudes towards Zika virus and its prevention in Malaysia. . ISPOR 19th Annual European Congress, October 29-November 2, 2016, Vienna, Austria.
158. Hashmi FK, Hassali MA, Saleem F, Babar ZU. A qualitative study exploring perception and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan. . ISPOR 19th Annual European Congress, October 29-November 2, 2016, Vienna, Austria.
159. Ibrahim I, Hassali MA, Saleem F, Al Tukmagi H. Factors associated with the use of complementary medicines in hypertension. . ISPOR 19th Annual European Congress, October 29-November 2, 2016, Vienna, Austria.
160. Tan BY, Shafie AA, Hassali MA, Saleem F, Muneswarao . Assessment of medication adherence and the associated cost of calendar blister pack among hypertensive
patients in Malaysia. . ISPOR 19th Annual European Congress, October 29-November 2, 2016, Vienna, Austria.
161. Irawati L, Hassali MA, Saleem F, Alrasheedy AA. Community residents’ knowledge and attitudes towards antibiotics in Penang, Malaysia: a cross-sectional study. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
162. AL-Tamimi SK, Hassali MA, Shafie AA, Alrasheedy AA. Comparision of perception towards generic medicines between final year pharmacy and medical students in Southeast Yemen. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
163. Hoay TL, Hassali MA, Gan V, Saleem F. Building intentions with the theory of planned behaviour: the mediating role of knowledge and expectations in successful new pharmacy public health services implementation. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
164. Dawood OT, Hassali MA, Saleem F. General public knowledge and awareness about medicines use in Penang, Malaysia. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
165. Ooi GS, Hassali MA, Shafie AA, Kong DC, Mak V, Chua GN. Assessment of community pharmacy services in Malaysia: perspectives from community pharmacists, general practitioners, consumers and health policy stakeholders. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
166. Tan CL, Gan VB, Saleem F, Hassali MA. Building intentions with the theory of planned behaviour: the mediating role of knowledge and expectations in implementing new pharmaceutical services in Malaysia. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
167. Saleem F, Hassali MA. Cost assessment for healthy diet in the state of Penang, Malaysia. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
168. Chan H, Lim CJ, Hassali MA, Saleem F. Closed-system transfer device for preparation of antineoplastic drugs in a Malaysian public hospital: is it truly cost saving? ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
169. Tan BY, Shafie AA, Hassali MA, Saleem F. Improving medication adherence through calendar packaging: results of a randomized controlled trial among hypertensive patients in Malaysia. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
170. Ibrahim I, Hassali MA, Saleem F. The use of alhijama as complimentary treatment in hypertension. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
171. Ismail WI, Hassali MA, Saleem F, Farooqui M. Perceptions of thalassemia patients’ on thalassemia and its treatment : a qualitative exploration. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
172. Ismail WI, Hassali MA, Saleem F, Farooqui M. Complementaryy and Alternative Medicine (CAM) disclosure to the health care providers: a qualitative insight from
Malaysia thalassemia patients. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
173. Nazir SU, Hassali MA, Saleem F. Disease related knowledge, medication adherence and glycaemic control among patients with type 2 diabetes mellitus in Pakistan. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
174. Irawati L, Hassali MA, Saleem F, Alrasheedy AA. Community residents’ knowledge and perceptions of antibiotic resistance in Penang, Malaysia: findings and implications. ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore.
Local Conferences
1. Hassali MA, Ibrahim MI, Sulaiman SA, Ahmad Z, Hassali JB. Pharmacoeconomic evaluation of community acquired pneumonia management in paediatrics: A comparative study between single regimen I.V ampicillin versus combination regimen with I.V ampicillin plus gentamicin. 1st Asean Conference on Medical Sciences, 18-21 May 2001, Kelantan, Malaysia.
2. Azman M, Dellimin A, Izham I, Hassali MA. Medication problems among geriatrics in an outpatient pharmacy setting at the University Science of Malaysia Teaching Hospital: an economic and clinical impact. 1st Malaysian Pharmacy Scientific Conference, 22-23 October 2001, Selangor, Malaysia.
3. Ahmed SI, Abd Aziz N, Hassali MA, Hassan Y, Sulaiman SA. HIV/AIDS-Related knowledge,attitudes& risk perceptions amongst final year medical and pharmacy students at Universiti Sains Malaysia. 1St USM-UNAIR Collaborative Conference,13-14th June 2007, Penang, Malaysia.
4. Ibrahim B, Hassali MA, Bahari MB, Atan Z, Hassali JB, Harun N. Knowledge of asthma and its management among rural adults patients attending a district hospital. 1St USM-UNAIR Collaborative Conference,13-14th June 2007, Penang, Malaysia.
5. Abdul RNS, Bahari MB, Hassali MA, Sim CG,Ismail HI. A study on surfactant usage in the management of respiratory distress syndrome in Neonatal Intensive Care Unit (NICU), Hospital Kuala Lumpur. 1stUSM-UNAIR Collaborative Conference,13-14th June 2007, Penang, Malaysia.
6. Khalid Y, Sulaiman SA, Hassali MA. Evaluation the knowledge and perception of diabetics and non-diabetics towards erectile dysfunction in Universiti Sains Malaysia Campus. 1St USM-UNAIR Collaborative Conference,13-14th June 2007, Penang, Malaysia.
7. Supian A, Hassali MA, Ibrahim MI. Impact of “Pharmacist Homecare Service” on medication adherence of hypertensive patients in Seremban. 1st Hospital Pharmacy Congress,24-27 April 2008, Kuala Lumpur, Malaysia.
8. Kadir NA, Ibrahim MI, Hassali MA. Direct costs in diabetes mellitus treatment at Hospital Sultanah Fatimah, Muar, Johor. 1st Hospital Pharmacy Congress,24-27 April 2008, Kuala Lumpur, Malaysia.
9. Supian A, Hassali MA, Ibrahim MI. Characteristic of drug wastage at HospitalTuanku Jafaar, Seremban: A descriptive study.5th National Pharmacy R&D Conference,28-30 July 2008, Putrajaya, Malaysia.
10. Supian A, Hassali MA, Ibrahim MI. Medication counseling beyond institution:Impact of pharmacist home counseling session on hypertensive patients’ blood pressure control.5th National Pharmacy R&D Conference,28-30 July 2008, Putrajaya, Malaysia.
11. Anchah L, Sim KH, Ibrahim MI, Alan FYY, Tiong LL, Bibi FMS, Hassali MA, Yahaya H.The EuroQol-5D (EQ-5D) and Short-Form 36(SF-36) Health Survey Questionnaires: Reliability in ACS patient based studies. 8thMalaysian Pharmacy Scientific Conference, 15-17th August 2008, Pahang, Malaysia.
12. Syed Zainuddin SNS, Sariff A, Hassali MA, Abd Rahman H, Ayob S. Characterization of drug related problems among geriatric patients at Kuantan Health Community Clinic. 8thMalaysian Pharmacy Scientific Conference, 15-17th August 2008, Pahang, Malaysia.
13. Jayabalan T, Al-Haddad M, Hassali MA, Shafie AA. The Flip Side of Medical Tourism.2nd National Symposium on Tourism Research: Theories and Applications; 2009 July 18, Universiti Sains Malaysia, Penang, Malaysia.
14. Azuwana S, Hassali MA, Ibrahim MIM. Characteristics of drug wastage at Hospital Tuanku Jaafar, Seremban-A Descriptive Study.13th National Institutes of Health (NIH) Scientific Meeting and the 4th National Conference for Clinical Research (NCCR),2-4th June 2010 Kuala Lumpur, Malaysia.
15. Ghani NA, Shafie A, Hassali MA. Comparison of HRQOL between patient receiving Methadone Maintenance Therapy (MMT) and rehabilitation program.13th National Institutes of Health (NIH) Scientific Meeting and the 4th National Conference for Clinical Research (NCCR),2-4th June 2010 Kuala Lumpur, Malaysia.
16. Teoh TF, Ooi LH, Lim CH, Hassali MA. Determination of appropriate dosing regimen for gentamicin in neonates- a prospective study at hospital Seberang Jaya. 6TH National Pharmacy R&D Conference, 14-16 June 2010 Penang, Malaysia.
17. Awaisu A, Gayah O.Che, Razak L, Sulastri S, Nur Afni A, Mohd Ikhwan H, Mohd Haniki HM, Akmal A, Hassali MA. Development and application of a tool for measuring nicotine withdrawal systoms in smoking cessation clinics in Malaysia. 6TH National Pharmacy R&D Conference, 14-16 June 2010 Penang, Malaysia.
18. Salmah B, Othman NH, Hassali MA, Akmal A, Ibrahim MIM. A national survey on the use of medicine by Malaysian consumers. 6TH National Pharmacy R&D Conference, 14-16 June 2010 Penang, Malaysia.
19. Abougalambaou ASI, Ibrahim SS, Sulaiman SAS, Hassali MA. Assessment of lipid profile among type 2 diabetes mellitus outpatients at Universiti Sains Malaysia Hospital.14th Asia Oceania Congress of Endocrinology,2-5th December 2010, Kuala Lumpur, Malaysia.
20. Chen LL, Tangiisuran B, Shafie AA, Hassali MA. Assessment of the prevalence of potentially inappropriate medications in Penang nursing homes using STOPP screening tools. 1st Conference of MPHARM Alumni, 27th-29th May 2011 Kelantan, Malaysia.
21. Jacob S, Rahman AF, Hassali MA. Attitudes and beliefs of Malaysian patients with depression towards antidepressants.1st Conference of MPHARM Alumni, 27th-29th May 2011 Kelantan, Malaysia.
22. Jacob S, Rahman AF, Hassali MA, Zakaria AZ. Effect of a pharmacy-managed adherence program on the attitudes and beliefs of patients with depression towards antidepressants. 16th Malaysian Conference on Psychological Medicine, 21st-23rd July 2011, Kuala Lumpur, Malaysia.
23. Jacob S, Mohammed F, Hassali MA, Shafie AA, Wong CW.Profile of clients attending a methadone clinic. 16th Malaysian Conference on Psychological Medicine, 21st-23rd July 2011, Kuala Lumpur, Malaysia.
24. Goh SL, Hassali MA, Shafie AA, Habil MH, Robson Haris NZ. Evaluation of an innovative workplace quit smoking program for smoking employees in a manufacturing companies. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
25. Ismail NE, Ismail NS, Mahmood WNW, Khan NAM, Hameed A, Adam A, Hassali MA, Shafie AA, Mohamed NHM, Mohd S, Yusuf E, Kasim Z, Efenide B, Baig MR. Perception of Pharmacy students at private Universities in Malaysia towards the role of community pharmacists. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
26. Ismail NE, Ismail NS, Mahmood WNW, Khan NAM, Hameed A, Adam A, Hassali MA, Shafie AA, Mohamed NHM, Mohd S, Yusuf E, Kasim Z, Efenide B, Baig MR. Perception of Pharmacy students at private Universities in Malaysia towards the role of pharmacists in academia. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
27. Chen LL, Tangiisuran B, Shafie AA, Hassali MA. Prevalnace and factors associated with potentially inappropriate medications among older residents in Penang nursing homes. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
28. Anchah L, Izham M, Sim KH, Alan FYY, Yanti NS, Tiong LL, Bibi FMS, Hassali MA, Yahaya H. Cost-utiliyu analysis of the modified cardiac rehabilitation program: A preference-
based on SF-36. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
29. Atif M, Sulaiman SAS, Hassali MA, Shafie AA, Saleem F, Saqib N, Zaman QM, Asif M. Development and validation of HPLC method for determination of glipizide in human plasma. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
30. Abrika OSS, Hassali MA. Abdulkarem AR. Perceptions of Libyan practitioners on the importance of social pharmacy subjects in the current pharmacy undergraduate curriculum. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
31. Ismail NE, Ismail NS, Mahmood WNW, Khan NAM, Hameed A, Adam A, Hassali MA, Shafie AA, Mohamed NHM, Mohd S, Yusuf E, Kasim Z, Efenide B, Baig MR. IPTS Pharmacist Wannabe: Personal and Career goal influences, commitment and future career ambitions. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
32. Atif M, Sulaiman SAS, Shafie AA, Hassali MA, Saleem F. HRQoL in co-morbid tuberculosis relapse patients: A case report from Malaysia. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
33. Haq N, Shafie AA, Hassali MA, Ibrahim MIM, Saleem F. Knowledge and awareness of patients regarding Hepatitis B. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
34. Hassali MA, Shafie AA, Yahaya AHM. Non-prescriptions medicines: What Malaysians purchases from community pharmacies? MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
35. Azhar S, Hassali MA, Ahmed M, Saleem F, Jamshed S, Masood I, Haq N. Perception of academic pharmacist towards their role in healthcare system of Pakistan: A qualitative assessment. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
36. Malik M, Hassali MA, Shafie AA, Hussain A. Current prescription trends in treatment of malaria in healthcare system of Pakistan. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
37. Jamshed SQ, Rajiah K, Iqbal MS, Saddiqui MJA, Saleem F, Hassali MA, Azhar I. The community pharmacist as a member of healthcare team in Karachi, Pakistan: Opinion of the patients. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
38. Fatokun O, Ibrahim MIM, Hassali MA. Generic promotion in Malaysia: Views from the Malaysian generic pharmaceutical industry stakeholders. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
39. Khor XY, Shafie AA, Hassali MA. Decision analysis modeling of dispensing separation policy in Malaysia. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
40. Jamshed SQ, Ibrahim MIM, Hassali MA, Low BY, Baber ZD, Saddiqui MJA. Is there any correlation between GPs perceptions and attitudes towards generic medicine prescribing in Karachi, Pakistan? MPS Pharmacy Scientific Conference, 21st-23rdOctober 2011, Kuala Lampur, Malaysia.
41. Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZD, Saddiqui MJA. Understanding and perceptionof community pharmacists towards generic medicine substitution: A questionnaire based study MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
42. Jamshed SQ, Azhar I, Babar ZD, Hassali MA, Saddiqui MJA, Saleem F. Understanding of primary care doctors about essential drug list (EDL): A qualitative study. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
43. Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZD, Shafie AA, Saddiqui MJA. The impact of didactic lecture to improve the understanding of Pharmacy students towards generic medicines. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
44. Hassali MA, Shafie AA, Hari R. Student’s evaluation, perception and knowledge on Pharmaceutical biotechnology course in Universiti Sains Malaysia. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
45. Malik M, Hassali MA, Shafie AA, Hussain H. Barriers to rational drug use in treatment of Malaria in healthcare facilities in Pakistan: A qualitative study. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
46. Omar WAW, Yusoff Mz, Hassali MA, Balamurugan T. The evaluation of prevalence and awareness towards hypertension control among Healthcare employess in Kerian district, Perak. MPS Pharmacy Scientific Conference, 21st-23rd October 2011, Kuala Lampur, Malaysia.
47. Saleem F, Hassali MA, Shafie AA. Association between knowledge and Health Related Quality of Life. 2nd Symposium of USM Fellowship 2011, 23-24 November, Penang, Malaysia.
48. Wei SL, Hassali MA, Shafie AA. Knowledge, perception and attitude of senior year pharmacy students about generic medicines in public universities of Malaysia. 2nd Symposium of USM Fellowship 2011, 23-24 November, Penang, Malaysia.
49. Ameer AS, Hassali MA, Thambyappa J, Shafie AA. A pilot study assessing perceptions of health status among low socio economic urban population in the state of Penang, Malaysia. 2nd Symposium of USM Fellowship 2011, 23-24 November, Penang, Malaysia.
50. Fadzilah S, Shafie AA, Hassali MA. The Impact of Medicaton Adherence on Cost among Type 2 Diabetes Patients. 8th National Pharmacy R&D Conference 2014, 10th-12th June 2014, Shah Alam Selangor.
51. Chow EP, Hassali MA. A pilot on The Effectiveness of Pharmacist initiated Home Medication Review Programme among Type 2 Diabetes Patients in The State of Penang, Malaysia. 8th National Pharmacy R&D Conference 2014, 10th-12th June 2014, Shah Alam Selangor.
52. Wong ZY, Hassali MA, Yahaya AH, Saleem F. Beliefs About Generic Medicines among Patients at a District Public Hospital in Malaysia. 8th National Pharmacy R&D Conference 2014, 10th-12th June 2014, Shah Alam Selangor.
53. Salmi MRR, Hassali MA, Saleem F. Practices and Self Confidence Towards Antibiotics Prescribing: An Exploratory Study Focusing Prescribers in The District of Kota Setar, Kedah Malaysia. 8th National Pharmacy R&D Conference 2014, 10th-12th June 2014, Shah Alam Selangor.
54. Lim CTY, Leong PC, Teoh TF, Atisha AH, Hassali MA, Chua GN. A survey Assessing Knowledge and Perception of Patients Towards Generic Medicines in Hospital Seberang Jaya (HSJ). 8th National Pharmacy R&D Conference 2014, 10th-12th June 2014, Shah Alam Selangor.

Prof. Dr. Alireza Heidari, PhD, D.Sc

Full Professor and Academic Tenure of Chemistry and Director of the BioSpectroscopy Core Research Laboratory at Faculty of Chemistry, California South University (CSU), Irvine President of American International Standards Institute (AISI), Irvine California, USA
Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.
• Biophysical Chemistry
• Biomolecular Spectroscopy
• Quantum Chemistry
• Nanochemistry
• Modern Electronic Structure Computations
• Theoretical Chemistry
• Mathematical Chemistry
• Computational Chemistry
• Vibrational Spectroscopy
• Molecular Modelling
• Ab initio & Density Functional Methods
• Molecular Structure
• Biochemistry
• Molecular Simulation
• Pharmaceutical Chemistry
• Medicinal Chemistry
• Oncology
• Synchrotron Radiation
• Synchrocyclotron Radiation
• LASER
• Anti–Cancer Nano Drugs
• Nano Drugs Delivery
• ATR–FTIR Spectroscopy
• Raman Spectroscopy
• Intelligent Molecules
• Molecular Dynamics
• Biosensors
• Biomarkers
• Molecular Diagnostics
• Numerical Chemistry
• Nucleic Acids
• DNA/RNA Monitoring
• DNA/RNA Hypermethylation & Hypomethylation
• Human Cancer Tissues
• Human Cancer Cells
• Tumors
• Cancer Tissues
• Cancer Cells

SCHOLARSHIP AWARDS:
•Sharif University of Technology scholarship for M.Sc. degree studies, Kish Island, Hormozgan, Iran, 2006.
•Islamic Azad University (IAU), North Tehran Branch, scholarship for M.Sc. degree studies, Tehran, Iran, 2006–2008.
•Islamic Azad University (IAU), North Tehran Branch, scholarship for research, Tehran, Iran, 2006–2008.
•Young Researchers Club (YRC) scholarship for M.Sc. degree studies from the Islamic Azad University (IAU), Tehran, Iran, 2006–2008.
•Young Researchers Club (YRC) scholarship for research from the Islamic Azad University (IAU), Tehran, Iran, 2006–2008.
•Islamic Azad University (IAU), Science & Research Campus, scholarship for Ph.D. degree studies, Tehran, Iran, 2009.
•Institute for Advanced Studies (IAS) scholarship for research, Tehran, Iran, 2009–2012.
•California South University (CSU) award of excellence in “Chemical Kinetics and Dynamics”, Irvine, California, USA, 2010.
•California South University (CSU) award of excellence in “Electrochemical Analysis”, Irvine, California, USA, 2012.
•California South University (CSU) award of distinction for Ph.D. in Chemistry with distinction in subject “Advanced Quantum Mechanics”, Irvine, California, USA, 2010.
•California South University (CSU) award of distinction for Ph.D. in Chemistry with distinction in subject “Advanced Research”, Irvine, California, USA, 2010.
•California South University (CSU) scholarship for Ph.D. degree studies from California South University (CSU), Irvine, California, USA, 2009–2012.
•California South University (CSU) scholarship for research, Irvine, California, USA, 2009–2012.
•California South University (CSU) scholarship for postdoctoral research, Irvine, California, USA, 2014.
•Australian Research Council (ARC) scholarship (International Postgraduate Research Scholarship (IPRS)) for research, Melbourne, Victoria, Australia, 2013–2014.
•Australian Research Council (ARC) award (Australian Postgraduate Award (APA)) for research, Melbourne, Victoria, Australia, 2013–2014.
•Monash University scholarship for research (Monash Graduate Scholarship (MGS)), Melbourne, Victoria, Australia, 2013–2014.
MEMBERSHIPS IN PROFESSIONAL SOCIETIES:
•National Memberships:
2006 – Present:
•An active member of the Iranian Mathematical Society (IMS), The Physics Society of Iran (PSI), The Islamic Azad University Young Researchers Club (YRC), Iranian Association for the Popularization of Sciences (IAPS), Central Committee for Iranian Mathematical House (CCIMH), Iranian Association for Management of Technology (IAMT), Iranian Society of Surface Science & Technology (ISST), Iranian Educational Administration Association (IEAA), Association for Scientific Development of Iran (ASDI), Iranian Curriculum Development Association (ICDA), Iranian Association of Chemical Engineers (IACE), Iranian Society of Acoustics and Vibration (ISAV), Iranian Society for Industry and Academia (ISIA), Council of Iranian Scientific Associations (CISA), Iranian Society of Engineering Education (ISEE), Iranian Project Management Association (IPMA), Iranian Education Research Association (IERA), Iranian Society of Optical and Photonics (ISOP), Iranian Metallurgical Engineers Society (IMES), Iran Society of Biophysical Chemistry (ISBC), Institute for Advanced Studies (IAS), Iranian Higher Education Association (IHEA), Iranian Operations Research Society (IORS), Iranian Nanotechnology Society (INS), Iranian Biotechnology Society (IBS), Iranian Fuzzy Systems Society (IFSS), Iranian Corrosion Association (ICA), Iran Composites Association (ICA), Biochemical Society of Iran (BSI), Iranian Catalysis Association (ICA), Iranian Statistical Society (ISS), Iranian Chemical Society (ICS), Nuclear Society of Iran (NSI), Iran Polymer Society (IPS), and Iran Color Society (ICS).
•International Memberships:
2009 – Present:
•The American Association for the Advancement of Science (AAAS), American Chemical Society (ACS), American Chemistry Council (ACC), American Society for Biochemistry and Molecular Biology (ASBMB), American Physical Society (APS), American Institute of Physics (AIP), American Mathematical Society (AMS), Mathematical Association of America (MAA), Royal Society of Chemistry (RSC), The Chemical Institute of Canada (CIC), The Canadian Society for Chemistry (CSC), The Royal Australian Chemical Institute (RACI), International Union of Pure and Applied Chemistry (IUPAC), Monash Campus Cluster (MCC), Monash Science Centre for Biospectroscopy, National Computational Infrastructure (NCI), Monash e–Research Centre, Australian Research Council (ARC), ARC Centre of Excellence for Electromaterials Science (ACES), Victorian Life Sciences Computational Initiative (VLSCI), Multi–modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE), Australian Synchrotron, The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Victorian Partnership for Advanced Copmputing (VPAC), National Computational Merit Allocation Scheme (NCMAS), iVEC, National Collaborative Research Infrastructure Strategy (NCRIS), National Health and Medical Research Council (NHMRC), Monash Chemical Society (MCS), Monash Science Society (MSS), Ustinov College, St Catharine’s College, National eResearch Collaboration Tools and Resources (NeCTAR), Monash Ionic Liquids Group, Research Data Storage Infrastructure (RDSI), VicNode, Monash Computational Chemistry Group, and International Neuroinformatics Coordinating Facility (INCF), European Scientific Institute (ESI), Ankara University Institute of Nuclear Sciences, National Institute of Science Communication and Information Resources (New Delhi, India), Indo–American Pharmaceutical Society, American Association of Pharmaceutical Scientists (AAPS), Euro Asia Research and Development Association (EARDA), Institute of Advanced Engineering and Science (IAES), International Academic Institute for Science and Technology (IAIEST), Platform for Young Researchers Welfare Society (PYRWS), Centre For Info Bio Technology (CIBTech), Institute of Research Advances, Association of Global Science Innovations (AGSI), American Institute of Science (AIS), Technical Research Organization India (TROI/TROINDIA), Indian Society for Technical Education (ISTE), Open Association of Research Society USA (OARS), American International Standards Institute (AISI), National Science Library (NSL), Council of Scientific and Industrial Research (New Delhi, India), International Society of Universal Research in Sciences, China National Knowledge Infrastructure (CNKI), International Committee of Medical Journal Editors (ICMJE), International Association of Teachers and Teacher Educators (IATTE), USA, RISHI Educational Society, Research Culture Society, National Institute of Science Communication and Information Resources (NISCAIR) (New Delhi, India), Council of Scientific and Industrial Research (ICSIR) (New Delhi, India), National Science Library (NSL) (New Delhi, India), Committee on Publishing Ethics (COPE), Sanskruti Multidisciplinary Research and Development Training Institute (SMRDTI) (Solapur, Maharashtra, India), Indian Academicians and Researchers Association (IARA).
HONORS & AWARDS:
•Student researcher of the year at the Islamic Azad University (IAU) for four consecutive years – 2002, 2003, 2004 and 2005, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
•Winner of the 13th National Iranian Student Book Festival Prize for the translation “Mathematics for Chemists (Volumes 1&2)”, Tehran, Iran, 2006.
•Student researcher of the year at the Islamic Azad University (IAU) for three consecutive years – 2006, 2007 and 2008, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
•Winner of the 15th National Iranian Student Book Festival for compiling “Principles of Modern Relativistic Quantum Mechanics”, Tehran, Iran, 2008.
•Winner of the 7th National Iranian Roshd Book Festival for the translation of “Mathematics for Chemists (Volumes 1&2)”, Tehran, Iran, 2008.
•Winner of the Best Poster Presentation Prize at the National Conference for Computing in Chemistry, Arak, Iran, 2008.
•Awarded best thesis prize from the Islamic Azad University (IAU), Tehran, Iran, 2008.
•Ranked top student for six consecutive years – 2002–2008, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
•Awarded 1st class honors for my B.Sc. in Pure Chemistry degree with a final overall GPA of 19.08/20 and accepted for an M.Sc. degree program without the mandatory pre–requisite entrance examination requirement by the Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2006.
•Awarded 1st class honors for my M.Sc. in Chemistry (Physical Chemistry) degree with a final overall GPA of 19.08/20 and accepted for Ph.D. studies without a mandatory pre–requisite entrance examination requirement by the Islamic Azad University (IAU), Science & Research Campus, Tehran, Iran, 2009.
•Awarded Honorary Doctorate Degree (Degree Honoris Causa) in Physics (Atomic and Molecular Physics) by the Islamic Azad University (IAU), Tehran, Iran, 2008.
•Winner of best thesis in Iran, Tehran, Iran, 2009.
•Awarded highest GPA for my M.Sc. thesis with a GPA score of 20/20, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2008.
•Winner at the 13th National Iranian Student Thesis Festival, Tehran, Iran, 2009.
•Winner of the 16th National Iranian Student Book Festival for compiling “Principles and Methods of Using Chemical Abstracts”, Tehran, Iran, 2009.
•Winner of the Best Poster Presentation Prize at the 1st Conference on the Application of Nanothechnology in the Petroleum and Petrochemical Industries, Mahshahr, Iran, May 2011.
•Winner of the Best Poster and Best Oral Presentation Prize at the 1st National Student Conference on Nanotechnology, Shahreza, Iran, July 2011.
•Participating at the Carbon Nanotubes workshop during the 1st National Student Conference on Nanotechnology, Shahreza, Iran, July 2011.
•Awarded Doctor of Science (D.Sc.) Diploma in Chemistry by the California South University (CSU), Irvine, California, USA, 2010.
•Winner of the Best Lecturer Prize in Caspian Higher Education Institute, Qazvin, Iran, 2012.
•Awarded M.Sc. degree offer from Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2006.
•Awarded Ph.D. degree offer from Islamic Azad University (IAU), Science & Research Campus, Tehran, Iran, 2009.
•Awarded Ph.D. degree offer from California South University (CSU), Irvine, California, USA, 2009.
•Awarded “Project Management” Postdoctoral Fellowship Program by School of Chemistry, Faculty of Science, Monash University, Melbourne, Victoria, Australia, 2013.
•Awarded “Modern Molecular Electronic–Structure Computations Theory” and also “Nanochemistry” Postdoctoral fellowship programs by California South University (CSU), Irvine, California, 2014.

Top Publications
[1] A. Heidari, C. Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer Cells”, Journal of Nanomedicine Research, Volume 2, Issue 5, 20 Pages, 2015.
[2] A. Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles”, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Pages 15–19, 2015.
[3] A. Heidari, “An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertility”, Int J Adv Technol 7: e007, 2016.
[4] A. Heidari, “Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Study”, J Pharmacogn Nat Prod 2: e103, 2016.
[5] A. Heidari, “A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile Complexes”, J Bioeng Biomed Sci S: 006, 2016.
[6] A. Heidari, “Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016.
[7] A. Heidari, “Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J Biomol Res Ther 5: e146, 2016.
[8] A. Heidari, “Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells”, J Bioanal Biomed 8: e135, 2016.
[9] A. Heidari, “A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells”, Adv Cancer Prev 1: e102, 2016.
[10] A. Heidari, “Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles”, J Biotechnol Biomater 6: e125, 2016.
[11] A. Heidari, “A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Study”, J Res Development 4: 144, 2016.
[12] A. Heidari, “Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding”, Biochem Physiol 5: e146, 2016.
[13] A. Heidari, “Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO) Nanoparticles on DNA of Cancer Cells: A Photodynamic Therapy Study”, Arch Cancer Res. 4: 1, 2016.
[14] A. Heidari, “Biospectroscopic Study on Multi–Component Reactions (MCRs) in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugs”, Arch Cancer Res. 4: 2, 2016.
[15] A. Heidari, “Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time–Dependent Bio–Heat Equation and Nd: YAG Lasers”, Arch Cancer Res. 4: 2, 2016.
[16] A. Heidari, “Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res. 4: 1, 2016.
[17] A. Heidari, “Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticles”, J Biomedical Sci. 5: 2, 2016.
[18] A. Heidari, “Measurement the Amount of Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol) and Absorbable Calcium (Ca2+), Iron (II) (Fe2+), Magnesium (Mg2+), Phosphate (PO4–) and Zinc (Zn2+) in Apricot Using High–Performance Liquid Chromatography (HPLC) and Spectroscopic Techniques”, J Biom Biostat 7: 292, 2016.
[19] A. Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7: e112, 2016.
[20] A. Heidari, “Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniques”, J Drug Metab Toxicol 7: e129, 2016.
[21] A. Heidari, “Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO) Nanoparticles as Anti–Cancer Drug in Formation of Nucleic Acids Complexes for Human Cancer Cells’ Treatment”, Biochem Pharmacol (Los Angel) 5: 207, 2016.
[22] A. Heidari, “A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”, Struct Chem Crystallogr Commun 2: 1, 2016.
[23] A. Heidari, “Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO) Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cells”, Pharm Anal Chem Open Access 2: 113, 2016.
[24] A. Heidari, “A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment”, Chemo Open Access 5: e129, 2016.
[25] A. Heidari, “Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applications”, J Pharmacokinet Exp Ther 1: e005, 2016.
[26] A. Heidari, “Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniques”, Insights Anal Electrochem 2: 1, 2016.
[27] A. Heidari, “Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP) Type Using a Set of Topological Descriptors”, J Heavy Met Toxicity Dis. 1: 2, 2016.
[28] A. Heidari, “Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys. 1: 2, 2016.
[29] A. Heidari, “A Translational Biomedical Approach to Structural Arrangement of Amino Acids’ Complexes: A Combined Theoretical and Computational Study”, Transl Biomed. 7: 2, 2016.
[30] A. Heidari, “Ab Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic Discov 6: e144, 2016.
[31] A. Heidari, “Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”, J Glycobiol 5: e111, 2016.
[32] A. Heidari, “Synthesis and Study of 5–[(Phenylsulfonyl)Amino]–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniques”, Transl Med (Sunnyvale) 6: e138, 2016.
[33] A. Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol 12: 4, 2016.
[34] A. Heidari, “An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acids”, Austin J Anal Pharm Chem. 3 (1): 1058, 2016.
[35] A. Heidari, C. Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC Nanocomposites”, Nano Res Appl. 2: 1, 2016.
[36] A. Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene”, International Journal of Advanced Chemistry, 4 (1) 5–9, 2016.
[37] A. Heidari, “Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues”, Arch Can Res. 4: 2, 2016.
[38] A. Heidari, “Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS) Drugs”, J Data Mining Genomics & Proteomics 7: e125, 2016.
[39] A. Heidari, “Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5) Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two DNA/RNA Molecules of Human Cancer Cells”, J Pharmacogenomics Pharmacoproteomics 7: e153, 2016.
[40] A. Heidari, “Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti–Microbial Drugs: A Clinical Approach”, Transl Biomed. 7: 2, 2016.
[41] A. Heidari, “A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO) Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP) Method”, Arch Can Res. 4: 2, 2016.
[42] A. Heidari, “Cheminformatics and System Chemistry of Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin as Anti–Cancer Nano Drugs: A Combined Computational and Experimental Study”, J Inform Data Min 1: 3, 2016.
[43] A. Heidari, “Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship (QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer Nano Drugs”, J Integr Oncol 5: e110, 2016.
[44] A. Heidari, “Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Method”, J Nanosci Curr Res 1: e101, 2016.
[45] A. Heidari, “Coplanarity and Collinearity of 4’–Dinonyl–2,2’–Bithiazole in One Domain of Bleomycin and Pingyangmycin to be Responsible for Binding of Cadmium Oxide (CdO) Nanoparticles to DNA/RNA Bidentate Ligands as Anti–Tumor Nano Drug”, Int J Drug Dev & Res 8: 007–008, 2016.
[46] A. Heidari, “A Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for the Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations”, J Pharmacovigil 4: e161, 2016.
[47] A. Heidari, “Nanotechnology in Preparation of Semipermeable Polymers”, J Adv Chem Eng 6: 157, 2016.
[48] A. Heidari, “A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for Analysis 5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
[49] A. Heidari, “DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivatives”, Biomedical Data Mining 5: e102, 2016.
[50] A. Heidari, “A Successful Strategy for the Prediction of Solubility in the Construction of Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Using Genetic Function Approximation (GFA) Algorithm”, J Mol Biol Biotechnol 1: 1, 2016.
[51] A. Heidari, “Computational Study on Molecular Structures of C20, C60, C240, C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logic”, J Material Sci Eng 5: 282, 2016.
[52] A. Heidari, “Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs)”, J Appl Computat Math 5: e143, 2016.
[53] A. Heidari, “The Impact of High Resolution Imaging on Diagnosis”, Int J Clin Med Imaging 3: 1000e101, 2016.
[54] A. Heidari, “A Comparative Study of Conformational Behavior of Isotretinoin (13–Cis Retinoic Acid) and Tretinoin (All–Trans Retinoic Acid (ATRA)) Nano Particles as Anti–Cancer Nano Drugs under Synchrotron Radiations Using Hartree–Fock (HF) and Density Functional Theory (DFT) Methods”, Insights in Biomed 1: 2, 2016.
[55] A. Heidari, “Advances in Logic, Operations and Computational Mathematics”, J Appl Computat Math 5: 5, 2016.
[56] A. Heidari, “Mathematical Equations in Predicting Physical Behavior”, J Appl Computat Math 5: 5, 2016.
[57] A. Heidari, “Chemotherapy a Last Resort for Cancer Treatment”, Chemo Open Access 5: 4, 2016.
[58] A. Heidari, “Separation and Pre–Concentration of Metal Cations–DNA/RNA Chelates Using Molecular Beam Mass Spectrometry with Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation and Various Analytical Methods”, Mass Spectrom Purif Tech 2: e101, 2016.
[59] A. Heidari, “Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA) Algorithm”, Insight Pharm Res. 1: 1, 2016.
[60] A. Heidari, “Cancer Risk Prediction and Assessment in Human Cells under Synchrotron Radiations Using Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Properties Relationship (QSPR) Studies”, Int J Clin Med Imaging 3: 516, 2016.
[61] A. Heidari, “A Novel Approach to Biology”, Electronic J Biol 12: 4, 2016.
[62] A. Heidari, “Innovative Biomedical Equipment’s for Diagnosis and Treatment”, J Bioengineer & Biomedical Sci 6: 2, 2016.
[63] A. Heidari, “Integrating Precision Cancer Medicine into Healthcare, Medicare Reimbursement Changes and the Practice of Oncology: Trends in Oncology Medicine and Practices”, J Oncol Med & Pract 1: 2, 2016.
[64] A. Heidari, “Promoting Convergence in Biomedical and Biomaterials Sciences and Silk Proteins for Biomedical and Biomaterials Applications: An Introduction to Materials in Medicine and Bioengineering Perspectives”, J Bioengineer & Biomedical Sci 6: 3, 2016.
[65] A. Heidari, “X–Ray Fluorescence and X–Ray Diffraction Analysis on Discrete Element Modeling of Nano Powder Metallurgy Processes in Optimal Container
Design”, J Powder Metall Min 6: 1, 2017.
[66] A. Heidari, “Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross–Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspective”, Arch Chem Res. 1: 2, 2017.
[67] A. Heidari, “Deficiencies in Repair of Double–Standard DNA/RNA–Binding Molecules Identified in Many Types of Solid and Liquid Tumors Oncology in Human Body for Advancing Cancer Immunotherapy Using Computer Simulations and Data Analysis”, J Appl Bioinforma Comput Biol, 6: 1, 2017.
[68] A. Heidari, “Electronic Coupling among the Five Nanomolecules Shuts Down Quantum Tunneling in the Presence and Absence of an Applied Magnetic Field for Indication of the Dimer or other Provide Different Influences on the Magnetic Behavior of Single Molecular Magnets (SMMs) as Qubits for Quantum Computing”, Glob J Res Rev. 4: 2, 2017.
[69] A. Heidari, “Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation of Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60, (SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and (SC6H13)60] Nano Clusters as Anti–Cancer Nano Drugs”, J Nanomater Mol Nanotechnol, 6: 3, 2017.
[70] A. Heidari, “Biomedical Resource Oncology and Data Mining to
Enable Resource Discovery in Medical, Medicinal, Clinical, Pharmaceutical,
Chemical and Translational Research and Their Applications in Cancer Research”,
Int J Biomed Data Min 6: e103, 2017.
[71] A. Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing,
Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for
Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy,
Hormone Therapy and Targeted Therapy under Synchrotorn Radiation”, J Dev Drugs 6: e154, 2017.
[72] A. Heidari, “A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer's, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Microbiome/Antibiotic Resistance and Endovascular Stroke”, J Bioengineer & Biomedical Sci 7: e127, 2017.
[73] A. Heidari, “Opinion on Computational Fluid Dynamics (CFD)
Technique”, Fluid Mech Open Acc 4: 157, 2017.
[74] A. Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis (MS) Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84, Au144(SR)60, Au68(SR)36, Au30(SR)18, Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 Nano Clusters”, J Surgery Emerg Med
1: 21, 2017.
[75] A. Heidari, “Developmental Cell Biology in Adult Stem Cells Death and Autophagy to Trigger a Preventive Allergic Reaction to Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy)”, Cell Biol (Henderson, NV) 6: 1, 2017.
[76] A. Heidari, “Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumors”, J Powder Metall Min 6: 170, 2017.
[77] A. Heidari, “Nanomedicine–Based Combination Anti–Cancer Therapy between Nucleic Acids and Anti–Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti–Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiation”, Am J Drug Deliv 5: 2, 2017.
[78] A. Heidari, “Clinical Trials of Dendritic Cell Therapies for Cancer Exposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech's Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progression”, J Biol Med Science 1: e103, 2017.
[79] A. Heidari, “The Design Graphene–Based Nanosheets as a New Nanomaterial in Anti–Cancer Therapy and Delivery of Chemotherapeutics and Biological Nano Drugs for Liposomal Anti–Cancer Nano Drugs and Gene Delivery”, Br Biomed Bull 5: 305, 2017.
[80] A. Heidari, “Integrative Approach to Biological Networks for Emerging Roles of Proteomics, Genomics and Transcriptomics in the Discovery and Validation of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data under Synchrotron Radiation”, Transcriptomics 5: e117, 2017.
[81] A. Heidari, “Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins and Cell Adhesion Intelligent Nanomolecules Adjustment in Cancer Metastases Using Metalloenzymes and under Synchrotron Radiation”, Lett Health Biol Sci 2 (2): 1–4, 2017.
[82] A. Heidari, “Treatment of Breast Cancer Brain Metastases through a Targeted Nanomolecule Drug Delivery System Based on Dopamine Functionalized Multi–Wall Carbon Nanotubes (MWCNTs) Coated with Nano Graphene Oxide (GO) and Protonated Polyaniline (PANI) in Situ During the Polymerization of Aniline Autogenic Nanoparticles for the Delivery of Anti–Cancer Nano Drugs under Synchrotron Radiation”, Br J Res, 4 (3): 16, 2017.
[83] A. Heidari, “Sedative, Analgesic and Ultrasound–Mediated Gastrointestinal Nano Drugs Delivery for Gastrointestinal Endoscopic Procedure, Nano Drug–Induced Gastrointestinal Disorders and Nano Drug Treatment of Gastric Acidity”, Res Rep Gastroenterol, 1: 1, 2017.
[84] A. Heidari, “Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to Treat High Cholesterol and Related Conditions and to Prevent Cardiovascular Disease under Synchrotron Radiation”, J Pharm Sci Emerg Drugs 5: 1, 2017.
[85] A. Heidari, “Non–Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics through Particle Therapy Accelerators with Monochromatic Microbeams”, J Cell Biol Mol Sci 2 (1): 1–5, 2017.
[86] A. Heidari, “Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood–Brain Barrier (BBB) Translocation to Targeted Deliver Anti–Cancer Nano Drugs into the Human Brain to Treat Alzheimer’s Disease under Synchrotron Radiation”, J Nanotechnol Material Sci 4 (2): 1–5, 2017.
[87] R. Gobato, A. Heidari, “Calculations Using Quantum Chemistry for Inorganic Molecule Simulation BeLi2SeSi”, Science Journal of Analytical Chemistry, Vol. 5, No. 6, Pages 76–85, 2017.
[88] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Med Oncol. Vol. 1 No. 1: 1, 2017.
[89] A. Heidari, “A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation”, Am J Ethnomed, Vol. 4 No. 1: 10, 2017.
[90] A. Heidari, “Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood–Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS) and Alzheimer's Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV) Nanocarriers under Synchrotron Radiation”, J Med Chem Toxicol, 2 (3): 1–5, 2017.
[91] A. Heidari, “Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET), Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatment”, Parana Journal of Science and Education (PJSE)–V.3, n.4, (10–19) October 12, 2017.
[92] A. Heidari, “A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment”, Open J Anal Bioanal Chem 1 (1): 014–020, 2017.
[93] A. Heidari, “Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation–Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO) Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activity”, Enz Eng 6: 1, 2017.
[94] A. Heidari, “Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS)”, Mod Appro Drug Des. 1 (1). MADD.000504. 2017.
[95] A. Heidari, “Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS) and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cells”, J Proteomics Enzymol 6: 1, 2017.
[96] A. Heidari, “Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation”, J Pharm Pharmaceutics 4 (2): 1–5, 2017.
[97] A. Heidari, C. Brown, “Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G), Fluoxetine Hydrochloride (Prozac and Sarafem), Propofol (Diprivan), Acetylsalicylic Acid (ASA) (Aspirin), Naproxen Sodium (Aleve and Naprosyn) and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systems”, Ann Adv Chem. 1 (2): 061–069, 2017.
[98] A. Heidari, “High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiation”, J Transl Res. 1 (1): 1–3, 2017.
[99] A. Heidari, “Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention, Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematica”, Current Trends Anal Bioanal Chem, 1 (1): 36–41, 2017.
[100] A. Heidari, “Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS) or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle) Using Synchrotron Radiation”, Arch Biotechnol Biomed. 1 (1): 067–0100, 2017.
[101] A. Heidari, “Visualizing Metabolic Changes in Probing Human Cancer Cells and Tissues Metabolism Using Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy and Self–Organizing Maps under Synchrotron Radiation”, SOJ Mater Sci Eng 5 (2): 1–6, 2017.
[102] A. Heidari, “Cavity Ring–Down Spectroscopy (CRDS), Circular Dichroism Spectroscopy, Cold Vapour Atomic Fluorescence Spectroscopy and Correlation Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Challenges Cancer Detect Ther 4 (2): e001, 2017.
[103] A. Heidari, “Laser Spectroscopy, Laser–Induced Breakdown Spectroscopy and Laser–Induced Plasma Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Hepatol Gastroenterol, 3 (4): 079–084, 2017.
[104] A. Heidari, “Time–Resolved Spectroscopy and Time–Stretch Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Pharmacovigilance and Drug Safety 4 (2): e001, 2017.
[105] A. Heidari, “Overview of the Role of Vitamins in Reducing Negative Effect of Decapeptyl (Triptorelin Acetate or Pamoate Salts) on Prostate Cancer Cells and Tissues in Prostate Cancer Treatment Process through Transformation of Malignant Prostate Tumors into Benign Prostate Tumors under Synchrotron Radiation”, Open J Anal Bioanal Chem 1 (1): 021–026, 2017.
[106] A. Heidari, “Electron Phenomenological Spectroscopy, Electron Paramagnetic Resonance (EPR) Spectroscopy and Electron Spin Resonance (ESR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Austin J Anal Pharm Chem. 4 (3): 1091, 2017.
[107] A. Heidari, “Therapeutic Nanomedicine Different High–Resolution Experimental Images and Computational Simulations for Human Brain Cancer Cells and Tissues Using Nanocarriers Deliver DNA/RNA to Brain Tumors under Synchrotron Radiation with the Passage of Time Using Mathematica and MATLAB”, Madridge J Nano Tech. Sci. 2 (2): 77–83, 2017.
[108] A. Heidari, “A Consensus and Prospective Study on Restoring Cadmium Oxide (CdO) Nanoparticles Sensitivity in Recurrent Ovarian Cancer by Extending the Cadmium Oxide (CdO) Nanoparticles–Free Interval Using Synchrotron Radiation Therapy as Antibody–Drug Conjugate for the Treatment of Limited–Stage Small Cell Diverse Epithelial Cancers”, Cancer Clin Res Rep, 1: 2, e001, 2017.
[109] A. Heidari, “A Novel and Modern Experimental Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White Synchrotron Radiation”, Cancer Sci Res Open Access 4 (2): 1–8, 2017.
[110] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Breast Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Oral Cancer Res 1 (1): 12–17, 2017.
[111] A. Heidari, “Vibrational Decihertz (dHz), Centihertz (cHz), Millihertz (mHz), Microhertz (μHz), Nanohertz (nHz), Picohertz (pHz), Femtohertz (fHz), Attohertz (aHz), Zeptohertz (zHz) and Yoctohertz (yHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, International Journal of Biomedicine, 7 (4), 335–340, 2017.
[112] A. Heidari, “Force Spectroscopy and Fluorescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, EC Cancer, 2 (5), 239–246, 2017.
[113] A. Heidari, “Photoacoustic Spectroscopy, Photoemission Spectroscopy and Photothermal Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, BAOJ Cancer Res Ther, 3: 3, 045–052, 2017.
[114] A. Heidari, “J–Spectroscopy, Exchange Spectroscopy (EXSY), Nucle¬ar Overhauser Effect Spectroscopy (NOESY) and Total Correlation Spectroscopy (TOCSY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Eng Sci J, 1 (2): 006–013, 2017.
[115] A. Heidari, “Neutron Spin Echo Spectroscopy and Spin Noise Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Biopharm Sci, 1: 103–107, 2017.
[116] A. Heidari, “Vibrational Decahertz (daHz), Hectohertz (hHz), Kilohertz (kHz), Megahertz (MHz), Gigahertz (GHz), Terahertz (THz), Petahertz (PHz), Exahertz (EHz), Zettahertz (ZHz) and Yottahertz (YHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Madridge J Anal Sci Instrum, 2 (1): 41–46, 2017.
[117] A. Heidari, “Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy and Non–Linear Two–Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Mater Sci Nanotechnol 6 (1): 101, 2018.
[118] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Near–Infrared Spectroscopy (NIRS) and Mid–Infrared Spectroscopy (MIRS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Int J Nanotechnol Nanomed, Volume 3, Issue 1, Pages 1–6, 2018.
[119] A. Heidari, “Infrared Photo Dissociation Spectroscopy and Infrared Correlation Table Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Austin Pharmacol Pharm, 3 (1): 1011, 2018.
[120] A. Heidari, “Novel and Transcendental Prevention, Diagnosis and Treatment Strategies for Investigation of Interaction among Human Blood Cancer Cells, Tissues, Tumors and Metastases with Synchrotron Radiation under Anti–Cancer Nano Drugs Delivery Efficacy Using MATLAB Modeling and Simulation”, Madridge J Nov Drug Res, 1 (1): 18–24, 2017.
[121] A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Open Access J Trans Med Res, 2 (1): 00026–00032, 2018.
[122] M. R. R. Gobato, R. Gobato, A. Heidari, “Planting of Jaboticaba Trees for Landscape Repair of Degraded Area”, Landscape Architecture and Regional Planning, Vol. 3, No. 1, 2018, Pages 1–9, 2018.
[123] A. Heidari, “Fluorescence Spectroscopy, Phosphorescence Spectroscopy and Luminescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, SM J Clin. Med. Imaging, 4 (1): 1018, 2018.
[124] A. Heidari, “Nuclear Inelastic Scattering Spectroscopy (NISS) and Nuclear Inelastic Absorption Spectroscopy (NIAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Pharm Sci, 2 (1): 1–14, 2018.
[125] A. Heidari, “X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Oncol Res; 2 (1): 1–14, 2018.
[126] A. Heidari, “Correlation Two–Dimensional Nuclear Magnetic Reso¬nance (NMR) (2D–NMR) (COSY) Imaging and Spectrosco¬py Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Can Sci, 1–1–001, 2018.
[127] A. Heidari, “Thermal Spectroscopy, Photothermal Spectroscopy, Thermal Microspectroscopy, Photothermal Microspectroscopy, Thermal Macrospectroscopy and Photothermal Macrospectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, SM J Biometrics Biostat, 3 (1): 1024, 2018.

[128] A. Heidari, “A Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers’ Cells, Tissues and Tumors before and after Synchrotron Radiation Therapy”, Open Acc J Oncol Med. 1 (1), 2018.

[129] A. Heidari, “Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues under Synchrotron Radiation”, J Endocrinol Thyroid Res, 3 (1): 555603, 2018.

[130] A. Heidari, “Nuclear Resonance Vibrational Spectroscopy (NRVS), Nuclear Inelastic Scattering Spectroscopy (NISS), Nuclear Inelastic Absorption Spectroscopy (NIAS) and Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (1e): 1–5, 2018.

[131] A. Heidari, “A Novel and Modern Experimental Approach to Vibrational Circular Dichroism Spectroscopy and Video Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White and Monochromatic Synchrotron Radiation”, Glob J Endocrinol Metab. 1 (3). GJEM. 000514–000519, 2018.

[132] A. Heidari, “Pros and Cons Controversy on Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Pharma J. 1 (1): 002–008, 2018.

[133] A. Heidari, “A Modern Comparative and Comprehensive Experimental Biospectroscopic Study on Different Types of Infrared Spectroscopy of Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, J Analyt Molecul Tech. 3 (1): 8, 2018.

[134] A. Heidari, “Investigation of Cancer Types Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, European Modern Studies Journal, Vol. 2, No. 1, 13–29, 2018.
[135] A. Heidari, “Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Imaging J Clin Medical Sci. 5 (1): 001–007, 2018.
[136] A. Heidari, “Small–Angle Neutron Scattering (SANS) and Wide–Angle X–Ray Diffraction (WAXD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (2e): 1–6, 2018.
[137] A. Heidari, “Investigation of Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver, Lung Cancer, Melanoma, Non–Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer and Non–Melanoma Skin Cancer Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, Ther Res Skin Dis 1 (1), 2018.
[138] A. Heidari, “Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy and Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, International Journal of Chemistry Papers, 2 (1): 1–12, 2018.
[139] A. Heidari, “Mössbauer Spectroscopy, Mössbauer Emission Spectroscopy and 57Fe Mössbauer Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Cancer Biology 2.3: 17–20, 2018.
[140] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy, Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy, Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy, Non–Linear Two–Dimensional Infrared Spectroscopy, Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy, Infrared Photodissociation Spectroscopy, Infrared Correlation Table Spectroscopy, Near–Infrared Spectroscopy (NIRS), Mid–Infrared Spectroscopy (MIRS), Nuclear Resonance Vibrational Spectroscopy, Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Organic & Medicinal Chem IJ. 6 (1): 555676, 2018.
[141] A. Heidari, “Correlation Spectroscopy, Exclusive Correlation Spectroscopy and Total Correlation Spectroscopy Comparative Study on Malignant and Benign Human AIDS–Related Cancers Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Bioanal Biomed. 2 (1): 001–007, 2018.
[142] A. Heidari, “Biomedical Instrumentation and Applications of Biospectroscopic Methods and Techniques in Malignant and Benign Human Cancer Cells and Tissues Studies under Synchrotron Radiation and Anti–Cancer Nano Drugs Delivery”, Am J Nanotechnol Nanomed. 1 (1): 001–009, 2018.

Vural Fidan, MD

Associate Professor Deputy Director of ENT Dept Yunus Emre Gov Hosp Eskisehir, TURKEY
Dr Vural Fidan has recieved his MD and PhD in Hacettepe University. He has attended sleep trainig at TUTDER. He was first at sleep training examp at TUTDER. He is an Otorhinolaryngologist at Yunus Emre Goverment Hospital.
otology, rhinology, sleep medicine
ACADEMIC HONORS AND AWARDS
• Best Oral Presentation Award (1st International Congress of Oral and Maxillofacial Surgery Society) (2007)
• Deputy Director of Otorhinolaryngology Dept, Erzurum Training and Research Hosp (2008-2011)
• Best Oral Presentation Award (Roundtable Meeting at Yale 2013)
• International Best Medical Book Award (Melatonin and Melatonergic Drugs in Clinical Practice 2014)
• Young Researchers Forum Award- Otolaryngology 2015 ( 2nd International Conference and Exhibition on Rhinology and Otology March 18-20, 2015 Dubai, UAE)
• Scientific and Technical Research Council of Turkey, International Scientific Publications Promotion Award 30.12.2010 Clarithromycin-induced mania in a child".
• Scientific and Technical Research Council of Turkey, International Scientific Publications Promotion Award 25.02.2012 Lightning strike: a rare cause of incudostapedial disruption with intact membrane.".
• Scientific and Technical Research Council of Turkey, International Scientific Publications Promotion Award 13.06.2013 "Melatonin and cortisol rhythm in patients with extensive nasal polyposis".
• Recognised Reviewer Award. ElsevierAugust 2015
• 5-9 Aralık 2017 tarihleri arasında Antalya’da düzenlenen 12. Ulusal Uyku Tıbbı ve Teknologları Kongresi’nde 2.lik ödülü ΄Osa’lı hastalarda PAP’nin natural killer T hücresine etkisi ̀
• 5-9 Aralık 2017 tarihleri arasında Antalya’da düzenlenen 12. Ulusal Uyku Tıbbı ve Teknologları Kongresi’nde 3.lük ödülü ΄CPAP tedavisine bağlı yüz felci: Atipik bir olgu
More than 20 SCI indexed articles.

Books / Chapters

• V. Fidan, C. Cingi, Kulak Burun Boğazda Semptomlar (Geniz Akıntısı), 91-93 pp., İstanbul, EA Yayıncılık, 2009
• V.Srinivasan, V Fidan Melatonin and Melatonergic Drugs (Chapter 28: Melatonin and melatonergic drugs in nasal polyposis), India, Springer Publishing, 2013 (Printing)
• V Fidan, A Dilci ; Allergic Diseases: Recent Advances (Allergic Rhinitis) 1-9 pp SM Group, 2016/ 987-0-9962745-9-3
• Sakalar E, Birdane L, Fidan V. Oral And Maxillofacial Diseases (Pediatric Maxillofacial Traumas) 987-0-9962745-6-2
• Dilci A, Koyuncu H, Fidan V. Obstructive Sleep Apnea (Obstructive Sleep Apnea Syndrome) 978-1-944685-89-8
• Erdogan E, Fidan V* and Giritli E. Different Aspects of Rhinosinusitis ( Radiologic Imaging in Chronic Sinusitis) SM Group, 2016 ISBN: 978-1-944685-87-4

Dr. Fernanda Machado Fonseca

Lecturer Department of Biomedicine Federal University of Piaui Sao Sebastiao Avenue, 2817, Postal Code: 64204035, Parnaiba Piaui, Brazil
EDUCATION AND QUALIFICATIONS
 Graduation in Biomedicine
University of Uberaba, BR (2002-2006)
 Master´s degree in Clinical Pathology (2007-2009)
Department of Microbiology, Federal University of Triangulo Mineiro, Brazil
 Ph.D. (2009-2013)
Department of Microbiology, Federal University of Triangulo Mineiro, Brazil
Microbiology, Infectious diseases, Immune response, Molecular biology.
SELECTED PUBLICATIONS
 ANDRADE-SILVA, LEONARDO EURIPEDES ; FERREIRA-PAIM, KENNIO ; FERREIRA, THATIANA BRAGINE ; VILAS-BOAS, ANDERSON ; MORA, DELIO JOSÉ ; MANZATO, VERÔNICA MORAIS ; FONSECA, FERNANDA MACHADO ; BUOSI, KELLI ; ANDRADE-SILVA, JULIANA; PRUDENTE, BRUNO DA SILVA ; ARAUJO, NATALIA EVELYN ; SALES-CAMPOS, HELIOSWILTON ; DA SILVA, MARCUS VINICIUS ; JÚNIOR, VIRMONDES RODRIGUES ; MEYER, WIELAND ; SILVA-VERGARA, MARIO LÉON . Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors. PLoS One, v.
13, p. e0193237, 2018.
 FERREIRA-PAIM, KENNIO ; ANDRADE-SILVA, LEONARDO ; FONSECA, FERNANDA M. ; FERREIRA, THATIANA B. ; MORA, DELIOJ. ; ANDRADE-SILVA, JULIANA ; KHAN, AZIZA ; DAO, AIKEN ; REIS, EDUARDO C. ; ALMEIDA, MARGARETE T. G. ; MALTOS, ANDRE ; JUNIOR, VIRMONDES R. ; TRILLES, LUCIANA ; RICKERTS, VOLKER ;
CHINDAMPORN, ARIYA ; SYKES, JANE E. ; COGLIATI, MASSIMO ; NIELSEN, KIRSTEN ; BOEKHOUT, TEUN ; FISHER, MATTHEW ; KWONCHUNG, JUNE ; ENGELTHALER, DAVID M. ; LAZÉRA, MARCIA ; MEYER, WIELAND ; SILVA-VERGARA, MARIO L. . MLST-Based Population Genetic Analysis in a Global Context Reveals Clonality amongst Cryptococcus neoformans var. grubii VNI Isolates from HIV Patients in Southeastern Brazil. PLoS Neglected Tropical Diseases (Online), v. 11, p. e0005223, 2017.
 ESTEVAM, R. ; SILVA, N. ; SILVA, E. W. ; FONSECA, F. M. ; OLIVEIRA, A. G. ; MARTINS, R. D. N. ; PEREIRA, S. A. ; PEREIRA, T. ; ADAD, S. J. ; RODRIGUES, V. ; RODRIGUES, D. B. . Modulation of Galectin-3 and Galectin 9 in gastric mucosa of patients with chronic gastritis and positive Helicobacter pylori infection. PATHOLOGY RESEARCH AND PRACTICE, v. 213, p. 1276-1281, 2017.
 RIOS NETO, MIGUEL ARAÚJO ; RIOS, VANESKA MAGALHÃES ; CORÁ, LUIZA FRANCO ; FONSECA, MARCELA MACHADO ; FERREIRA-PAIM, KENNIO ; FONSECA, FERNANDA MACHADO . High rates of antimicrobial resistance of ESBL-producing Enterobacteriaceae isolated from clinical samples in Northeast of Brazil. Infectious Diseases, v. 50, p. 229-231, 2017.
 FERREIRA-PAIM, KENNIO ; FERREIRA, THATIANA BRAGINE ; ANDRADE-SILVA, LEONARDO ; MORA, DELIO JOSE ; SPRINGER, DEBORAH J. ; HEITMAN, JOSEPH ; FONSECA, FERNANDA MACHADO ; MATOS, DULCILENA ; MELHEM, MÁRCIA SOUZA CARVALHO ; SILVA-VERGARA, MARIO LEÓN . Phylogenetic Analysis of Phenotypically
Characterized Cryptococcus laurentii Isolates Reveals High Frequency of Cryptic Species. Plos One, v. 9, p. e108633, 2014.
 FONSECA, FERNANDA MACHADO; ETCHEBEHERE, RENATA MARGARIDA ; QUEIROZ, DULCIENE MARIA DE MAGALHÃES ; ROCHA, ANDREIA MARIA CAMARGOS ; JUNQUEIRA, IRACEMA SALDANHA ; FONSECA, DAURIN NARCISO DA ; RODRIGUES, ALINE LIBÉRIO BRAGA ; CREMA, EDUARDO ; DE OLIVEIRA, ADRIANA GONÇALVES . Histological and endoscopic features of the stomachs of patients with Chagas disease in the era of Helicobacter pylori. Revista da Sociedade Brasileira de Medicina Tropical, v. 47, p. 739-746, 2014.
 FONSECA, F. M.; QUEIROZ, DULCIENE MARIA DE MAGALHÃES ; ROCHA, ANDREIA MARIA CAMARGOS ; PRATA, ALUÍZIO ; CREMA, EDUARDO ; RODRIGUES JUNIOR, VIRMONDES ; RAMIREZ, LUIZ EDUARDO ; OLIVEIRA, ADRIANA GONÇALVES DE . Seroprevalence of Helicobacter pylori infection in chagasic and nonchagasic patients from the same geographical region of Brazil. Revista da Sociedade Brasileira de Medicina Tropical, v. 45, p. 194-198, 2012.

Dr. Longo-Mbenza Benjamin

Professor Department of Internal Medicine

University of Kinshasa

Medical School

Democratic Republic of Congo

1. B.M.M. Sumbua, B. Longo-Mbenza, S. Ahuka-Mundeke, J.M. Muwonga, G. Mvumbi-Lelo, H.M. Maphana, D. Kayembe Nzongola-Nkasu, F.M. Kalumbua. Association between the viruses of the acquired immunodeficiency syndrome and the hepatitis C virus among young blood donors in Kinshasa: Retrospective analysis of 10 years. Transfusion Clinique et Biologique, 2018
2. Mireille Solange Nganga Nkanga, Benjamin Longo-Mbenza, Peter Vandenberghe, Fons Verdonck, Venant Tchokonte-Nana, Nkama Claude Nlandu, Roth Laure Mapapa
Miakassissa, Paul Roger Beia Kazadi, Antoine Lufimbo Katawandja, Jacques Bikaula Ngwidiwo, Ntolo Jean-Pierre Mufuta, Kuanda Thomas Solo, Mbombo Aurore Cecilia
Orphée Beia. Feasibility of iFISH patterns in hematologic malignancies among Congolese patients at Kinshasa University clinics. Asian Pacific Journal of Tropical Biomedicine, 2017
3. T Apalata, W H Carr, B Longo-Mbenza, W A Sturm, P Moodley. Association between symptomatic vulvovaginal candidiasis and HIV RNA levels in plasma and genital
secretions among women on HAART. SAJHIVMED, 2014
4. Charles Bitamazire Businge, Benjamin Longo-Mbenza, Oladele Vincent Adeniyi, Victor Nzuzi Babeki, Archille Kitambala Kaboka, Moise Mvitu Muaka, Mireille Solange Nganga Nkanga, Christophe Masiala Tsobo, Roland Vangu, Emmanuel Mabiala Diambu, Daniel Ter Goon. Increased Risk and Severity of Pre-Eclampsia among Peri-Urban Women in Kinshasa Province, Democratic Republic of Congo: The Role of Nutritional Transition, Obesity and Dyslipidemia. International Journal of Tropical Medecine, 2017
5. Oladele V. Adeniyi, Parimalane Yogeswaran, Graham Wright, Benjamin Longo-Mbenza. Dia?eti? patie?ts’ pe?spe?tives on the challenges of glycaemic control. AOSIS
OpenJournals. African Journal of Primary Health Care & Family Medicine, 2015
6. Christophe T. Masiala, Samy W. Masamba, M. Mbodo, Benjamin Longo-Mbenza, Simon F. Mbungu, Dieudonné N. Vangu. Lead and Mercury Pollution in Breast Milk in Kinshasa: Mother and Child Health Risks. Journal of Innovation and Research in Health Sciences & Biotechnology, 2015
7. David Kadhaya Muballe, Benjamin Longo-Mbenza, Constance Sewani Rusike. Oxidative Stress and Inflammatory Response in Traumatic Brain Injury: A Technical Review.
Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
8. Etienne Mokondjimobe, Olivier Pambou, Gildas N. Beatsengue, Reine Eboka-Loumingou, Benjamin Longo-mbenza, Henri J. Parra, Edouard Ngou-milama. Détermination
Immunoenzymatique des Valeurs Fréquentes des Hormones de Reproduction chez la Femme Congolaise. Journal of Innovation and Research in Health Sciences &
Biotechnology, 2015
9. Kebolo B Andre, Longo-Mbenza Benjamin, Palata K Vandewalle P, Palat K. Molecular genetics to differenciate radula morphology from species of yhe family of achatinidae (mollusca, gastropoda, and pulmonata) in democratic republic of congo. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
10. Marie-Josée Muaka Diela, Ange Manso Mena, Moïse Mvitu Muaka, Benjamin Longo- Mbenza. Lésions Radiologiques Atypiques du Thorax au Cours de la Coïnfection
Tuberculose Pulmonaire – VIH/SIDA à la Clinique Bondeko de Kinshasa. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
11. Nganga Nkanga Mireille, Longo-Mbenza Benjamin, Dieudonné Mumba Ngoyi, Muwonga Masidi Jérémie, Sokolua Mvika Eddy, Susungu Etienne, Mapapa Cécile Roth, Kayembe Nzongola-Nkasu Donatien. Valeurs de références de certains paramètres h??atologi?ues ?hez l’e?fa?t à Ki?shasa. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
12. Wumba Roger, Longo-Mbenza Benjamin, Menotti Jean, Mandina Madone, Kintoki Fabien, Zanga Josue, Banzulu-Makola, Nseka Tommy, Mukendi Jean-Pierre, Ngatu
Nlandu Roger, Kendjo Eric, Sala Jean, Thellier Marc, Michel Aloni, Lokotola Lueme Christian, Rhenazo Andre, Kensense Mossanda, Teke Apalata. Detection of Cryptosporidium hominis and Identification to the Species Level using Real-Time PCR, Nested PCR and RFLP among Bonobos Co-infected by Ascaris lumbricoides. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
13. Nanjoh MK, Vundle Z, Longo-Mbenza B. Morbidity and Mortality Trends for Noncommunicable Diseases in ORTDM-EC-SA. 1st International Conference on Clinical
Trial and Innovative Therapeutics. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
14. Mvitu Muaka Moise, Longo-Mbenza Benjamin, Muaka Diela Marie-Josée, Tsilulu Vangu Laurence, Kibokela Ndembe Dalida, Longo Phemba Igor, Lokotola Lueme Christian, Teke Apalata, Kensense Mossanda. Alarming Prevalence and Associated Causes of Visual Disability among Patients with Type-2 Diabetes Mellitus: Management Challenges in a Country without Integration of Eye Health into Primary Health Care. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
15. Nganga Nkanga Mireille, Longo-Mbenza Benjamin, Dieudonné Mumba Ngoyi, Muwonga Masidi Jérémie, Sokolua Mvika Eddy, Susungu Etienne, Kayembe Nzongola-Nkasu Donatien. Valeu?s de R?f??e??es de Ce?tai?s Bio?a??ueu?s ?hez L’e?fa?t à Ki?shasa. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
16. Landry Martial Miguel, Etienne Mokondjimobe, Donatien Moukassa, Ange Antoine Abena, Jean-Rosaire Ibara, Benjamin Longo-Mbenza. Comprehensive and critical review of mini-theses of bachelor of biomedical sciences presented at faculty of health sciences from 2005 to 2014, Brazzaville, republic of Congo. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
17. Nganga Nkanga Mireille, Verdonck Fons, Vandenberghe Peter, Longo-Mbenza Benjamin, Mbaya Tshiyamu Aimé, Sumbu Matondo ma Nzambi Blaise, Mayuku Fukiau
Gustave, Nganga Nzonzila Alain, Beia Kazadi Paul Roger, Mbunga Kilola Branly, Kayembe Nzongola-Nkasu Donatien. Présentation sanguine et médullaire des hémopathies et pathologies apparentées malignes aux cliniques universitaires de Kinshasa: étude préliminaire. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
18. Nganga Nkanga Mireille, Longo-Mbenza Benjamin, Verdonck Fons, Vandenberghe Peter, Mbaya Tshiyamu Aimé, Sumbu Matondo Ma Nzambi Blaise, Mayuku Fukiau
Gustave, Kadima Mutambayi José. Approches conventionnelle, innovative, technologique et critique des hemopathies malignes: revue. Journal of Innovation and
Research in Health Sciences & Biotechnology, 2017
19. B Kebolo, K Palata, P Vandewalle, B Longo-Mbenza. Ecologie et diversité des escargots géants africains à Mbandaka, Kinshasa, Maï-ndombe et au kongo central, RD Congo. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
20. Benjamin Longo-Mbenza. Human leukocyte antigen - drb1 and cardiomyopathy in black Central Africans at Lomo Medical center from Kinshasa, Limete, Democratic Republic of the Congo: scientific letter to editor. Letter to Editor. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
21. Mireille Solange Nganga Nkanga, Benjamin Longo-Mbenza, Jacques Bikaula Ngwidiwo, Antoine Lufimbo Katawandja, Cécile Roth Laure Mapapa Miakassissa, Paul Roger Beia Kazadi, Solo Kuanda Thomas, Jimmy Yuma Ilemba, Blady Mpibi Mpiana, Mokondjimobe Etienne, Aurore Cecilia Orphée Beia Mbombo, Victor Nzuzi Babeki. Migration toward a chaotic Kinshasa megacity: effects of metal toxicity, erosions, floods, wastes, garage stations, working in industries, and the occurrence of cases with hematologic malignancy. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
22. Seudjip Nono L. J, Bunga Muntu P, Longo-Mbenza B. Profil des Groupes Lésionnels des Dermatoses Infantiles aux Cliniques Universitaires de Kinshasa, RD Congo. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
23. Buhendwa Rudahaba Augustin, Mathieu Roelants, Martine Thomis, Lepira Bompeka François, Nkiama Ekisawa Constant, Tady Muyala, Longo-Mbenza Benjamin. Références de l’?paisseu? des plis ?uta??s et du pou??e?tage de g?aisse ?o?po?elle ?hez les e?fa?ts et adolescents scolarisés de 6 à 18 ans de la ville de Kinshasa, RDC. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
24. Blaise Matondo Manzambi Sumbu, Benjamin Longo-Mbenza, Mireille Nganga-Nkanga, Jérémie Muwonga Masidi, Donatien Kayembe Nzongola-Nkasu, Mbayo Kalumbu Ferdinand, Teke Apalata, Steve Ahuka-Mundeke. S??op???ale??e du Vi?us de L’h?patite C chez les Donneurs de Sang Aux Cliniques Universitaires de Kinshasa: 2005-2006 et ???8‐????. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
25. Fabien Mbala Kintoki, Guillit Lufiauluisu, François Bompeka Lepira, Jean-Robert Makulo, Auguy Longo, Bernard Kianu Phanzu, Roger Dimosi Wumba, Eleuther Vita Kintoki, Benjamin Longo-Mbenza. Frequency and Determinants of Visceral and Subcutaneous Obesity in a Student Environment at the University of Kinshasa, Democratic Republic of the Congo. Journal of Innovation and Research in Health Sciences & Biotechnology, 2015
26. Ngoma MV, Longo MB, Mampunza MM, Peuskens J, Vansteelandt K. Valeurs deréférences utiles à l’e?plo?atio? ?eu?ops??hologi?ue des ps??hoses fo??tio??elles ?o? affectives et spécifiques en milieu congolais. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
27. Fabien Mbala Kintoki, Guillit Lufiauluisu, François Bompeka Lepira, Jean-Robert Makulo, Auguy Longo, Bernard Kianu Phanzu, Roger Dimosi Wumba, Eleuther Vita Kintoki, Benjamin Longo-Mbenza. Hyperuricémie, Groupes Sanguins et autres Facteurs de Risque Cardiovasculaire en Milieu Hospitalier de Kinshasa. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
28. Ntombizodumo Nxasana, Sandeep D. Vasaikar, Benjamin Longo-Mbenza, and Teke Apalata. Epidemiology of Intestinal Parasites among School Children in Mthatha, South Africa. Journal of Innovation and Research in Health Sciences & Biotechnology, 2015
29. Mvitu Muaka M, Longo-Mbenza B, Bunga Muntu P, Muaka Diela MJ, Tulomba Mona D, Kibokela Ndembe D, Mokondjimobe E, Gombet T, Wayiza Masamba, Longo Phemba I, Lokotola Lueme C, Apalata T, Mossanda KSA. Prevalence of Retinopathy between Non- Diabetic and Type 2 Diabetic Patients in Central Africa: Effects of Vegetables Intake, Nutrients and Antioxidants. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
30. Kebolo B, Palata K, Vandewalle P, Longo-Mbenza B. Anatomie comparée des organes génitaux des escargots géants de la famille des achatinidae (mollusca: gasteropoda: pulmonata) en République Démocratique du Congo. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
31. Ngoma Malanda Valdo, Longo-Mbenza Benjamin, Mampunza M.M, Peuskens J, Vansteelandtk, Joos S.F. Les troubles cognitifs des psychoses fonctionnelles non
affectives chez le congolais. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
32. Itokua EK MD, Ngiyulu R MD PhD, Makulo JR MD PhD, Lepira BF MD PhD, Aloni M MD, Sadiki NH MD MPH, Gini JL MD PhD, Ekulu FP MD, Budionngo A, Kayembe JM MD PhD, Tshilolo LM MD PhD, Manzombi PCM MD, Longo-Mbenza B MD, PhD, DSc. GPx and Cu-
Zn SOD Activities in Homozygous Sickle Cell Anemia: the Primary Role of Hydroxyurea. Journal of Innovation and Research in Health Sciences & Biotechnology, 2016
33. Benjamin Longo-Mbenza, Teke Apalata, Christian K. Kibatala. Chlamydia pneumoniae as an Independent Risk Factor for Acute Myocardial Infarction among Central Africans. Journal of Innovation and Research in Health Sciences & Biotechnology, 2015
34. Mireille Solange Nganga Nkanga, Benjamin Longo-Mbenza, Jacques Bikaula Ngwidiwo, Antoine Lufimbo Katawandja, Cécile Roth Laure Mapapa Miakassissa, Paul Roger Beia Kazadi, Solo Kuanda Thomas. The effects of heavy metal toxicity and micronutrient deficiencies on the levels of serum uric acid in bantu central africans diagnosed with hematologic malignancy in Kinshasa, Democratic Republic of Congo. Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
35. Benjamin Longo-Mbenza, Jean Bosco Kasiam Lasi On` Kin, Jean Claude Manzala Kumbi, Augustin Nge Okwe, Nelly Kangola Kabangu, Baudoin Buassa-bu-Tsumbu, Dieudonné Vangu Ngoma, Simon Mbungu Fuele, Igor Longo Phemba, Etienne Mokondjimobe, Thierry Raoul Gombet, Ben Longo Mbenza. Are QT intervals associated with metabolic syndrome among Central Africans? Journal of Innovation and Research in Health Sciences & Biotechnology, 2017
36. Benjamin Longo-Mbenza, Moise Mvitu Muaka, Thierry Gombet, Igor Longo Phemba, Stephen Cook, Emmanuel Mve Mengome. Associations of High Density Lipoprotein Cholesterol and Framingham Cardiovascular Risk with Diabetic Retinopathy in African Type 2 Diabetics. World Journal of Cardiovascular Diseases, 2014
37. Kofoworola Olajire Awotedu, Benjamin Longo-Mbeza, Abolade Ajani Awotedu, Chukuma Ekpebegh. Arterial Stiffness in HIV Patients in a Semi Urban Area of South
Africa. Clinical Microbiology, 2015
38. Chukwuma Ekpebegh, FMCP; Benjamin Longo-Mbenza, DSc; Ernesto Blanco-Blanco, MD. ISLET IMMUNITY AND BETA CELL RESERVE OF INDIGENOUS BLACK SOUTH
AFRICANS WITH KETOACIDOSIS AT INITIAL DIAGNOSIS OF DIABETES. Official Journal of ISHIB, 2013
39. Don F. du Toit, Benjamin Longo-Mbenza, Benedict J. Page, Venant Tchokonte-Nana. Efficiency of Co-Expression of Transcription Factors Pdx1, Ngn3, NeuroD and Pax6 with Insulin: A Statistical Approach. International Journal of Statistics in Medical Research, 2013
40. John Nasila Sungwacha, Joanne Tyler, Benjamin Longo-Mbenza, Jean Bosco Kasiam Lasi On'Kin, Thierry Gombet, Rajiv T Erasmus. Assessing clustering of metabolic syndrome components available at primary care for Bantu Africans using factor analysis in the general population. BMC Research Notes, 2013
41. Mireille Solange Nganga Nkanga, Benjamin Longo-Mbenza, Oladele Vincent Adeniyi, Jacques Bikaula Ngwidiwo, Antoine Lufimbo Katawandja, Paul Roger Beia Kazadi, Alain Nganga Nzonzila. Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic
malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC). BMC Cancer, 2017
42. Oladele Vincent Adeniyi, Benjamin Longo-Mbenza, Daniel Ter Goon. Female sex, poverty and globalization as determinants of obesity among rural South African type 2 diabetics: a cross-sectional study. BMC Public Health, 2015
43. Wandabwa JN, Businge C, Longo-Mbenza B, Mdaka ML, Kiondo P. Peripartum hysterectomy: two years experience at Nelson Mandela Academic hospital, Mthatha,
Eastern Cape South Africa. African Health Sciences, 2013
44. Dhaffala A, Longo-Mbenza B, Kingu JH, Peden M, Kafuko-Bwoye A, Clarke M, Mazwai EL. Demographic profile and epidemiology of injury in Mthatha, South Africa. African Health Sciences, 2013
45. Chukwuma O Ekpebegh, Benjamin Longo-Mbenza, Ernesto Blanco-Blanco. Glycosylated haemoglobin is markedly elevated in new and known diabetes patients with
hyperglycaemic ketoacidosis. African Health Sciences, 2014
46. Teke Apalata, William H. Carr, Willem A. Sturm, Benjamin Longo-Mbenza, Prashini Moodley. Determinants of Symptomatic Vulvovaginal Candidiasis among Human
Immunodeficiency Virus Type 1 Infected Women in Rural KwaZulu-Natal, South Africa. Hindawi Publishing Corporation Infectious Diseases in Obstetrics and Gynecology, 2014
47. Bertrand Fikahem Ellenga Mbolla, Annie Rachel Okoko, Jean Robert Mabiala Babela, Gaston Ekouya Bowassa, Thierry Raoul Gombet, Suzy-Gisèle Kimbally-Kaky, Benjamin Longo-Mbenza. Prehypertension and Hypertension among Schoolchildren in Brazzaville, Congo. Hindawi Publishing Corporation Infectious Diseases in Obstetrics and Gynecology, 2014
48. Teke Apalata, Benjamin Longo-Mbenza, A. Willem Sturm, William H. Carr, Prashini Moodley. Expression of toll-like receptor (TLR)-2 and TLR4 in monocytes following
stimulations by genital secretions of HIV infected and uninfected women with symptomatic vulvo-vaginal candidiasis. International Journal of Medicine and Medical
Sciences, 2014
49. Oladele Vincent Adeniyi, Parimalaranie Yogeswaran, Benjamin Longo-Mbenza, Daniel Ter Goon, Anthony Idowu Ajayi. Cross-sectional study of patients with type 2 diabetes in OR Tambo district, South Africa. BMJ Open, 2016
50. Nlandu Roger Ngatu, Ryoji Hirota, Maiko Kaneko Okajima, Luzitu Severin Nangana, Basilua Andre Muzembo, Masamitsu Eitoku, Okitotsho Stanislas Wembonyama, Tatsuo Kaneko, Benjamin Longo-Mbenza, Narufumi Suganuma. Efficacy of leaf extracts of Vernonia amygdalina Del. from central Africa on atopic eczema. Annals of
Phytomedicine An International Journal, 2014
51. Nlandu Roger Ngatu, Mimi Mukuamu, Ryoji Hirota, Luzitu Severin Nangana, Benjamin Longo-Mbenza, Narufumi Suganuma. Severe, chronic and recalcitrant atopic dermatitis associated with Tinea capitis: Diagnostic approach and effects of topical Vernonia amygdalina Del. Extracts. Annals of Phytomedicine An International Journal, 2014
52. Kianu Phanzu Bernard, Mpembele Mabaka Evelyne, Kianu Phanzu Bernard, Kintoki Vita Eleuth??e, M?uti?i Ik?a Ndol Fisto?, M’?uyamba Kabangu Jean-Réné, Longo-Mbenza Benjamin. Correlations between Pulse Pressure and Anthropometric Indices of Obesity: Cross-sectional Study in a Congolese Southwest Port City. Journal of Heart and Cardiovascular Research, 2017
53. Benjamin Longo-Mbenza, Teke Apalata, Murielle Longokolo, Marcel Mbula Mambimbi, Etienne Mokondjimobe, Thierry Gombet, Bertrain Ellenga, Baudouin Buassa-bu-Tsumbu, Guy Milongo Dipa, Evelyne Lukoki Luila, Augustin Nge Okwe. Association of Helicobacter pylori infection with the metabolic syndrome among HIV-infected black Africans receiving highly active antiretroviral therapy. Cardiovascular Journal of Africa, 2015
54. Bernard Kianu Phanzu, Mpembele Mabaka Evelyne, Eleuthère Kintoki Vita, Jean Robert Makulo Risassi, Floriant Kiazayawoko Zola, Jean De Dieu Manyebwa Kalemera, Jean Bos?o Kasia? Lasio?’ki? F?a?çois Lepi?a Bo?peka, Benjamin Longo-Mbenza, Jean Réné Mbuyamba Kabangu, Michel Lutete Kelani, Jody Mbuilu Pukuta, Nanoue Masolo Muze Kianu. Rates of Hypertension Prevalence, Awareness, Treatment, and Control in a Congolese South-West Port City. The Influence of Gender According to Age Groups. Global Journal of Medical Research, 2015
55. Charles Bitamazire Businge, Benjamin Longo-Mbenza, Verona Mathews. Risk factors for incident HIV infection among antenatal mothers in rural Eastern Cape, South Africa. Global Health Action, 2016
56. Chukwuma O Ekpebegh, Benjamin Longo-Mbenza, Ernesto Blanco-Blanco. Autoimmune Clinical Features and Thyroid Antibody Profiles in Black South Africans with Toxic Graves and Primary Hypothyroidsim. International Journal of Endocrinology and Metabolic Disorders, 2015
57. Cook Stephen, Longo-Mbenza Benjamin. The East London glaucoma prediction score: web-based validation of glaucoma risk screening tool. Int J Ophthalmol, 2013
58. Mvitu Muaka Moise, Longo-Mbenza Benjamin, Cibanda Yokobo Enoch, Longo Phemba Igor. Mayombian ethnic, vegetables low intake, insulin treatment, diabetic nephropathy and severe diabetic retinopathy are determinants of blindness in diabetic Africans. Int J Ophthalmol, 2013
59. Benjamin Longo-Mbenza, Moise Mvitu Muaka, Wayiza Masamba, Lucien Mwuizila Kini, Igor Longo Phemba, Dalida Kibokela Ndembe, Doris Tulomba Mona. Retinopathy in non diabetics, diabetic retinopathy and oxidative stress: a new phenotype in Central Africa? Int J Ophthalmol, 2014
60. K Ekoru, GAV Murphy, EH Young, H Delisle, CS Jerome, F Assah, B Longo-Mbenza, JPD Nzambi, JBK On'Kin, F Buntix, MC Muyer, DL Christensen, CS Wesseh, A Sabir, C Okafor, ID Gezawa, F Puepet, O Enang, T Raimi, E Ohwovoriole, OO Oladapo, P Bovet, W Mollentze, N Unwin, WK Gray, R Walker, K Agoudavi, S Siziya, J Chifamba, M Njelekela, CM Fourie, S Kruger, AE Schutte, C Walsh, D Gareta, A Kamali, J Seeley, SA Norris, NJ Crowther, D Pillay, P Kaleebu, AA Motala, MS Sandhu on behalf of the African Partnership for Chronic Disease Research (APCDR). Deriving an optimal threshold of waist circumference for detecting cardiometabolic risk in sub-Saharan Africa.
International Journal of Obesity, 2017
61. Bertrand Fikahem Ellenga-Mbolla, Henri Germain Monabeka, Paul Macaire Ossou-Nguiet, Gilbert Fabrice Otiobanda, Kryste Chancel Mahoungou Guimbi, Thierry Raoul
Gombet, Suzy-Gisèle Kimbally-Kaky, Benjamin Longo Mbenza. Stroke in type 2 diabetes mellitus patients admitted to emergency unit in Central African country (Congo):
Preliminary findings. Journal of Diabetes Mellitus, 2013
62. Oladele Vincent Adeniyi, Parimalaranie Yogeswaran, Benjamin Longo-Mbenza, Daniel Ter Goon. Uncontrolled Hypertension and Its Determinants in Patients with
Concomitant Type 2 Diabetes Mellitus (T2DM) in Rural South Africa. PLOS ONE, 2016
63. Lukuke Hendrick Mbutshu, Kaj Francoise Malonga, Nlandu Roger Ngatu, Sakiko Kanbara, Benjamin Longo-Mbenza, Narufumi Suganuma. Incidence and Predictors of HandeArm Musculoskeletal Complaints among Vibration-exposed African Cassava and Corn Millers. Safety and Health at Work, 2014
64. Benjamin Longo-Mbenza, Moise Mvitu Muaka. The Protective Effect of Phaseolus Vulgaris on Cataract in Type 2 Diabetes: A Profitable Hypothesis. Medical Hypothesis,
Discovery & Innovation Ophthalmology Journal, 2013
65. Thierry Raoul Gombet, Paul Macaire Ossou-Nguiet, Thibaut Naibe Gankama, Bertrand Fikahem Ellenga-Mbolla, Gilbert Fabrice Otiobanda, Karen Obondzo-Aloba, Benjamin Longo-Mbenza. Hypertension and intracerebral hemorrhage in Brazzaville. World Journal of Cardiovascular Diseases, 2013
66. Bertrand Fikahem Ellenga Mbolla, Thierry Raoul Alexis Gombet, Henri Germain Monabeka, Paul Macaire Ossou-Nguiet, Solange Flore Mongo-Ngamami, Christian
Michel Kouala Landa, Suzy-Gisèle Kimbally-Kaky, Benjamin Longo-Mbenza. Hypertension, diabetes mellitus, overweight and obesity in employees under health transition at the railways company in Congo-Brazzaville. World Journal of Cardiovascular Diseases, 2014
67. Prof. B. Longo-Mbenza, Research Professor. Title: Pollution, poverty, violence, climate change, and endemic infections explain mechanism and epidemic of non-communicable diseases in sub-Saharan Africa. Sata Conference Group, 2017
68. Benjamin LONGO-MBENZA. Environment pollution sustainable development, poverty, climate change, endemic infections, molecular biology, double burden malnutrition, multimorbidity and disability for management of endemic noncommunicable diseases in sub-saharan Africa. Sata Conference Group, 2017
69. Charles Bitamazire Businge, Benjamin Longo-Mbenza, Oladele Vincent Adeniyi, Victor Nzuzi Babeki, Achille Kitambala Kaboka, Moise Mvitu Muaka, Mireille Solange Nganga Nkanga, Christophe Masiala Tsobo, Roland Vangu, Emmanuel Mabiala Diambu. Is Iodine Deficiency in Pregnancy Associated with Increased Risks and Severity of Subclinical Hypothyroidism, Pre-eclampsia and Future Cardiovascular Diseases? International Journal of Tropical Medecine, 2017
70. Charles Bitamazire Businge, Benjamin Longo-Mbenza, Oladele Vincent Adeniyi, Victor Nzuzi Babeki, Achille Kitambala Kaboka, Moise Mvitu Muaka, Mireille Solange Nganga Nkanga, Christophe Masiala Tsobo, Roland Vangu, Emmanuel Mabiala Diambu. Exploration of the Underlying Inflammatory and Oxidative Stress Pathological
Mechanisms in Pre-eclampsia Using Principal Component Analysis. International Journal of Tropical Medecine, 2017
71. Charles Bitamazire Businge, Benjamin Longo-Mbenza, Andre Pascal Kengne, Victor Nzuzi Babeki, Achille Kitambala Kaboka, Moise Mvitu Muaka, Mireille Solange Nganga Nkanga, Christophe Masiala Tsobo, Roland Vangu, Emmanuel Mabiala Diambu. Serum Potassium/Magnesium Ratio, Urinary Iodine Concentration, Thyroid-stimulating Hormone, Fasting Plasma Glucose, and the Oxidized low-density Lipoprotein/Albumin Ratio: Potential Biomarkers for Prediction of Pre-eclampsia. International Journal of Tropical Medecine, 2017
72. Gombet Thierry, Longo-Mbenza Benjamin, Ellenga-Mbolla Bertrand, Ikama M. Stephan, Kimbally-Kaky Gisèle, Nkoua Jean-Louis, Nge Okwe Augustin. Prevalence rates and cardiometabolic determinants of diabetes mellitus and pre-diabetes with projected coronary heart disease at bank site of Brazzaville. World Journal of Cardiovascular
Diseases, 2014
73. Bernard Kianu Phanzu, Benjamin Longo-Mbenza, Jea? Bos?o Kasia? Lasio?’ki?, Jod? Mbuilu Pukuta, Eleuthère Kintoki Vita, Nanoue Masolo Muze Kianu. What Are the Determinants of Insulin Resistance (IR) and How Effective Is the Sub-Saharan Africa-Specific Threshold of Abdominal Obesity (AO-SSA) Identifying IR in Congolese Black Hypertensive Patients? World Journal of Cardiovascular Diseases, 2014
74. Charifa Annis, Bernard Kianu Phanzu, Moussa Sidibe, Mustapha El Hattaoui, Benzaroual Dounia, Jean-R??? M’?u?a??a Ka?a?gu, Benjamin Longo-Mbenza. The Influence of Ethnicity in the Relationship between Sedentary Screen Time and Left Ventricular Mass: Insights from the MAG-SALVAGES. World Journal of Cardiovascular Diseases, 2017
75. Charifa Annis, Bernard Kianu Phanzu, Sidibe Moussa, Mustapha El Hattaoui, Benzaroual Dounia, Jean-Re?? M’?u?a??a Ka?a?gu, Benjamin Longo-Mbenza. Lifestyle Changes for Abdominal Obesity Prevention and Encouraging Fruit Consumption May Be Beneficial in Preventing Left Ventricular Hypertrophy in Sub-Saharan African and
Maghreb. World Journal of Cardiovascular Diseases, 2017
76. Bernard Phanzu Kianu1, Charifa Annis, Sidibe Moussa, Eleuthère Vita Kintoki, Karimi El Saloua, Dounia Benzaroual, Mustapha El Hattaoui, Benjamin Longo-Mbenza, Jena-Réné M’?u?a??a Ka?a?gu. Left Ve?t?i?ula? Measu?e?e?ts i? Black Sub-Saharan Africans and White Maghreb. World Journal of Cardiovascular Diseases, 2017
77. Manne-Goehler J, Atun R, Stokes A, Goehler A, Houinato D, Houehanou C, Hambou MM, Mbenza BL, Sobngwi E, Balde N, Mwangi JK, Gathecha G, Ngugi PW, Wesseh CS, Damasceno A, Lunet N, Bovet P, Labadarios D, Zuma K, Mayige M, Kagaruki G, Ramaiya K, Agoudavi K, Guwatudde D, Bahendeka SK, Mutungi G, Geldsetzer P, Levitt NS, Salomon JA, Yudkin JS, Vollmer S, Bärnighausen T. Research Methodology and Data Center, 2016
78. Macaire Ossou-Nguiet, Thibaut Naibe Gankama, Bertrand Fikahem Ellenga-Mbolla, Gilbert Fabrice Otiobanda, Karen Obondzo-Aloba, Benjamin Longo-Mbenza,
Hypertension and intracerebral hemorrhage in Brazzaville. Contribution of CT scan one pidemiology and management of stroke in a Central African country. World Journal of Cardiovascular Diseases, 2013
79. Gombet Thierry, Longo-Mbenza Benjamin, Mokondjimobe Etienne, Buassa-bu-Tsumbu Baudouin, Mvitu Muaka Moise, Bunga Muntu Paulo. Determinants of Non-High Density Lipoprotein-Cholesterol in Bantu Central African Type 2 Diabetic Patients. Journal of Cardiology and Therapy, 2014
80. Benjamin Longo-Mbenza, Teke Apalata, Murielle Longokolo, Marcel Mbula Mambimbi, Etienne Mokondjimobe, Baudouin Buassa-bu-Tsumbu, Thierry Gombet, Bertrain Ellenga, Guy Milongo Dipa, Evelyne Lukoki Luila, Augustin Nge Okwe. Association of Helicobacter pylori infection with the metabolic syndrome among HIV-infected black Africans receiving highly active antiretroviral therapy: cardiovascular topic. Cardiovascular Journal of Africa, 2015
81. Don F. du Toit, Benjamin Longo-Mbenza b, Benedict J. Page, Venant Tchokonte-Nana. Efficiency of co-expression of transcription factors Pdx1, Ngn3, NeuroD and Pax6 with insulin: A statistical approach. Original article : International Journal of Diabetes Mellitus, 2013
82. On'kin JBKL, Longo-Mbenza B, Tchokonte-Nana V, Okwe AN, Kabangu NK. Hyperbolic relation between beta-cell function and insulin sensitivity for type 2 diabetes mellitus, malaria, influenza, Helicobacter pylori, Chlamydia pneumoniae, and hepatitis C virus infection-induced inflammation/oxidative stress and temporary insulin resistance in Central Africans. Turk J Med Sci. 2017
83. Kintoki Mbala F, Longo-Mbenza B, Mbungu Fuele S, Zola N, Motebang D4, Nakin V, Lueme Lokotola C, Simbarashe N, Nge Okwe A. Impact of seasons, years El Nino/La Nina and rainfalls on stroke-related morbidity and mortality in Kinshasa. J Mal Vasc. 2016
84. Ekpebegh C, Longo-Mbenza B. Mortality in hyperglycemic crisis: a high association with infections and cerebrovascular disease. Minerva Endocrinol. 2013
85. Ekpebegh C, Longo-Mbenza B, Blanco-Blanco E. Islet immunity and beta cell reserve of indigenous Black South Africans with ketoacidosis at initial diagnosis of diabetes. Ethn Dis. 2013
86. Ekpebegh CO, Longo-Mbenza B. Clinical, immunologic and insulin secretory characteristics of young black South African patients with diabetes: Hospital based
single centre study. Diabetes Res Clin Pract. 2013
87. Jennifer Manne-Goehler MD, Rifat Atun MBBS, Andrew Stokes PhD, Alexander Goehler MD, Dismand Houinato MD, Corine Houehanou MD, Mohamed Msaidie Salimani Hambou, Benjamin Longo Mbenza MD, Eugène Sobngwi MD, Naby Balde MD, Joseph Kibachio Mwangi MD, Gladwell Gathecha MS, Paul Waweru Ngugi MA, C Stanford Wesseh MA, Albertino Damasceno MD, Nuno Lunet PhD, Pascal Bovet MD, Demetre Labadarios MBChB, Till Bärnighausen MD. Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. The Lancet Diabetes & Endocrinology, 2016
88. T Apalata, B Longo-Mbenza, AW Sturm, WH Carr, P Moodley. Factors Associated with Symptomatic Vulvovaginal Candidiasis: A Study among Women Attending a Primary Healthcare Clinic in Kwazulu-Natal, South Africa. Ann Med Health Sci Res. 2014
89. Mbadu Kivuidi V, Longo-Mbenza B, Bompangue D, Kizungu R. IMPACT OF THE PROGRAM "VILLAGES AND SCHOOLS CLEANSED" ON THE INCIDENCE OF THE DIARRHEAL DISEASES IN THE TOWN OF KINSHASA OF 2004 TO 2016. "CASE OF BINZA METEO, BINZA OZONE, NGAFULA MOUNT AND NSELE". Congrès International sur les Stratégies et les Enjeux du Développement Durable. Kinshasa, 2017
90. J NKOY BELILA, B LONGO- MBENZA MD, PhD. DSC; C MAMBUENI THAMBA Msc, M WETSHI OSOMBA tr. Développement durable, stress psycho social (SPS) et facteurs de risque de maladies cardiovasculaires (FRMCV) en milieu de travail/SNEL. Congrès International sur les Stratégies et les Enjeux du Développement Durable. Kinshasa, 2017
91. Mireille Solange Nganga Nkanga, Benjamin Longo-Mbenza, Yolande Voumbo Matoumona, Etienne Mokondjimobe, Ange Antoine Abena, Jacques Silou, Jacques
Bikaula Ngwidiwo, Antoine Lufimbo Katawandja, Alain Nganga Nzonzila, Paul Roger Beia Kazadi, Donatien Kayembe Nzongola-Nkasu. Mortality Predicted by Incident
Hematological Malignancy, Bacteremia and Lack of Chimiotherapy at Kinshasa University Clinics. Joint 5th SASA International Conference & 2nd Rwanda Biotechnology
Conference, 2017
92. Kebolo B., Palata K., Longo-Mbenza B., Vandewalle P. ELEVAGE EN CAPTIVITE DESESCARGOTS GEANTS AFRICAINS DE LA FAMILLE DES ACHATINIDAE A KINSHASA, RDC. Congrès International sur les Stratégies et les Enjeux du Développement Durable. Kinshasa, 2017
93. MANDINA NDONA M, LONGO-MBENZA B, RENZAHO A, KAPEND L, VOUMBO MATOUMONA Y, NZUZI BABEKI V, LEPIRA MPAKA F, SITUAKIBANZA N. H, WUMBA
DIMOSI R, APALATA TEKE R, KAYEMBE NTUMBA JM, MVUMBI LELO G, LONGO MB, MAMBUENI THAMBA C. EPIDEMIC INCIDENCE OF VITAMIN D DEFICIENCY PREDICTED BY HIV/AIDS, FEMALE GENDER, AGEING, CLIMATE CHANGE, DRY SEASON,POLLUTION, MIGRATION ORIGIN AND POVERTY RELATED ISSUES AMONG DWELLERS EXPOSED TO 2015-EL NINO AND LIVING IN KINSHASA MEGACITY FROM2016 TO 2017, DR CONGO. SPADS CONFERENCE 2017 Uganda : PREVENTION AND CONTROL OF TROPICAL DISEASE EPIDEMICS IN RESOURCE LIMITED SETTINGS, 2017
94. Mvitu Muaka Moise, Longo-Mbenza Benjamin, Voumbo Matumona Yolande, Monkondji Mobe Etienne, Muaka Diela Marie-Josée, Ndjali Dedel Christelle, Mbungu
Fuele Simon. HEMORRAGIC STROKE DEFINED BY FACTOR ANALYSIS WITH KEITHWAGNER GRADES OF HYPERTENSIVE RETINOPATHY AT TEACHING HOSPITAL OF
KINSHASA, DR CONGO. SPADS CONFERENCE 2017 Uganda : PREVENTION AND CONTROL OF TROPICAL DISEASE EPIDEMICS IN RESOURCE LIMITED SETTINGS, 2017
95. Mvitu Muaka Moise, Longo-Mbenza Benjamin, Muaka Diela Marie-Josée, Ndjali Dedel Christelle, Mbungu Fuele Simon. AGEING FOR ISCHAEMIC STROKE DEFINED BY FACTOR ANALYSIS WITH KEITH-WAGNER GRADES OF HYPERTENSIVE RETINOPATHY AT TEACHING HOSPITAL OF KINSHASA, DR CONGO. SPADS CONFERENCE 2017 Uganda : PREVENTION AND CONTROL OF TROPICAL DISEASE EPIDEMICS IN RESOURCE LIMITED SETTINGS, 2017
96. Mvitu Muaka Moise, Longo-Mbenza Benjamin, Voumbo Matumona Yolande, Monkondji Mobe Etienne, Muaka Diela Marie-Josée, Ndjali Dedel Christelle, Mbungu
Fuele Simon. CLASSIFICATION OF STAGES OF SEVERITY OF HYPERTENSIVE RETINOPATHY USING KEITH-WAGNER AMONG PATIENTS WITH ACUTE STROKE AT TEACHING HOSPITAL OF KINSHASA. SPADS CONFERENCE 2017 Uganda : PREVENTION AND CONTROL OF TROPICAL DISEASE EPIDEMICS IN RESOURCE LIMITED SETTINGS, 2017
97. Mvitu Muaka Moise, Longo-Mbenza Benjamin, Voumbo Matumona Yolande, Monkondji Mobe Etienne, Muaka Diela Marie-Josée, Ndjali Dedel Christelle, Mbungu
Fuele Simon. CLASSIFICATION OF GLOMERULAR HYPERFILTRATION, NORMAL GLOMERULAR FILTRATION, KIDNEY DYSFUNCTION STAGES BY BODY COMPOSITION,
SIRIRAJ SCORE, KEITH-WAGNER SCORE, HEMODYNAMICS, AND ATHEROGENICITY INDEXES. SPADS CONFERENCE 2017 Uganda : PREVENTION AND CONTROL OF TROPICAL DISEASE EPIDEMICS IN RESOURCE LIMITED SETTINGS, 2017
98. Mvitu Muaka Moise, Longo-Mbenza Benjamin, Voumbo Matumona Yolande, Monkondji Mobe Etienne, Muaka Diela Marie-Josée, Ndjali Dedel Christelle, Mbungu
Fuele Simon. CLASSIFICATION OF STAGES OF SEVERITY OF HYPERTENSIVE RETINOPATHY USING WONG-MITTCHELL AMONG PATIENTS WITH ACUTE STROKE AT TEACHING HOSPITAL OF KINSHASA. SPADS CONFERENCE 2017 Uganda : PREVENTION AND CONTROL OF TROPICAL DISEASE EPIDEMICS IN RESOURCE LIMITED SETTINGS, 2017
99. Jean Bosco Kasia? Lasi ON’KIN, Benjamin LONGO-MBENZA, Venant TCHOKONTE-NANA, Augustin Nge OKWE, Nelly Kangola KABANGU. Hyperbolic relation between beta-cell function and insulin sensitivity for type 2 diabetes mellitus, malaria, influenza, Helicobacter pylori, Chlamydia pneumoniae, and hepatitis C virus infection-induced
inflammation/oxidative stress and temporary insulin resistance in Central Africans. Turkish Journal of Medical Sciences, 2017
100. B.M.M. Sumbua, B. Longo-Mbenza, S. Ahuka-Mundeke, J.M. Muwonga, G. Mvumbi-Lelo, H.M. Maphana, D. Kayembe Nzongola-Nkasu, F.M. Kalumbu. Association entre les ?i?us du s??d?o?e d’i??u?od?fi?ie??e a??uise et le?i?us de l’h?patite C ?hez les jeu?es donneurs de sang à Kinshasa : analyserétrospective de 10 années. Transfusion Clinique et Biologique, 2017
101. LONGO LONGO G., BONDO MATONDO B., LONGO MBENZA B. IMPACT OF The Antiretro- Viral TREATMENT AFTER INTRODUCTION OF TENOFOVIR INTO A Urbano-Rural MEDIUM OF TSHELA: MORBIDITE AND MORTALITE. Congrès International sur les Stratégies et les Enjeux du Développement Durable. Kinshasa, 2017
102. B. Longo-Mbenza. Exposome, Aging, infections, Climate change and variability, and biomarkers of inflation, immune dysfunction, endothelial dysfunction, oxidative stress, and thrombo-embolism for Stroke in Sub- Saharan Africa. Brain Disorders & Therapy. Open Access Journals gaining more Readers and Citations. 2015

Dr. Simon Walusimbi

Senior Research Fellow Makerere University Lung Institute

Uganda

PROFESSIONAL EXPERIENCE
• Makerere University Lung Institute (Senior Research Fellow) 2016-todate
• Part-time lecturer Makerere University School of Public Health 2016-todate
• Board member (Uganda Stop TB partnership) 2014-todate
• PI of project to evaluate new TB tests for diagnosis of TB in HIV patients. 2010-2014
• Consultant TRACK TB (USAID) Annual NTLP Performance Report 2013/14 Aug/2014
• Consultant Baylor College, Uganda. Revision of national HIV/TB training materials Jul/2013
• Consultant TBCARE (USAID) Uganda Project. Implementation of CBDOTS in Kampala Oct /2013
• Technical Advisor, TB/HIV Services, Makerere University Joint AIDS program. 2008-2016
• Program Officer, RTI-International Uganda. HIV Counseling, Testing and basic care project. 2005-2008
• Medical Officer and Acting medical superintendent, Nkozi Mission Hospital. 2002-2004
• Resident Doctor, Mulago Teaching Hospital. 2000-2001
AWARDS AND GRANTS
• Evaluation of the Uganda 2013 TB/HIV collaborative policy 2017; MaKSPH/CDC (165,000USD)
• Evaluation of Child TB Diagnostic Algorithm for Uganda 2016-2018; Makerere University/SIDA(20,000USD)
• Expanding TB/HIV integrated activities in RRHs of Uganda 2008-2010 (CDC grant)
• Expanding access to coverage and utilization of HTC in Karamoja region 2010-2015 (USAID grant)
• Provision of comprehensive HIV care in National Referral Hospitals 2010-2015 (CDC grant)
• Scholarship for training in advanced molecular clinical microbiology in Africa, Wellcome trust, 2013
• Award for best abstract on HIV co-infections and morbidities, Uganda Society of Health Scientists, 2013
• Research scholarship from the World Federation of Scientists, 2012 and 2013
• Grant for PhD training from Makerere University/ SIDA. 2010 to 2014
• Scholarship from the Belgian Technical Cooperation Agency for Tropical Diseases Control. 2010
• Scholarship from Makerere University for specialist training in HIV/AIDS care. 2003
• State scholarship to study Medicine and Surgery (MB.ChB) at Makerere University. 1995 to 2000

KEY ACHIEVEMENTS 2003 to date
• Contributor to the 2015-2020 District HIV Strategic Plans for ten districts in central Uganda
• Contributor to the 2015 Uganda National TB Strategic Plan 20015/16-2019/2020
• Contributor to the 2013 Uganda National Guidelines on Collaborative TB/HIV Activities
• Contributor to the 2010 Uganda Ministry of Health Manual of TB and Leprosy treatment and Control
• Contributor to the 2009 Uganda Ministry of Health TB infection control guidelines-2009
• Contributor to the 2005 Uganda Ministry of Health HIV counseling, testing and basic care guidelines
• Implemented the set up of integrated TB/HIV clinics in five regional referral hospitals.
• Implemented introduction of Routine HIV testing services in 16 hospitals and health centers.
• Established the Department of Radiology, Nkozi Hospital.
• Established the Infectious diseases/ HIV clinic in Nkozi Hospital.
LICENSES AND AFFILIATIONS
• Registered with the Uganda Medical and Dental Practitioners’ Council.
• Member of the Uganda Medical Association.
• Member of the Uganda Society of Health Scientists
• Member of the Uganda Thoracic society

Dr. Fakher Rahim

Health Research Institute Ahvaz Jundishapur University of Medical Sciences

Golestan Ave., Ahvaz, 61537-15794

Iran

Education
1995-1997: Technician in Anesthesiology, Ahvaz Jundishapur University of Medical Sciences, Iran
1998-2002: B.sc in public management from Ahvaz University of Sciences, Iran
2003- 2005: B.sc of Bioinformatics, Pune University, Pune, India
2005-2007: M.sc of Bioinformatics, Pune University, Pune, India
2010-2011: M.Phil, in epidemiology, Tehran University of Medical Sciences, Iran
2011-2013: PhD in molecular medicine, Ahvaz Jundishapur University of Medical Sciences, Iran
Fields of Interest
1. Bioinformatics and in silico studies
2. Systematic review and meta-analysis
3. Molecular epidemiology
4. Genetics of inborn errors
5. Molecular modeling and simulation, drug designing
1. Ebrahimi A, Rahim F. Crigler-Najjar syndrome: current perspectives and the application of clinical genetics. Endocr Metab Immune Disord Drug Targets. 2017 Dec 13. [PMID: 29237388]
2. Sayyah, M., Siahpoush, A., Rahim, F. The role of alcoholic extract of Zataria multiflora Boiss in controlling opium withdrawal symptoms: A randomized, double-blind study. Archives of Psychiatry and Psychotherapy. 2017; 19 (3): 27-33. [doi: 10.12740/APP/74385]
3. Jahangiri, M., Khodadi, E., Rahim, F., Saki, N., Saki Malehi, A. Decision-tree-based methods for differential diagnosis of β-thalassemia trait from iron deficiency anemia. Expert Systems. 2017; 34 (3), e12201 [doi: 10.1111/exsy.12201]
4. Sayyah M, Shirbandi K, Saki-Malehi A, Rahim F. Use of a problem-based learning teaching model for undergraduate medical and nursing education: a systematic review and meta-analysis. Adv Med Educ Pract. 2017 Oct 3; 8: 691-700. doi: 10.2147/AMEP.S143694. eCollection 2017. Review. [PMID: 29042827]
5. Heidari N, Abroun S, Bertacchini J, Vosoughi T, Rahim F, Saki N. Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis. Cell J. 2017 spring; 19(Suppl 1):9-26. [PMID: 28580304]
6. Rahim F. Risks and Benefits of Immediate antiepileptic Drug Treatment for a First Unprovoked Seizure. Am J Nurs. 2017 Jun;117(6):46. [PMID: 28541990]
7. Khademvatan S, Masjedizadeh R, Yousefi-Razin E, Mahbodfar H, Rahim F, Yousefi E, Foroutan M. PCR-based molecular characterization of Blastocystis hominis subtypes in southwest of Iran. J Infect Public Health. 2017 Apr 9. pii: S1876-0341(17)30101-6. doi: 10.1016/j.jiph.2017.03.009. [PMID: 28404232]
8. Saki N, Shirzad R, Rahim F, Saki Malehi A. Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2(V617F) mutations and laboratory findings: a meta-analysis. Clin Transl Oncol. 2017 Jul;19(7):874-883. Review. [PMID: 28205126]
9. Rahim F. Commentary on a Cochrane Review of Hormone Therapy for Preventing Cardiovascular Disease in Postmenopausal Women. Nurs Womens Health. 2017 Feb - Mar;21(1):9-11. [PMID: 28187847]
10. Khademvatan S, Masjedizadeh R, Rahim F, Mahbodfar H, Salehi R, Yousefi-Razin E, Foroutan M. Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients. Parasitol Int. 2017 Apr;66(2):142-145. [PMID: 28087441]
11. Shahrabi S, Khosravi A, Shahjahani M, Rahim F, Saki N. Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights. Oncol Rev. 2016 Dec 14; 10(2):311. [PMID: 28058097]
12. Noorimotlagh Z, Haghighi NJ, Ahmadimoghadam M, Rahim F. An updated systematic review on the possible effect of nonylphenol on male fertility. Environ Sci Pollut Res Int. 2017 Feb; 24(4):3298-3314. [PMID: 27826822]
13. Bayat A, Farhadi M, Emamdjomeh H, Saki N, Mirmomeni G, Rahim F. Effect of conductive hearing loss on central auditory function. Braz J Otorhinolaryngol. 2017 Mar - Apr;83(2):137-141. doi: 10.1016/j.bjorl.2016.02.010. Epub 2016 Apr 22. PubMed PMID: 27236631.
14. Saeidimehr S, Ebrahimi A, Saki N, Goodarzi P, Rahim F. MicroRNA-Based Linkage between Aging and Cancer: from Epigenetics View Point. Cell J. 2016 Jul-Sep;18(2):117-26. Epub 2016 May 30. Review. [PMID: 27540517]
15. Masoumi K, Forouzan A, Barzegari H, Asgari Darian A, Rahim F, Zohrevandi B, Nabi S. Effective Factors in Severity of Traffic Accident-Related Traumas; an Epidemiologic Study Based on the Haddon Matrix. Emerg (Tehran). 2016 Spring; 4(2):78-82. [PMID: 27274517]
16. Malehi AS, Rahim F. Prognostic classification index in Iranian colorectal cancer patients: Survival tree analysis. South Asian J Cancer. 2016 Jan-Mar;5(1):23-6. doi: 10.4103/2278-330X.179703. [PMID: 27169118]
17. Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S, Rahim F, Malehi AS. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis. Acta Trop. 2016 Jun;158:160-9. Review. [PMID:26952970]
18. Azizidoost S, Ahmadzadeh A, Rahim F, Shahjahani M, Seghatoleslami M, Saki N. Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche. Tumour Biol. 2016 Feb;37(2):1493-503.. Review. [PMID: 26662805]
19. Abroun S, Saki N, Ahmadvand M, Asghari F, Salari F, Rahim F. STATs: An Old Story, Yet Mesmerizing. Cell J. 2015 Fall;17(3):395-411.. Review. [PMID: 26464811]
20. Jalaeikhoo H, Yekaninejad MS, Hajizamani S, Rahim F, Ahmadzadeh A, Keyhani M, Sadeghi Hariri B, Saki N. Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients. Arch Iran Med. 2015 Sep;18(9):577-81. [PMID: 26317598]
21. Gholipour C, Rahim F, Fakhree A, Ziapour B. Using an Artificial Neural Networks (ANNs) Model for Prediction of Intensive Care Unit (ICU) Outcome and Length of
Stay at Hospital in Traumatic Patients. J Clin Diagn Res. 2015 Apr;9(4):OC19-23. [PMID: 26023581]
22. Saeidimehr S, Ebadi A, Kalantari F, Firoozabadi MD, Rahim F. A Validation Study for POSSUM and EuroSCORE as a Predictor of Mortality After Selective Cardiac Surgery. Acta Med Indones. 2015 Jan;47(1):38-44. [PMID: 25948766.]
23. Saeidi S, Jaseb K, Asnafi AA, Rahim F, Pourmotahari F, Mardaniyan S, Yousefi H, Alghasi A, Shahjahani M, Saki N. Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRAN. Int J Hematol Oncol Stem Cell Res. 2014 Jul 1;8(3):30-6. [PMID: 25642306]
24. Hosseini SM, Arvandi S, Razmjoo S, Shahbazian H, Rahim F, Rafie T, Barahman M, Bagheri A. Radiation sensitization with sodium nitrite in patients with brain metastases: a pilot randomized controlled trial. Med Oncol. 2015 Mar;32(3):46. [PMID: 25634801]
25. Masoumi K, Asgari Darian A, Forouzan A, Barzegari H, Rahim F, Feli M, Fallah Bagher Sheidaii M, Porozan S. The efficacy of intranasal desmopressin as an adjuvant in the acute renal colic pain management. Pain Res Treat. 2014;2014:320327. [PMID: 25548665]
26. Khademvatan S, Abdizadeh R, Rahim F, Hashemitabar M, Ghasemi M, Tavalla M. Stray cats gastrointestinal parasites and its association with public health in ahvaz city, South Western of iran. Jundishapur J Microbiol. 2014 Aug;7(8):e11079. doi: 10.5812/jjm.11079. Epub 2014 Jul 1. [PMID: 25485047]
27. Ebrahimi A, Rahim F. Recent immunomodulatory strategies in transplantation. Immunol Invest. 2014;43(8):829-37. doi: 10.3109/08820139.2014.915414. Review. [PMID: 25296237]
28. Shahrabi S, Azizidoost S, Shahjahani M, Rahim F, Ahmadzadeh A, Saki N. New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia. Tumour Biol. 2014 Nov;35(11):10627-33. Review. [PMID: 25234716]
29. Rahim F, Ebrahimi A. Gene therapy modalities in lung transplantation. Transpl Immunol. 2014 Sep;31(3):165-72. Review. [PMID: 25160118]
30. Rahim F, Hajizamani S, Mortaz E, Ahmadzadeh A, Shahjahani M, Shahrabi S, Saki N. Molecular regulation of bone marrow metastasis in prostate and breast cancer. Bone Marrow Res. 2014;2014:405920. Review. [PMID: 25147739]
31. Shirazi AS, Razi T, Cheraghi F, Rahim F, Ehsani S, Davoodi M. Diagnostic accuracy of magnetic resonance imaging versus clinical staging in cervical cancer. Asian Pac J Cancer Prev. 2014;15(14):5729-32. [PMID: 25081693]
32. Alizadeh S, Bavarsad MS, Dorgalaleh A, Khatib ZK, Dargahi H, Nassiri N, Hamid F, Rahim F, Jaseb K, Saki N. Frequency of beta-thalassemia or beta-hemoglobinopathy carriers simultaneously affected with alpha-thalassemia in Iran. Clin Lab. 2014;60(6):941-9. [PMID: 25016698]
33. Ardeshir Larijani F, Kalantar Motamedi SM, Keshtkar AA, Khashayar P, Koleini Z, Rahim F, Larijani B. The relation between serum vitamin D levels and blood pressure: a population-based study. Acta Med Iran. 2014; 52(4):290-7. [PMID: 24901860]
34. Rahmani AH, Jalali A, Alemzadeh-Ansari MH, Tafazoli M, Rahim F. Dosage comparison of snake anti-venomon coagulopathy. Iran J Pharm Res. 2014 Winter;13(1):283-9. [PMID: 24734082]
35. Azizidoost S, Bavarsad MS, Bavarsad MS, Shahrabi S, Jaseb K, Rahim F, Shahjahani M, Saba F, Ghorbani M, Saki N. The role of notch signaling in bone marrow niche. Hematology. 2015 Mar;20(2):93-103. Review. [PMID: 24724873]
36. Masbi MH, Mohammadiasl J, Galehdari H, Ahmadzadeh A, Tabatabaiefar MA, Golchin N, Haghpanah V, Rahim F. Characterization of wild-type and mutated RET proto- oncogene associated with familial medullary thyroid cancer. Asian Pac J Cancer Prev. 2014;15(5):2027-33. [PMID: 24716929]
37. Saki N, Abroun S, Hajizamani S, Rahim F, Shahjahani M. Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma. Cell J. 2014 Summer;16(2):99-110. Review. [PMID: 24567933]
38. Saki N, Rahim F, Nikakhlagh S, Sarafraz M, Jafarzadeh E. Quality of life in children with recurrent acute otitis media in southwestern of iran. Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(Suppl 1):267-70. [PMID]
39. Rahim F, Galehdari H, Mohammadi-Asl J, Saki N. Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP -Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation. Genet Res Int. 2013;2013: 546909. [PMID: 23997956]
40. Rahim F, Jalali A, Tangestani R. Breast cancer frequency and exposure to cadmium: a meta- analysis and systematic review. Asian Pac J Cancer Prev. 2013;14(7):4283 -7. [PMID: 23991990]
41. Azizidoost S, Babashah S, Rahim F, Shahjahani M, Saki N. Bone marrow neoplastic niche in leukemia. Hematology. 2013 Jul 31. [PMID: 23905984]
42. Panahi M, Saki N, Ashourzadeh S, Rahim F. Expressional correlation of human epidermal growth factor receptor 2, estrogen/progesterone receptor and protein 53 in breast cancer. Asian Pac J Cancer Prev. 2013;14(6):3699 -703. [PMID: 23886168]
43. Galehdari H, Saki N, Mohammadi -Asl J, Rahim F. Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations. Int J Mol Epidemiol Genet. 2013 Jun 25;4(2):77-85. [PMID: 23875061]
44. Khademvatan S, Adibpour N, Eskandari A, Rezaee S, Hashemitabar M, Rahim F. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes. Exp Parasitol. 2013 Jul 16;135(2):208-216. [PMID: 23872452]
45. Nasab NM, Bahrammi MA, Nikpour MR, Rahim F, Naghibis SN. Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia. J Pak Med Assoc. 2012 Jul;62(7):677 -80. [PMID: 23866514].
46. Khademvatan S, Rahim F, Tavalla M, Abdizadeh R, Hashemitabar M. PCR-based molecular characterization of Toxocara spp. using feces of stray cats: a study from Southwest Iran. PLoS One. 2013 Jun 3; 8(6):e65293. [PMID: 23755213]
47. Assar S, Idani E, Monajemzadeh M, Ganai M, Rahim F. Remission of childhood asthma after entering the second decade of life: a hospital based cohort. Iran J Allergy Asthma Immunol. 2013 May 15;12(2):124-8. [PMID: 23754350]
48. Nikakhlagh S, Rahim F, Boostani H, Shirazi ST, Saki N. The effect of adenotonsillectomy on quality of life in adults and pediatric patients. Indian J Otolaryngol Head Neck Surg. 2012 Jun;64(2):181 -3. [PMID: 23730582]
49. Ranjbari N, Almasi S, Mohammadi -Asl J, Rahim F. BRAF mutations in Iranian patients with papillary thyroid carcinoma. Asian Pac J Cancer Prev. 2013;14(4):2521 -3. [PMID: 23725167]
50. Abroun S, Saki N, Fakher R, Asghari F. Biology and bioinformatics of myeloma cell. Lab Hematol. 2012 Dec;18(4):30 -41. doi: 10.1532/LH96.11003. Review. [PMID: 23253865]
51. Nikakhlagh S, Rahim F, Saki N, Mohammadi H, Maliheh YM. Antrochoanal polyps: report of 94 cases and review the literature. Niger J Med. 2012 Apr-Jun;21(2):156-9. Review. [PMID: 23311182]
52. Ranjbari N, Rahim F. The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma. Med Hypotheses. 2013 Mar; 80(3):311-4. [PMID: 23313072]
53. Rahim F, Soltani A, Haghpanah V. Developing organized level of biomedical evidence: evidence-based biomedicine. Front Physiol. 2012; 3: 428. [PMID: 23162472]
54. Aghayan HR, Goodarzi P, Baradaran-Rafii A, Larijani B, Moradabadi L, Rahim F, Arjmand B. Bacterial contamination of amniotic membrane in a tissue bank from Iran. Cell Tissue Bank. 2013 Sep;14(3):401-6. [PMID: 23095908]
55. Feghhi M, Altayeb SM, Haghi F, Kasiri A, Farahi F, Dehdashtyan M, Movasaghi M, Rahim F. Incidence of retinopathy of prematurity and risk factors in the South-Western region of iran. Middle East Afr J Ophthalmol. 2012 Jan;19(1):101 -6. [PMID: 22346123]
56. Nader S, Nikakhlagh S, Rahim F, Fatehizade P. Endolaryngeal lipoma: case report and literature review. Ear Nose Throat J. 2012 Feb;91(2):E18-21. Review. [PMID: 22359140]
57. Motamedi SM, Majdzadeh R, Larijani FA, Raheem F, Koleini Z, Larijani B. Potentially preventable incidence of diabetes due to ris k factor modification. J Diabetes Metab Disord. 2012 Aug 24;11(1):8. [PMID: 23497419]
58. Jalali A, Khalilian H, Ahmadzadeh A, Sarvestani S, Rahim F, Zandian K, Asar S. Renal function in transfusion-dependent pediatric beta-thalassemia major patients. Hematology. 2011 Jul;16(4):249 -54. [PMID: 21756543]
59. Khademvatan S, Gharavi MJ, Rahim F, Saki J. Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains. Korean J Parasitol. 2011Mar;49(1):17 -23. [PMID: 21461264]
60. Dehdashti H, Dehdashtian M, Rahim F, Payvasteh M. Sonographic measurement of abdominal esophageal length as a diagnostic tool in gastroesophageal reflux disease in infants. Saudi J Gastroenterol. 2011 Jan-Feb;17(1):53-7. [PMID: 21196654]
61. Rahim F. Correlation of beta-thalassemia mutations with alpha-thalassemia: an experience of the southwestern region of Iran. Hematology. 2010 Dec; 15(6):430 -3. [PMID: 21114907]
62. Nikakhlagh S, Rahim F, Aryani FH, Syahpoush A, Brougerdnya MG, Saki N. Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryngol. 2011 Sep-Oct;32(5):402-7. [PMID: 20947211]
63. Nikakhlagh S, Ghafourian-Boroujerdnia M, Saki N, Soltan-Moradi MR, Rahim F. Immunologic factors in patients with chronic polypoid sinusitis. Niger J Med. 2010 Jul-Sep;19(3):316-9. [PMID: 20845638]
64. Nikakhlagh S, Tahmasebi M, Badri R, Saki N, Rahim F, Badri S. Craniofacial variables in subjects with and without habitual snoring: A cephalometric comparison. Indian J Otolaryngol Head Neck Surg. 2010 Sep;62(3):304-9. [PMID: 23120730]
65. Saki G, Rahim F, Vaysi OA. Effect of forced swimming stress on in-vivo fertilization capacity of rat and subsequent offspring quality. J Hum Reprod Sci. 2010 Jan;3(1):32-4. [PMID: 20607006]
66. Saki N, Nikakhlagh S, Rahim F. Sphenochoanal polyps. J Coll Physicians Surg Pak. 2010 May;20(5):353-4. [PMID: 20642937]
67. Saki N, Rahim F, Nikaghlagh S, Saki G. Meta-analysis of the leech as a live foreign body: detection, precaution and treatment. Pak J Biol Sci. 2009 Dec 15;12(24):1556-63. [PMID: 20334116]
68. Shirazi AS, Sametzadeh M, Kamankesh R, Rahim F. Accuracy of sonography in diagnosis of acute appendicitis running. Pak J Biol Sci. 2010 Feb 15;13(4):190-3. [PMID: 20437687]
69. Nikakhlagh S, Ghafourian-Boroujerdnia M, Saki N, Soltan-Moradi MR, Rahim F. Immunologic factors in patients with chronic polypoid sinusitis. Niger J Med. 2009 Oct-Dec; 18(4):380-3. [PMID: 20120141]
70. Saadipour K, Sarkaki A, Alaei H, Badavi M, Rahim F. Forced exercise improves passive avoidance memory in morphine -exposed rats. Pak J Biol Sci. 2009 Sep 1; 12(17):1206-11. [PMID: 19943456]
71. Saki G, Rahim F, Alizadeh K. Effect of forced swimming stress on count, motility and fertilization capacity of the sperm in adult rats. J Hum Reprod Sci. 2009 Jul;2(2):72-5. [PMID: 19881152]
72. Saki N, Nikakhlagh S, Rahim F, Abshirini H. Foreign body aspirations in infancy: a 20-year experience. Int J Med Sci. 2009 Oct 14;6(6):322-8. [PMID: 19851473]
73. Rahim F. Microcytic hypochromic anemia patients with thalassemia: genotyping approach. Indian J Med Sci. 2009 Mar;63(3):101-8. [PMID: 19359777]
74. Davoodi M, Saki N, Saki G, Rahim F. Anatomical variations of neurovascular structures adjacent sphenoid sinus by using CT scan. Pak J Biol Sci. 2009 Mar 15;12(6):522-5. [PMID: 19580003]
75. Rahim F. In silico comparison of simple sequence repeats in high nucleotides-rich genomes of microorganism. Pak J Biol Sci. 2008 Oct 15; 11(20):2372-81. [PMID: 19137845]
76. Saki G, Rahim F, Moradi L. The study of developmental capacity of vitrified mouse blastocysts in different straws after transfer to mouse pseudo pregnant. Pak J Biol Sci. 2008 Jul 15;11(14):1809-14. [PMID: 18817221]
77. Nikakhlagh S, Ghafourian-Boroujerdnia M, Saki N, Soltan-Moradi MR, Rahim F. Immunologic factors in patients with chronic polypoid sinusitis. Niger J Med. 2009 Oct-Dec; 18(4):380-3. [PMID: 20120141]
78. Saadipour K, Sarkaki A, Alaei H, Badavi M, Rahim F. Forced exercise improves passive avoidance memory in morphine-exposed rats. Pak J Biol Sci. 2009 Sep 1; 12(17):1206-11. [PMID: 19943456]
79. Saki G, Rahim F, Alizadeh K. Effect of forced swimming stress on count, motility and fertilization capacity of the sperm in adult rats. J Hum Reprod Sci. 2009 Jul;2(2):72-5. [PMID: 19881152]
80. Saki N, Nikakhlagh S, Rahim F, Abshirini H. Foreign body aspirations in infancy: a 20-year experience. Int J Med Sci. 2009 Oct 14;6(6):322-8. [PMID: 19851473]
81. Rahim F. Microcytic hypochromic anemia patients with thalassemia: genotyping approach. Indian J Med Sci. 2009 Mar;63(3):101-8. [PMID: 19359777]
82. Davoodi M, Saki N, Saki G, Rahim F. Anatomical variations of neurovascular structures adjacent sphenoid sinus by using CT scan. Pak J Biol Sci. 2009 Mar 15;12(6):522-5. [PMID: 19580003]
83. Rahim F. In silico comparison of simple sequence repeats in high nucleotides-rich genomes of microorganism. Pak J Biol Sci. 2008 Oct 15; 11(20):2372-81. [PMID: 19137845]
84. Saki G, Rahim F, Moradi L. The study of developmental capacity of vitrified mouse blastocysts in different straws after transfer to mouse pseudo pregnant. Pak J Biol Sci. 2008 Jul 15;11(14):1809-14. [PMID: 18817221]
85. Keikhaei B, Zandian K, Rahim F. Existence of cord compression in extramedullary hematopoiesis due to beta thalassemia intermedia. Hematology. 2008 Jun;13(3):183-6. [PMID: 18702878]
86. Rahim F, Kaikhaei B, Zandian K, Hoseini A. Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran. Hematology. 2008 Feb;13(1):59-64. [PMID: 18534068]
87. Sarkaki A, Badavi M, Hoseiny N, Gharibnaseri MK, Rahim F. Postmenopausal effects of intrastriatal estrogen on catalepsy and pallidal electroencephalogram in an animal model of Parkinson's disease. Neuroscience. 2008 Jun 26;154(3):940-5. [PMID: 18472223]
88. Fakher R, Bijan K, Taghi AM. Application of diagnostic methods and molecular diagnosis of hemoglobin disorders in Khuzestan province of Iran. Indian J Hum Genet. 2007 Jan;13(1):5-15. [PMID: 21957335]
89. Rahim F, Abromand M. Spectrum of ß-Thalassemia mutations in various Ethnic Regions of Iran. Pakistan journal of medical sciences. 2008; 24 (3): 410.
90. Rahim F. An in silico development of selective inhibitor for histamine receptors. Biotechnology. 2010; 9 (2): 157-163.
91. Rahim F, Keikhaei B. Better differential diagnosis of iron deficiency anemia from beta-thalassemia trait. Turk J Hematol. 2009; 26 (3): 138-145.
92. Rahim F, Saki G, Bazrafkan M. Effect of alcohol extracts of the Ruta graveolens L. on the count, motility and in vitro fertilization capacity of rat's sperm. Asian Journal of Plant Sciences. 2010; 9 (1): 63-66
93. Rahim F, Saki G, Ghavamizadeh B, Jafaee A, Kadkhodaee M. The effect of oxamate on fertilization capacity of mouse sperm in vitro. Int J of Pharmaco.2009; 5 (2): 178-180.
94. Khaghani S, Bihamta MR, Rahim F, Khaghani S. Study of Qualitative and Quantitative Traits in Red Bean in Non-Stress and Drought Conditions. Asian Journal of Plant Sciences. 2008; 7 (6): 563-568.
95. Adibpour N, Rahim F, Rezaeei S, Khalaj A, Ebrahimi A. In silico designing selective inhibitor of drugs, medicinal plants compounds and experimental ligands for pteridine reductase targeting visceral leishmaniasis African Journal of Microbiology Research. 2012; 6 (5): 917-926.
96. Nejad SEM, Nikpour MRA, Rahim F, Naghibi SN, Bahrammi MA. A randomized open-label comparison of lamotrigine and valproate in patients with juvenile myoclonic epilepsy. Int. J. Pharmacol. 2009; 5: 313-318.
97. Cina M, Rahim F, Davudi M. The accuracy of ultrasonography technique in detection of the intussusception. 2009; 9: 3922-3926.
98. Eidani I, Keikhaei B, Rahim F, Bagheri A. Evaluation of pulmonary function in ß-thalassemia major patients. Pak J Med Sci 2009; 25(5):749-754.
99. Bavrasad R, Nejad SEM, Yarahmadi AR, Sajedi SI, Rahim F. Assessment of the middle dose of topiramate in comparison with sodium valproate for migraine prophylaxis: a randomized double blind study. Int. J. Pharmacol. 2010; 6 (5): 670-675.
100. Bavrasad R, Seyedzadeh AN, Nezhad SEM, Mousavinasab N, Rahim F. Effect of the Activated factor VII on Prognostic and Reducing the Bleeding in Patients with Cerebral Hemorrhage. 2010; 6 (2): 142-146.
101. Rahim F, Keikhaei B, Sarkaki A, Doulah AH. Ibotenic Acid-Induced Hematological Disorders in Rat Model of Alzheimer's Disease. Asian Journal of Animal and Veterinary Advances. 2010; 5 (1): 13-23.
102. Saki G, Rahim F, Dahaz S. Effect of supplementation of zinc on count, motility and in vitro fertilization capacity of spermatozoa of magnetic field exposed rats. Journal of Biological Sciences. 2010; 10: 174-177.
103. Saki J, Akhlaghi L, Maraghi S, Meamar AR, Mohebali M, Oormazdi H, Razmjou E, Khademvatan S, Rahim F. Evaluation of modified Novy-MacNeal-Nicolle medium for isolation of Leishmania parasites from cutaneous lesions of patients in Iran. Research Journal of Parasitology. 2009; 4 (2): 56 – 62.
104. Keikhaei B, Zandian K, Rahim F, Soltani A, Hoseini M. Cord compression due to extramedullary hematopoiesis in two patients of ss-thalassemia intermedia. Pakistan journal of medical sciences. 2007; 23 (5): 765.
105. Vatanpour H, Jalali A, Rowan E, Rahim F. Effects of Odontobuthus Doriae Scorpion Venom on Mouse Sciatic Nerve Iranian Journal of Pharmaceutical Research. 2013; 12: 143-148.
106. Rahim F, Hamid F, Galedari H, Khamisipour GH, Keikhaei B, Jaseb K, Saki N. Three Different Co-existing α-Thalassemia Mutations and Sickle Cell Disease in a Pregnant Woman. 2013; 44: e72-e76
107. Razie S, Panahi M, Ahangarpor A, Rahim F, Saki G. Study of level of inhibin B and ultra-structure of sertoli cells in contra-lateral testis after unilateral blunt testis trauma in rat Asian J. Biol. Sci. 2011; 4: 70-76.
108. Keikhaei B, Badavi M, Pedram M, Zandian K, Rahim F. Serum Zinc Level in Thalassemia Major. Pak J Med Sci. 2010; 26(4):942-945.
109. Zadeh BSM, Moghimi H, Santos P, Hadgraft J, Majella E Lane, Rahim F. Formulation of microemulsion systems for improvement of nitrofurazone
permeation through silicon membrane as burn wound imitating coverage. International Journal of Pharmacology. 2010; 6: 264-270.
110. Khaghani S, Shoushtari RV, Zolfagharieh HR, Rahim F. The Effect of Gamma Irradiation on the Adult Stage of Confused Flour Beetle, Tribolium confusum Duval. International Journal of Botany. 2010; 6: 157-160.
111. Davoudi M, Sharifi MSZ, Rahim F. Study the Complications of Ct-guidance Fine Needle Biopsy in Intra-thoracic Masses International Journal of Cancer Research. 2010; 6: 243-250.
112. Ebadi A, Ramezani A, Rahim F, Afraee N. Postoperative cardiac arrest due to Cardiac surgery complications. Pak J Med Sci. 2010; 26 (1): 43-48.
113. Rahim F, Keikhaei B, Sarkaki A, Doulah AH. Hematological Disorders in Ibotonic Acid-Induced Rat Model of Alzheimer's disease Journal of Animal and Veterinary Advances. 2009; 8 (11): 2262-2268.
114. Tahmasebi M, Shaterzadeh MJ, Shokrollahi E, Rahim F. Lateral lumbosacral radiological angular Indices in standing and lying positions and their relation with chronic nonspecific low back pain. Archives des sciences. 2013; 66(4): 21-37.
115. Saki N, Ardeshir Larijani F, Rahim F. The association of Helicobacter Pylori infection with otitis media: a meta-analysis. Archives des sciences. 2013; 66(4):452-470.
116. Masoumi K, Forouzan A, Darian AA, Barzegari H, Rahim F, Fallah M, Sheidaii B, Porozan S. Comparison of the clinical efficacy of intranasal desmopressin with intramuscular sodium diclofenac in acute renal colic. Archives Des Sciences. 2013; 66(4):38-49.
117. Nikakhlagh S, Saki N, Baghbdrani RA, Rahim F, Sheikh AFZ. Microbiology of Adenoid in children with recurrent of otitis media. Asian Journal of Biological Sciences. 2011; 4(3):252-258.
118. Nikakhlagh S, Rahim F, Khodadadi A, Saki N. The association between Epstein-Barr virus with nasopharyngeal carcinoma in patients from southwestern region of Iran. International Journal of Cancer Research.2010; 6(2):89-94.
119. Nikakhlagh S, Rahim F, Saki G, Khosravi A, Rekabi H, Saki N. Deep Neck Infections: A Case Study of 12-Year. Asian Journal of Biological Sciences. 2010; 3(3):128-133.
120. Rahim F, Saki G. Assessment of Motility and Survival Rate of Asthenospermic Men's Sperm Cultured in Media Plus Leukemia Inhibitor Factor. International Journal of Pharmacology. 2010; 6 (3): 306-310.
121. Rahim F, Saki G. Use of Open Pulled Straw as a Carrier in Vitrification of Metaphase II Oocyte in Mice. Asian Journal of Biological Sciences. 2010; 3(2):85-91.
122. Rahim F, Saki G, Ghavamizadeh B, Jafaee A, Kadkhodaee M. The Effect of Oxamate on Fertilization Capacity of Mouse Sperm in vitro. International Journal of Pharmacology. 2009; 5 (2): 178-180.
123. Jasemi M, Saki G, Rahim F. Progressive Sperm Motility, Sperm Condensation and Spontaneous Pregnancy Rate in Infertile Varicocele Patients at 3-12 Months after Varicocelectomy. Journal of Applied Sciences. 2009; 9: 2640-2644.
124. Khademvatan S, Saki J, Gharavi MJ, Rahim F. Allium sativum extract induces apoptosis in Leishmania major (MRHO/IR/75/ER) promastigotes Journal of medicinal plants research. 2011; 5 (16): 3725-3732.
125. Saki G, Rahim F, and Jasemi Zergani M. Vitrification of Small Volume of Normal Human Sperms: Use of Open Pulled Straw Carrier. Journal of Medical Sciences. 2009; 9: 30-35.
126. Zadeh BSM, Dahanzadeh S, Rahim F. Preparation and evaluation of the self-emulsifying drug delivery system containing loratadine. International Journal of Advances in Pharmaceutical Sciences. 2010; 1 (3); 239-248.
127. Rahim F, Ebadi A, Saki G, Remazani A. Prevalence of congenital heart disease in iran: a clinical study. J Med Sci. 2009; 8 (6): 547-552.
128. Rahim F, Keikhaei B, Aberumand M. Prenatal diagnosis (PND) of β-thalassemia in the Khuzestan province, Iran. Journal of Clinical and Diagnostic Research. 2007; 1 (6): 454-459.
129. Keikhaei B, Rahim F, Zandian KHM, Pedram M. comparison of different indices for better differential diagnosis of iron deficiency anemia from b thalassemia trait. BLOOD (KHOON). 2007: 4 (2): 95-104.
130. Rahim F, Deshpande A, Hosseini A. Fuzzy expert system for fluid management in general anaesthesia. Journal of Clinical and Diagnostic Research. 2007; 1 (4): 256-267.
131. Shahali SH, Shaterzadeh Yazdi MJ, Goharpey SH, Rahim F. Reliability of the Persian version of coronary revascularization outcome questionnaire (CROQ) in cardiac patients undergoing cabg and ptca procedures. Journal of Clinical and Diagnostic Research. 2008; 2:919-924.
132. Rahim F. Bioinformatics and proteomic approaches to disease: in vivo and in silico proteome analysis tools. Journal of Clinical and Diagnostic Research. 2008; 2:879-886.
133. Rahim F, Ahadi R. Thalassemia and hemoglobin disorders in Khuzestan province of Iran. Journal of Clinical and Diagnostic Research. 2008; 2:820-826.
134. Rahim F, Keikhaei B, Zandian K, Soltani A. Diagnosis and treatment of cord compression secondary to extramedullary hematopoiesis in patients with beta-thalassemia intermedia. Journal of Clinical and Diagnostic Research. 2008; 2:643-647. 89. Sarkaki AR, Saadipour KH, Badavi M, Alaei H, Rahim F. Effects of forced treadmill exercise on pain threshold in morphine-addicted rats. Journal of Clinical and Diagnostic Research. 2007; 1: 555-560.
135. Panahi M, Rahim F, Rashidi I, Irani S. Incidence of aplastic anaemia in khuzestan province, IRAN: A RETROSPECTIVE SINGLE-CENTRE STUDY. Journal of Clinical and Diagnostic Research. 2007; 1:352-355.
136. Rahim F, Saki N. Age-specific cutoff in discriminating Iron deficiency anemia from beta-thalassemia traits. Iranian Journal of Blood and Cancer.2010; 2 (4): 197.
137. Hossein SA, Rahim F, Mola, K. Omega-3 induced change in clinical parameters of rheumatoid arthritis. Journal of Medical Sciences. 2009; 9 (2): 93-97.
138. Salimi A, Ghollasi M, Saki N, Rahim F, Dehghanifard A, Alizadeh SH, Farshdousti Hagh M, Soleimani M. Application of Nanoscaffolds and Mesenchymal Stem Cells in Tissue Engineering. Iranian Journal of Blood and Cancer. 2010; 3 (1): 11-20.
139. Rahim F, Keikhaei B, Ebadi A. Clinical Manifestation of Pulmonary Dysfunction in ß-Thalassemia Major. Journal of Medical Sciences. 2008; 8 (5): 484-490.
140. Saki N, Dehghani Fard A, Kaviani S, Jalali Far MA, Kheirollah SH, Mousavi A, Rahim F. Beta Thalassemia: Epidemiology and Diagnostic and Treatment Approaches in Iran. Genetic 3rd melinium. 2012; 10 (1): 2674-2683.
141. Rahim F, Allahmoradi H, Salari F, Shahjahani M, Dehghani Fard A, Hosseini SA, Mousakhani H. Evaluation of Signaling Pathways Involved in γ-Globin Gene Induction Using Fetal Hemoglobin Inducer Drugs. International Journal of Hematology-Oncology and Stem Cell Research. 2013; 7 (3): 40-45.
142. Saki N, Jalalifar MA, Soleimani M, Hajizamani S, Rahim F. Adverse Effect of High Glucose Concentration on Stem Cell Therapy. International Journal of Hematology-Oncology and Stem Cell Research. 2013; 7 (3): 33-39.
143. Dehghanifard A, Shahjahani M, Galehdari H, Rahim F, Hamid F, Jaseb K, Amin AA, Jalalifar MA, Saki N. Prenatal diagnosis of different polymorphisms of β-globin gene in Ahvaz. International Journal of Hematology-Oncology and Stem Cell Research. 2013; 7 (2): 17-22.
144. Ahmadizadeh M, Sarkaki A, Farboud Y, Mohammadian B, Rahim F. Effect of Exercise on Morphine-Induced Toxicity in Rat. Jundishapur Scientific Medical Journal. 2012; 11 (3): 325-333.
145. Saki J, Kadkhodaei Elyaderani M, Rahim F, Saki Gh, Kalantar Mahdavi SARD. The effect of oxamate on LDH-c4 activity of sperm in rats. Qom University of Medical Sciences Journal. 2012; 3 (4): 3-10.
146. Saki GH, Radan K, Mostafa Radmard SH, Rashidi I, Rahim F. The effect of unilateral testicular blunt trauma and protective effect of zinc on spermatogenesis of contra lateral testis of pre-pubertal wistar rat. Qom University of Medical Sciences Journal. 2012; 3 (1): 35-40.
147. Sarkaki A, Mohammadian M, Panahi M, Ahangarpour A, Rahim F. Effects of Forced Exercise on Withdrawal Syndrome, Brain Hippocampus Neurons Count and Level of Serum Corticosterone in Morphine Addicted Male Rats. Jundishapur Scientific Medical Journal. 2012; 11 (1): 11-24.
148. Saki N, Nikakhlagh S, Sarafraz M, Rahim F, Zarpeyma S. Epidemiological study of otitis media in children aged less than 6 years referring to health centers of Hovaiezeh city. Jundishapur Scientific Medical Journal. 2010; 9 (1): 31.

Book / Book Chapter
1. Mostafa Feghhi, Fakher Rahim. Retinopathy of Prematurity: Epidemiology, Incidence, and Blindness. LAP Lambert Academic Publishing, 2012: Page:1-100. ISBN:9783659206863.
2. Nader Saki, Fakher Rahim, Soheila Nikakhlagh. Quality of Life and Otolaryngology Disease. LAP Lambert Academic Publishing, 2012: Page: 1-112. ISBN: 9783659191572.
3. Ammar Ebrahimi, Neda Lalvand, Fakher Rahim. Bioengineering and Expression of Human Fviii Gene. Lambert Academic Publishing, 2011. Page: 1-99. ISBN: 9783845400723.
4. Fakher Rahim, Najmaldin Saki and Mohammad Ali Jalalai far (2011). The Role of Gene Mutations Detection in Defining the Spectrum of ß – Thalassemia in Various Ethnic Regions, Human Genetic Diseases, Dr. Dijana Plaseska-Karanfilska (Ed.), ISBN: 978-953-307-936-3, InTech, DOI: 10.5772/24295.
5. Rahim, Fakher, Arjmand, Babak.,. Stem Cell Clinical Trials for Multiple Sclerosis: The Past, Present and Future. Editor: Pham, Phuc Van In: Neurological Regeneration. Cham, Springer International Publishing, 2017 Pages: 159-172. ISBN: 978-3-319-33719-7 (Print) 978-3-319-33720-3 (Online)
6. Babak Arjmand, Parisa Goodarzi, Khadijeh Falahzadeh, Hamid Reza Aghayan, Fakher Rahim, Fereshteh Mohamadi-Jahani, Bagher Larijani. GMP-Compliant Perinatal Tissue-Derived Stem Cells. Editors: Babak Arjmand. In: Perinatal Tissue-Derived Stem Cells. Cham, Springer International Publishing, 2017. Pages: 189-213. ISBN: 978-3-319-46408-4 (Print) 978-3-319-46410-7 (Online)
7. Fakher Rahim, Ammar Ebrahimi, Farideh Ghanbari. The Oncogenic and Tumor Suppressive Roles of MicroRNAs and Tmor: Cancer and Aging Cross-talk. LAP Lambert Academic Publishing, 2016. ISBN: 3659942898, 9783659942891.

Dr. Carlos Miguel Rios-González

Nihon Gakko University Soldado Ovelar c/ Yataity Cora

Fernando de la Mora, Paraguay

Carlos Miguel is a doctor, a specialist in health research, a student of the master's degree in scientific research methodology, director of research at Nihon Gakko University, a researcher at the Regional Institute of Health Research, a research tutor at the National Institute of Health, 70 articles published , reviewer of several journals, experience as a lecturer in the event, and member of scientific societies.
Sexual minorities, Gender identity, HIV, Social stigma, transgender
Memberships and scientific activities

1. 2018- present - Editorial member – Journal of Public Health of Paraguay.
2. 2017- present- Member of the Advisory Board of the Latin American Federation of Scientific Societies of Medical Students (FELSOCEM).
3. 2017- present - Member associate - The International Union against Sexually Transmitted Infections (IUSTI)
4. 2017- present - Membership - International Society for Infectious Diseases .
5. 2017- present – Membership – World Society of Virology
6. 2017- present- Member of the Seedbed of Research in Infectology and Epidemiology of the University of Tolima (Colombia).
7. 2017- present. International Editor Journal SCientifica .
8. 2016- 2017 . Vice president. Latin American Federation of Scientific Societies of Medical Students (FELSOCEM).
9. 2016- present. General secretary. Paraguayan Society of Sexually Transmitted Infections.
10. 2016- Founding member. Paraguayan Society of Sexually Transmitted Infections.
11. 2016- present. Director of the Scientific Direction. Scientific Society of Medicine students of the National University of Caaguazú (SOCIEM UNC @).
12. 2015 - 2016 . Director of the Permanent Committee of Medical Education. Latin American Federation of Scientific Societies of Medical Students (FELSOCEM).
13. 2014- present. International Editor Latin American Student Medical Science and Research Journal.
14. 2014- present. Founder and editor in Chief. Scientific Journal Paradigms of Current Medicine.
15. 2014-2015- Deputy Director of the Permanent Committee of Medical Education . Latin American Federation of Scientific Societies of Medical Students (FELSOCEM).
16. 2014- 2015- Official Interchange Place in research. The International Federation Medical Students Associations (IFMSA).
17. 2014-2015 Director of Medical Education. Scientific Society of Medicine students of the National University of Caaguazú (SOCIEM UNC @).
18. 2013-2014 Director of Publications. Scientific Society of Medicine students of the National University of Caaguazú (SOCIEM UNC @).
19. 2012- present. Active member of the Scientific Society of Medicine students of the National University of Caaguazú (SOCIEM UNC @).
20. 2012- 2013. Vice President of the Student Center of the Faculty of Medical Sciences of the National University of Caaguazu.
21. 2012- 2017. Member of the Federation of University Students of Coronel Oviedo.
Bibliographic production scientific :
Published:
1. Bibliometric study of international scientific production in O'nyong - Nyong virus during the years 1962-2016, Journal of Infection and Public Health, 2016. ARABIA SAUDITA. Disponible en: http://www.jiph.org/article/S1876-0341(16)30061-2/abstract
2. Escasa publicación científica en estudiantes de medicina de Paraguay, Educación Médica, v.17 f: 2, p. 80-81, 2016. ESPAÑA. Disponible en: http://www.elsevier.es/es-revista-educacion-medica-71-articulo-escasa-publicacion-cientifica-estudiantes-medicina-S1575181316300298
3. Knowledge about Dengue, Zika and Chikungunya in Latin American students, 2016, Medicina Universitaria, 2016. MEXICO. Disponible en: http://www.elsevier.es/en-revista-medicina-universitaria-304-avance-2
4. El aporte de la Federación Latinoamericana de Sociedades Científicas de Estudiantes de Medicina a la educación médica latinoamericana., Revista de la Fundación Educación Médica, v. 19 f: 2, p. 69, 2016. ESPAÑA. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2014-98322016002200003
5. Características epidemiológicas y clínicas de la leishmaniasis visceral en Paraguay de enero de 2008 a diciembre de 2014., Revista Médica de Risaralda, v. 22 f: 2, p. 83-86, 2016. COLOMBIA. Disponible en: http://search.bvsalud.org/cvsp/resource/pt/lil-786678
6. El papel de las revistas científicas estudiantiles en la difusión de hallazgos en pregrado., Revista Hispanoamericana de Ciencias de la Salud, v. 2 f: 1, p. 103, 2016. COSTA RICA. Disponible en: http://uhsalud.com/index.php/revhispano/article/view/119
7. Reflexiones sobre la infección por Zika en Paraguay, Revista chilena de infectología, v. 33 f: 2, p. 240-241, 2016. CHILE. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182016000200017
8. El embarazo y la infección por el virus del Zika: un problema emergente de la salud pública paraguaya, Pediatría (Asunción), v. 43 f: 1, p. 77-78, 2016. PARAGUAY. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S1683-98032016000100010&lng=en&nrm=iso
9. Ectopia testicular cruzada unilateral: presentación de un caso clínico y revisión bibliográfica., Revista ANACEM, v. 8 f: 2, p. 68-70, 2016. CHILE. Disponible en: http://www.revistaanacem.cl/wp-content/uploads/2016/06/anacem_revistavol8N2_clinicos5.pdf
10. Tabaquismo en estudiante de medicina de la Universidad Nacional de Caaguazú, mayo de 2015, Revista Médica de Chile, v. 144, p. 680-684, 2016. CHILE. Disponible en: http://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/4788
11. Prácticas de riesgo para transmisión de VIH en adultos de la ciudad de General Elizardo Aquino, Diciembre 2014 - Enero 2015. Paraguay, Horizonte Medico,
v. 15 f: 2, 2015. PERU. Disponible en: http://www.scielo.org.pe/pdf/hm/v15n2/a03v15n2.pdf
12. Una visión panorámica sobre la investigación en Pregrado en Universidades de Paraguay., Revista Scientifica, v. 13 f: 1, p. 52, 2015. BOLIVIA. Disponible en: http://www.revistasbolivianas.org.bo/scielo.php?pid=S1813-00542015000100011&script=sci_arttext
13. Prevalencia de HTA en el barrio Gral. Bernardino Caballero, Paraguay, Revista Scientifica, v. 13 f: 1, p. 13-17, 2015. BOLIVIA. Disponible en: http://ojsbolivia.org.bo/index.php/RSC/article/view/623/606
14. Prevalencia de sífilis en embarazadas de un hospital de Paraguay, 2014, CIMEL, v. 20 f: 1,2015. PERU. Disponible en: https://www.researchgate.net/publication/282887030_PREVALENCIA_DE_SIFILIS_EN_EMBARAZADAS_QUE_ACUDEN_AL_CONTROL_PRENATAL_EN_UN_HOSPITAL_2014
15. Indexaciones de la revistas biomédicas a SciELO Paraguay, Revista Científica Ciencia Médica,v. 18 f: 2, p. 57, 2015. BOLIVIA. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332015000200013
16. La automedicación: un problema de salud pública en auge constante, Revista Del Nacional (Itauguá), v. 7 f: 2, p. 56-56, 2015. PARAGUAY. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2072-81742015000200013&lng=es&nrm=iso&tlng=es
17. Prevalencia de automedicación en dos barrios de la ciudad de coronel Oviedo - Paraguay, marzo a mayo 2014, Revista Scientifica, v. 12 f: 1, p. 46-50, 2014. BOLIVIA. Disponible en: http://www.revistasbolivianas.org.bo/scielo.php?pid=S1813-00542014000100008&script=sci_arttext
18. Proceso editorial de la Revista Científica Paradigmas de la Medicina Actual., Revista Cientifica Paradigmas de la Medicina Actual, v. 1 f: 1, p. 61-63, 2015. PARAGUAY. Disponible en: https://www.academia.edu/19984120/Proceso_editorial_de_la_Revista_Cient%C3%ADfica_Paradigmas_de_la_Medicina_Actual
19. El desafío de publicar desde Pregrado., Revista Cientifica Paradigmas de la Medicina Actual, v. 1 f: 1, p. 5-6, 2015. PARAGUAY. Disponible en: https://www.academia.edu/19984183/El_desaf%C3%ADo_de_publicar_desde_Pregrado
20. La investigación científica en Dengue, Zika y Chikungunya: evaluación bibliométrica de las contribuciones de la literatura paraguaya, Revista Científica Ciencia Médica, v. 19 f: 1, 2016. BOLIVIA. Disponible: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332016000100014
21. Obstáculos para la investigación Científica en Estudiantes de Medicina del Paraguay, 2016. Educ. Medica. ESPAÑA. Disponible en: http://www.sciencedirect.com/science/article/pii/S1575181316301115
22. Percepción del Ambiente Educativo en Estudiantes de Medicina de Latinoamérica, 2015. CIMEL. V. 21 f: 2, p. 38-41 PERU. Disponible en: https://www.cimel.felsocem.net/index.php/CIMEL/article/view/640
23. Características de las actividades de educación médica realizadas por la sociedades científicas de estudiantes de medicina de Latinoamérica, 2015-2016. Rev. Fundación Educación Médica. ESPAÑA. Disponible en: http://www.educmed.net/sec/verRevista.php?id=4554a1254a7263186515
24. Conocimientos sobre Leishmania spp. y Leishmaniasis en estudiantes de medicina de Latinoamérica, 2016. Rev Chilena Infectol 2016; 33 (4): 481-482. CHILE. Disponible en: http://www.revista.sochinf.cl/PDF_inf_4_2016/23-Rios-Gonzalez.pdf
25. El rol de las revistas científicas estudiantiles en la difusión de conocimientos en pregrado. MedUNAB. 2016; 19(1):7-8. COLOMBIA. Disponible en: http://revistas.unab.edu.co/index.php?journal=medunab&page=article&op=view&path%5B%5D=2616
26. Análisis bibliométrico de la producción científica sobre VIH/sida en el Paraguay 1987 - 2015. Rev. Scientifica. 2016; 14(1):41 BOLIVIA. Disponible en: https://drive.google.com/file/d/0B4l7cRlP7nCgajE2dlpHWEtuUm8/view
27. Outbreak of Burkholderia cepacia in a hemodialysis unit of Paraguay, 2014. Journal of Infection and Public Health. ARABIA SAUDITA. Disponible en: http://www.jiph.org/article/S1876-0341(16)30131-9/fulltext
28. Global impact of the World Hepatitis Day: an evaluation using Google Trends. Journal of Infection and Public Health. ARABIA SAUDITA. Disponible en: http://www.jiph.org/article/S1876-0341(16)30154-X/fulltext
29. Need for more research on and health interventions for Transgender people. Sexual health. AUSTRALIA. Disponible en: http://www.publish.csiro.au/sh/sh16148
30. O'nyong'nyong virus: next arbovirus in Latin America?. Journal of Infection and Public Health. ARABIA SAUDITA. Disponible en: http://www.jiph.org/article/S1876-0341(17)30036-9/pdf
31. Conocimientos, actitudes y prácticas sobre el Zika en estudiantes de medicina, 2016. Rev Cient Cienc Méd. 2016 ; 19( 2 ): 33-37.BOLIVIA Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332016000200006&lng=es&nrm=iso
32. Reflexiones sobre el III Debate Latinoamericano de Ética y Experiencias Médicas, 2015. CIMEL. PERU. Disponible en: http://www.cimel.felsocem.net/index.php/CIMEL/article/view/747/394
33. El inglés como clave del aprendizaje y avance científico en estudiantes de medicina de Latinoamérica. Educación Médica. Rev. Educación Medica. ESPAÑA. Disponible en: http://www.elsevier.es/es-revista-educacion-medica-71-avance-resumen-el-ingles-como-clave-del-S1575181317300591
34. Evaluación bibliométrica de la Producción Científica Mundial sobre el Virus Toscana. Medicina Clínica y Social 2017. Paraguay. Disponible en: http://www.medicinaclinicaysocial.org/index.php/MCS/article/view/4/3
35. Importancia de la oferta de tamizaje del VIH en Paraguay. CIMEL. Disponible en: http://www.cimel.felsocem.net/index.php/CIMEL/article/view/779
36. The importance of scientific research in higher education. Medicina Universitaria. Disponible en: http://www.sciencedirect.com/science/article/pii/S1665579617300169
37. Infectious diseases in patients over 65 years attended in Leticia, The Amazonas, Colombia. Medicina Universitaria. MEXICO. Disponible en: http://www.sciencedirect.com/science/article/pii/S1665579617300157
38. Evaluation of the scientific production on HIV in indigenous people, from 1989 to 2016. Travel Medicine and Infectious deseases. ESTADOS UNIDOS. Disponible en: http://www.sciencedirect.com/science/article/pii/S1477893917300893
39. A bibliometric analysis of global Angiostrongylus cantonensis research. Asian Pacific Journal of Tropical Disease. PAISES BAJOS. Disponible en: http://oaji.net/articles/2017/3556-1499412980.pdf
40. Predisposición para la participación de estudiantes de medicina en encuestas online: una reflexión sobre la experiencia. Fundación Educación Médica. ESPAÑA. Disponible en: http://www.educmed.net/edumed/sec/verRevista.php?id=75434a1289a1766454366
41. Análisis bibliométrico sobre la producción científica relacionada con el cólera. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. CUBA. Disponible en; http://revzoilomarinello.sld.cu/index.php/zmv/article/view/1132/pdf_421
42. When has it been studied about La Crosse Virus?: bibliometric analysis of world scientific production. Journal of Infection and Public Health. ARABIA SAUDITA. Disponible en: http://www.sciencedirect.com/science/article/pii/S1876034117301776
43. Reflections on the epidemiology of HIV/AIDS in Latin America. Journal of Infection and Public Health. ARABIA SAUDITA. Disponible en: http://www.sciencedirect.com/science/article/pii/S1876034117301788
44. El uso de gas lacrimógeno en protestas como factor nocivo para la salud. Revista Hispanoamericana de Ciencias de la Salud. COSTA RICA. Disponible en: http://www.uhsalud.com/index.php/revhispano/article/view/245
45. Características epidemiológicas del VIH en Paraguay durante el 2015. Revista Chilena de Infectologia. CHILE. Disponible en: http://www.revista.sochinf.cl/PDF-inf4-2017/art25.pdf
46. Virus que poseen transmisión sexual como vía alternativa: reflexión sobre las ITS secundarias del siglo XXI. Revista Chilena de Infectologia. CHILE. Disponible en: http://www.revista.sochinf.cl/PDF-inf4-2017/art26.pdf
47. El Zika virus en Paraguay. Revista del Instituto de Medicina Tropical. Vol 12, Jul 1. Disponible en: https://www.mspbs.gov.py/dependencias/imt/adjunto/2cfccb-2ElVirusZikaenParaguay89.pdf
48. Nivel de conocimiento sobre terminologías médicas en Guaraní de los profesionales de salud del Hospital Regional de Coronel Oviedo. DEL NACIONAL. PARAGUAY. Disponible en: http://scielo.iics.una.py/pdf/hn/v9n1/2072-8174-hn-9-01-00004.pdf
49. La utilidad de Google Trends para la investigación epidemiológica: caso Zika. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. CUBA. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/1155/pdf_424
50. A bibliometric analysis of global research in Oropouche. Travel Medicine and Infectious Disease. REINO UNIDO.Disponible en: http://www.travelmedicinejournal.com/article/S1477-8939(17)30132-1/fulltext
51. Prevalence of HIV/SYPHILIS and quality of antenatal care for prevention of mother-to-child transmission (PMTCT) in parturient and puerperal women in Paraguay. Sexually Transmitted Infection. Reino UNIDO. Disponible en: http://sti.bmj.com/content/93/Suppl_2/A94.1
52. Prevalencia de disfunción sexual en mujeres climatéricas de un hospital de Paraguay, 2013. Cuba http://revzoilomarinello.sld.cu/index.php/zmv/issue/view/32
53. Automedicación en adultos de 11 ciudades de Latinoamérica, 2015-2016: estudio Multicéntrico . Revista CIMEL. PERU. Disponible en: http://www.cimel.felsocem.net/index.php/CIMEL/article/view/706/414
54. Reflections on Ebola virus infection. Asian Pacific Journal of Tropical Disease. PAISES BAJOS. Disponible en: http://oaji.net/articles/2017/3556-1511938008.pdf
55. Reflexiones sobre la importancia y el impacto del desarrollo de vacunas contra las arbovirosis. Revista Chilena De Infectologia. CHILE http://www.sochinf.cl/portal/templates/sochinf2008/documentos/2017/avances/octubre/Carta%20al%20editor%20VACUNAS-PARA-ARBOVIRUS.pdf
56. La capacitación en investigación científica en estudiantes de medicina. ESPAÑA. Revista de Fundación Educación médica. ESPAÑA. Disponible en: https://www.educacionmedica.net/sec/verRevista.php?id=856a1301a553676613853
57. El rol docente en la promoción de la investigación científica en pregrado. ESPAÑA. Disponible en: http://www.elsevier.es/es-revista-educacion-medica-71-avance-el-rol-docente-promocion-investigacion-S1575181317301596
58. La Tuberculosis e infección por VIH/sida: una visión panorámica. BOLIVIA. Rev. SCientifica. Disponible en: http://www.revistasbolivianas.org.bo/scielo.php?script=sci_arttext&pid=S1813-00542017000200008&lng=es&nrm=iso&tlng=es
59. Los medios de comunicación, la automedicación y el aumento de la resistencia a los antimicrobianos. CUBA. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/1182/pdf_439
60. Situación epidemiológica de la infección por el Chikungunya en Paraguay. Revista Chilena de Salud Pública. CHILE. Disponible en: http://www.revistasaludpublica.uchile.cl/index.php/RCSP/article/viewFile/47570/49631
61. Conocimientos en estudiantes de medicina de Paraguay sobre ley general VIH/SIDA. CUBA. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/1220
62. Reflexiones sobre la importancia y el impacto del rol universitario en la prevención de los accidentes intrahospitalarios. COSTA RICA. Disponible en: http://www.uhsalud.com/index.php/revhispano/article/view/259
63. Accidente cerebrovascular isquémico asociado a Meningoencefalitis Bacilar en paciente con VIH: A propósito de un caso y revisión de la literatura. CUBA. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/1219/0
64. El virus O’nyong-Nyong en Latinoamérica: ¿un riesgo ignorado?. MEDICINA CLINICA Y SOCIAL. PARAGUAY. Disponible en: https://www.researchgate.net/publication/313799786_O'nyong'nyong_virus_next_arbovirus_in_Latin_America
65. Conocimiento sobre la infección por el virus del Zika en dos barrios de Paraguay. Revista Electronica Dr. Zoilo Marianello.CUBA Disponible en: http://www.revzoilomarinello.sld.cu/index.php/zmv/article/view/1270
66. Mortality rate and Predictors in children under 15 years old who acquired HIV from mother to child transmission in Paraguay. PAISES BAJOS. AIDS and Behavior. Disponible: https://link.springer.com/article/10.1007/s10461-018-2053-1
67. Reflexiones sobre la importancia y el impacto del desarrollo de vacunas contra las arbovirosis. Revista Chilena de Infectologia. Disponible en: https://scielo.conicyt.cl/pdf/rci/v34n5/0716-1018-rci-34-05-0520.pdf
68. Características clínicas y epidemiológicas de las intoxicaciones en el Hospital General Docente Ambato de Ecuador, 2013 a 2014. Rev. Virtual de la Sociedad Paraguaya de Medicina Interna. Disponible en: http://www.revista.spmi.org.py/index.php/rvspmi/article/view/122
69. Producción científica de los decanos de las facultades de medicina en Paraguay. Disponible en: http://www.elsevier.es/es-revista-educacion-medica-71-avance-produccion-cientifica-los-decanos-las-S1575181318300172
70. Sintomatología ansiosa y depresiva en estudiantes de medicina de la Universidad Católica Campus Guairá, 2017. Revista CIMEL. PERU. Disponible en: https://www.cimel.felsocem.net/index.php/CIMEL/article/view/1070
71. El esprue tropical, una enfermedad olvidada como diagnóstico diferencial de la enfermedad celiaca. Rev. Fac. Med. COLOMBIA. Disponible en: https://revistas.unal.edu.co/index.php/revfacmed/article/view/68105
72. Panorámica sobre las publicaciones científicas paraguayas en SCOPUS. Educ. Med. ESPAÑA. Disponible en: https://www.sciencedirect.com/science/article/pii/S1575181318300603
73. The LGBT community and HIV: an incorrect medical judgment. Travel Medicine and Infectious Diseases.USA. https://www.travelmedicinejournal.com/article/S1477-8939(18)30090-5/fulltext

Dr. Rajshree Katke, MD (Obst & Gyanec), FIGOG

Professor of Obstetrics and Gyanecology Superintendent of Cama and Albless Hospitals Mumbai, India
Education Qualification (MBBS, MD (OBGY),FICOG), FMAS:
• MBBS From Government Medical College, Aurangabad(1987)
• M.D. (OB-GY) from Government Medical College, Aurangabad (1993)
• F.I.C.O.G in 2011
• Fellowship in minimally Access Surgery in 2013
• Training in Ultrasound Obstetric & Gynecological and Foetal Heart Monitoring
• Diploma in Acupuncture
• Computer Training MS CIT
Honours and Awards:
• Appreciation Letter from The General Secretary (United Nations) Hon. Shri BAN Ki-Moon visited Cama hospital and admired about our hospital administration and patient’s treatment carried out in year May 2012.
• Appreciation Letter from Additional Chief Secretary Maharashtra (Chief Secretary of Government of Maharashtra) Mr. Jayant Kumar Bantiha also admired the Hospital and the arrangement made regarding the visit of the UN Secretary.
• Padmashree Dr. T.P. Lahane, Dean Grant Government Medical College, Mumbai gave an Award for Best Associate Professor. year Jan 2012
• Rajiv Gandhi Excellence Award and Gold Medal for outstanding achievements yr. 2012
• National Mahila Ratna Gold Medal Award for outstanding achievements yr. 2012
• AMWI (Association of Medical Women India, Mumbai Branch) Achievement Award yr. 2012
• Best Superintendent in charge award was given by Human Rights Association of India.
• Under my primary Authorship papers presented in various OBGY conferences got prizes.
• Felicitates by Giant Group of Ulhasnagar Saheli on Women’s Day Celebration.
• Appreciation Certificate by Member of Parliament Shri. Milind Devara for Conducting the Camp at Colaba.
• (NIC) National & International Compendium, New Delhi, Eminent Educationalist Award For Outstanding Achievement yr.2012.
• Award given by MDAC on World AIDS Day 1st December 2012 for bet work in the RTI/STI-HIV Infections.
• Name conclude in who is who booklet by International Compendium, New Delhi. yr.2012
• Photon Research Award 2014 for outstanding scientific contribution in September 2014, The Mumbai Obsterics and Gynaecological society
• Breast Cancer CME presented by Department of Radiotherapy and Oncology from Grant Government Medical College & Cama and Albless Hospital, Mumbai in August 2014.
• Appreciation award from association of Fellow Gynecologists in May 2014
• Association Of Medical Women In India Founded - 1907 (Golden Jubilee Award 2014,Confered On 7-3-15)AMWI
• Participated as a Faculty/Delegate in Scientific deliberations between 3rd,5thFeb 2014 at 57th AICOG 2014,Patna.
• Participated as a faculty/Delegate in CME on Breast cancer on 23rd Aug 2014 ,From Grant govt. Medical College and Sir J.J.Group of Hospitals, Mumbai.
• Bharat Vibhushan Samman Puraskar presented by the Economic and human resource development association(EHRDA),New Delhi in Dec 2013
• International Education Excellence award for outstanding achievements in the field of education by Indian Solidarity Council in May 2013
• Award from MDAC on worlds AIDS Day from National AIDS Control organization(NACO) in December 2012
• National Mahila Rattan Gold Medal Award from International Institute of Education & Management (New Delhi) in Oct 2012
• Achievement Award by Association of Medical Woman in India (Mumbai) for Duty and Devotion IN April 2012
• Appreciation award for Best Superintendent IN charge of CAMA & Albless Hospital from human rights Association of India in April 2012.
• Appreciation letter from Secretary of Woman's State commission in May 2012.
• Member Of Scientific committee of MEDICON 2011 By the fourth international medical students research conference in May 2011
• Gold Medal in Medicine in 3rd M.B.B.S.
• Received School Prize for Best Handwriting.
• Chairperson at AMWI OBGY Conference Shirin Mehtaji AT KEM HOSPITAL.
• On Editorial board of SM International Journal.
• Certificate Of Appreciation for Women and Children at Gokhale School, Kharghar, on 26th July 2015.
• Certificate Of Participation as a faculty in the Outreach CME on Recent Advances in Obstetrics And Gynaecoloty held at Ramada Plaza, Palm Grove,Juhu Beach, Mumbai on 31.5.2015.
• Certificate Of Participation As a Delegate has attended LAWMEDICON 2015 held at the department Of surgery,Grant Medical College and Sir J.J.Group Of Hospital, Mumbai, on Saturday, 04th April,2015 as a delegate.
• Certificate Of Participated in CME ON CHRONIC DISEASE MANAGEMENT - DIABETES Organised by department of Medicine,Grant Government Medical College and Sir, J.J.Group Of Hospital, Mumbai on 17th June 2015 as a delegate.
• Certificate is to certify that has attended and participated as a Delegate during THE ULTIMATE ADVANCES IN GYNAECOLOGY,dated.27.4.2015.
• Gynecological Society held in Mumbai,Feb 25th-28th,2016 at Auditorium, L.T.M. Certificate of participation as faculty at the Hotel J.W.Marriott,Juhu ,Mumbai in the 44th Annual Conference of the Mumbai Obstetrics and Gynecological Society on Feb 6th & 7th 2016.
• Certificate of participation as a faculty in the MOGS Post Graduate CME – 2016 of The Mumbai Obstetric and Medical College,sion,Mumbai.
• LIFE TIME ACHIEVEMENT AWARD for outstanding achievements from NATIONAL & INTERNATIONAL COMPENDIUM on April, 2016.
• FOGSI Gynae Oncology conference Widening horizon in women cancer A Token of Appreciation for your dignified presence and vital contribution towards the scientific program At Kala Academy Panaji Goa on 29th -31st July 2016.
• Excellence Award of BURRAF Welfare Society , Thane on 6th Oct, 2017Appreciation Award of meritorious Academic & Research Contribution World Diabetes Day on 14th Nov.2017, Gokuldas Tejpal Hospital Mumbai.
• FOGSI The Federation of Obstetrics and Gynecological Societies of India Appreciation on 15th Nov. 2017
• FEMM Conference 2017 & Association of Fellow Gynaecologists Appreciation award FacultyLiveOperative Workshop R.N.Copper Hospital 17thNov,2017
• Certificate of participation as a Faculty CME on held at Kohinoor hall, opp dadar central railway membai on Oct 15th 2017 .
• FEMM Conference valuable participation as our esteemed faculty at the FEMM 2017 Conference held at the St.Regis Hotel,Mumbai 19th Nov2017.
• Honouring Partnership (MDCS) Guest Lecture Award on 1st Dec 2017.
• Certificate is awarded for having actively participated as a faculty in 61st AICOG held at Bhubaneshwar,Odisha on 17th Jan to 21st Jan 2018.
• Certificate is awarded for having actively participated as FACULTY/DELEHATE in the PRE-CONGRESS WORKSHOP held during the 61st ALL India Congress of Obstetrics and Gynaecology,2018 at Bhubaneshwar,Odisha on 17thJan to 21st Jan2018.
Professional Membership:
• Life member of All India Medical Women’s Association
• Life member of FOGSI
• Life member of MOGS
• Life member of AMASICON
1. Surgical Importance of the Round Ligament in Journal of Gynecologic Surgery 15(3):163-167 • September 1999
2. Uterine septum misdiagnosed on hysterosalpingogram in International Journal of Gynecology & Obstetrics 69(3):261-3 • July 2000
3. Thalassemia Major with Central Placenta Previa in Journal of Obstetrics and Gynecology of India 54(1):80-81 • February 2004
4. First Trimester Medical Termination of PregnancyJanuary 2012 In book: Comprehensive Abortion Care & Post Abortion Contraception,
5. Postpartum Collapse By Dr. Rajshree KatkeJanuary 2013 In book: Postpartum Collapse, Chapter: Postpartum Collapse,
6. Live secondary abdominal pregnancy-by chance!!April 2013 in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
7. Secondary abdominal pregnancy following rupture of bicornuate uterus in early third trimester: a case report and review of literature in International Journal of Reproduction, Contraception, Obstetrics and GynecologyJune 2013
8. A rare case of successful pregnancy outcome with giant paraovarian cyst: a case report and review of literature In International Journal of Reproduction, Contraception, Obstetrics and Gynecology in October 2013
9. Clear Cell Carcinoma of the Uterine Cervix: A Case Series of Five Patients in JOURNAL OF CASE REPORTS December 2013.
10. Advanced Rhabdomyosarcoma During Pregnancy In January 2014
11. Giant Borderline Mucinous Cystadenoma With Previous 3 Cesareans January 2014
12. Uterine Arterio-venous Malformation with Hemoperitoneum in JOURNAL OF CASE REPORTS Feb 2014
13. A huge benign mucinous cystadenoma of ovary: a case report and review of literature in International Journal of Reproduction, Contraception, Obstetrics and Gynecology March 2014
14. Socio-Economic Factors Influencing Milk Donation in Milk Banks in India: An Institutional Study in International Journal of Reproduction, Contraception, Obstetrics and Gynecology May 2014
15. Extremely rare case report of chronic inversion of uterus with submucous fundal fibroid with dragging of bladder wall and ureters along with: a case report and review of literature in International Journal of Reproduction, Contraception, Obstetrics and Gynecology May 2014
16. Bilateral serous cystadenofibroma of ovary with paratubal cyst: a rare case report in International Journal of Reproduction, Contraception, Obstetrics and Gynecology June 2014
17. Extreme Sequele of Cystic Degeneration of Huge Fibroids Mimicking Like Endometrioma in One Case and Ovarian Neoplasm in Two Cases in SEAJCRR June 2014
18. Torsion of Huge Cystic Teratoma of Ovary with Multiple Fibroids Uterus: A Case Report and Review of Literature in International Journal of Reproduction, Contraception, Obstetrics and Gynecology June 2014
19. An interesting case of pseudoaneurysm of internal iliac artery: rare case report with review of literaturein International Journal of Reproduction, Contraception, Obstetrics and Gynecology June 2014
20. A Rare Case of Carcinoma of Ovary with Carcinoma of Cervix in JOURNAL OF CASE REPORTS June 2014
21. Spindle Cell Sarcoma Arising from Nerve Sheath Presenting as Huge Abdominal Massin JOURNAL OF CASE REPORTS July 2014
22. Rupture and torsion of a huge ovarian cyst with ipsilateral para-ovarian cyst presented as haemoperitoneum and acute abdomen: A rare case report and review of literature in International Journal of Research in Health Sciences July 2014
23. A rare and successfully managed case of idiopathic thrombocytopenic purpura (ITP) with previous caesarean with splenectomy with hepatitis C positivein International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sept 2014
24. Thrombocytopenia during pregnancy: an institutional based studyin International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sept 2014
25. Rising incidence of unwed mothers in India; associated social parameters & institutional guidelines for managing themin International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sept 2014
26. LSCS audit in a tertiary care center in Mumbai: to study indications and risk factors in LSCS and it's effect on early peri-natal morbidity and mortality ratein International Journal of Reproduction, Contraception, Obstetrics and Gynecology Oct 2014
27. Successful Outcome of Pregnancy in Borderline Malignant Ovarian Tumor in JOURNAL OF CASE REPORTS Oct 2014
28. Successful Outcome of Triplet Pregnancy with Peripartum Cardiomyopathyin JOURNAL OF CASE REPORTS Oct 2014
29. Huge Mucinous Cystadenoma Of Ovary With Massive Third Degree Uterovaginal Prolapse In Postmenopausal Woman : Rare Case Report And Review Of Literaturerate in International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nov 2014
30. Practicalities and benefits of human milk banks in India in International Journal of Gynecology & Obstetrics November 2014
31. Case Report of Uterine Carcinosarcoma with Incisional Site Recurrence in Journal of Obstetrics and Gynecology of India 64(1) • December 2014
32. Huge Clear Cell Carcinomas of Ovary: A Case Series in JOURNAL OF CASE REPORTS Dec 2014
33. Atypical presentation of uterine choriocarcinoma a case report with review of literature in Clinical Cancer Investigation Journal Jan 2015
34. A Huge Retroperitoneal Neurofibroma mimicking broad ligament fibroid in postmenopausal women: An extremely rare report with review of literature in SEAJCRR Jan 2015
35. Diagnostic Hysteroscopy - Gold standard in management of AUB: Retrospective Study of 40 cases of Abnormal Uterine Bleeding and correlation of Hysteroscopy findings with Ultrasound and Histopathologic findingsConference: FIGO CONFERENCE AT VANCOURE Jan 2015
36. An Unusual Case of Acute Puerperal Uterine Inversion : A Case Report and Review of Literature in International Journal of Medical and Health Sciences Jan 2015
37. MTP and PCPNDT Act • January 2015 In book: Playing by the Rules,
38. Maternal Death Review January 2015 In book: Playing by the Rules,
39. Use of diagnostic hysteroscopy in abnormal uterine bleeding in perimenopausal age group and its clinicopathological co-relation with ultrasound and histopathology findings: experience in a tertiary care institute in International Journal of Reproduction, Contraception, Obstetrics and Gynecology March 2015
40. Huge Mucinous Cystadenocarcinoma with Mucocele of Appendix in a Postmenopausal Woman: Extremely Rare Case Report with Review of Literature in Gynecology, an open access journal March 2015
41. A rare presentation of heteropagus conjoined twin: a case report with review of literature Rajshree Dayanand Katke*, Nidhi Sudhakar Kurkal, Tamanna Vinaik, Priyanka Pagare in International Journal of Reproduction, Contraception, Obstetrics and Gynecology April 2015
42. Torsion of a Huge Ovarian Fibroma Presented as Acute Abdomen in JOURNAL OF CASE REPORTS May 2015
43. The Impact of Maternal HbsAg Carrier Status on Pregnancy Outcomes: An Institutional Experience in Gynecology, an open access journal May 2015
44. Torsion of Huge Benign Serous Cyst-adenoma of Ovary in Adolescent Girl: A Case Report and Review of Literature in SEAJCRR June 2015
45. Huge Bilateral Serous Papillary Cystadenocarcinoma in Journal of Medical Case Reports June 2015
46. Small cell carcinoma of cervix: Rare and enigmatic in Clinical Cancer Research July 2015
47. Rare Presentation of Serous Cystadenoma as Hemorrhagic Cyst in Obstetrics & Gynecology International Journal July 2015
48. Rupture and torsion of a huge ovarian cyst with ipsilateral para-ovarian cyst presented as haemoperitoneum and acute abdomen: A rare case report and review of literature in International Journal of Research in Health Sciences.Jul 2014
49. A Huge Benign Serous Cyst-adenoma of Ovary in Adolescent Girl : A Case Report and Review of Literature in SEAJCRR July 2015
50. Rare Presentation of Serous Cystadenoma as Hemorrhagic Cyst in Obstetrics & Gynecology International Journal Aug 2015
51. Rupture and torsion of a huge ovarian cyst with ipsilateral para-ovarian cyst presented as haemoperitoneum and acute abdomen: A rare case report and review of literature in International Journal of Research in Health Sciences.July 2014.
52. Prediction of outcome of tubal ectopic pregnancy on the basis of site of implantation of embryo in the fallopian tube in International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sept 2015
53. Multifetal Pregnancy: Maternal and Neonatal Outcome in Obstetrics & Gynecology International Journal Nov 2015
54. Role of the Neoadjuvant Chemotherapy with Interval Debulking in Advanced Ovarian Malignancy in SM Journal of Gynecology and Obstetrics Nov 2015
55. Changing Trends in Indications of lower section Caesarean Section (LSCS) over a Decade in a Tertiary Care Centre: An Institutional Study in Journal of Radiology Case Reports December 2015
56. Can we widen the scope of medical management in ectopic pregnancy? In International Journal of Reproduction, Contraception, Obstetrics and Gynecology Jan 2016
57. How empowered are women to choose contraception? in International Journal of Medical Science and Public Health in Jan 2016
58. Huge Dermoid Cyst 7 kg Weight in a Post-Menopausal Woman Mimicking a Malignant Ovarian Tumour: Rare Case with Review of Literature in General Medicine: Open Access Jan 2016
59. Unavoidable Caesarian Myomectomy In A Case Of Transverse Lie With Huge Fibroid At Incision in SEAJCRR Jan 2016
60. Gestational Trophoblastic Disease And Its Complications:Review Of Patient Profiles And Management At A Tertiary Care Centrein SEAJCRR Feb 2016
61. ParousSeptate uterus: to treat or not to?in SEAJCRR Feb 2016
62. Ovarian Fibroma in Young Women with Infertility Mimicking Uterine Fibroid in JOURNAL OF CASE REPORTS March 2016
63. Giant mucinous cystadenocarcinoma of ovary: A case report and review of literature in J Mid-life Health march 2016
64. Socio-epidemiological factors of medical termination of pregnancy: an overview in a tertiary care institute in International Journal of Reproduction, Contraception, Obstetrics and Gynecology April 2016
65. Minimally invasive hysterectomy for benign disease: our experience study in in International Journal of Reproduction, Contraception, Obstetrics and Gynecology April 2016
66. Rare case presentation of symplastic leiomyoma in nulliparous female in Clinical Cancer investigation Journal July 2016
67. Role of diagnostic laparoscopy in the management of female infertilityin International Journal of Reproduction, Contraception, Obstetrics and Gynecology August 2016
68. Placenta previa: outcomes in scarred and unscarred uterusin International Journal of Reproduction, Contraception, Obstetrics and Gynecology August 2016
69. Large (7.2 kg) Subserosal Fibroid with Monkenberg’s Calcification in a Postmenopausal Woman: Extremely Rare Case with Review of Literature in iMedPub Journals Gynecology & Obstetrics Case report Aug 2016
70. Large Cervical Fibroid in JOURNAL OF CASE REPORTS Aug 2016
71. Large (7.2 kg) Subserosal Fibroid with Monkenberg’s Calcification in a Postmenopausal Woman: Extremely Rare Case with Review of Literature in Gynecology & Obstetrics Case report Aug 2016.
72. Sacrospinous fixation: an efficient technique for prevention and treatment of vault prolapse In International Journal of Research in Health Sciences Sept 2016
73. Role of neoadjuvant chemotherapy and radiotherapy in locally advanced carcinoma of the cervix in Clinical Cancer Investigation journal Sept 2016
74. Large cervical fibroid JOURNAL OF CASE REPORTS Sept 2016
75. Case Report of a Huge Serous Cystadenoma (7.2kg) In a Perimenopausal Woman in MOJ Clinical & Medical Case Reports Nov 2016
76. Atypical Presentation of Invasive Mole in a Young Female with Chemo resistance Case Report and Review of Literature in Journal of Gynecol Women’s Health Jan 2017
77. A Giant Ovarian Tumour (7.5kg) During Pregnancy with its Successful Perinatal and Surgical Outcome In SAJ case Reports Feb 2017

Khalid Al Aboud, MD

Consultant Dermatopathologist and Venereologist Head of Public Health Department King Faisal Hospital Makkah, Saudi Arabia
Khalid Al Aboud, holds Bachelor of Medicine and Bachelor of Surgery (MBBS) from King Abdulaziz University, Saudi Arabia.Recently he finished his fellowship in dermatopathology from Wake Forest University, Winston-Salem, North Carloina, USA.Khalid Al Aboud who is currently the head of public health department in King Faisal Hospital, Makkah, Saudi Arabia , has diverse medicals interests and has several publications in Sexually Transmitted Infections, dermatology , pathology and public health. In 2008 , he received Zakon prize from the Society of History of Dermatology.He Conducted national researches on several public health problems including leprosy, leishmania and skin cancers.He is on the Editorial and Advisory Boards of several peer-reviewed scientific journals.

Prof. Dr. Alireza Heidari, PhD, DSc

Full Distinguished Professor and Academic Tenure of Chemistry and Director of the BioSpectroscopy Core Research Laboratory Faculty of Chemistry, California South University (CSU), Irvine, California, USA President of American International Standards Institute (AISI) Irvine, California, USA
Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than four hundred reputed international conferences, seminars, congresses, symposiums, and forums around the world as yet. Also, he possesses many published articles in the Science Citation Index (SCI)/International Scientific Indexing (ISI), PubMed and Scopus Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Indonesia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is an expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than one thousand reputed international awards, prizes, scholarships, and honors. Heretofore, he has multiple editorial duties in many reputed international and peer-reviewed journals, books and publishers. Hitherward, he is a member of more than four hundred reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.
• Biophysical Chemistry
• Biomolecular Spectroscopy
• Quantum Chemistry
• Nanochemistry
• Modern Electronic Structure Computations
• Theoretical Chemistry
• Mathematical Chemistry
• Computational Chemistry
• Vibrational Spectroscopy
• Molecular Modelling
• Ab initio & Density Functional Methods
• Molecular Structure
• Biochemistry
• Molecular Simulation
• Pharmaceutical Chemistry
• Medicinal Chemistry
• Oncology
• Synchrotron Radiation
• Synchrocyclotron Radiation
• LASER
• Anti–Cancer Nano Drugs
• Nano Drugs Delivery
• ATR–FTIR Spectroscopy
• Raman Spectroscopy
• Intelligent Molecules
• Molecular Dynamics
• Biosensors
• Biomarkers
• Molecular Diagnostics
• Numerical Chemistry
• Nucleic Acids
• DNA/RNA Monitoring
• DNA/RNA Hypermethylation & Hypomethylation
• Human Cancer Tissues
• Human Cancer Cells
• Tumors
• Cancer Tissues
• Cancer Cells
SCHOLARSHIP AWARDS:
• Sharif University of Technology scholarship for M.Sc. degree studies, Kish Island, Hormozgan, Iran, 2006.
• Islamic Azad University (IAU), North Tehran Branch, scholarship for M.Sc. degree studies, Tehran, Iran, 2006–2008.
• Islamic Azad University (IAU), North Tehran Branch, scholarship for research, Tehran, Iran, 2006–2008.
• Young Researchers Club (YRC) scholarship for M.Sc. degree studies from the Islamic Azad University (IAU), Tehran, Iran, 2006–2008.
• Young Researchers Club (YRC) scholarship for research from the Islamic Azad University (IAU), Tehran, Iran, 2006–2008.
• Islamic Azad University (IAU), Science & Research Campus, scholarship for Ph.D. degree studies, Tehran, Iran, 2009.
• Institute for Advanced Studies (IAS) scholarship for research, Tehran, Iran, 2009–2012.
• California South University (CSU) award of excellence in “Chemical Kinetics and Dynamics”, Irvine, California, USA, 2010.
• California South University (CSU) award of excellence in “Electrochemical Analysis”, Irvine, California, USA, 2012.
• California South University (CSU) award of distinction for Ph.D. in Chemistry with distinction in subject “Advanced Quantum Mechanics”, Irvine, California, USA, 2010.
• California South University (CSU) award of distinction for Ph.D. in Chemistry with distinction in subject “Advanced Research”, Irvine, California, USA, 2010.
• California South University (CSU) scholarship for Ph.D. degree studies from California South University (CSU), Irvine, California, USA, 2009–2012.
• California South University (CSU) scholarship for research, Irvine, California, USA, 2009–2012.
• California South University (CSU) scholarship for postdoctoral research, Irvine, California, USA, 2014.
• Australian Research Council (ARC) scholarship (International Postgraduate Research Scholarship (IPRS)) for research, Melbourne, Victoria, Australia, 2013–2014.
• Australian Research Council (ARC) award (Australian Postgraduate Award (APA)) for research, Melbourne, Victoria, Australia, 2013–2014.
• Monash University scholarship for research (Monash Graduate Scholarship (MGS)), Melbourne, Victoria, Australia, 2013–2014.
MEMBERSHIPS IN PROFESSIONAL SOCIETIES:
National Memberships:
2006 – Present:
An active member of the Iranian Mathematical Society (IMS), The Physics Society of Iran (PSI), The Islamic Azad University Young Researchers Club (YRC), Iranian Association for the Popularization of Sciences (IAPS), Central Committee for Iranian Mathematical House (CCIMH), Iranian Association for Management of Technology (IAMT), Iranian Society of Surface Science & Technology (ISST), Iranian Educational Administration Association (IEAA), Association for Scientific Development of Iran (ASDI), Iranian Curriculum Development Association (ICDA), Iranian Association of Chemical Engineers (IACE), Iranian Society of Acoustics and Vibration (ISAV), Iranian Society for Industry and Academia (ISIA), Council of Iranian Scientific Associations (CISA), Iranian Society of Engineering Education (ISEE), Iranian Project Management Association (IPMA), Iranian Education Research Association (IERA), Iranian Society of Optical and Photonics (ISOP), Iranian Metallurgical Engineers Society (IMES), Iran Society of Biophysical Chemistry (ISBC), Institute for Advanced Studies (IAS), Iranian Higher Education Association (IHEA), Iranian Operations Research Society (IORS), Iranian Nanotechnology Society (INS), Iranian Biotechnology Society (IBS), Iranian Fuzzy Systems Society (IFSS), Iranian Corrosion Association (ICA), Iran Composites Association (ICA), Biochemical Society of Iran (BSI), Iranian Catalysis Association (ICA), Iranian Statistical Society (ISS), Iranian Chemical Society (ICS), Nuclear Society of Iran (NSI), Iran Polymer Society (IPS), and Iran Color Society (ICS).
International Memberships:
2009 – Present:
The American Association for the Advancement of Science (AAAS), American Chemical Society (ACS), American Chemistry Council (ACC), American Society for Biochemistry and Molecular Biology (ASBMB), American Physical Society (APS), American Institute of Physics (AIP), American Mathematical Society (AMS), Mathematical Association of America (MAA), Royal Society of Chemistry (RSC), The Chemical Institute of Canada (CIC), The Canadian Society for Chemistry (CSC), The Royal Australian Chemical Institute (RACI), International Union of Pure and Applied Chemistry (IUPAC), Monash Campus Cluster (MCC), Monash Science Centre for Biospectroscopy, National Computational Infrastructure (NCI), Monash e–Research Centre, Australian Research Council (ARC), ARC Centre of Excellence for Electromaterials Science (ACES), Victorian Life Sciences Computational Initiative (VLSCI), Multi–modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE), Australian Synchrotron, The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Victorian Partnership for Advanced Copmputing (VPAC), National Computational Merit Allocation Scheme (NCMAS), iVEC, National Collaborative Research Infrastructure Strategy (NCRIS), National Health and Medical Research Council (NHMRC), Monash Chemical Society (MCS), Monash Science Society (MSS), Ustinov College, St Catharine’s College, National eResearch Collaboration Tools and Resources (NeCTAR), Monash Ionic Liquids Group, Research Data Storage Infrastructure (RDSI), VicNode, Monash Computational Chemistry Group, and International Neuroinformatics Coordinating Facility (INCF), European Scientific Institute (ESI), Ankara University Institute of Nuclear Sciences, National Institute of Science Communication and Information Resources (New Delhi, India), Indo–American Pharmaceutical Society, American Association of Pharmaceutical Scientists (AAPS), Euro Asia Research and Development Association (EARDA), Institute of Advanced Engineering and Science (IAES), International Academic Institute for Science and Technology (IAIEST), Platform for Young Researchers Welfare Society (PYRWS), Centre For Info Bio Technology (CIBTech), Institute of Research Advances, Association of Global Science Innovations (AGSI), American Institute of Science (AIS), Technical Research Organization India (TROI/TROINDIA), Indian Society for Technical Education (ISTE), Open Association of Research Society USA (OARS), American International Standards Institute (AISI), National Science Library (NSL), Council of Scientific and Industrial Research (New Delhi, India), International Society of Universal Research in Sciences, China National Knowledge Infrastructure (CNKI), International Committee of Medical Journal Editors (ICMJE), International Association of Teachers and Teacher Educators (IATTE), USA, RISHI Educational Society, Research Culture Society, National Institute of Science Communication and Information Resources (NISCAIR) (New Delhi, India), Council of Scientific and Industrial Research (ICSIR) (New Delhi, India), National Science Library (NSL) (New Delhi, India), Committee on Publishing Ethics (COPE), Sanskruti Multidisciplinary Research and Development Training Institute (SMRDTI) (Solapur, Maharashtra, India), Indian Academicians and Researchers Association (IARA), Scholars Academic & Scientific Society (SAS).
HONORS & AWARDS:
• Student researcher of the year at the Islamic Azad University (IAU) for four consecutive years – 2002, 2003, 2004 and 2005, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
• Winner of the 13th National Iranian Student Book Festival Prize for the translation “Mathematics for Chemists (Volumes 1&2)”, Tehran, Iran, 2006.
• Student researcher of the year at the Islamic Azad University (IAU) for three consecutive years – 2006, 2007 and 2008, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
• Winner of the 15th National Iranian Student Book Festival for compiling “Principles of Modern Relativistic Quantum Mechanics”, Tehran, Iran, 2008.
• Winner of the 7th National Iranian Roshd Book Festival for the translation of “Mathematics for Chemists (Volumes 1&2)”, Tehran, Iran, 2008.
• Winner of the Best Poster Presentation Prize at the National Conference for Computing in Chemistry, Arak, Iran, 2008.
• Awarded best thesis prize from the Islamic Azad University (IAU), Tehran, Iran, 2008.
• Ranked top student for six consecutive years – 2002–2008, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
• Awarded 1st class honors for my B.Sc. in Pure Chemistry degree with a final overall GPA of 19.08/20 and accepted for an M.Sc. degree program without the mandatory pre–requisite entrance examination requirement by the Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2006.
• Awarded 1st class honors for my M.Sc. in Chemistry (Physical Chemistry) degree with a final overall GPA of 19.08/20 and accepted for Ph.D. studies without a mandatory pre–requisite entrance examination requirement by the Islamic Azad University (IAU), Science & Research Campus, Tehran, Iran, 2009.
• Awarded Honorary Doctorate Degree (Degree Honoris Causa) in Physics (Atomic and Molecular Physics) by the Islamic Azad University (IAU), Tehran, Iran, 2008.
• Winner of best thesis in Iran, Tehran, Iran, 2009.
• Awarded highest GPA for my M.Sc. thesis with a GPA score of 20/20, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2008.
• Winner at the 13th National Iranian Student Thesis Festival, Tehran, Iran, 2009.
• Winner of the 16th National Iranian Student Book Festival for compiling “Principles and Methods of Using Chemical Abstracts”, Tehran, Iran, 2009.
• Winner of the Best Poster Presentation Prize at the 1st Conference on the Application of Nanothechnology in the Petroleum and Petrochemical Industries, Mahshahr, Iran, May 2011.
• Winner of the Best Poster and Best Oral Presentation Prize at the 1st National Student Conference on Nanotechnology, Shahreza, Iran, July 2011.
• Participating at the Carbon Nanotubes workshop during the 1st National Student Conference on Nanotechnology, Shahreza, Iran, July 2011.
• Awarded Doctor of Science (D.Sc.) Diploma in Chemistry by the California South University (CSU), Irvine, California, USA, 2010. Winner of the Best Lecturer Prize in Caspian Higher Education Institute, Qazvin, Iran, 2012.
• Awarded M.Sc. degree offer from Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2006.
• Awarded Ph.D. degree offer from Islamic Azad University (IAU), Science & Research Campus, Tehran, Iran, 2009.
• Awarded Ph.D. degree offer from California South University (CSU), Irvine, California, USA, 2009.
• Awarded “Project Management” Postdoctoral Fellowship Program by School of Chemistry, Faculty of Science, Monash University, Melbourne, Victoria, Australia, 2013.
• Awarded “Modern Molecular Electronic–Structure Computations Theory” and also “Nanochemistry” Postdoctoral fellowship programs by California South University (CSU), Irvine, California, 2014.
[1] A. Heidari, C. Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer Cells”, J Nanomed Res., Volume 2, Issue 5, 20 Pages, 2015.
[2] A. Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles”, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Issue 1, Pages 15–19, 2015.
[3] A. Heidari, “An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertility”, Int J Adv Technol 7: e007, 2016.
[4] A. Heidari, “Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Study”, J Pharmacogn Nat Prod 2: e103, 2016.
[5] A. Heidari, “A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile Complexes”, J Bioeng Biomed Sci S: 006, 2016.
[6] A. Heidari, “Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016.
[7] A. Heidari, “Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J Biomol Res Ther 5: e146, 2016.
[8] A. Heidari, “Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells”, J Bioanal Biomed 8: e135, 2016.
[9] A. Heidari, “A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells”, Adv Cancer Prev 1: e102, 2016.
[10] A. Heidari, “Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles”, J Biotechnol Biomater 6: e125, 2016.
[11] A. Heidari, “A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Study”, J Res Development 4: 144, 2016.
[12] A. Heidari, “Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding”, Biochem Physiol 5: e146, 2016.
[13] A. Heidari, “Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO) Nanoparticles on DNA of Cancer Cells: A Photodynamic Therapy Study”, Arch Cancer Res. 4: 1, 2016.
[14] A. Heidari, “Biospectroscopic Study on Multi–Component Reactions (MCRs) in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugs”, Arch Cancer Res. 4: 2, 2016.
[15] A. Heidari, “Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time–Dependent Bio–Heat Equation and Nd: YAG Lasers”, Arch Cancer Res. 4: 2, 2016.
[16] A. Heidari, “Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res. 4: 1, 2016.
[17] A. Heidari, “Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticles”, J Biomedical Sci. 5: 2, 2016.
[18] A. Heidari, “Measurement the Amount of Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol) and Absorbable Calcium (Ca2+), Iron (II) (Fe2+), Magnesium (Mg2+), Phosphate (PO4–) and Zinc (Zn2+) in Apricot Using High–Performance Liquid Chromatography (HPLC) and Spectroscopic Techniques”, J Biom Biostat 7: 292, 2016.
[19] A. Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7: e112, 2016.
[20] A. Heidari, “Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniques”, J Drug Metab Toxicol 7: e129, 2016.
[21] A. Heidari, “Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO) Nanoparticles as Anti–Cancer Drug in Formation of Nucleic Acids Complexes for Human Cancer Cells’ Treatment”, Biochem Pharmacol (Los Angel) 5: 207, 2016.
[22] A. Heidari, “A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”, Struct Chem Crystallogr Commun 2: 1, 2016.
[23] A. Heidari, “Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO) Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cells”, Pharm Anal Chem Open Access 2: 113, 2016.
[24] A. Heidari, “A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment”, Chemo Open Access 5: e129, 2016.
[25] A. Heidari, “Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applications”, J Pharmacokinet Exp Ther 1: e005, 2016.
[26] A. Heidari, “Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniques”, Insights Anal Electrochem 2: 1, 2016.
[27] A. Heidari, “Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP) Type Using a Set of Topological Descriptors”, J Heavy Met Toxicity Dis. 1: 2, 2016.
[28] A. Heidari, “Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys. 1: 2, 2016.
[29] A. Heidari, “A Translational Biomedical Approach to Structural Arrangement of Amino Acids’ Complexes: A Combined Theoretical and Computational Study”, Transl Biomed. 7: 2, 2016.
[30] A. Heidari, “Ab Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic Discov 6: e144, 2016.
[31] A. Heidari, “Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”, J Glycobiol 5: e111, 2016.
[32] A. Heidari, “Synthesis and Study of 5–[(Phenylsulfonyl)Amino]–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniques”, Transl Med (Sunnyvale) 6: e138, 2016.
[33] A. Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol 12: 4, 2016.
[34] A. Heidari, “An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acids”, Austin J Anal Pharm Chem. 3 (1): 1058, 2016.
[35] A. Heidari, C. Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC Nanocomposites”, Nano Res Appl. 2: 1, 2016.
[36] A. Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene”, International Journal of Advanced Chemistry, 4 (1) 5–9, 2016.
[37] A. Heidari, “Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues”, Arch Can Res. 4: 2, 2016.
[38] A. Heidari, “Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS) Drugs”, J Data Mining Genomics & Proteomics 7: e125, 2016.
[39] A. Heidari, “Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5) Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two DNA/RNA Molecules of Human Cancer Cells”, J Pharmacogenomics Pharmacoproteomics 7: e153, 2016.
[40] A. Heidari, “Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti–Microbial Drugs: A Clinical Approach”, Transl Biomed. 7: 2, 2016.
[41] A. Heidari, “A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO) Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP) Method”, Arch Can Res. 4: 2, 2016.
[42] A. Heidari, “Cheminformatics and System Chemistry of Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin as Anti–Cancer Nano Drugs: A Combined Computational and Experimental Study”, J Inform Data Min 1: 3, 2016.
[43] A. Heidari, “Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship (QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer Nano Drugs”, J Integr Oncol 5: e110, 2016.
[44] A. Heidari, “Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Method”, J Nanosci Curr Res 1: e101, 2016.
[45] A. Heidari, “Coplanarity and Collinearity of 4’–Dinonyl–2,2’–Bithiazole in One Domain of Bleomycin and Pingyangmycin to be Responsible for Binding of Cadmium Oxide (CdO) Nanoparticles to DNA/RNA Bidentate Ligands as Anti–Tumor Nano Drug”, Int J Drug Dev & Res 8: 007–008, 2016.
[46] A. Heidari, “A Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for the Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations”, J Pharmacovigil 4: e161, 2016.
[47] A. Heidari, “Nanotechnology in Preparation of Semipermeable Polymers”, J Adv Chem Eng 6: 157, 2016.
[48] A. Heidari, “A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for Analysis 5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
[49] A. Heidari, “DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivatives”, Biomedical Data Mining 5: e102, 2016.
[50] A. Heidari, “A Successful Strategy for the Prediction of Solubility in the Construction of Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Using Genetic Function Approximation (GFA) Algorithm”, J Mol Biol Biotechnol 1: 1, 2016.
[51] A. Heidari, “Computational Study on Molecular Structures of C20, C60, C240, C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logic”, J Material Sci Eng 5: 282, 2016.
[52] A. Heidari, “Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs)”, J Appl Computat Math 5: e143, 2016.
[53] A. Heidari, “The Impact of High Resolution Imaging on Diagnosis”, Int J Clin Med Imaging 3: 1000e101, 2016.
[54] A. Heidari, “A Comparative Study of Conformational Behavior of Isotretinoin (13–Cis Retinoic Acid) and Tretinoin (All–Trans Retinoic Acid (ATRA)) Nano Particles as Anti–Cancer Nano Drugs under Synchrotron Radiations Using Hartree–Fock (HF) and Density Functional Theory (DFT) Methods”, Insights in Biomed 1: 2, 2016.
[55] A. Heidari, “Advances in Logic, Operations and Computational Mathematics”, J Appl Computat Math 5: 5, 2016.
[56] A. Heidari, “Mathematical Equations in Predicting Physical Behavior”, J Appl Computat Math 5: 5, 2016.
[57] A. Heidari, “Chemotherapy a Last Resort for Cancer Treatment”, Chemo Open Access 5: 4, 2016.
[58] A. Heidari, “Separation and Pre–Concentration of Metal Cations–DNA/RNA Chelates Using Molecular Beam Mass Spectrometry with Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation and Various Analytical Methods”, Mass Spectrom Purif Tech 2: e101, 2016.
[59] A. Heidari, “Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA) Algorithm”, Insight Pharm Res. 1: 1, 2016.
[60] A. Heidari, “Cancer Risk Prediction and Assessment in Human Cells under Synchrotron Radiations Using Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Properties Relationship (QSPR) Studies”, Int J Clin Med Imaging 3: 516, 2016.
[61] A. Heidari, “A Novel Approach to Biology”, Electronic J Biol 12: 4, 2016.
[62] A. Heidari, “Innovative Biomedical Equipment’s for Diagnosis and Treatment”, J Bioengineer & Biomedical Sci 6: 2, 2016.
[63] A. Heidari, “Integrating Precision Cancer Medicine into Healthcare, Medicare Reimbursement Changes and the Practice of Oncology: Trends in Oncology Medicine and Practices”, J Oncol Med & Pract 1: 2, 2016.
[64] A. Heidari, “Promoting Convergence in Biomedical and Biomaterials Sciences and Silk Proteins for Biomedical and Biomaterials Applications: An Introduction to Materials in Medicine and Bioengineering Perspectives”, J Bioengineer & Biomedical Sci 6: 3, 2016.
[65] A. Heidari, “X–Ray Fluorescence and X–Ray Diffraction Analysis on Discrete Element Modeling of Nano Powder Metallurgy Processes in Optimal Container
Design”, J Powder Metall Min 6: 1, 2017.
[66] A. Heidari, “Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross–Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspective”, Arch Chem Res. 1: 2, 2017.
[67] A. Heidari, “Deficiencies in Repair of Double–Standard DNA/RNA–Binding Molecules Identified in Many Types of Solid and Liquid Tumors Oncology in Human Body for Advancing Cancer Immunotherapy Using Computer Simulations and Data Analysis: Number of Mutations in a Synchronous Tumor Varies by Age and Type of Synchronous Cancer”, J Appl Bioinforma Comput Biol, 6: 1, 2017.
[68] A. Heidari, “Electronic Coupling among the Five Nanomolecules Shuts Down Quantum Tunneling in the Presence and Absence of an Applied Magnetic Field for Indication of the Dimer or other Provide Different Influences on the Magnetic Behavior of Single Molecular Magnets (SMMs) as Qubits for Quantum Computing”, Glob J Res Rev. 4: 2, 2017.
[69] A. Heidari, “Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation of Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60, (SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and (SC6H13)60] Nano Clusters as Anti–Cancer Nano Drugs”, J Nanomater Mol Nanotechnol, 6: 3, 2017.
[70] A. Heidari, “Biomedical Resource Oncology and Data Mining to
Enable Resource Discovery in Medical, Medicinal, Clinical, Pharmaceutical,
Chemical and Translational Research and Their Applications in Cancer Research”,
Int J Biomed Data Min 6: e103, 2017.
[71] A. Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing,
Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for
Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy,
Hormone Therapy and Targeted Therapy under Synchrotorn Radiation”, J Dev Drugs 6: e154, 2017.
[72] A. Heidari, “A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer's, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Microbiome/Antibiotic Resistance and Endovascular Stroke”, J Bioengineer & Biomedical Sci 7: e127, 2017.
[73] A. Heidari, “Opinion on Computational Fluid Dynamics (CFD)
Technique”, Fluid Mech Open Acc 4: 157, 2017.
[74] A. Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis (MS) Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84, Au144(SR)60, Au68(SR)36, Au30(SR)18, Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 Nano Clusters”, J Surgery Emerg Med
1: 21, 2017.
[75] A. Heidari, “Developmental Cell Biology in Adult Stem Cells Death and Autophagy to Trigger a Preventive Allergic Reaction to Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy)”, Cell Biol (Henderson, NV) 6: 1, 2017.
[76] A. Heidari, “Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumors”, J Powder Metall Min 6: 170, 2017.
[77] A. Heidari, “Nanomedicine–Based Combination Anti–Cancer Therapy between Nucleic Acids and Anti–Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti–Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiation”, Am J Drug Deliv 5: 2, 2017.
[78] A. Heidari, “Clinical Trials of Dendritic Cell Therapies for Cancer Exposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech's Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progression”, J Biol Med Science 1: e103, 2017.
[79] A. Heidari, “The Design Graphene–Based Nanosheets as a New Nanomaterial in Anti–Cancer Therapy and Delivery of Chemotherapeutics and Biological Nano Drugs for Liposomal Anti–Cancer Nano Drugs and Gene Delivery”, Br Biomed Bull 5: 305, 2017.
[80] A. Heidari, “Integrative Approach to Biological Networks for Emerging Roles of Proteomics, Genomics and Transcriptomics in the Discovery and Validation of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data under Synchrotron Radiation”, Transcriptomics 5: e117, 2017.
[81] A. Heidari, “Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins and Cell Adhesion Intelligent Nanomolecules Adjustment in Cancer Metastases Using Metalloenzymes and under Synchrotron Radiation”, Lett Health Biol Sci 2 (2): 1–4, 2017.
[82] A. Heidari, “Treatment of Breast Cancer Brain Metastases through a Targeted Nanomolecule Drug Delivery System Based on Dopamine Functionalized Multi–Wall Carbon Nanotubes (MWCNTs) Coated with Nano Graphene Oxide (GO) and Protonated Polyaniline (PANI) in Situ During the Polymerization of Aniline Autogenic Nanoparticles for the Delivery of Anti–Cancer Nano Drugs under Synchrotron Radiation”, Br J Res, 4 (3): 16, 2017.
[83] A. Heidari, “Sedative, Analgesic and Ultrasound–Mediated Gastrointestinal Nano Drugs Delivery for Gastrointestinal Endoscopic Procedure, Nano Drug–Induced Gastrointestinal Disorders and Nano Drug Treatment of Gastric Acidity”, Res Rep Gastroenterol, 1: 1, 2017.
[84] A. Heidari, “Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to Treat High Cholesterol and Related Conditions and to Prevent Cardiovascular Disease under Synchrotron Radiation”, J Pharm Sci Emerg Drugs 5: 1, 2017.
[85] A. Heidari, “Non–Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics through Particle Therapy Accelerators with Monochromatic Microbeams”, J Cell Biol Mol Sci 2 (1): 1–5, 2017.
[86] A. Heidari, “Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood–Brain Barrier (BBB) Translocation to Targeted Deliver Anti–Cancer Nano Drugs into the Human Brain to Treat Alzheimer’s Disease under Synchrotron Radiation”, J Nanotechnol Material Sci 4 (2): 1–5, 2017.
[87] R. Gobato, A. Heidari, “Calculations Using Quantum Chemistry for Inorganic Molecule Simulation BeLi2SeSi”, Science Journal of Analytical Chemistry, Vol. 5, No. 6, Pages 76–85, 2017.
[88] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Med Oncol. Vol. 1 No. 1: 1, 2017.
[89] A. Heidari, “A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation”, Am J Ethnomed, Vol. 4 No. 1: 10, 2017.
[90] A. Heidari, “Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood–Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS) and Alzheimer's Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV) Nanocarriers under Synchrotron Radiation”, J Med Chem Toxicol, 2 (3): 1–5, 2017.
[91] A. Heidari, “Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET), Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatment”, Parana Journal of Science and Education (PJSE)–v.3, n.4, (10–19) October 12, 2017.
[92] A. Heidari, “A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment”, Open J Anal Bioanal Chem 1 (1): 014–020, 2017.
[93] A. Heidari, “Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation–Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO) Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activity”, Enz Eng 6: 1, 2017.
[94] A. Heidari, “Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS)”, Mod Appro Drug Des. 1 (1). MADD.000504. 2017.
[95] A. Heidari, “Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS) and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cells”, J Proteomics Enzymol 6: 1, 2017.
[96] A. Heidari, “Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation”, J Pharm Pharmaceutics 4 (2): 1–5, 2017.
[97] A. Heidari, C. Brown, “Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G), Fluoxetine Hydrochloride (Prozac and Sarafem), Propofol (Diprivan), Acetylsalicylic Acid (ASA) (Aspirin), Naproxen Sodium (Aleve and Naprosyn) and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systems”, Ann Adv Chem. 1 (2): 061–069, 2017.
[98] A. Heidari, “High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiation”, J Transl Res. 1 (1): 1–3, 2017.
[99] A. Heidari, “Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention, Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematica”, Current Trends Anal Bioanal Chem, 1 (1): 36–41, 2017.
[100] A. Heidari, “Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS) or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle) Using Synchrotron Radiation”, Arch Biotechnol Biomed. 1 (1): 067–0100, 2017.
[101] A. Heidari, “Visualizing Metabolic Changes in Probing Human Cancer Cells and Tissues Metabolism Using Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy and Self–Organizing Maps under Synchrotron Radiation”, SOJ Mater Sci Eng 5 (2): 1–6, 2017.
[102] A. Heidari, “Cavity Ring–Down Spectroscopy (CRDS), Circular Dichroism Spectroscopy, Cold Vapour Atomic Fluorescence Spectroscopy and Correlation Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Challenges Cancer Detect Ther 4 (2): e001, 2017.
[103] A. Heidari, “Laser Spectroscopy, Laser–Induced Breakdown Spectroscopy and Laser–Induced Plasma Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Hepatol Gastroenterol, 3 (4): 079–084, 2017.
[104] A. Heidari, “Time–Resolved Spectroscopy and Time–Stretch Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Pharmacovigilance and Drug Safety 4 (2): e001, 2017.
[105] A. Heidari, “Overview of the Role of Vitamins in Reducing Negative Effect of Decapeptyl (Triptorelin Acetate or Pamoate Salts) on Prostate Cancer Cells and Tissues in Prostate Cancer Treatment Process through Transformation of Malignant Prostate Tumors into Benign Prostate Tumors under Synchrotron Radiation”, Open J Anal Bioanal Chem 1 (1): 021–026, 2017.
[106] A. Heidari, “Electron Phenomenological Spectroscopy, Electron Paramagnetic Resonance (EPR) Spectroscopy and Electron Spin Resonance (ESR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Austin J Anal Pharm Chem. 4 (3): 1091, 2017.
[107] A. Heidari, “Therapeutic Nanomedicine Different High–Resolution Experimental Images and Computational Simulations for Human Brain Cancer Cells and Tissues Using Nanocarriers Deliver DNA/RNA to Brain Tumors under Synchrotron Radiation with the Passage of Time Using Mathematica and MATLAB”, Madridge J Nano Tech. Sci. 2 (2): 77–83, 2017.
[108] A. Heidari, “A Consensus and Prospective Study on Restoring Cadmium Oxide (CdO) Nanoparticles Sensitivity in Recurrent Ovarian Cancer by Extending the Cadmium Oxide (CdO) Nanoparticles–Free Interval Using Synchrotron Radiation Therapy as Antibody–Drug Conjugate for the Treatment of Limited–Stage Small Cell Diverse Epithelial Cancers”, Cancer Clin Res Rep, 1: 2, e001, 2017.
[109] A. Heidari, “A Novel and Modern Experimental Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White Synchrotron Radiation”, Cancer Sci Res Open Access 4 (2): 1–8, 2017.
[110] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Breast Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Oral Cancer Res 1 (1): 12–17, 2017.
[111] A. Heidari, “Vibrational Decihertz (dHz), Centihertz (cHz), Millihertz (mHz), Microhertz (μHz), Nanohertz (nHz), Picohertz (pHz), Femtohertz (fHz), Attohertz (aHz), Zeptohertz (zHz) and Yoctohertz (yHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, International Journal of Biomedicine, 7 (4), 335–340, 2017.
[112] A. Heidari, “Force Spectroscopy and Fluorescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, EC Cancer, 2 (5), 239–246, 2017.
[113] A. Heidari, “Photoacoustic Spectroscopy, Photoemission Spectroscopy and Photothermal Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, BAOJ Cancer Res Ther, 3: 3, 045–052, 2017.
[114] A. Heidari, “J–Spectroscopy, Exchange Spectroscopy (EXSY), Nucle¬ar Overhauser Effect Spectroscopy (NOESY) and Total Correlation Spectroscopy (TOCSY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Eng Sci J, 1 (2): 006–013, 2017.
[115] A. Heidari, “Neutron Spin Echo Spectroscopy and Spin Noise Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Biopharm Sci, 1: 103–107, 2017.
[116] A. Heidari, “Vibrational Decahertz (daHz), Hectohertz (hHz), Kilohertz (kHz), Megahertz (MHz), Gigahertz (GHz), Terahertz (THz), Petahertz (PHz), Exahertz (EHz), Zettahertz (ZHz) and Yottahertz (YHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Madridge J Anal Sci Instrum, 2 (1): 41–46, 2017.
[117] A. Heidari, “Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy and Non–Linear Two–Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Mater Sci Nanotechnol 6 (1): 101, 2018.
[118] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Near–Infrared Spectroscopy (NIRS) and Mid–Infrared Spectroscopy (MIRS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Int J Nanotechnol Nanomed, Volume 3, Issue 1, Pages 1–6, 2018.
[119] A. Heidari, “Infrared Photo Dissociation Spectroscopy and Infrared Correlation Table Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Austin Pharmacol Pharm, 3 (1): 1011, 2018.
[120] A. Heidari, “Novel and Transcendental Prevention, Diagnosis and Treatment Strategies for Investigation of Interaction among Human Blood Cancer Cells, Tissues, Tumors and Metastases with Synchrotron Radiation under Anti–Cancer Nano Drugs Delivery Efficacy Using MATLAB Modeling and Simulation”, Madridge J Nov Drug Res, 1 (1): 18–24, 2017.
[121] A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Open Access J Trans Med Res, 2 (1): 00026–00032, 2018.
[122] M. R. R. Gobato, R. Gobato, A. Heidari, “Planting of Jaboticaba Trees for Landscape Repair of Degraded Area”, Landscape Architecture and Regional Planning, Vol. 3, No. 1, 2018, Pages 1–9, 2018.
[123] A. Heidari, “Fluorescence Spectroscopy, Phosphorescence Spectroscopy and Luminescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, SM J Clin. Med. Imaging, 4 (1): 1018, 2018.
[124] A. Heidari, “Nuclear Inelastic Scattering Spectroscopy (NISS) and Nuclear Inelastic Absorption Spectroscopy (NIAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Pharm Sci, 2 (1): 1–14, 2018.
[125] A. Heidari, “X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Oncol Res; 2 (1): 1–14, 2018.
[126] A. Heidari, “Correlation Two–Dimensional Nuclear Magnetic Reso¬nance (NMR) (2D–NMR) (COSY) Imaging and Spectrosco¬py Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Can Sci, 1–1–001, 2018.
[127] A. Heidari, “Thermal Spectroscopy, Photothermal Spectroscopy, Thermal Microspectroscopy, Photothermal Microspectroscopy, Thermal Macrospectroscopy and Photothermal Macrospectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, SM J Biometrics Biostat, 3 (1): 1024, 2018.

[128] A. Heidari, “A Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers’ Cells, Tissues and Tumors before and after Synchrotron Radiation Therapy”, Open Acc J Oncol Med. 1 (1), 2018.

[129] A. Heidari, “Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues under Synchrotron Radiation”, J Endocrinol Thyroid Res, 3 (1): 555603, 2018.

[130] A. Heidari, “Nuclear Resonance Vibrational Spectroscopy (NRVS), Nuclear Inelastic Scattering Spectroscopy (NISS), Nuclear Inelastic Absorption Spectroscopy (NIAS) and Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (1e): 1–5, 2018.

[131] A. Heidari, “A Novel and Modern Experimental Approach to Vibrational Circular Dichroism Spectroscopy and Video Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White and Monochromatic Synchrotron Radiation”, Glob J Endocrinol Metab. 1 (3). GJEM. 000514–000519, 2018.

[132] A. Heidari, “Pros and Cons Controversy on Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Pharma J. 1 (1): 002–008, 2018.

[133] A. Heidari, “A Modern Comparative and Comprehensive Experimental Biospectroscopic Study on Different Types of Infrared Spectroscopy of Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, J Analyt Molecul Tech. 3 (1): 8, 2018.

[134] A. Heidari, “Investigation of Cancer Types Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, European Modern Studies Journal, Vol. 2, No. 1, 13–29, 2018.
[135] A. Heidari, “Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Imaging J Clin Medical Sci. 5 (1): 001–007, 2018.
[136] A. Heidari, “Small–Angle Neutron Scattering (SANS) and Wide–Angle X–Ray Diffraction (WAXD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (2e): 1–6, 2018.
[137] A. Heidari, “Investigation of Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver, Lung Cancer, Melanoma, Non–Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer and Non–Melanoma Skin Cancer Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, Ther Res Skin Dis 1 (1), 2018.
[138] A. Heidari, “Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy and Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, International Journal of Chemistry Papers, 2 (1): 1–12, 2018.
[139] A. Heidari, “Mössbauer Spectroscopy, Mössbauer Emission Spectroscopy and 57Fe Mössbauer Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Cancer Biology 2.3: 17–20, 2018.
[140] A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Organic & Medicinal Chem IJ. 6 (1): 555676, 2018.
[141] A. Heidari, “Correlation Spectroscopy, Exclusive Correlation Spectroscopy and Total Correlation Spectroscopy Comparative Study on Malignant and Benign Human AIDS–Related Cancers Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Bioanal Biomed. 2 (1): 001–007, 2018.
[142] A. Heidari, “Biomedical Instrumentation and Applications of Biospectroscopic Methods and Techniques in Malignant and Benign Human Cancer Cells and Tissues Studies under Synchrotron Radiation and Anti–Cancer Nano Drugs Delivery”, Am J Nanotechnol Nanomed. 1 (1): 001–009, 2018.
[143] A. Heidari, “Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Ann Biomet Biostat. 1 (1): 1001, 2018.
[144] A. Heidari, “Grazing–Incidence Small–Angle Neutron Scattering (GISANS) and Grazing–Incidence X–Ray Diffraction (GIXD) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron Radiation”, Ann Cardiovasc Surg. 1 (2): 1006, 2018.
[145] A. Heidari, “Adsorption Isotherms and Kinetics of Multi–Walled Carbon Nanotubes (MWCNTs), Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) for Eliminating Carcinoma, Sarcoma, Lymphoma, Leukemia, Germ Cell Tumor and Blastoma Cancer Cells and Tissues”, Clin Med Rev Case Rep 5: 201, 2018.
[146] A. Heidari, “Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Pharmaceutical Sciences 2.5: 30–35, 2018.
[147] A. Heidari, “Small–Angle X–Ray Scattering (SAXS), Ultra–Small Angle X–Ray Scattering (USAXS), Fluctuation X–Ray Scattering (FXS), Wide–Angle X–Ray Scattering (WAXS), Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS), Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS), Small–Angle Neutron Scattering (SANS), Grazing–Incidence Small–Angle Neutron Scattering (GISANS), X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD), Wide–Angle X–Ray Diffraction (WAXD), Grazing–Incidence X–Ray Diffraction (GIXD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Oncol Res Rev, Volume 1 (1): 1–10, 2018.
[148] A. Heidari, “Pump–Probe Spectroscopy and Transient Grating Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Adv Material Sci Engg, Volume 2, Issue 1, Pages 1–7, 2018.
[149] A. Heidari, “Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS) and Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Insights Pharmacol Pharm Sci 1 (1): 1–8, 2018.
[150] A. Heidari, “Acoustic Spectroscopy, Acoustic Resonance Spectroscopy and Auger Spectroscopy Comparative Study on Anti–Cancer Nano Drugs Delivery in Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Nanosci Technol 5 (1): 1–9, 2018.
[151] A. Heidari, “Niobium, Technetium, Ruthenium, Rhodium, Hafnium, Rhenium, Osmium and Iridium Ions Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Nanomed Nanotechnol, 3 (2): 000138, 2018.
[152] A. Heidari, “Homonuclear Correlation Experiments such as Homonuclear Single–Quantum Correlation Spectroscopy (HSQC), Homonuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Homonuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Austin J Proteomics Bioinform & Genomics. 5 (1): 1024, 2018.
[153] A. Heidari, “Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy and Nuclear Resonance Vibrational Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Appl Biotechnol Bioeng. 5 (3): 142‒148, 2018.
[154] A. Heidari, “Time–Dependent Vibrational Spectral Analysis of Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Cancer Oncol, 2 (2): 000124, 2018.
[155] A. Heidari, “Palauamine and Olympiadane Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Arc Org Inorg Chem Sci 3 (1), 2018.
[156] R. Gobato, A. Heidari, “Infrared Spectrum and Sites of Action of Sanguinarine by Molecular Mechanics and ab initio Methods”, International Journal of Atmospheric and Oceanic Sciences. Vol. 2, No. 1, pp. 1–9, 2018.
[157] A. Heidari, “Angelic Acid, Diabolic Acids, Draculin and Miraculin Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment Under Synchrotron and Synchrocyclotron Radiations”, Med & Analy Chem Int J, 2 (1): 000111, 2018.
[158] A. Heidari, “Gamma Linolenic Methyl Ester, 5–Heptadeca–5,8,11–Trienyl 1,3,4–Oxadiazole–2–Thiol, Sulphoquinovosyl Diacyl Glycerol, Ruscogenin, Nocturnoside B, Protodioscine B, Parquisoside–B, Leiocarposide, Narangenin, 7–Methoxy Hespertin, Lupeol, Rosemariquinone, Rosmanol and Rosemadiol Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Int J Pharma Anal Acta, 2 (1): 007–014, 2018.
[159] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy, Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy, Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy, Non–Linear Two–Dimensional Infrared Spectroscopy, Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy, Infrared Photodissociation Spectroscopy, Infrared Correlation Table Spectroscopy, Near–Infrared Spectroscopy (NIRS), Mid–Infrared Spectroscopy (MIRS), Nuclear Resonance Vibrational Spectroscopy, Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (2): 1–14, 2018.
[160] A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations”, Chronicle of Medicine and Surgery 2.3: 144–156, 2018.
[161] A. Heidari, “Tetrakis [3, 5–bis (Trifluoromethyl) Phenyl] Borate (BARF)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Medical Research and Clinical Case Reports 2.1: 113–126, 2018.
[162] A. Heidari, “Sydnone, Münchnone, Montréalone, Mogone, Montelukast, Quebecol and Palau’amine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Sur Cas Stud Op Acc J. 1 (3), 2018.
[163] A. Heidari, “Fornacite, Orotic Acid, Rhamnetin, Sodium Ethyl Xanthate (SEX) and Spermine (Spermidine or Polyamine) Nanomolecules Incorporation into the Nanopolymeric Matrix (NPM)”, International Journal of Biochemistry and Biomolecules, Vol. 4: Issue 1, Pages 1–19, 2018.
[164] A. Heidari, R. Gobato, “Putrescine, Cadaverine, Spermine and Spermidine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Parana Journal of Science and Education (PJSE)–v.4, n.5, (1–14) July 1, 2018.
[165] A. Heidari, “Cadaverine (1,5–Pentanediamine or Pentamethylenediamine), Diethyl Azodicarboxylate (DEAD or DEADCAT) and Putrescine (Tetramethylenediamine) Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Hiv and Sexual Health Open Access Open Journal. 1 (1): 4–11, 2018.
[166] A. Heidari, “Improving the Performance of Nano–Endofullerenes in Polyaniline Nanostructure–Based Biosensors by Covering Californium Colloidal Nanoparticles with Multi–Walled Carbon Nanotubes”, Journal of Advances in Nanomaterials, Vol. 3, No. 1, Pages 1–28, 2018.
[167] R. Gobato, A. Heidari, “Molecular Mechanics and Quantum Chemical Study on Sites of Action of Sanguinarine Using Vibrational Spectroscopy Based on Molecular Mechanics and Quantum Chemical Calculations”, Malaysian Journal of Chemistry, Vol. 20 (1), 1–23, 2018.
[168] A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part I)”, Malaysian Journal of Chemistry, Vol. 20 (1), 33–73, 2018.
[169] A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part II)”, Malaysian Journal of Chemistry, Vol. 20 (1), 74–117, 2018.
[170] A. Heidari, “Uranocene (U(C8H8)2) and Bis(Cyclooctatetraene)Iron (Fe(C8H8)2 or Fe(COT)2)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Chemistry Reports, Vol. 1, Iss. 2, Pages 1–16, 2018.
[171] A. Heidari, “Biomedical Systematic and Emerging Technological Study on Human Malignant and Benign Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (3): 1–7, 2018.
[172] A. Heidari, “Deep–Level Transient Spectroscopy and X–Ray Photoelectron Spectroscopy (XPS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Res Dev Material Sci. 7(2). RDMS.000659, 2018.
[173] A. Heidari, “C70–Carboxyfullerenes Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (3): 1–7, 2018.
[174] A. Heidari, “The Effect of Temperature on Cadmium Oxide (CdO) Nanoparticles Produced by Synchrotron Radiation in the Human Cancer Cells, Tissues and Tumors”, International Journal of Advanced Chemistry, 6 (2) 140–156, 2018.
[175] A. Heidari, “A Clinical and Molecular Pathology Investigation of Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations Using Cyclotron versus Synchrotron, Synchrocyclotron and the Large Hadron Collider (LHC) for Delivery of Proton and Helium Ion (Charged Particle) Beams for Oncology Radiotherapy”, European Journal of Advances in Engineering and Technology, 5 (7): 414–426, 2018.
[176] A. Heidari, “Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, J Oncol Res; 1 (1): 1–20, 2018.
[177] A. Heidari, “Use of Molecular Enzymes in the Treatment of Chronic Disorders”, Canc Oncol Open Access J. 1 (1): 12–15, 2018.
[178] A. Heidari, “Vibrational Biospectroscopic Study and Chemical Structure Analysis of Unsaturated Polyamides Nanoparticles as Anti–Cancer Polymeric Nanomedicines Using Synchrotron Radiation”, International Journal of Advanced Chemistry, 6 (2), 167–189, 2018.
[179] A. Heidari, “Adamantane, Irene, Naftazone and Pyridine–Enhanced Precatalyst Preparation Stabilization and Initiation (PEPPSI) Nano Molecules”, Madridge J Nov Drug Res. 2 (1): 61–67, 2018.
[180] A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Madridge J Nov Drug Res, 2 (1): 68–74, 2018.
[181] A. Heidari, R. Gobato, “A Novel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNA of Human Cancer Cells–Containing Cocaine (Coke), Lysergide (Lysergic Acid Diethyl Amide or LSD), Δ⁹–Tetrahydrocannabinol (THC) [(–)–trans–Δ⁹–Tetrahydrocannabinol], Theobromine (Xantheose), Caffeine, Aspartame (APM) (NutraSweet) and Zidovudine (ZDV) [Azidothymidine (AZT)] as Anti–Cancer Nano Drugs by Coassembly of Dual Anti–Cancer Nano Drugs to Inhibit DNA/RNA of Human Cancer Cells Drug Resistance”, Parana Journal of Science and Education, v. 4, n. 6, pp. 1–17, 2018.
[182] A. Heidari, R. Gobato, “Ultraviolet Photoelectron Spectroscopy (UPS) and Ultraviolet–Visible (UV–Vis) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Parana Journal of Science and Education, v. 4, n. 6, pp. 18–33, 2018.
[183] R. Gobato, A. Heidari, A. Mitra, “The Creation of C13H20BeLi2SeSi. The Proposal of a Bio–Inorganic Molecule, Using Ab Initio Methods for the Genesis of a Nano Membrane”, Arc Org Inorg Chem Sci 3 (4). AOICS.MS.ID.000167, 2018.
[184] R. Gobato, A. Heidari, A. Mitra, “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and H”, ResearchGate, See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/326201181, 2018.
[185] R. Gobato, A. Heidari, “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and H”, J Nanomed Res.7 (4): 241‒252, 2018.
[186] A. Heidari, “Bastadins and Bastaranes–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018.
[187] A. Heidari, “Fucitol, Pterodactyladiene, DEAD or DEADCAT (DiEthyl AzoDiCArboxylaTe), Skatole, the NanoPutians, Thebacon, Pikachurin, Tie Fighter, Spermidine and Mirasorvone Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4): 1–8, 2018.
[188] E. Dadvar, A. Heidari, “A Review on Separation Techniques of Graphene Oxide (GO)/Base on Hybrid Polymer Membranes for Eradication of Dyes and Oil Compounds: Recent Progress in Graphene Oxide (GO)/Base on Polymer Membranes–Related Nanotechnologies”, Clin Med Rev Case Rep 5: 228, 2018.
[189] A. Heidari, R. Gobato, “First–Time Simulation of Deoxyuridine Monophosphate (dUMP) (Deoxyuridylic Acid or Deoxyuridylate) and Vomitoxin (Deoxynivalenol (DON)) ((3α,7α)–3,7,15–Trihydroxy–12,13–Epoxytrichothec–9–En–8–One)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Parana Journal of Science and Education, Vol. 4, No. 6, pp. 46–67, 2018.
[190] A. Heidari, “Buckminsterfullerene (Fullerene), Bullvalene, Dickite and Josiphos Ligands Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Hematology and Thromboembolic Diseases Prevention, Diagnosis and Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018.
[191] A. Heidari, “Fluctuation X–Ray Scattering (FXS) and Wide–Angle X–Ray Scattering (WAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018.
[192] A. Heidari, “A Novel Approach to Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–9, 2018.
[193] A. Heidari, “Terphenyl–Based Reversible Receptor with Rhodamine, Rhodamine–Based Molecular Probe, Rhodamine–Based Using the Spirolactam Ring Opening, Rhodamine B with Ferrocene Substituent, Calix[4]Arene–Based Receptor, Thioether + Aniline–Derived Ligand Framework Linked to a Fluorescein Platform, Mercuryfluor–1 (Flourescent Probe), N,N’–Dibenzyl–1,4,10,13–Tetraraoxa–7,16–Diazacyclooctadecane and Terphenyl–Based Reversible Receptor with Pyrene and Quinoline as the Fluorophores–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Glob Imaging Insights, Volume 3 (5): 1–9, 2018.
[194] A. Heidari, “Small–Angle X–Ray Scattering (SAXS), Ultra–Small Angle X–Ray Scattering (USAXS), Fluctuation X–Ray Scattering (FXS), Wide–Angle X–Ray Scattering (WAXS), Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS), Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS), Small–Angle Neutron Scattering (SANS), Grazing–Incidence Small–Angle Neutron Scattering (GISANS), X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD), Wide–Angle X–Ray Diffraction (WAXD), Grazing– Incidence X–Ray Diffraction (GIXD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–10, 2018.
[195] A. Heidari, “Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) and Nuclear Resonance Vibrational Spectroscopy (NRVS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–7, 2018.
[196] A. Heidari, “Small–Angle X–Ray Scattering (SAXS) and Ultra–Small Angle X–Ray Scattering (USAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–7, 2018.
[197] A. Heidari, “Curious Chloride (CmCl3) and Titanic Chloride (TiCl4)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules for Cancer Treatment and Cellular Therapeutics”, J. Cancer Research and Therapeutic Interventions, Volume 1, Issue 1, Pages 01–10, 2018.
[198] R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi via Quantum Chemistry Using Ab Initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G**(3df, 3pd)”, Arc Org Inorg Chem Sci 3 (5), Pages 402–409, 2018.
[199] A. Heidari, “C60 and C70–Encapsulating Carbon Nanotubes Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Integr Mol Med, Volume 5 (3): 1–8, 2018.
[200] A. Heidari, “Two–Dimensional (2D) 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (6): 1–8, 2018.
[201] A. Heidari, “FT–Raman Spectroscopy, Coherent Anti–Stokes Raman Spectroscopy (CARS) and Raman Optical Activity Spectroscopy (ROAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[202] A. Heidari, “A Modern and Comprehensive Investigation of Inelastic Electron Tunneling Spectroscopy (IETS) and Scanning Tunneling Spectroscopy on Malignant and Benign Human Cancer Cells, Tissues and Tumors through Optimizing Synchrotron Microbeam Radiotherapy for Human Cancer Treatments and Diagnostics: An Experimental Biospectroscopic Comparative Study”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[203] A. Heidari, “A Hypertension Approach to Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[204] A. Heidari, “Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[205] A. Heidari, “2–Amino–9–((1S, 3R, 4R)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One, 2–Amino–9–((1R, 3R, 4R)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One, 2–Amino–9–((1R, 3R, 4S)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One and 2–Amino–9–((1S, 3R, 4S)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One–Enhanced Precatalyst Preparation Stabilization and Initiation Nano Molecules”, Glob Imaging Insights, Volume 3 (6): 1–9. 2018.
[206] R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi via Quantum Chemistry Using Ab Initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G**(3df, 3pd)”, American Journal of Quantum Chemistry and Molecular Spectroscopy, Vol. 2, No. 1, pp. 9–17, 2018.
[207] A. Heidari, “Production of Electrochemiluminescence (ECL) Biosensor Using Os–Pd/HfC Nanocomposites for Detecting and Tracking of Human Gastroenterological Cancer Cells, Tissues and Tumors”, Int J Med Nano Res 5: 1, 022–034, 2018.
[208] A. Heidari, “Enhancing the Raman Scattering for Diagnosis and Treatment of Human Cancer Cells, Tissues and Tumors Using Cadmium Oxide (CdO) Nanoparticles”, J Toxicol Risk Assess 4: 1, 012–025, 2018.
[209] A. Heidari, “Human Malignant and Benign Human Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiation Using Anti–Cancer Nano Drugs Delivery”, Integr Mol Med, Volume 5 (5): 1–13, 2018.
[210] A. Heidari, “Analogous Nano Compounds of the Form M(C8H8)2 Exist for M = (Nd, Tb, Pu, Pa, Np, Th, and Yb)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Integr Mol Med, Volume 5 (5): 1–8, 2018.
[211] A. Heidari, “Hadron Spectroscopy, Baryon Spectroscopy and Meson Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Integr Mol Med, Volume 5 (5): 1–8, 2018.

Viroj Wiwanitkit, MD

Special Lecturer, Chulalongkorn University, Bangkok Thailand/ University Professor Visiting University Professor, Hainan Medical University, Hainan China/Honorary Professor, Dr DY Patil University, India/ Visiting Professor, Faculty of Medicine Serbia/ Adjunct Professor, University of Nis, Joesph Ayo Babalola University Nigeria
Professor Dr. Viroj Wiwanitkit is currently working as a medical professor and Asian Scholar. He graduated in medical doctor (M.D). (honors) and works in medical academics in many universities. At present, he is appointed as a visiting University Professor, Hainan Medical University, China; visiting professor, Faculty of Medicine, University of Nis, Serbia; adjunct professor, Joseph Ayobabalola University, Nigeria and Professor, Senior Expert, Surin Rajabhat University, Thailand. He has many international publications in the medical field. His research interest includes tropical medicine and public health, Laboratory medicine, clinical biochemistry, molecular biology, and microbiology. At present, he is the medical scientist who has more than 1,800 article publications and he has the most number (the first world rank) of international publications as the first and the last author. He also serves as editor in chief and editorial board of about 100 international medical journals published from several countries around the world.
Area of research interest
• Tropical medicine
• Laboratory science (biomedical)
• Nanoscience and nanotechnology
• Bioinformatics and medical engineering
• Family medicine, social medicine and public health
Degree: M.D. (honors)
Board of Family Medicine, Thai Medical Council
Fellowship of Clinical Scientist Association, USA (invited)
Fellowship of International Society of Gene therapy and Molecular biology
(invited)
Fellowship of International Society of Cancer Therapy (invited)
Membership of European Society of Pediatric Nutrition (invited)
Nominated by Marquis Who’s Who Records
Special academic and honors
• Invited reviewer of many regional and international medical and science journals
• Invited speaker in many International Congress
• Editor in chief of more than 10 international journals
• Editorial board of more than 60 international journals
• The world scientist with the most numbers of international publications as the first author
• Invited lecturer for many universities in Thailand and other countries
• The author with the 1st global rank with the most number of international publication as the first author
Researches and publications
• More than 2,300 publications in the international journal (in science and medicine index such as Scopus, PubMed, Medline, ChemAbstract and ISI)
• More than 150 presentations in international congress (as Key note Speaker and Session Speaker)
• Invited chapters in many international textbooks (more than 150)
• Many textbooks in Thailand and International level (more than 30)

Shivaji K Jadhav, PhD

Scientific Officer–F Molecular Oncology Department Lilac Insights Pvt Limited Navi Mumbai 400710, Maharashtra, India
Dr Shivaji K Jadhav completed his graduation in Microbiology and Post graduation in Biotechnology from Karnataka University and further he completed PhD in Biochemistry (Molecular HIV Virology) from University of Mumbai and He has carried out his molecular Virology research at National Institute for Research in Reproductive Health [NIRRH] a premier Indian Council of Medical Research, (ICMR) Institute in Mumbai.
Presently he is working at Lilac Insights Private Limited as Scientific Officer – F in Department of Molecular Oncology and the lab is fully equipped with state of art of facility to carry out Onco Molecular test Panels for Haematological malignancies and Solid Tumors with advanced sequencing technologies, Before Joining Lilac, Dr Shivaji was working at Head of Laboratory Operations at Mapmygenome and Co.Head of Infectious Disease at Sandor Life sciences. He has also worked as Senior Scientist C at NIMR, Indian Council of Medical Research, (ICMR ) Goa in project “Malaria Evolution in South Asia” funded by National Institute of Health and International Centre of Excellence for Malaria Research, (ICEMR) National Institute of Allergy and Infectious diseases (NIAID) USA. He has worked with team of scientists at NIMR on Vectors, infection rate, vector competency and host Pathogen interaction in malaria. He has been awarded with Prestigious Fogarty International HIV/AIDS Training and Research Fellowship programme from National Institute of Health, USA, He has been trained in Advance Molecular Virology techniques, HIV Drug Resistance, True Gene Sequencing and Mucosal Transmission of HIV and genetic diversity at Boston School of Medicine and Harvard Medical School,USA. He was mentored under the guidance of Dr Deborah Anderson and Dr Manish Sagar. He has total fourteen years of experience in the area of Molecular Diagnostics, Virology and Infectious Diseases; He has been awarded with thirteen International young Scientist Awards, Global Health, International Travel grants and Scholarships.
EDUCATIONAL ACHIEVEMENTS/SCHOLARSHIPS /TRAININGS
• Advanced Training on malaria Parasitology at Mahidol Vivax Research Centre, Mahidol Vivax Research Centre .
• Fogarty Short-term International HIV/AIDS Training Programme (ATRIP) Award: NIH- USA: Worked as a Research fellow in HIV / AIDS Clinical Virology: Miriam/Brown University Boston USA, Mentors Dr. Deborah. J. Anderson, at Boston Medical School, Dr.Manish Sagar, Harvard University, Dr Kenneth. Mayer, Boston, USA (2008 -2009)
• Senior Research Fellowship: (SRF) Indian Council of Medical Research, India.
• Senior Research Fellowship: ICMR-DBT Project on HIV/AIDS, NIRRH, India.
• Junior Research Fellowship: Department of Biotechnology Project, NIRRH.
• Department of Biotechnology - Biotechnology Industrial Training Programme (BITP-BCIL) New Delhi.

INTERNATIONAL YOUNG SCIENTIST/GLOBAL HEALTH/ AWARDS
• Sydney, Australia (IAS Society Conference): 2007.
• Bangkok, Thailand (Keystone Symposium): 2008.
• Boston, United States of America, (USA): 2008-2009.
• (Fogarty AITRIP) - Boston University - Harvard Medical School, Boston, USA
• Pittsburgh, Pennsylvania, USA. (Microbicide Conference): 2010.
• Georgia, Atlanta, USA (AIDS Vaccine): 2010.
• Denver, Colorado, USA (Vaccine): 2012.
• Utrecht, Netherlands (Dynamics & Evolution): 2013.
• Rio de Janeiro, Brazil, (Advancing Vaccines): 2013.
• Seattle, Washington USA. (Adjuvant Meeting): 2014.
• Bangkok, Thailand (Mahidol Vivax Research Centre): 2015.
• Global Academy Fellowship Award – IAS HIV Cure – Bushbuckridge,
Mpumalanga, South Africa towards an HIV Cure: Global Fellows Research Academy 29–31 May 2017.
• IAS Cure & Cancer Forum Paris, France 21 & 22 July 2017: Organized by the International AIDS Society (IAS)
• Global Health Award –Infectious disease –Whistler, Canda March 2019.
• Shivaji K Jadhav, Shilpa M Velhal, Alaka Deshpande, Atmaram H Bandivdekar. Association of Human Mannose receptor in sexual transmission of Human Immunodeficiency Virus in serodiscordant couples. AIDS Res Hum Retroviruses. 2013 Jan; 29(1):156-63. (Impact Factor 2.246) Citation-7
https://www.ncbi.nlm.nih.gov/pubmed/23148569
• Alaka K Deshpande, Shivaji K Jadhav, Atmaram H Bandivdekar. Possible Transmission of HIV infection due to human bite,.AIDS Research and Therapy. March 31; 8(1):16. 2011 [Highly Accessed] (Impact Factor - 2.52)
https://www.ncbi.nlm.nih.gov/pubmed/21453452
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083326/
• Shivaji K Jadhav, Shilpa M Velhal, Alaka Deshpande, Anurupa Maitra, Chinnaraj Saravanan, Atmaram H Bandivdekar.(2011) Characterization of Human Immunodeficiency Virus (HIV1 C) Variants in Peripheral Blood Mononuclear Cells (PBMCs) and Spermatozoa. Journal of Medical Virology, 2011:83: 760–767. (Impact factor -2.89) Citation- 6
https://www.ncbi.nlm.nih.gov/pubmed/21412785
• Uday Kumar GJ, Shivaji Kashinath J, Manohar Gangappa P (2013) Immune Reconstitution Inflammatory Syndrome (IRIS) Affecting the Central Nervous System (CNS) In Patient with HIV and Tuberculosis on Antiretroviral Therapy. 2:653 doi:10.4172/scientificreports.653
• Jadhav SK (2018) An Overview: Laboratory Safety and work Practices in Infectious Disease Research. J HIV Clin Sci Res 5(1): 001-006.DOI: http://doi.org/10.17352/2455-3786.000126.
• S K Jadhav, S M Velhal, A Deshpande and AH Bandivdekar “Analysis of HIV Variants in blood and semen in serodiscordants by Heteroduplex mobility assay” Abstract from Ninth International Congress on Drug Therapy in HIV Infection. Glasgow, UK. 9–13 November 2008, Published: 10 November 2008. Journal of the International AIDS Society, 2008, 11 (Suppl 1):P211,
• Shivaji K Jadhav, S M Velhal, Alaka Deshpande, A H Bandivdekar. Molecular Characterization of HIV Variants in Urogenital secretions of HIV positive individuals and its Association with Sexual Transmission of HIV.AIDS Research and Human Retroviruses, October 2010, 26(10): A-1-A-184. hp://www.liebertonline.com/aid
• Shivaji K Jadhav, Alaka Deshpande and Atmaram H Bandivdekar. A7, Possible Transmission of HIV Infection Due to Human Bite. JAIDS, Journal of Acquired Immune Deficiency Syndromes. 59():71, April 2012.doi: 10.1097/01.qai.0000413786.74706.57
• Ashwani Kumar, Rajeshwari Hosmani, Shivaji Jadhav, Trelita de Sousa, Ajeet Mohanty, Milind Naik, Adarsh Shettigar, Satyajit Kale, Neena Valecha, Laura Chery, and Pradipsinh Rathod. Anopheles subpictus carry human malaria parasites in an urban area of western India and may facilitate perennial malaria transmission. Malar J. 2016 Feb 27;15(1):124. Malaria Journal, (Impact factor 3.2)
• Anopheles Subpictus , A New dominant malaria vector in an urban area of western India. Ashwani Kumar, Praveen Balabaskaran Nina, Ajeet Mohanty , Rajeshwari Hosmani , Shivaji Jadhav , Satyajit Kale , Anjali Mascarenhas , Edwin Gomes , Neena Valecha , Laura Chery ,Pradipsinh Rathod. Presented at 65th ASTMH-2016-Annual-Meeting- November 13–17, 2016 Atlanta, Georgia USA. Abstract No-1664.

Shrabanti Chowdhury, PhD

Department of Genetics and Genomic Sciences Icahn Institute for Genomics and Multiscale Biology New York, NY 10128, USA
Dr. Shrabanti Chowdhury currently a Postdoctoral research fellow at Icahn School of Medicine at Mount Sinai (ISMMS), NY, USA, working under the supervision of Dr. Pei Wang. Prior to joining ISMMS, She worked as a Postdoc fellow at Wayne State University School of Medicine for a year and a half. She had received her PhD in 2016 from University of California Riverside (UCR) (2011-2016). I worked on the design of factorial experiments under the supervision of Dr. Subir Ghosh in my PhD dissertation. She earned my Masters degree in Statistics from a renowned institute in India: Indian Institute of Technology Kanpur (IITK) in 2011.

For her academic excellence, She has received several awards including Dean's distinguished fellowship award (UCR), D.V. Gokhale international grant in Statistics (UCR), Academic excellence award (IITK) and several travel awards for attending international workshops and conferences. I have been invited several times at renowned conferences for presenting my research work. She has also organized a conference session in the world-famous Statistical conference JSM (Joint Statistical Meeting).

She currently holds editorial board member for the journal "Biostatistics and Epidemiology International Journal" and have referred (review responsibility) research papers for journals (Plos One, Pharmaceutical Statistics, Statistics and Probability Letters, Computational Statistics and Data Analysis, Journal of Probability and Statistics).
Her research interest lies broadly in developing novel statistical methodologies with application in biomedical sciences. Currently, she conducting research on integrative proteogenomics analysis leading to cancer biomarkers discovery, funded by NIH/NCI grant in the lab of Dr. Pei Wang at Icahn School of Medicine at Mount Sinai. Primarily my research focuses on imputation of omics data by iterative prediction model, network learning for proteomics data using probability graphical models. She did a few collaborative works on cluster randomized trials using application from HIV risks among Bahamian children and adolescents. Also, she worked on another collaboration on Innovative Designs for Biobehavioral Research in Adolescent HIV. Other areas of Statistics/Biostatistics she interested in include but not limited to: adaptive design including SMART designs, personalized medicine (dynamic treatment regime), Bayesian non parametric modeling and high dimensional variable selection for zero inflated count outcome models.
Recipient of International Indian Statistical Association (IISA) Travel Award (2018).
Recipient of Patient-Centered Outcome Research Institute (PCORI) Trainee Scholarship Award (2016).
Recipient of D.V. Gokhale Travel Grant (2015).
Recipient of prestigious Dean's Distinguished Fellowship Award, University of California,
Riverside. (2011-2012).
Recipient of N. Balakrishnan Award and Academic excellence Award, Indian Institute of
Technology Kanpur, India (2010).
Recipient of Sangheeta Pradhan Memorial Award, Indian Institute of Technology Kanpur, India
(2010).
F Chowdhury, Shrabanti, Chatterjee, Saptarshi, Mallick, Himel, Banerjee, Prithish, Garai, Broti. Group Regularization for Zero-inated Count Regression Models with an Application to Insurance Ratemaking (Journal of Applied tatistics(2018)).
F Chowdhury, Shrabanti, Tiwari, Ram C. and Ghosh, Samiran. Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio (Statistics in Biopharma-ceutical Research(2018)).
F Chowdhury, Shrabanti, Tiwari, Ram C. and Ghosh, Samiran. Approaches for testing non-inferiority in two-arm trials for Risk Ratio and Odds Ratio (Journal of Biopharmaceutical Statistics(2018)).
F Chowdhury, Shrabanti, Tiwari, Ram C. and Ghosh, Samiran. Non-inferiority Testing for Risk Ratio, Odds Ratio and Number Needed to Treat in Three-arm Trial (Computational Statistics and data Analysis(2018)).
F Chatterjee, Saptarshi, Chowdhury, Shrabanti, Mallick, Himel, Banerjee, Prithish, Garai, Broti. Group Regularization for Zero-inated Count Regression Models with an Application to Healthcare Demand in Germany (Statistics in Medicine(2018)).
F Banerjee, Prithish, Garai, Broti, Mallick, Himel, Chowdhury, Shrabanti, Chatterjee, Saptarshi. Group Regularization for Zero-inated Count Regression Models with an Application to Insurance Ratemaking (Journal of Probability and Statistics(2018)).
F Ghosh, Subir and Chowdhury, Shrabanti. CV, ECV, and Robust CV designs for replications under a class of linear models for factorial experiments (Journal of Statistical Planning and Inference(2017)).
F Chatterjee, Saptarshi, Chowdhury, Shrabanti and Basu, Sanjib. Tests for Association Using Cut Point Based Categorization of Prognostic Variables (Submitted in Biometrics).
F Clark, David et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma (Submitted in Cell)
F Naar, Sylvie and others. Innovative Designs for Biobehavioral Research in Adolescent HIV (Submitted in AIDS and Behavior).
F Chowdhury, Shrabanti, Lukemire, Joshua and Mandal, Abhyudyay. A-Com Var: A Flexible Ex-tension of Common Variance Designs (Submitted in Journal of Statistical Theory and Practice).
F Ma, Weiping, Kim, Sunkyu, Chowdhury, Shrabanti and others. Novel Imputation Strategy of Proteomics Data: DreamAI (Near Submission).
F Tignor, Nicole, Ma, Weiping, Chowdhury, Shrabanti and others. Objective Measurement of Activity and Sleep in an Observational study of a chronic disease using HealthKit and ResearchKit: The Asthma Mobile Health Study (Near Submission).
F Chowdhury, Shrabanti, Wang, Bo and Heo, Moonseong. Statistical power and sample size re-quirements to detect an intervention by time interaction in four level longitudinal cluster randomized trial (Near Submission).
F Chatterjee, Suvo, Chowdhury, Shrabanti and Ryu, Duchwan. Locale-Dependent Bayesian Smoothing Splines with Dynamically Weighted Particle Filter (In progress).
Join as a Editor